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Abstract 
Chronic obstructive pulmonary disease (COPD) patients are generally more sedentary and 
less physically active than healthy adults; putting them at increased risk of hospitalisation and 
death. For patients with mild-moderate COPD, physical activity appears to be reduced 
compared with apparently healthy adults but differences in time spent sedentary are less well 
established. Additionally, there is a need for a greater understanding of the correlates of 
behaviour in mild-moderate patients with much of the existing literature focusing on more 
severe or mixed stage patient samples and with many studies lacking objective behavioural 
monitoring, not adjusting for confounders and a paucity of data on correlates of sedentary 
time. Despite having mild-moderate airflow obstruction, these patients also report a range of 
symptom burdens with some individuals reporting severe symptoms. Subsequently, these 
patients represent a sub-set of individuals who may require lifestyle interventions. Therefore, 
factors associated with patients reporting more severe symptoms need to be identified to help 
understand how this phenomenon may manifest and be intervened upon. For patients with 
more advanced COPD who are admitted to hospital for an acute exacerbation behavioural 
intervention focussing on less intense movement may be a more suitable approach for 
reducing the risk of readmissions than more intense physical activity or exercise. To date no 
studies have specifically targeted reductions in sedentary behaviour in COPD. In addition, 
wearable self-monitoring technology may facilitate the provision of such interventions, 
removing important participation barriers such as travel and cost, but this has not been 
sufficiently examined in COPD. 
This thesis investigated: (i) objectively measured physical activity and sedentary time and the 
correlates of these behaviours for mild-moderate COPD patients and apparently healthy 
adults (Study One); (ii) factors associated with self-reported symptom severity and 
exacerbation history in mild-moderate COPD patients (Study Two) and (iii) the feasibility 
and acceptability of a home-based sedentary behaviour intervention using wearable self-
monitoring technology for COPD patients following an acute exacerbation (Study Three). 
Methods: Study One: COPD patients were recruited from general practitioners and 
apparently healthy adults from community advertisements. Objectively measured moderate-
to-vigorous physical activity (MVPA), light activity and sedentary time for 109 mild-
moderate COPD patients and 135 apparently healthy adults were obtained by wrist-worn 
accelerometry. Patients with at least four valid days (≥10 waking hours) out of a possible 
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seven were included in analysis. A range of demographic, social, symptom-based, general 
health and physical factors were examined in relation to physical activity and sedentary time 
using correlations and linear regressions controlling for confounders (age, gender, smoking 
status, employment status and accelerometer waking wear time). Study Two: In 107 patients 
recruited from general practitioners, symptoms were assessed using the COPD Assessment 
Test (CAT) and Modified Medical Research Council (mMRC) questionnaires. Twelve-month 
exacerbation history was self-reported. Exercise capacity was assessed via incremental 
shuttle walk test (ISWT) and self-reported usual walking speed. Physical activity and 
sedentary time were obtained from a wrist-worn accelerometer. Study Three: Patients were 
randomised in-hospital into a usual care (Control), Education or Education + Feedback group 
with the intervention lasting 14 days following discharge. The intervention groups received 
information about reducing prolonged sitting. The Education + Feedback group also received 
real-time feedback on their sitting time, number of stand-ups and step count at home through 
an inclinometer linked to a smart device app. The inclinometer also provided vibration 
prompts to encourage movement when the wearer had been sedentary for too long. Feasibility 
of recruitment (e.g. uptake and retention) and intervention delivery (e.g. fidelity) were 
assessed. Acceptability of the intervention technology (e.g. wear compliance, app usage and 
response to vibration prompts) was also examined. 
Results: Study One: COPD patients were more sedentary (592±90 versus 514±93 minutes 
per day, p<0.05) and accrued less MVPA (12±18 versus 33±32 minutes per day, p<0.05) than 
apparently healthy adults. For COPD patients, self-reported dyspnea and percentage body fat 
were independent correlates of sedentary time and light activity with exercise capacity 
(incremental shuttle walk test) an independent correlate of MVPA. For apparently healthy 
adults, percentage body fat and exercise capacity were independent correlates of sedentary 
time and light activity. Percentage body fat was an independent correlate of MVPA. Study 
Two: ISWT (B=-0.016±0.005, partial R2=0.117, p=0.004) and years living with COPD 
(B=0.319±0.122, R2=0.071, p=0.011) were independently associated with CAT score. ISWT 
(B=-0.002±0.001, R2=0.123, p<0.001) and vector magnitude counts per minute (VMCPM) 
(B=0.0001±0.0000, R2=0.050, p=0.011) were independently associated with mMRC grade. 
MVPA was independently associated with previous exacerbations (B=-0.034±0.012, 
R2=0.081, p=0.005). Patients reporting a CAT score of >20 or an mMRC score of ≥2 had 
lower VMCPM, were more sedentary and took part in less light activity than patients 
reporting a CAT score of 0-10 or mMRC of 0, respectively. Patients reporting ≥2 
iv 
 
exacerbations took part in less MVPA than patients reporting zero exacerbations. Study 
Three: Study uptake was 31.5% providing a final sample of 33 COPD patients. Retention of 
patients at two-week follow-up was 51.5% (n=17). Reasons for drop-out were mostly related 
to being unable to cope with their COPD.  Patients wore the inclinometer for 11.8±2.3 days 
(and charged it 8.4±3.9 times) with at least one vibration prompt occurring on 9.0±3.4 days 
over the 14 day study period. Overall, 325 vibration prompts occurred with patients 
responding 106 times (32.6%). 40.6% of responses occurred within 5 minutes of the prompt 
with patients spending 1.4±0.8 minutes standing and 0.4±0.3 minutes walking, taking 
21.2±11.0 steps.  
Discussion: Study One: COPD patients were less active and more sedentary than apparently 
healthy adults; however, factors predicting behaviour were similar between groups. 
Correlates differed between sedentary time, light activity and MVPA for both groups. 
Interventions to boost physical activity levels and reduce sedentary time should be offered to 
patients with mild-moderate COPD, particularly those reporting more severe breathlessness. 
Study Two: Worse exercise capacity, low levels of physical activity and more time spent 
sedentary are some of the factors associated with patients of the same severity of airflow 
limitation reporting differing symptom severities. These patients may benefit from both 
lifestyle and exercise interventions. Study Three: Recruitment and retention rates suggest a 
trial targeting sedentary behaviour in hospitalised COPD patients is feasible. A revised 
intervention, building on the successful components of the present feasibility study is 
justified. 
Conclusion: The findings from this thesis have contributed a greater understanding of 
physical activity and sedentary behaviour in COPD and can inform the development of 
tailored physical activity and sedentary behaviour interventions for patients across the grades 
of COPD severity. 
Keywords: accelerometry, behaviour, breathlessness, COPD-SEAT, exacerbations, 
PhARaoH Study, symptoms 
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Chapter 1: Introduction and literature review 
1.1 Introduction 
Following the industrial revolution, the requirement of individuals to be physically active at 
work, in the home, for travel and for recreation has markedly reduced, resulting in a global 
pandemic of physical inactivity (Lee et al., 2012). Globally, physical inactivity has been 
estimated to cost healthcare systems more than $53.8 billion with inactivity-related 
mortalities attributed to $13.7 billion losses in productivity and 13.4 million disability-
adjusted life-years (Ding et al., 2016). In the UK physical inactivity has been found to be 
responsible for 3% of disability-adjusted life-years; equating to over £1 billion in annual 
costs (Allender, Foster, Scarborough, & Rayner, 2007). The hypokinetic and obesogenic 
environments and norms of today’s society means that the vast majority of people are at risk 
of developing a range of illnesses including cardiovascular disease, hypertension and diabetes 
mellitus by not engaging in physical activity of sufficient intensity, duration and regularity. 
For example, less than 5% of adults in the UK and the US achieve government 
recommendations of moderate-to-vigorous physical activity (MVPA) per day (Craig, Mindell, 
& Hirani, 2009; Troiano et al., 2008). It is estimated that physical inactivity causes 9% of 
premature mortality worldwide; on par with other risk factors such as smoking and obesity 
(Lee et al., 2012). Additionally, 67% of older adults (≥60 years of age) spend more than 8.5 
hours per day sedentary (Harvey, Chastin, & Skelton, 2013). This pandemic of inactivity and 
sedentariness has led the Chief of Knowledge Officer of the National Health Service (NHS) 
to coin this lack of movement as “walking deficiency syndrome” and “excessive sitting 
syndrome”, calling walking the “elixir of life” (Gray, 2009).  
Chronic obstructive pulmonary disease (COPD) is a debilitating and progressive condition 
characterised by persistent airflow obstruction and breathlessness (Global Initiative for 
Chronic Obstructive Lung Disease., 2014). Whilst COPD primarily affects the respiratory 
system, it also has significant negative impacts on extra-pulmonary outcomes such as weight 
loss and muscle wasting (Shrikrishna & Hopkinson, 2012). Together, these abnormalities 
limit ventilation whilst enhancing the ventilatory requirement during physical activity; 
contributing to severe breathlessness and fatigue (Troosters et al., 2013). Consequently, 
engaging in more intense physical activity such as exercise can become an unpleasant 
experience which many patients actively try to avoid (Troosters et al., 2013). This activity 
avoidance leads to a downward spiral of muscle deconditioning, reduced fitness and 
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increased breathlessness causing patients to become trapped in a vicious cycle of physical 
inactivity and increasing symptom severity (Cooper, 2009; Polkey & Moxham, 2006). 
Lower levels of physical activity increase patients’ risk of hospitalisation and premature 
mortality (Vaes et al., 2014). There is evidence that physical activity is reduced and more 
time is spent sedentary in COPD patients (Pitta et al., 2005) but there is little evidence 
examining sedentary behaviour in this population. Additionally, understanding the correlates 
of behaviour in mild-moderate COPD patients is required to inform tailored interventions. To 
date, much of the focus has been on examining factors related to physical activity in COPD, 
with a systematic review by Gimeno-Santos (Gimeno-Santos et al., 2014) revealing 
inconsistent associations with a range of socio-demographic, lifestyle, environmental, clinical 
and functional factors. The majority of studies included in this review did not adjust 
associations for potential confounders and only half of the 86 studies used an objective 
measure of physical activity (e.g. pedometer or accelerometer) (Gimeno-Santos et al., 2014). 
Moreover, only three (6.7%) studies specifically examined mild-moderate COPD patients. 
Being sedentary is an independent construct to that of being physically inactive and with the 
growing interest of its role in COPD (Hill, Gardiner, Cavalheri, Jenkins, & Healy, 2015) it 
seems pertinent to also explore its correlates. Despite this, there is a severe lack of evidence 
examining correlates of sedentary behaviour in COPD (Park et al., 2013). Moreover, there is 
a lack of comparison between behavioural correlates between COPD patients and apparently 
healthy adults; insights from which will determine the need for specific risk profiling and 
intervention designs. 
Like many chronic diseases, COPD is heterogeneous with patients not only varying in the 
severity of physiological impairment (airway obstruction) but also the magnitude of 
symptoms and subsequent impact on their quality of life (Jones, Adamek, Nadeau, & Banik, 
2013). With this comes an interesting construct whereby patients with the same physiological 
progression of COPD report very different symptom burden and impact on their daily life. 
Reasons for this discordance between disease progression and symptom severity are likely 
multifaceted but evidence is lacking on what factors contribute to this observation. One 
possible contributor to this phenomenon may be patients’ levels of physical activity and 
sedentary behaviour; relating to whether patients have started their journey (or how far along 
they are) on the downward spiral of physical inactivity (Cooper, 2009; Polkey & Moxham, 
2006). Patients in the earlier stages of COPD progression (mild-moderate airway obstruction) 
who report significant burden from their symptoms comprise a particularly noteworthy group 
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who may benefit from significant risk reductions for premature death and hospitalisation 
from taking part in behavioural interventions (Lange et al., 2012). 
For patients with more severe airway obstruction, physical activity and sedentary behaviour 
can also play an important role in COPD. Patients with advanced COPD are at high risk of 
hospitalisation as a result of severe breathlessness (Garcia-Aymerich et al., 2011). When 
patients return home from hospital, they are not yet fully recovered and their physical activity 
is significantly lower than pre-hospital levels, putting them at increased risk of readmission 
(Pitta et al., 2006). Pulmonary rehabilitation is currently offered to patients admitted to 
hospital but for the minority who take part this does not come until at least four weeks after 
discharge (Steiner, Holzhauer-Barrie, Lowe, Searle, Skipper, Welham, & Roberts, 2015a). 
Therefore, interventions promoting the engagement of physical activity are needed earlier to 
supplement the established benefits of rehabilitation (Spruit et al., 2013). Interventions 
immediately after discharge have been largely focussed around rehabilitation/exercise with 
mixed results (Eaton et al., 2009; Greening et al., 2014; Puhan et al., 2012). Little is known as 
to the feasibility and acceptability of alternative approaches targeting lifestyle; specifically 
reductions in sedentary behaviour which may be perceived by patients as more suitable or 
achievable compared with exercise.  
The purpose of Study One was to assess the behavioural profiles of mild-moderate COPD 
patients and identify the correlates of objectively measured physical activity and sedentary 
time all in comparison to apparently heathy adults. Study Two aimed to identify factors 
associated with self-reported symptom severities in patients with similar airway obstruction 
(mild-moderate) using an array of clinical, functional, psycho-social, behavioural and 
demographic factors. Study Three was a feasibility trial to reduce prolonged periods of 
sedentary behaviour in COPD patients at home upon discharge following an acute 
exacerbation. The intervention used wearable self-monitoring technology to provide real-time 
feedback to patients on their time spent sitting, number of sit-to-stand transitions and step 
count. Patients were also provided with a vibration prompt when they had been sedentary for 
too long. The study examines the feasibility of the trial design, recruitment, adherence and 
procedures and the acceptability of the intervention among patients receiving the intervention. 
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1.2 Literature review 
1.2.1 Background to COPD 
Definition and causes of COPD 
COPD is a common, preventable and treatable disease, characterised by persistent airflow 
limitation that is usually progressive and associated with an enhanced chronic inflammatory 
response in the airways and the lung to noxious particles or gases (Global Initiative for 
Chronic Obstructive Lung Disease., 2014). The chronic airflow limitation which 
characterises COPD manifests as a combination of obstructive bronchiolitis and emphysema; 
with the relative contribution of each varying between individuals (Global Initiative for 
Chronic Obstructive Lung Disease., 2014). COPD is the result of cumulative exposures to 
noxious gases and/or chemicals over a number of years. Most often, COPD prevalence 
almost directly relates to the prevalence of tobacco smoking but in many countries, air 
pollution, from sources such as wood burning and other biomass fuels, is also a major risk 
factor (Salvi & Barnes, 2009).  
The characteristic symptoms of COPD are chronic and burgeoning breathlessness, cough, and 
sputum production; each with day-to-day variability (Kessler et al., 2011). Airflow limitation 
can develop after these symptoms as well as advance without the emergence of cough and 
sputum production. It is recommended that a clinical diagnosis of COPD should be 
considered in any individual who presents with breathlessness (dyspnea), chronic cough or 
sputum production, and a history of exposure to risk factors such as tobacco smoke, 
occupational dusts or chemicals (Global Initiative for Chronic Obstructive Lung Disease., 
2014). Spirometry is required to make the diagnosis (Zwar et al., 2011) with the presence of 
post-bronchodilator forced expiratory volume in one second/forced vital capacity (FEV1/FVC) 
ratio <0.70 confirming the presence of chronic airflow obstruction.  
Prevalence of COPD 
Increases in data quality control (e.g. systematic quality control criteria for spirometry) within 
large scale studies (e.g. (Menezes et al., 2005); (Buist et al., 2007)) have enabled some 
conclusions to be drawn regarding COPD prevalence (Global Initiative for Chronic 
Obstructive Lung Disease., 2014). A systematic review and meta-analysis of studies across 
28 countries found the overall prevalence of COPD in adults aged ≥40 years was 9-10% 
(Halbert et al., 2006). In the UK it has been estimated that 835,000 people are diagnosed with 
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COPD and an estimated 2.2 million individuals have undiagnosed COPD; equivalent to 13% 
of the population of England aged 35 and over (Shahab, Jarvis, Britton, & West, 2006). 
Consequently, health campaigns have been launched in the UK to identify those ‘missing 
millions’ (Falzon, Soljak, Elkin, Blake, & Hopkinson, 2013).  
COPD morbidity and mortality 
It is important to recognise the complex nature of COPD progression which can be 
characterised by both patient experiences (e.g. psychological wellbeing and ability to perform 
daily tasks) and clinical outcomes (e.g. hospitalisations and death) (Rothman et al., 2009). 
Whilst all patients with COPD suffer from chronic airway obstruction, the impact of COPD 
on symptom perception, activity avoidance and overall quality of life can vary considerable 
between people. 
Measures of morbidity or disease progression for COPD typically include number of 
physician visits, emergency department visits, and hospitalisations (Global Initiative for 
Chronic Obstructive Lung Disease., 2014). Morbidity from COPD can be worsened by other 
conditions such as cardiovascular disease and diabetes mellitus which may impact patients’ 
health and provide additional burdens to existing COPD management (Global Initiative for 
Chronic Obstructive Lung Disease., 2014). COPD has been estimated to account for 
approximately one-quarter of all General Practitioner consultations and 2.8 million bed days 
per year (Respiratory Alliance, Jan 2003). 
The under-recognition of COPD as a primary cause of mortality on death certificates and the 
challenge of under-diagnosis remain important hurdles to overcome in order to accurately 
establish mortality data (Tálamo et al., 2007). COPD has been found to be more likely to be 
listed as a contributing factor to death even when it is the primary cause (Jensen, Godtfredsen, 
Lange, & Vestbo, 2006). Despite this, COPD is now estimated to be the third leading cause 
of death worldwide (Lozano et al., 2013); representing an important public health challenge 
that is both preventable and manageable. COPD is the fifth biggest killer disease in the UK 
causing approximately 25,000 deaths a year in England and Wales (National Statistics, 2008). 
Unfortunately, the global burden of COPD is projected to increase during the coming decades 
due to increasing exposure to COPD risk factors (e.g. smoking exposures) in combination 
with an ageing population and reduced mortality from other conditions (e.g. infectious 
diseases) (Lopez et al., 2006).  
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Economic burden of COPD 
In the European Union, direct costs from respiratory disease are estimated to be around 6% of 
the total healthcare budget, with COPD accountable for 56% (€38.6 billion) of this 
respiratory disease cost (Loddenkemper, 2003). COPD exacerbations constitute the greatest 
proportion of the total COPD burden on healthcare systems. Concomitantly, there is a strong 
direct relationship between COPD severity and the cost of care with hospitalisation and 
ambulatory oxygen costs mounting with disease progression (Global Initiative for Chronic 
Obstructive Lung Disease., 2014). Moreover, these estimates fail to incorporate the economic 
value of the care provided to COPD patients by their family and friends. Because healthcare 
systems are unlikely to provide long term supportive care, COPD may not only force the 
patient to leave the workplace, but also a family member to provide homecare. Particularly 
for developing countries where human capital is generally the most important asset, the 
indirect costs of COPD may represent a serious threat to their economies (Global Initiative 
for Chronic Obstructive Lung Disease., 2014).  
1.2.2 Terminology: Sedentary behaviour, Physical Activity and Exercise 
Physical activity definition 
Physical activity is a complex and multidimensional construct (LaPorte, Montoye, & 
Caspersen, 1985) and is typically defined from a physiological perspective as “any bodily 
movement produced by skeletal muscle which results in caloric expenditure” (Caspersen, 
Powell, & Christenson, 1985). All human movement can be sub-divided into frequency (e.g. 
per hour, per day); intensity (e.g. light, moderate, vigorous); duration (e.g. seconds, minutes); 
mode (e.g. walking, running); and context (e.g. transportation, leisure-time) (Haskell, 2001; 
Montoye, 2000). It is perhaps the complexity of defining physical activity that has resulted in 
the misnomer of “exercise”. The importance of distinguishing these terms is pivotal to our 
understanding of how individuals behave and therefore how best we can help them to 
improve activity behaviours. Most notably the terms exercise and moderate-to-vigorous 
physical activity (MVPA) are often used interchangeably. MVPA is typically classified as at 
least three metabolic equivalents (METS), with one MET equivalent to resting metabolic rate 
(approximately 3.5ml/O2/kg/min) (Jette, Sidney, & Blumchen, 1990). However, exercise is a 
subset of physical activity which is planned, structured, repetitive and purposeful to 
improving or maintaining one or more components of physical fitness (Caspersen et al., 
1985). Whilst some exercise is likely to meet the intensity threshold for MVPA, not all 
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MVPA can be assumed to be exercise (or vice versa). For example, active transport such as 
cycling to work or running for the bus may also meet the threshold of MVPA but would not 
be considered exercise. 
Physical inactivity versus sedentary 
A similar misconstruction has been widely presented as the lower end of movement 
continuum, between physical inactivity and sedentary behaviour. Physical inactivity is a lack 
of sufficient physical activity (Hamilton, Healy, Dunstan, Zderic, & Owen, 2008) i.e. a level 
of MVPA not sufficient to meet physical activity guidelines (Davies, Burns, Jewell, & 
McBride, 2011). Sedentary behaviour, however, is not a lack of sufficient activity but a 
distinct construct defined not only by energy expenditure or intensity but also by posture. It is 
defined as any waking activity characterized by an energy expenditure ≤1.5 METS and a 
sitting or reclining posture (Sedentary Behaviour Research, 2012). Consequently, physical 
(in)activity and sedentary behaviour should be considered as independent but interacting 
constructs both of which require specialised assessment and interpretation. 
Active couch potato: putting the definitions in context 
The constructs of physical activity and sedentary behaviour are not mutually exclusive. An 
individual can have high or low levels of MVPA in combination with high or low levels of 
sedentary behaviour (Marschollek, 2013). Therefore, it is possible for someone to be 
considered sufficiently physically active (meeting or exceeding guidelines) whilst accruing 
high amounts of sedentary time e.g. an office worker who goes for a run in the morning 
before work but then sits at a desk for most of the working day. Conversely, a person may not 
undertake a lot of MVPA but, at the same time, may not spend a large amount of time 
sedentary e.g. a waiter/waitress who is on their feet for long periods (low levels of 
sedentariness) but does not meet MVPA recommendations. 
1.2.3 Measurement of physical activity and sedentary behaviour 
Overview 
The measurement of human movement comprises two constructs: the behaviour (physical 
activity, sedentary behaviour) and the physiological consequence of the behaviour (energy 
expenditure) (Lamonte & Ainsworth, 2001). The vast choices of how to measure these 
constructs faced by researchers vary in feasibility and accuracy (Figure 1.1). Assessments of 
free-living energy expenditure include calorimetry and doubly-labelled water. Tools for 
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measuring behaviour include direct observation, diaries, recall questionnaires, pedometers, 
accelerometers and inclinometers.  
 
Figure 1.1 Behaviour and energy expenditure measurement options according to accuracy 
and feasibility (dashed lines indicate recent advances in measurement), adapted from Esliger 
(Esliger, 2011). 
 
The following sections provide an overview of the methodological approaches for measuring 
physical activity and sedentary behaviour used in this thesis. The section relating to 
accelerometry is more detailed as it is primary method pertinent to this thesis. 
Self-report 
Self-report measures such as recall questionnaires, diaries, logs and surveys remain the most 
popular method for measuring physical activity levels (particularly in large samples) (Adamo, 
Prince, Tricco, Connor-Gorber, & Tremblay, 2009) due in part to low cost and minimal 
participant burden (Dishman, Washburn, & Schoeller, 2001). However, there are significant 
limitations to self-report approaches which cannot be overlooked. It is reported that up to 15% 
of adults in the UK are illiterate, with that proportion increasing in elderly populations (Wolf, 
Gazmararian, & Baker, 2005). Therefore, many individuals may struggle to comprehend 
questions using more complex language or formatting. Consequently, individuals may ask a 
friend or relative for assistance, introducing significant bias and inaccuracy. Regardless, self-
report measures are open to social desirability bias, with individuals found to greatly over-
report levels of physical activity and underestimate time spent sedentary (Adamo et al., 2009). 
For example, the proportion of US adults found to meet activity guidelines was 62.0% based 
on self-report and 9.6% for accelerometry (Tucker, Welk, & Beyler, 2011). Similarly, COPD 
patients have been found to overestimate time spent walking (Pitta, Troosters, Spruit, 
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Decramer, & Gosselink, 2005). Furthermore, the lack of a conceptual framework 
underpinning self-reported measures of activity in COPD is an important limitation (Frei et 
al., 2011; E. Gimeno-Santos et al., 2011). Whilst the absolute numbers obtained from self-
report measures may be subject to bias and recall inaccuracies, they can provide useful 
insight into the context of behaviours e.g. location and type. For example, TV viewing is a 
highly prevalent sedentary pursuit which has been linked to numerous deleterious health 
effects (Dunstan et al., 2005; Williams, Raynor, & Ciccolo, 2008). By examining not only the 
amount but also type of activities (both active and sedentary) a greater understanding of how 
best to intervene can be gleaned. For example, the PROactive project aims to develop patient 
reported outcome tools to understand the behavioural adaptation of patients with COPD 
through the detection of clinically relevant changes in physical activity and symptoms in a 
way that is easily understood by patients and healthcare providers alike (Gimeno-Santos et al., 
2015).  
Inclinometers 
Inclinometers, or posture sensors, are able to detect the posture of the wearer through in-built 
algorithms (i.e. lying down, sitting, standing, or stepping). These devices have been purpose 
built to measure sedentary behaviour but many also provide valid measures of step counts in 
adults (Dahlgren, Carlsson, Moorhead, Häger-Ross, & McDonough, 2010; Grant, Dall, 
Mitchell, & Granat, 2008). Unlike many other monitors, these devices are typically worn in 
contact with the skin to remove extraneous factors such as loose clothing which will 
contaminate posture allocation. Although this approach improves the accuracy of sedentary 
behaviour measurement, it can result in compliance issues due to reactions to adhesive pads 
for thigh-worn sensors and the absorption of sweat into straps for inclinometers worn around 
the lower back. Despite the emergence of sedentary behaviour as an independent risk factor 
for developing chronic diseases (Healy et al., 2007; Healy et al., 2008), there are fewer 
devices available for researchers compared with physical activity monitors. The ActivPAL is 
the most commonly used inclinometer in behavioural research, worn on the thigh and a well-
established valid measure of sedentary behaviour (Kozey-Keadle, Libertine, Lyden, 
Staudenmayer, & Freedson, 2011). However, placement on the thigh requires adhesive pads 
to be attached to the skin. Therefore, this approach could be considered intrusive and the 
adhesive pads can be painful to remove and can induce skin irritation (e.g. rashes) (Mutrie et 
al., 2012). Additionally, there are a lack of inclinometers that have the capability to provide 
real-time feedback to the wearer; with most monitors only providing information or prompts 
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based on periods of inactivity (Sanders et al., 2016). Of the identified inclinometers, a 
commercial device called a LUMO was found to offer the highest number of feedback 
attributes, including immediate information on sitting time and stand-ups as well as posture-
specific vibration prompts (Sanders et al., 2016). This device has been validated as a measure 
of both sedentary behaviour (Rosenberger, Buman, Haskell, McConnell, & Carstensen, 2016) 
and walking (Kooiman et al., 2015). With time, developments in both the research and 
commercial sectors will increase the options for posture sensing for researchers. 
Accelerometers 
For many years accelerometry has been a popular method for free-living assessment of 
physical activity with accelerometers now commonplace in large-scale observational studies 
such the National Health and Nutrition Examination Survey (Troiano et al., 2008), Health 
Survey for England (Craig et al., 2009) and more recently a sub-sample of the UK Biobank 
comprising ~100,000 participants (Allen et al., 2012). Accelerometers are now at the 
forefront of physical activity measurement in COPD, with extensive validation work 
concluding that triaxial and multisensory devices are the most accurate for quantifying 
movement in COPD patients (Rabinovich et al., 2013; Van Remoortel et al., 2012). Although 
advancements in accelerometry have allowed this technology to become a key player in 
understanding health and behaviour, there are many options for researchers which can make 
it difficult to choose the best device and/or model for a given research task.  
Accelerometers are most often worn on the waist, hip, wrist or lower limbs and contain a 
piezoelectric crystal spring-loaded with a test mass in contact with the crystal. When 
acceleration occurs, the force applied to the crystal generates a voltage equivalent to the 
acceleration produced. Accelerometers can measure movement in one (uniaxial), two (biaxial) 
or three (triaxial) planes or combine the three axes to provide vector magnitude (Equation 
1.1). Low and high pass frequency filtering are used to remove accelerations outside the 
range of plausible human movement (0-60 m/s2 with a frequency response less than 10Hz) 
(Welk, 2002).  
Equation 1.1: 𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑉𝑉𝑚𝑚𝑚𝑚𝑉𝑉 =  �𝑥𝑥2 + 𝑦𝑦2 + 𝑧𝑧2 
Accelerometers are generally set up to collect raw acceleration data at 30-100 Hz but this 
data is usually integrated upwards to epoch level data (e.g. every 60 seconds); resulting in 
arbitrary units called activity counts (Figure 1.2). These counts are then used as an objective 
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assessment of movement intensity with high count values corresponding to greater intensity. 
It is important to note that these count values are proprietary and manufacturer-specific thus 
only allow comparisons with data from similar models.  
 
Figure 1.2 Concept of how raw data (Hz) from an accelerometer is summed to epoch data 
(e.g. 5, 15, 30 or 60-s) in the form of counts, adapted from Esliger (Esliger, 2011). The 
symbol ‘Hz’ corresponds to 60 raw data points per second. 
 
In order to facilitate interpretation of these activity counts, calibration studies have converted 
count data using METS. For adults, light, moderate and vigorous intensity movement is most 
often classified as 1.50-2.99 METS, 3.00-5.99 METS and ≥6.00 METS, respectively. For 
these MET ranges, corresponding cut-points have been derived from prediction equations 
(Freedson, Melanson, & Sirard, 1998) or receiver operator curves (Jago, Zakeri, Baranowski, 
& Watson, 2007). The use of accelerometric data are complicated by the derivation of 
multiple cut-points each of which produce different results within the same data (Orme et al., 
2014; Strath, Bassett Jr, & Swartz, 2003). Additionally, the decision of which epoch to 
analyse data in (e.g. 15 versus 60 seconds) has an independent contribution to physical 
activity results (Orme et al., 2014). Despite these limitations, categorising physical activity 
(light, moderate, vigorous) per epoch allows the easy calculation of time spent being 
physically active; arguably the most important variable for health research (Welk, 2002).  
Although inclinometers directly measure posture to determine whether the wearer is in 
sedentary behaviour (sitting or reclining), there has been work to assess sedentary time using 
accelerometry. The term sedentary time rather than behaviour should be used when reporting 
accelerometry-derived outcomes due to the lack of postural insight. Similar to the derivation 
of physical activity cut-points, sedentary equivalents have been produced, corresponding to 
<1.5 METS. With increasing recognition of the importance of capturing the 24-hour day 
(Chaput, Carson, Gray, & Tremblay, 2014) the objective quantification of sleep has come to 
the forefront of the behaviour quantification paradigm.  
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Within the 24-hour period movement takes place across the intensity spectrum from sleep to 
vigorous physical activity (Figure 1.3) all of which have important health implications 
(Schuit, van Loon, A Jeanne M, Tijhuis, & Ocké, 2002). Wrist-worn accelerometry has 
recently come to the forefront of physical activity monitoring. This emergence is, in part, due 
to the surge in commercially available devices, with 69% of US adults tracking their 
behaviour (Fox & Duggan, 2013). Most commercial devices are worn on the wrist; in 
keeping with user preference (Alley et al., 2014). One of the greatest benefits of placing 
activity monitors on the wrist is the comfort and convenience for wearers, so much so that 
they can be worn 24 hours a day (i.e. during both waking and sleeping hours). Inspired from 
the commercial sector, research-grade accelerometers have now started to move monitors 
from the waist to the wrist. Consequently, wear compliance (the extent to which people wear 
a device) is significantly improved (van Hees et al., 2011) which subsequently opens up new 
analytical opportunities such as the sedentary sphere (Rowlands et al., 2016). The movement 
towards placing accelerometers on the wrist has gained significant momentum and has now 
been incorporated into two large epidemiological studies (Allen et al., 2012; Troiano et al., 
2008). By improving wear compliance, research studies may benefit from obtaining more 
representative data, less subject to bias (e.g. devices put on when going for a walk but taken 
off to watch television in the evening). The greater proportion of participants with ‘valid’ 
days will also improve statistical power. ‘Valid day’ is a term to indicate that an activity 
monitor was worn for enough time to be representative of the person’s day. This concept is 
important as between-day stability for each participant is needed to obtain a representative 
picture of their habitual activity, with more valid days equating to increased reliability. A 
wide range of valid day criteria have been used in COPD literature ranging from six hours to 
‘all data’ (Byrom & Rowe, 2016). Moreover, 47% of studies were found to not report valid 
day criteria (Byrom & Rowe, 2016). 
 
Figure 1.3 The movement continuum for 24-hour behaviour (Tremblay, Colley, Saunders, 
Healy, & Owen, 2010) 
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Traditionally, participants are asked to remove activity monitors for sleep, but even within 
24-hour protocols there may be other reasons why participants are asked to remove devices. 
For example, participants are typically asked to remove devices for water-based activities 
such as showers, baths and swimming to prevent damage to devices and potential loss of data. 
Additionally, participants may not want to wear devices during social events or might ‘want a 
break’ from wearing them. As a result, monitors may be removed and placed on a level 
surface (e.g. table), detecting a perfect lack of movement (equivalent to an activity count of 
zero). Regardless of the reason, it is important not to mistake these zeros for sedentary time. 
Therefore, purpose-built algorithms have been developed to identify biologically implausible 
runs of consecutive zeros e.g. 60 minutes (Troiano et al., 2008) or 90 minutes (Choi , Liu, 
Matthews, & Buchowski, 2011; Choi, Ward, Schnelle, & Buchowski, 2012). Not only is wear 
time important for signifying the representativeness of a person’s daily activity but it is an 
important covariate for statistical analysis. If a person wears an accelerometer longer than 
someone else, they will automatically accrue more time across the intensity spectrum. 
Importantly, converting the amount of time in a given intensity into a proportion of wear time 
does not permit direct comparisons between individuals. This is because having a longer wear 
time will have a greater impact of sedentary time than for physical activity (particularly 
MVPA) as this behaviour comprises the majority of most people’s waking day. Unfortunately, 
a recent systematic review found that 87% of studies examining physical activity in COPD 
did not report how a valid day was defined (Byrom & Rowe, 2016). Therefore, it cannot be 
assumed that these studies conducted quality assurance or quality control analyses on their 
data.  
In summary, there are a range of methods for quantifying human movement through energy 
expenditure assessment, posture sensing, accelerometry and self-report. Each approach brings 
with it varying strengths and weaknesses making it vital that researchers choose the technique 
most suitable for their research question. Issues such as cost, feasibility (e.g. free-living 
capabilities), participant burden and reactivity must be considered.  
1.2.4 Physical activity, sedentary behaviour and health outcomes 
Physical activity provides a vast array of health benefits and protects against a plethora of 
non-communicable diseases. Protective effects of physical activity against premature 
mortality, coronary heart disease, stroke, hypertension, type 2 diabetes, cancers of the breast 
and colon, depression, cognitive impairment, poor sleep, risk of hip fracture and osteoporosis 
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are established (Physical Activity Guidelines Advisory Committee, 2008). The relationship 
between the volume of physical activity performed and the size of the subsequent risk 
reduction for all-cause mortality has demonstrated an inverse, curvilinear relationship 
(Physical Activity Guidelines Advisory Committee, 2008) (Figure 1.4). Of note, there is no 
lower threshold for the health benefits of increasing one’s physical activity as mortality risk 
reduces with the first increase in activity beyond baseline behaviour. Therefore, the notion of 
‘something is better than nothing’ (Blair, Kohl, Gordon, & Paffenbarger Jr, 1992) may be a 
more suitable message than suggesting a particular threshold (e.g. public health guidelines). 
Importantly, the rate of risk reduction is more pronounced for those individuals who are less 
physically active to begin with. Given that most people reside in this region of the activity 
scale (Lee et al., 2012; Tucker et al., 2011) there is much benefit to be gleaned from helping 
the least active individuals to move more, regardless of whether this increase reaches a 
predetermined threshold such as MVPA.  
 
Figure 1.4 Risk of all-cause mortality by hours per week of MVPA (Powell, Paluch, & Blair, 
2011) 
Spending more time sitting or watching TV (a surrogate measure for leisure-time sedentary 
behaviour) has been linked to a greater risk of death from all-causes and developing 
cardiovascular disease and obesity after controlling for time spent engaging in MVPA (Healy 
et al., 2008; Katzmarzyk, Church, Craig, & Bouchard, 2009). In a recent review, time spent 
in prolonged sedentary behaviour has been found to be associated with an increased risk of 
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cardiovascular disease in a dose-response manner (Eijsvogels, George, & Thompson, 2016). 
In a cross-sectional analysis of 4757 adults, sedentary time was found to be detrimentally 
associated with waist circumference, high density lipoprotein-cholesterol, C-reactive protein, 
triglycerides, insulin, beta cell function and insulin sensitivity (Healy, Matthews, Dunstan, 
Winkler, & Owen, 2011). 
Indeed, replacing sedentary behaviour with light activity, even for just a single minute, is 
beneficial (Healy et al., 2008). In a sample of 168 Australian adults increased breaks in 
accelerometry-derived sedentary time was associated with lower waist circumference 
(B=0.16, p=0.026), BMI (B=0.19, p=0.026), triglycerides (B=0.18, p=0.029) and 2-hour 
plasma glucose (B=0.18, p=0.025), independent of total time spent sedentary and in MVPA 
(Healy et al., 2008). The association of breaks in sedentary time was also found in a large US 
cohort with increasing breaks associated with lower waist circumference and C-reactive 
protein (Healy et al., 2011). The sedentary behaviour profiles of two individuals with a 
different number of breaks in sedentary time as shown in Figure 1.5. Whilst these individuals 
share the same total time spent sedentary, the “prolonger” is at increased risk of 
cardiometabolic disease compared with the “breaker” who regularly breaks up their sedentary 
behaviour with physical activity (Dunstan, Healy, Sugiyama, & Owen, 2010). 
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Figure 1.5 Breaks in sedentary time: same amount of sedentary time, but different ways of 
accumulation. CPM = counts per minute (Dunstan et al., 2010) 
Not only do increased sedentary time and less frequent breaks in sedentary behaviour convey 
an increased risk of detrimental cardio-metabolic health but data from the Canada Fitness 
Surveys suggests prolonged sitting is related to an increased risk of premature death 
(Katzmarzyk et al., 2009). Additionally, in a prospective study of TV viewing as a marker of 
sedentary behaviour, each one-hour increase in time spent watching TV was associated with 
an 11% increased risk of all-cause mortality and an 18% increased risk of cardiovascular 
disease mortality (Dunstan et al., 2009). In a study of 7744 men followed-up over 21 years 
those who reported more than 10 hours a week sitting for transport had an 82% greater risk of 
dying from cardiovascular disease than those reporting less than four hours a week (Warren 
et al., 2010). (Dunstan et al., 2009). 
With the growing evidence and recognition of the importance of reducing time spent 
sedentary (particularly prolonged periods) and the benefits of replacing sedentary behaviour 
with physical activity of any intensity, it has been suggested that population 
recommendations should be re-conceptualised to account for this (Smith, Ekelund, & Hamer, 
2015). Additionally, it has been suggested that interventions may benefit from targeting 
increases in physical activity through incidental movement such as standing and light 
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activities (Smith et al., 2015). This may be particularly appropriate for behavioural 
interventions in the UK and other westernised countries where there are endless opportunities 
to be sedentary as a result of the abundance of labour-saving technologies, screen-time and 
environmental constraints which limit the need for people to move (Brownson, Boehmer, & 
Luke, 2005; Smith et al., 2015). Furthermore, targeting changes in behaviour at the lower end 
of the movement spectrum may be met with fewer barriers, including lower cognitive effort 
to increase light intensity activity which in turn produces a less noticeable physiological 
response (e.g. sweating or increased body temperature) and minimal cost (i.e. no specialist 
facilities, equipment or memberships compared with MVPA or exercise) (Smith et al., 2015).  
Increasing physical activity and reducing sedentary behaviour confer risk reductions for a 
range of chronic conditions. Individuals who are the least active have the most to gain from 
small increases in physical activity, regardless of the intensity at which it is performed. 
Replacing sedentary behaviour with light intensity activity should be encouraged but more 
intense movement leads to further improved health benefits. Targeting sedentary behaviour 
and light activity may act as a more palatable conduit for ultimately increasing MVPA. 
1.2.5 Physical Activity and Sedentary Behaviour in COPD 
Levels of physical activity and sedentariness in COPD 
Increasing overall levels of physical activity and reducing time spent in sedentary pursuits are 
important goals in COPD management. In order to accomplish this, it is vital to understand 
not only the levels, but also the patterns of these behaviours. Both physical activity and the 
accumulation of time sedentary are recognised as multi-faceted behaviours involving 
frequency, intensity (mostly for activity), time and type. By accurately and objectively 
profiling the nature in which these activities are performed, more appropriate interventions 
may be implemented.  
In a seminal study of 50 COPD patients (64±7 years, FEV1%pred 43±18) and 25 apparently 
healthy adults (66±5 years, FEV1%pred 111±20), Pitta and colleagues (Pitta et al., 2005) 
objectively assessed the differences in physical activity and sedentary behaviour between 
groups using the DynaPort activity monitor. Patients with COPD were found to have 
significantly reduced walking time (44 vs 81 min), standing time (191 vs 295 min) and 
movement intensity (1.8 vs 2.4 m/s2, all p<0.001) in comparison with apparently healthy 
adults (Pitta et al., 2005). Moreover, COPD patients spent more time in sitting and lying 
postures compared with apparently healthy adults (374 v 306 and 87 vs 29 min, respectively, 
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all p<0.05) (Pitta et al., 2005). In 30% of COPD patients, walking time did not reach the 
recommended 30 minutes of moderate intensity activity per day. Even for patients achieving 
this threshold, their walking intensity was, on average, 17% lower compared with that of 
apparently healthy adults (Pitta et al., 2005). Therefore, even the most active COPD patients 
are unlikely to walk at intensities sufficient to induce the benefits in the form of fitness 
maintenance.  
Donaire-Gonzalez and colleagues (Donaire-Gonzalez et al., 2015) showed that, in a sample 
of 177 COPD patients (94% male, 71±8 years), patients on average perform over half (57%) 
of their physical activity in bouts of at least 10 minutes. The observed median number of 
bouts was 4.4 and 2.6 for overall physical activity and MVPA, respectively, with a mean bout 
duration of approximately 20 minutes (Donaire-Gonzalez et al., 2015). However, patients 
with severe or very severe COPD perform physical activity in shorter bouts which are 
performed less frequently, resulting in significantly fewer steps and less time in physical 
activity compared with those with mild or moderate COPD (Donaire-Gonzalez et al., 2015). 
These findings suggest that targeting bouts of activity rather than activity as whole may be 
more appropriate for patients with more advanced COPD and patients at the milder end of 
disease progression may be better able to engage with more intense physical activity.  
Few studies have objectively examined sedentary behaviours through posture sensors (able to 
capture specific behaviours such as sitting, standing, stepping and lying down). A study by 
Kawagoshi and colleagues (Kawagoshi et al., 2013; Kawagoshi et al., 2015) investigated the 
postural changes of a small sample of COPD patients (n=26) and apparently healthy adults 
(n=20) using triaxial accelerometers positioned at the mid-thigh and trunk. Patients with 
COPD were found to have significantly reduced continuous walking time and total times of 
both slow walking (<2km/hour) and fast walking (≥2km/hour) (Kawagoshi et al., 2013). 
Furthermore, despite COPD patients having similar time spent standing compared with 
apparently healthy adults, patients spent more time sitting in total and had a longer average 
sedentary bout length (Kawagoshi et al., 2013). Consequently, COPD patients accumulated 
fewer daily breaks in sedentary time than apparently healthy adults (49 vs 84, respectively) 
(Kawagoshi et al., 2013). These findings have been corroborated by a systematic review of 
time usage of COPD patients (Hunt, Madigan, Williams, & Olds, 2014). COPD patients were 
found to spend more time in sedentary behaviours; have limited engagement in physical 
activities; have higher healthcare requirements (e.g. medical appointments); and experience 
difficulties performing activities of daily living (e.g. on average, showering 2.5 times per 
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week and preparing meals 4.7 times per week) (Hunt et al., 2014). These findings raise 
concerns about not only the inactive lifestyle of patients but also the highly sedentary nature 
of daily life in this population.  
Physical activity in mild-moderate COPD patients 
The clinical expression of COPD in its early phase (mild stage) is dependent on numerous 
factors including, the nature and extent of physiological impairment; the compensatory 
responses used to maintain sufficient pulmonary gas exchange; and the avoidance of physical 
activity due to breathlessness (O’Donnell & Gebke, 2014). In the past, mild airway 
obstruction has been perceived to present with few clinical consequences; not requiring 
intervention (Guenette et al., 2011). However, there is increasing evidence contradicting such 
perspectives with findings that exercise capacity and dyspnea severity are important 
consequences of worsening lung function; even in patients with undiagnosed COPD 
(Troosters et al., 2010). Over time, these negative health consequences can lead to 
deconditioning and increased symptom severity, compelling patients to become more 
sedentary and less physically active. 
Van Remoortel and colleagues (Van Remoortel et al., 2013) aimed to investigate the 
associations between objectively measured physical activity and clinical characteristics in 
persons newly diagnosed with COPD. One hundred and twenty-four smokers or former 
smokers were recruited comprising 59 newly diagnosed COPD patients (38 mild, 21 
moderate) and 65 matched smoking controls. Physical activity was found to be significantly 
lower in newly diagnosed COPD patients compared with smoking controls (7986 vs 9765 
steps/day and 64 vs 110 min of MVPA, p<0.05) (Van Remoortel et al., 2013). These findings 
highlight that declines in physical activity occur in mild-moderate disease; supporting the 
guidance from the Centre for Disease Control which lists physical activity as a vital sign for 
patients with mild COPD (Centers for Disease Control and Prevention, 2010).  
In a study of 161 patients with stable COPD and 40 apparently healthy adults, Shrikrishna 
and colleagues (Shrikrishna et al., 2012) found that patients with mild disease were less 
physically active than apparently healthy controls (7960±3430 versus 11735±4399 steps per 
day, p=0.002). Physical activity was shown to have a negative linear relationship with lung 
function (e.g. steps per day r=0.6, p<0.001) (Shrikrishna et al., 2012). In a study of 224 
physician-diagnosed COPD patients and 1386 age-matched non-smoking controls, using data 
from National Health and Nutrition Examination Survey 2003-6, patients with COPD were 
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found to spend a greater proportion of time sedentary (72% vs 68%, p<0.05, respectively) 
(Park et al., 2013). COPD patients also spent less time in light and moderate-to-vigorous 
physical activity (27% vs 31% and 0.007% vs 0.013%, p<0.05, respectively) (Park et al., 
2013). These patients also have respiratory constraints when performing activities of daily 
living (Chin et al., 2013; Van Helvoort, Willems, Dekhuijzen, Van Hees, & Heijdra, 2016).  
In a recent study of 39 patients with mild-moderate COPD and 20 apparently healthy adults, 
significant respiratory impairment was observed in patients during stair climbing, vacuuming 
and displacing groceries in a cupboard (Van Helvoort et al., 2016). Half of patients developed 
dynamic hyperinflation compared with 10-35% of apparently healthy adults despite physical 
activity (average vector magnitude) not being significantly different between groups. Similar 
findings have been observed during incremental cycle ergometer tests with mild COPD 
patients reaching their physiological limit at 36% lower peak oxygen uptake and 41% lower 
ventilation compared with apparently healthy adults (Chin et al., 2013). In more severe 
COPD or study populations with a range of COPD severities, indicators of respiratory 
constraint including dynamic hyperinflation and end-expiratory lung volume during exercise 
have been found to be associated with reduced physical activity levels (Garcia-Rio et al., 
2009; Lahaije, van Helvoort, Dekhuijzen, Vercoulen, & Heijdra, 2013). 
Physical activity, sedentary behaviour and mortality 
Using data from the Copenhagen City Heart Study, a prospective study of 1270 COPD 
patients and 8734 controls (median follow-up of 17.1 years and 5392 deaths), Vaes and 
colleagues (Vaes et al., 2014) examined the relationship between self-reported physical 
activity and mortality. Patients with COPD who reported moderate or high levels of baseline 
physical activity but reported low physical activity levels at follow-up had the highest hazard 
ratios of mortality (HR 1.73 and 2.35, respectively, both p<0.001) (Vaes et al., 2014). For 
COPD patients with low baseline physical activity, no differences in risk of mortality were 
observed between unchanged and increased physical activity at follow-up (Vaes et al., 2014). 
A higher baseline FEV1 was associated with a lower risk of reduced physical activity (OR 
0.51 and 0.55 for patients with a moderate or high baseline physical activity, respectively, 
p<0.001). Additionally, age (inversely), male sex, not smoking and cohabitating were found 
to be linked with higher physical activity levels. Smoking for a longer number of years was 
also associated with a reduction in physical activity in COPD patients. Stimulating physical 
activity levels at all stages of COPD should be encouraged to help reduce healthcare costs 
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(Garcia-Aymerich, Lange, Benet, Schnohr, & Anto, 2006) and improve survival rates (Vaes 
et al., 2014). 
In a study of 2295 patients followed up for 12 months after an acute exacerbation of COPD, 
physical activity was measured using self-reported walking frequency at baseline 
(retrospective recall) and two months after discharge (Esteban et al., 2016). Multivariate 
regression models revealed that patients whose physical activity worsened during these two 
months were more likely to die within one year (OR 2.78 – 6.31) (Esteban et al., 2016). 
Physical inactivity during this time was a stronger predictor of one year mortality than the 
presence of comorbidities and long-term domiciliary oxygen therapy or non-invasive 
mechanical ventilation at home (Esteban et al., 2016). Whilst limitations of this study include 
recall bias and sample homogeneity (97% male) targeting physical inactivity during the post-
exacerbation period may have significant benefits to COPD patients’ quality of life. 
There is a considerable lack of data exploring the association between a sedentary lifestyle 
and risk of mortality in COPD patients. It is important to understand if this relationship exists 
and, if it does, the strength of the relationship. A large prospective cohort study in Japan 
(33,414 men and 43,274 women) investigated the role of TV viewing and mortality (Ukawa 
et al., 2015). Over a 19.4 year median follow-up, 278 individuals (88% male) suffered a 
COPD-related death. Compared with men who reported watching TV for <2 hours/day, those 
who reported watching >4 hours/day were significantly more likely to die from COPD (HR 
1.63 95%CI 1.04 – 2.55) (Ukawa et al., 2015). This relationship was observed independent of 
age, smoking status, body mass index (BMI), marital status, alcohol consumption and 
exercise participation. The average time reported for TV viewing was linearly and positively 
associated with COPD-related mortality (p=0.04) (Ukawa et al., 2015). Interestingly, these 
findings were only observed in men (Ukawa et al., 2015). Despite the large sample size and 
long follow-up period, the self-reported assessment of sedentary behaviour is an important 
limitation as well as the focus only on the leisure-time component of these complex 
behaviours. Misclassifications which would have arisen from these issues would, however, 
contribute to a potential underestimation of the true hazard ratios. The mechanism linking 
sedentary behaviour and increased risk of COPD-related mortality has yet to be fully 
elucidated. Prolonged sedentary behaviour has been shown to increase inflammatory markers 
(e.g. IL-6, TNF-α, leptin) (Zhan et al., 2009) which have been found to increase susceptibility 
to respiratory impairment (Gimeno et al., 2011). Additionally, sedentary behaviour has been 
found to contribute to metabolic dysfunction (Helmerhorst, Wijndaele, Brage, Wareham, & 
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Ekelund, 2009) which may lead to hyperinsulinemia which can cause cell differentiation, 
apoptosis and proliferation (Nandeesha, 2009).  
Patients with moderate-severe COPD are less physically active and spend more time 
sedentary compared with apparently healthy adults. However, there is a lack of evidence 
examining the physical activity and sedentary of mild-moderate COPD patients in 
comparison to apparently healthy adults. Moreover, low levels of physical activity have been 
consistently linked to an increased risk of all-cause and respiratory disease mortality; 
highlighting the need for a better understanding of the correlates of these behaviours and 
whether these correlates differ between patients and apparently healthy individuals.  
1.2.7 Correlates and determinants of physical activity in COPD 
It is not only important to examine levels of physical activity and sedentary behaviour but 
understanding the correlates (factors associated with) and determinants (those with a causal 
relationship to) of these behaviours is needed to inform lifestyle interventions. In a systematic 
review by Gimeno-Santos and colleagues (Gimeno-Santos et al., 2014) a range of 
demographic, psycho-social, environmental, clinical and functional factors were examined in 
relation to physical activity. The review found inconsistent associations with most of the 
evidence graded as ‘very low’ or ‘low’ quality (Gimeno-Santos et al., 2014). The following 
sections will explore the correlates and determinants of physical activity and sedentary 
behaviour in COPD, with a primary focus on correlates which are pertinent to this thesis. 
Determinants 
Studies examining determinants require prospective data through longitudinal or prospective 
(over time) designs whereby individuals are followed up at at least two time-points or 
through a randomised controlled trial. In a prospective cohort study of 409 COPD patients 
followed for five years, physical activity was examined using self-report at baseline and 
every six months (Yu, Frei, & Puhan, 2015). Multivariate longitudinal analyses found that (in 
order of strength of association) exercise capacity, age, employment status, smoking pack 
years, fatigue, gender, education history, taking part in a fitness programme, depressive 
symptoms, FEV1, and medication usage to be independent baseline predictors of physical 
activity (Yu et al., 2015).  
Correlation studies are based on cross-sectional data (a single time-point) and are important 
for a number of reasons, as outlined by Stanovich (Stanovich, 2013). Many scientific 
24 
 
hypotheses are presented in the form of correlations or lack of correlation, making such 
studies directly relevant to these hypotheses. Although correlation does not infer causality, 
establishing causation does require correlation. Therefore, whilst correlation studies cannot 
definitively infer causation, they can rule them out. Additionally, some variables are unable 
to be manipulated, such as age, sex and ethnicity. Thus, scientific insight into such variables 
must be made through correlations. Furthermore, evidence obtained from correlation studies 
can lead to the testing of that evidence under controlled condition (Stanovich, 2013). The 
following sections will explore correlates of physical activity and sedentary behaviour in 
COPD. 
Correlates 
A breakdown of identified cross-sectional studies examining correlates of physical activity in 
COPD included in the systematic review by Gimenos-Santos and colleagues (Gimeno-Santos 
et al., 2014) is provided in Table 1.1. Of the 36 studies, two (5.6%) examined mild-moderate 
COPD patients and 12 studies (33.3%) assessed patients with moderate to very severe disease. 
The majority of studies used self-report measures of physical activity with 18 (50.0%) studies 
using accelerometry. Of these 18 studies only four (8.9% of identified studies) also examined 
sedentary behaviour. Additionally, only seven studies (15.6% of identified studies) included a 
comparison group (six different criteria) in their analysis (mean n=29±16). It is unclear 
whether correlates of sedentary behaviour differ between those associated with physical 
activity.  
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Table 1.1 Cross-sectional studies examining correlates of physical activity  
Reference N 
COPD 
Severity 
Comparison 
group PA Method 
SB Assessed 
† 
(Altenburg et al., 2013) 155 Mixed No Pedometer No 
(Beauchamp et al., 2012) 37 Severe Yes (n=20) A 
Self-report 
(balance) No 
(Berry, Adair, & Rejeski, 2006) 291 Mixed No 
Self-report 
(ADLs) No 
(Bestall et al., 1999) 100 Severe No 
Self-report 
(ADLs) No 
(Bon et al., 2011) 190 Mild No Self-report No 
(Chao, Ramsdell, Renvall, & 
Vora, 2011) 21 NP No SR (Lifetime) No 
(Eisner et al., 2008) 1202 Mixed No 
Self-report 
(ADLs) No 
(Eliason, Zakrisson, Piehl-Aulin, 
& Hurtig-Wennlöf, 2011) 44 Mod-Severe Yes (n=17) B Accelerometer Yes 
(Garcia-Aymerich et al., 2004) 346 Severe No Self-report No 
(Garcia-Aymerich et al., 2009) 341 Mixed No Self-report No 
(Garcia-Rio et al., 2009) 110 Mod-Severe No Accelerometer No 
(Hartman, Boezen, de Greef, & 
Nick, 2013) 113 Mixed No Accelerometer Yes 
(Inal-Ince, Savci, Coplu, & 
Arikan, 2005) 30 Severe Yes (n=30) C 
Self-report 
(ADLs) No 
(Jehn et al., 2012) 107 Mixed No Accelerometer No 
(Katajisto et al., 2012) 719 Mixed No Self-report No 
(Lahaije et al., 2013) 57 Mixed No Accelerometer No 
(Lee, Kim, Lim, Jung, & Park, 
2011) 131 Mixed No Self-report No 
(Lemmens, Nieboer, & 
Huijsman, 2008) 278 Mixed No Self-report No 
(Lores, García-Río, Rojo, 
Alcolea, & Mediano, 2006) 23 Mod-Severe Yes (n=12) B Accelerometer No 
(Monteiro et al., 2012) 74 Mod-Severe No Accelerometer No 
(Moy, Matthess, Stolzmann, 
Reilly, & Garshick, 2009) 17 Mixed No Accelerometer No 
(Nguyen et al., 2013) 148 Mod-Severe No Accelerometer No 
(Pitta et al., 2006) 23 Severe No Accelerometer Yes 
(Pitta et al., 2008) 40 Severe No Accelerometer No 
(Pitta et al., 2009) 80 Severe No Accelerometer Yes 
(Silva et al., 2011) 95 Mixed No Self-report No 
(Skumlien, Haave, Morland, 
Bjortuft, & Ryg, 2006) 110 Mixed No 
Self-report 
(ADLs) No 
(Troosters et al., 2010) 70 Mixed Yes (n=30) D Accelerometer No 
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(Van Gestel et al., 2012) 154 Mixed No Accelerometer No 
(Van Remoortel et al., 2013) 59 Mild-Mod Yes (n=65) E Accelerometer No 
(Waatevik et al., 2012) 370 NP No Self-report No 
(Wakabayashi et al., 2011) 389 Mixed No 
Self-report 
(ADLs) No 
(Watz et al., 2008) 170 Mixed No Accelerometer No 
(Watz et al., 2009) 170 Mixed Yes (n=30) F Accelerometer No 
(Watz, Waschki, Meyer, & 
Magnussen, 2009) 163 Mixed No Accelerometer No 
(Yeo, Karimova, & Bansal, 
2006) 27 Mixed No 
Self-report 
(ADLs) No 
Abbreviations: ADLs, activities of daily living; Mod, moderate; NP, not provided; PA, physical activity; SB, 
sedentary behaviour 
†, sedentary behaviour assessed using the same method as physical activity 
A, free from respiratory disease and health problems impacting mobility; B, unable to access full text;                  
C, sedentary (unspecified) hospital workers; D, not involved in competitive sport and free from respiratory 
disease; E, current smokers free from respiratory disease; F, chronic bronchitis 
 
COPD is characterised by poor lung function as a result of chronic airflow obstruction. In a 
study of 163 COPD patients and 29 patients with chronic bronchitis, physical activity was 
examined in relation to respiratory Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) classifications (Watz et al., 2009). Daily steps, MVPA and overall physical activity 
level decreased from chronic bronchitis patients to very severe COPD patients by 69%, 69% 
and 61%, respectively (Watz et al., 2009). Physical activity was also found to decrease with 
advancing dyspnea severity with patients reporting a modified MRC (mMRC) score of four 
averaging less than 2000 steps per day (Watz et al., 2009). mMRC score has been 
independently associated with physical activity level and step count after controlling for 
factors including age, gender, BMI, FEV1%pred, and calf muscle oxidative capacity (Adami, 
Cao, Porszasz, Casaburi, & Rossiter, 2015). It is important to understand the relationship 
between breathlessness and physical activity across COPD severities. Regardless of the level 
of airway obstruction, patients are at risk of falling into the vicious cycle of physical 
inactivity, putting them at greater risk for an acute exacerbation. Even in mild-moderate 
patients, breathlessness during exertion may lead to activity-avoidance behaviours which 
compound symptoms and quality of life. 
In COPD patients with moderate to severe airway obstruction, functional exercise capacity, 
as measured by six-minute walk distance (6MWD), has been found to reflect daily physical 
activity (Pitta et al., 2005). In a study of 73 COPD patients (67±7 years, 60% female 
FEV1%pred 43±16), a multivariate regression revealed that lung function explained the 
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highest proportion of variance in physical activity level (R2=0.20) followed by walking speed 
(R2=0.18), quadriceps strength (R2=0.16) and fat-free mass index (R2=0.08) (Andersson et al., 
2013). These findings are supported by Pitta and colleagues (Pitta et al., 2005) which found 
exercise capacity, as measured by the 6MWD, to be the strongest predictor of walking time 
(partial R2 = 0.56), standing time (partial R2 = 0.35) and movement intensity (partial R2 = 
0.23). Additionally, both quadriceps muscle wasting and 6MWD have been associated with 
physical activity in mild-moderate COPD patients (Hartman, Boezen, de Greef, & Ten 
Hacken, 2013; Shrikrishna et al., 2012). Whilst significant associations between physical 
function and physical activity may exist (van Gestel et al., 2012), the 6MWD, sit-to-stand test 
and grip strength could not be used to reliably predict physical activity level in COPD (van 
Gestel et al., 2012). Therefore, exercise capacity and physical activity must be treated as 
separate constructs requiring specific measurement.  
Comorbidities are commonplace in COPD and it has been estimated that 23% of patients 
have three or more concurrent conditions (Van Manen et al., 2001). The Towards a 
Revolution in COPD Health study observed that COPD mortalities were more frequently 
caused by a comorbid condition than from COPD itself (McGarvey et al., 2007). In a study of 
228 COPD patients, those with at least one comorbid condition had a significantly lower 
physical activity level than patients free from comorbidities (Sievi et al., 2015). However, 
physical activity level did not significantly decline with presence of multiple chronic ailments 
(Sievi et al., 2015). In a large multicentre observational study of 4574 COPD patients 
(67.1±10.0 years, 83.8% male, FEV1%pred 54.0±23.7), level of physical activity was 
determined by time spent walking; with patients classified as having a high (>60 min/day), 
medium (30-60 min/day) or low (<30 min/day) physical activity level (Miravitlles, Cantoni, 
& Naberan, 2014). Compared with patients in the high physical activity group, those in the 
low physical activity group were found to have a higher mean number of comorbidities 
(Charlson Index 2.20 vs 1.65, p<0.001) and a higher BMI (28.4 vs 27.9kg/m2, p=0.034) 
(Miravitlles et al., 2014).  
Specific comorbidities have been associated with physical activity level. Physical 
comorbidities, classified as a BMI ≥32kg/m2, musculoskeletal conditions affecting lumbar 
spine or lower limbs, at least one lower limb joint replacement restricting mobility/range of 
motion, peripheral vascular disease, or neurological conditions, are highly prevalent in COPD 
patients (McNamara, McKeough, McKenzie, & Alison, 2014). McNamara and colleagues 
(McNamara et al., 2014) compared COPD patients with physical comorbidities, patients with 
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COPD alone, and apparently healthy adults. Patients with COPD and physical comorbidities 
were found to have reduced levels of physical activity (determined by energy expenditure, 
steps and activity duration) compared with patients with COPD alone and apparently healthy 
adults (e.g. 1841 vs 6623 v 10619 steps per day, respectively) (McNamara et al., 2014). It is 
important to recognise not only the prevalence of comorbidities in COPD but also the 
consequences of patients having multiple chronic conditions. Targeting physical activity and 
sedentariness may help to prevent and manage comorbidities in COPD. 
Levels of anxiety and depression are highly prevalent in COPD patients (Maurer et al., 2008). 
Although the association of anxiety and depression has not been extensively examined, 
evidence has shown negative relationship with self-reported physical activity. For example, 
the presence of depression has been found to be a significant independent predictor of low 
walking time, defined as <30 min/day (OR 1.58, 95%CI 1.25-2.01) (Miravitlles et al., 2014). 
The proportion of patients with anxiety (63.2%) and depression (69.1%) was found to be very 
high in the low physical activity group (Miravitlles et al., 2014). Additionally, in a 
longitudinal study of 220 patients, every additional point score on the Hospital Anxiety and 
Depression Scale (HADS) depression score was associated with 81 fewer steps per day 
(Duefias-Espin et al., 2016). However, there is conflicting evidence with some studies finding 
no association with depression (Moy et al., 2009; H. Watz et al., 2008). Anxiety levels have 
been positively associated with step count after controlling for confounders including 
dyspnea and exercise capacity (Nguyen et al., 2013). Moreover, anxiety levels were found to 
negate the inverse relationship between depression and physical activity (Nguyen et al., 2013). 
Unlike anxiety and depression, levels of self-efficacy have been consistently positively 
associated with physical activity (Gimeno-Santos et al., 2014); independently predicting daily 
physical activity when controlling for lung function, exercise capacity and other 
psychological factors (e.g. anxiety and depression) (Altenburg et al., 2013). 
In a study of 224 COPD patients recruited as part of a large population survey in the US 
(Park et al., 2013), factors associated with mean activity intensity, sedentary time, light 
intensity physical activity and MVPA were examined. Patients with an education level below 
high school (approximately equivalent to post-16 education in the UK), who were 
unemployed, and who reported breathlessness spent more time sedentary. COPD patients 
who were older, had lower health perception, and had a larger BMI were found to have lower 
mean activity intensity and spent less time in light intensity physical activity. Patients who 
29 
 
were older, female, reported breathlessness and had lower health perception took part in less 
MVPA (Park et al., 2013). 
In a study of 59 patients and 65 smoking controls, objectively measured physical activity 
(steps and MVPA) was found to be lower in COPD patients compared to smoking controls 
(e.g. 7986±2648 versus 9765±3078 steps per day, p<0.05) (Van Remoortel et al., 2013). This 
highlights the importance of intervening on patients in the preclinical stage of COPD 
progression. Factors associated with physical activity were dyspnea, lower diffusion capacity, 
poor exercise capacity and low maximal oxygen uptake (Van Remoortel et al., 2013). 
Physical activity may start to decline in mild-moderate COPD but more evidence is needed to 
ascertain whether physical activity is lower and sedentary time is greater in mild-moderate 
patients compared with apparently healthy adults using objective monitoring. 
For patients with mild-moderate COPD longer sitting time has been associated with higher 
fat-free mass, more positive perception of treatment control and 12-month exacerbation 
history (Hartman et al., 2013). For patients with severe-very severe COPD, longer sitting 
time has been associated with external regulation in exercise (no choice, others make me do it) 
and use of long-term oxygen therapy (Hartman et al., 2013); suggesting that symptoms may 
be the key limiting factor in patients with more advanced COPD. Additionally, sitting time 
was not significantly impacted by lung function, with no difference observed across 
respiratory GOLD classifications (Hartman et al., 2013). Therefore, factors associated with 
physical activity do not necessarily have associations with sedentary behaviour or sedentary 
time.  
In summary, a range of demographic, psycho-social, environmental, clinical and functional 
factors have been examined in relation to physical activity but there are inconsistent findings 
with many findings rated as low confidence. Whilst the use of objective monitoring to assess 
physical activity is improving, more work is needed to refine the accuracy and reliability of 
processing and utilisation (Byrom & Rowe, 2016). Moreover, even in studies using 
accelerometry, there is a need to identify factors related to sedentary time in this population. 
This is important for two main reasons: health risks from sedentary behaviour are 
independent of levels of MVPA (Healy et al., 2007; Healy et al., 2008) and COPD patients 
spend most of their day sedentary (Kawagoshi et al., 2013). 
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1.2.8 COPD symptom severity 
Traditional COPD assessment 
Traditionally, the severity of a patient’s COPD was based solely on airway obstruction, 
assessed via spirometry. From this, the patient’s FEV1/FVC ratio and FEV1%pred is used to 
classify the stage of the disease. However, COPD is a complex and heterogeneous disease 
and the severity of airflow limitation has been found to be poorly related to many clinically 
relevant aspects of the disease including dyspnea, quality of life and exacerbation frequency 
(Hurst et al., 2010; Weatherall et al., 2009). Consequently, in the GOLD 2011 report a 
combined assessment was proposed to better reflect the complexity of COPD (Rabe et al., 
2007) as well as provide a more personalised stratification for improved COPD management 
(Agusti, Sobradillo, & Celli, 2011). 
Combined COPD assessment 
The GOLD 2011 assessment includes two dimensions; namely, the impact of the disease as 
perceived by the patient and the risk of future exacerbations (Figure 1.6) (Vestbo et al., 2013). 
This classification creates four groups stratifying patients by exacerbation risk (low, high) 
and symptoms (low, high). Group allocations are as follows: A: low risk, low symptoms; B: 
low risk, high symptoms; C: high risk, low symptoms; D: high risk, high symptoms (Global 
Initiative for Chronic Obstructive Lung Disease., 2011).  
To classify patients into the “low symptom” or “high symptom” groups, the use of the 
mMRC dyspnea scale (<2 or ≥2, respectively) or the COPD Assessment Test (CAT) 
questionnaire (<10 or ≥10, respectively) is recommended. Exacerbation risk can be defined 
by either exacerbation history in the previous year (<2, low risk and ≥2, high risk) or by 
airflow limitation as per traditional spirometric classification (FEV1≥50% predicted, low risk 
and FEV1, <50% predicted, high risk) (Global Initiative for Chronic Obstructive Lung 
Disease., 2011).  
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Figure 1.6 The GOLD combined assessment to group patients based on risk of exacerbations 
(determined by lung function classification or exacerbation history) and symptoms (CAT for 
health status and mMRC for dyspnea-related disability) (Global Initiative for Chronic 
Obstructive Lung Disease., 2011) 
 
When there is a discrepancy between the risk categories, as assessed by the FEV1 and/or 
exacerbation history, the variable indicating the highest risk should be used (Vestbo et al., 
2013).  Interestingly, discrepancy criteria are not provided for the variables grouping patients 
by symptom severity. This means that there is no current guidance for the interpretation of a 
patient’s symptom level if they report an mMRC of 1 (low) and a CAT score of 15 (high), for 
example. This is an important limitation of the system due to the established discrepancy 
between the recommended cut-off values for mMRC (<2) and CAT (<10). Using data from 
European primary-care COPD patients (n=51,810), Jones and colleagues (Jones et al., 2013) 
suggested that an mMRC cut-point of ≥1 rather than ≥2 had the closest equivalence to a CAT 
cut-point of ≥10. In a sample of 1659 COPD patients, Price and colleagues (Price et al., 2014) 
found that 890 (53.65%) patients moved between groups depending on whether the mMRC 
or CAT score was used. Whilst the incorporation of self-reported symptoms into a risk model 
is intuitive, strict cut-offs and the assumption that questionnaires can be used interchangeably 
may limit the utility of this assessment in practice.   
Additionally, there is a lack of ‘face validity’ with the GOLD 2011 A-D groups with patients 
in group B (high symptoms but low exacerbation risk) more likely to progress to D (high 
symptoms and high exacerbation risk) rather than progressing to group C (low symptoms but 
32 
 
high exacerbation risk). Furthermore, data from 6628 COPD patients from the Copenhagen 
Heart Study found GOLD mMRC group B patients to have significantly worse 3 year all-
cause hospitalisation rates compared with group C (Lange et al., 2012); despite group B 
corresponding to mild-moderate COPD and group C equating to severe COPD. This further 
highlights the importance of understanding what factors are associated with symptom 
severity; particularly in patients with mild-moderate airflow obstruction who are discordant 
in their self-reported symptoms (i.e. group B).  
Indeed, analysis of 6628 COPD patients followed for more than four years.(Lange et al., 2012) 
found that mortality rates were 3.8%, 10.6%, 8.2% and 20.1% in groups A, B, C and D, 
respectively (Lange et al., 2012). Notably, group B and D, both characterised by a high 
degree of symptom severity had five-to-eight-times higher mortality from cardiovascular 
disease and cancer than groups A and C (Lange et al., 2012). Agusti and colleagues (Agusti, 
Calverley, Celli, & et al., 2010) found that group B patients also had higher prevalence of 
comorbidities and persistent systemic inflammation. These findings are striking and highlight 
that those patients with mild-moderate disease stage whom report high symptom burden can 
be at greater risk of premature mortality than some patients with much more advanced COPD. 
A similar pattern has been found for physical activity levels between the GOLD 2011 groups. 
Durheim and colleagues (Durheim et al., 2015) examined accelerometry-derived daily steps 
in 326 COPD patients. Group A patients were more active (6791±3567 steps) than all other 
groups and group B patients accumulated significantly fewer steps than group C patients 
(4216±2729 versus 5456±3132 steps, p<0.05) (Durheim et al., 2015). These findings were 
confirmed by Demeyer and colleagues (Demeyer et al., 2016) across different symptom 
questionnaires (mMRC dyspnea scale, CAT and Clinical COPD Questionnaire). 
Overall, the GOLD 2011 combined assessment groups offer a useful concept for the 
multidimensional stratification of patients in order to better reflect the multifaceted nature of 
COPD. However, evidence regarding the utility of this system is inconsistent and the lack of 
interchangeable measures of symptoms and risk severely limits its utility across studies and 
in clinical practice. The individual components of the GOLD 2011 groups should still be 
examined (as continuous variables where possible) when assessing the role of physical 
activity and sedentary behaviour in COPD. 
In a comprehensive assessment of symptoms (including dyspnea, health status, anxiety and 
depression) over a 24 hour period in 727 patients (67.2±8.8 years, 65.8% male) with stable 
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COPD (FEV1%pred 52.8±20.5), Miravitlles and colleagues (Miravitlles et al., 2014b) 
examined associations with physical activity. For each part of the 24-hour day (early morning, 
daytime and night-time), significant associations were observed between patient-reported 
symptoms and physical activity (referred to as sedentary, moderately active or active; p<0.05) 
(Miravitlles et al., 2014b). In this instance, the term ‘sedentary’ should be replaced with 
‘inactive’ as the definition of ‘sedentary’ in this study was “does not perform any type of 
physical activity”. Compared with patients who were classified as active, those who were 
inactive had a higher proportion of symptoms across the whole 24-hour period (64.2% vs 
50.4%) (Miravitlles et al., 2014b).  
Durr and colleagues (Dürr et al., 2014) investigated the associations between physical activity 
with physical function and CAT score. Patients were categorised into four groups according 
to their CAT score: low (0-10), medium (11-20), high (21-30) and very high (31-40) impact 
on health-related quality of life. Average daily steps (β= -0.31), 6MWD (β= -0.32) and age 
(β= -0.39) were found to be independent predictors of CAT score (all p<0.05) but average 
daily time spent in physical activity above 3METs (MVPA) was not significant (β 0.08, 
p=0.498) (Dürr et al., 2014). Although not directly measured in this study, the significant 
independent association between steps taken and health-related quality of life may suggest 
the beneficial effects of light intensity (or the subsequent reduction in sedentary time) in 
COPD patients; particularly in light of evidence that for COPD patients walking does not 
happen at the required intensity to elicit improvements in fitness (Vitorasso et al., 2012). 
Specifically examining of the role of sedentary time as well as physical activity on symptom 
severity is required to elucidate the type of intervention(s) required to improve patients’ 
quality of life. 
Patient discordance between the severity of their airflow obstruction and their self-reported 
symptom severity is an interesting phenomenon highlighting not only the limitations of 
relying solely on lung function as an indicator of disease progression but may also help 
stratify patients for interventions. GOLD 2011 combined groups B and C, as previously 
explained, include patients with this discordance. However, discordance can be positive or 
negative. For example, a patient with severe airflow obstruction who reports a low symptom 
burden (positive) may be controlling their breathlessness and other symptoms well (e.g. 
through medication, exercise, physical activity or combinations thereof). On the other hand, a 
patient with mild-moderate airflow obstruction reporting high levels of symptoms (negative) 
may require additional self-management advice. In an international survey of 3265 COPD 
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patients across North America and Europe, this disparity was observed with 35.8% of 
patients reporting their disease as mild to moderate also reporting that they are too breathless 
to leave the house (Rennard et al., 2002). Regardless, understanding what factors are 
associated with this discordance is needed to improve patient stratification and to identify the 
interventions that will be most beneficial to them. An example of how interventions could be 
prescribed based on patient characteristics (exercise capacity and physical activity level) has 
been presented by Singh (Singh, 2014) (Figure 1.7).  In this example, patients with acceptable 
levels of exercise capacity but have a low step count may be provided with an intervention 
targeting their physical activity levels.  
 
Figure 1.7 Proposed stratification of interventions based on physical activity and exercise 
capacity (Singh, 2014). The figure is colour coded as follows: red, requires combined 
intervention; amber, requires one intervention; green, requires maintenance programme.  
 
Revised combined COPD assessment 
In November 2016, a revised combined COPD assessment (Global Initiative for Chronic 
Obstructive Lung Disease., 2017) was produced, following the findings from the ‘GOLD 
rush’ publications. Given the GOLD 2011 combined assessment did not perform better than 
spirometric classifications for the prediction of mortality and other health outcomes, ABCD 
groups are now to be based only on exacerbation history and symptoms (mMRC and CAT). 
Criteria for these components have not been altered from the GOLD 2011 criteria (Figure 
1.6). Spirometric classification is recommended in conjunction with the revised combined 
COPD assessment (Global Initiative for Chronic Obstructive Lung Disease., 2017). It is clear 
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that the GOLD combined COPD assessment will be an ever-evolving criteria. Therefore, it 
seems pertinent for research to focus more on the understanding of the potential influencers 
on the components which make up the groups i.e. exacerbation history, dyspnea (mMRC) and 
symptoms (CAT).  
1.2.9 Physical activity, sedentary behaviour and acute exacerbations 
Defining an acute exacerbation 
An exacerbation of COPD is defined as an acute event characterised by a worsening of the 
patient’s respiratory symptoms that is beyond normal day-to-day variations; leading to a 
change in medication (Celli & Barnes, 2007). The average annual number of exacerbations 
experienced by COPD patients is 0.8-2.0 (Hoogendoorn, Hoogenveen, Rutten-van Molken, 
Vestbo, & Feenstra, 2011; Hurst et al., 2010) but as the disease progresses, exacerbations can 
become more frequent and/or more severe and the level of dyspnoea can become debilitating 
(Suter, Hennessey, Florez, & Newton Suter, 2011). It is projected that the number of COPD 
admissions will rise by at least 150% from 2010 to 2030 with subsequent annual inpatient 
days increasing by 185% (Khakban et al., 2016). Exacerbations can lower patient quality of 
life and their ability to perform activities of daily living such as washing, shopping and 
cleaning (Suter et al., 2011) and it can often take weeks to recover from (Seemungal, 
Donaldson, Paul, & et al., 1998).  
Long-term prognosis following hospitalisation for COPD exacerbation is poor, with a five-
year mortality rate of approximately 50% (Hoogendoorn, Feenstra, Hoogenveen, Al, & 
Molken, 2010). Therefore, patients should now receive a COPD discharge care bundle 
(including smoking cessation interventions, referral to pulmonary rehabilitation and inhaler 
technique training) which has been found to reduce readmission rates (Laverty et al., 2015). 
Patients with more frequent and more severe respiratory symptoms, a lower exercise capacity 
and worse lung function are also at risk of shorter-term survival following an acute 
exacerbation (Garcia-Aymerich et al., 2011). Previous admissions to hospital, use of long-
term oxygen therapy, poor health-related quality of life and physical inactivity have been 
found to be predictive of readmissions for an exacerbation (Bahadori & FitzGerald, 2007). 
Physical activity and risk of hospitalisation 
A study of 340 patients, who were recruited during their hospital stay for an exacerbation and 
followed-up one year later, investigated the role of modifiable risk factors in reducing 
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readmission rates (Garcia-Aymerich et al., 2003). After adjusting for significant clinical 
factors (e.g. ≥3 admission in the previous year and low FEV1%pred), a high level of physical 
activity (equivalent to ≥60 minutes a day) was associated with a 46% reduction in the risk of 
readmission (HR 0.54 95%CI 0.34-0.86) (Garcia-Aymerich et al., 2003). This was the first 
study to establish a reduced risk of readmission through leading a more physically active 
lifestyle.  The finding of at least one hour a day walking conferring an almost 50% lower risk 
of readmission is striking. Moreover, this relationship did not diminish when adjusting for 
COPD severity, nutritional status or pulmonary rehabilitation participation (Garcia-Aymerich 
et al., 2003). However, the self-reported nature of physical activity assessment and the 
sample comprising mostly males are important limitations to the generalisability of these 
findings.  
In a large population-based prospective study of 2386 COPD patients (54% male), self-
reported physical activity was found to be associated with an increased risk of hospitalisation 
and mortality (Garcia-Aymerich et al., 2006). When patients were stratified into very low, 
low, moderate and high physical activity levels, those in the low-to-high groups had 
significantly reduced odds of hospital admissions (OR 0.72 95%CI 0.53-0.97), all-cause 
mortality (HR 0.76 95%CI 0.65-0.90) and respiratory mortality (HR 0.70 95%CI 0.48-1.02) 
compared with the very low group, independent of age, sex, COPD severity and concomitant 
heart disease (Garcia-Aymerich et al., 2006).  
A study by Esteban and colleagues (Esteban et al., 2014), which followed 543 COPD patients 
for three years, corroborated these findings. COPD patients who maintained a lower level of 
self-reported physical activity were found to have an increased rate of hospitalisation (OR 
1.90 95%CI 1.09-3.32). For patients who began with the highest level of physical activity but 
who decreased their physical activity in the follow-up period also showed an increased 
readmission rate (OR 2.13 95%CI 1.15-3.98). In a cohort from the National Emphysema 
Treatment Trial, physical activity was found to be an independent predictor of hospitalisation 
with patient-reported activity levels greater than two hours per week associated with 
significant reductions in hospital admissions (Benzo et al., 2010).  
A potential mechanism by which physical activity might prevent or reduce hospitalisations 
following an acute exacerbation of COPD could be related to the capacity for physical 
activity to reduce systemic inflammation (as expressed by markers including C-reactive 
protein) (Pitta et al., 2008). Additionally, physical activity may promote local changes in lung 
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physiology which can lead to improved pulmonary gas exchange and increased maximal 
expiratory pressure (Pitta et al., 2008). Maximal expiratory pressure has a positive correlation 
with maximal voluntary ventilation which reflects the amount of available ventilatory reserve; 
activated when doing physical activity (Pitta et al., 2008). Furthermore, physical activity 
more strongly correlates with maximal voluntary ventilation than it does with FEV1 or 
inspiratory capacity (Garcia-Rio et al., 2009) supporting the notion that patients would 
benefit from increasing daily physical activity regardless of disease stage. 
There is a paucity of information on changes in physical activity prior, during and after an 
exacerbation; largely due to the difficulties of obtaining such baseline (pre-exacerbation) 
physical activity data. In a prospective study of 73 COPD patients, respiratory symptoms and 
daily step count (measured using a pedometer) were recorded by the patients for 12 months 
(Alahmari et al., 2014). Patients recorded their step count for a median 198 days (IQR 134-
353). Overall days of data for the study were 14,653 in a stable state and 2508 during 
exacerbation periods. Average self-reported daily step count declined significantly, from 
4154±2586 during the week before an exacerbation to 3673±2258 during the initial seven 
days after experiencing an exacerbation. Moreover, patients who experienced more frequent 
exacerbations had a greater decline in daily step count but the recovery of step count was 
faster than that for respiratory symptoms (Alahmari et al., 2014).  Whilst the reliance on 
patients to accurately report their step count is an important limitation, this study highlights 
well the impact of an exacerbation on activity levels. Moreover, the finding that step count 
returns to baseline quicker than symptoms suggests that it may be feasible to facilitate this 
return to baseline during the post-exacerbation period.  
Post-discharge physical activity levels 
When discharged following an exacerbation, patients are generally less active than during 
periods of stable symptoms (Pitta et al., 2006). Therefore, behavioural interventions after 
patients leave the hospital and before starting pulmonary rehabilitation may be important for 
preventing readmissions and tackling the vicious cycle of inactivity and deconditioning 
which is often worsened by highly sedentary and lengthy hospital stays (Kortebein, 2009).  
In a study of 50 COPD patients (71±10 years) admitted for an acute exacerbation physical 
activity levels were assessed using the SenseWear Armband MF-SW for three days in-
hospital, during the first week following discharge and at six weeks post-discharge (Tsai, 
Alison, McKenzie, & McKeough, 2016). There was a significant increase in average daily 
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step count over the time points with a mean (SD) step count of 1385 (1972) in-hospital, 2040 
(2680) in the first week and 2328 (2745) at six weeks (p<0.001) (Tsai et al., 2016). Similarly, 
increases in moderate intensity physical activity (3.0-6.0 METS) were observed over the time 
points with patients spending 16±27 minutes, 32±46 minutes and 35±58 minutes in-hospital, 
at one week and six weeks, respectively (Tsai et al., 2016). Additionally, in a study of 54 
patients suffering an acute exacerbation, physical activity levels over 30 days for those 
deemed to participate in ‘low levels’ of physical activity (average of <60 minutes per day 
vector magnitude units ≥3000 over the first 7 days) were more likely to have 30-day all-cause 
readmissions than those with higher activity (OR=6.7, p=0.02) (Chawla, Bulathsinghala, 
Tejada, Wakefield, & ZuWallack, 2014). These findings highlight the need to intervene in the 
critical period.  
Barriers and enablers of physical activity 
Qualitative investigations provide rich contextual insight into patient perceptions. A study by 
Thorpe and colleagues (Thorpe, Kumar, & Johnston, 2014) conducted semi-structured 
interviews to examine barriers and enabler of physical activity in patients with COPD 
following admission to hospital for an acute exacerbation (n=28). A plethora of barriers and 
enablers were identified and these are summarised in Figure 1.8. The main barriers identified 
were health-related (e.g. comorbidities, COPD symptoms and illness), environment-related 
(e.g. weather, transport and finance), and self-related (e.g. age and oxygen therapy). The main 
enabling factors were access (e.g. to equipment and health professionals), social (e.g. support 
and routine), and personal (e.g. motivation and goal setting) (Thorpe et al., 2014). It is pivotal 
for these factors to be adequately addressed in order to help optimise the implementation and 
success of interventions to promote physical activity following an exacerbation. 
 
Figure 1.8 Barriers and enablers of physical activity in COPD patients hospitalised following 
an acute exacerbation (Thorpe et al., 2014) 
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Critical period for intervention 
Pulmonary rehabilitation is a proven treatment for patients with stable COPD and is a well-
established central therapy within routine care. Pulmonary rehabilitation facilitates recovery 
post-exacerbation and it is recommended internationally that eligible patients admitted for an 
exacerbation should be referred (Rochester et al., 2015; Spruit et al., 2013). Patients who 
accept pulmonary rehabilitation should be enrolled within one month of discharge (British 
Thoracic Society, 2014) but only 22% of providers meet this recommendation (Steiner, 
Holzhauer-Barrie, Lowe, Searle, Skipper, Welham, & Roberts, 2015b). Median (IQR) days 
from enrolment to initial assessment is 52 (44-65) and from initial assessment to commencing 
pulmonary rehabilitation is 65 (53-84) (Steiner, Holzhauer-Barrie, Lowe, Searle, Skipper, 
Welham, & Roberts, 2015b). Given the striking delay from discharge to beginning 
rehabilitation, some studies have attempted to intervene during this post-exacerbation and 
pre-rehabilitation period. 
In a systematic review and pooled analysis conducted in 2010, nine studies (n=432) of post-
exacerbation pulmonary rehabilitation were identified (Puhan et al., 2011). Studies were 
deemed to be of moderate methodological quality with pooled analysis revealing that 
pulmonary rehabilitation reduces hospital admissions (pooled OR 0.22 95%CI 0.08-0.58) and 
mortality (pooled OR 0.28 95%CI 0.10-0.84). Rehabilitation also significantly improved 
health-related quality of life, respiratory symptoms and exercise capacity above the 
minimally important differences for COPD patients who have recently experienced an acute 
exacerbation (Puhan et al., 2011). Post-exacerbation rehabilitation caused no adverse events 
in the nine identified studies signifying it is both an effective and safe intervention for these 
patients (Puhan et al., 2011). 
In a study of 60 patients admitted for an exacerbation of COPD, Seymour and colleagues 
(Seymour et al., 2010) found that those receiving post-exacerbation rehabilitation (n=30) had 
significantly lower readmission rates for an exacerbation at three months (7% versus 33%; 
OR 0.15, 95%CI 0.03-0.72, p=0.02). Additionally, all unplanned hospital attendance were 
significantly lower for patients receiving post-exacerbation rehabilitation (27% versus 57%; 
OR 0.28, 95%CI 0.10-0.82, p=0.02) (Seymour et al., 2010). Whilst the number of patients 
screened during the study recruitment period (June 2005 to April 2008) is not provided, the 
recruitment of 60 patients in this period suggests many patients are not willing to participate 
in pulmonary rehabilitation at this time. 
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Greening and colleagues (Greening et al., 2014) conducted a study of early rehabilitation in 
post-exacerbation patients comprising a six week progressive aerobic exercise, resistance 
training and neuromuscular electrical stimulation starting within 48 hours of admission. 
Significantly higher one year mortality rates were observed in the early rehabilitation group 
compared with usual care (OR 1.05 to 2.88, p=0.03) (Greening et al., 2014). Additionally, 
when offered pulmonary rehabilitation three months after recruitment, uptake in the early 
rehabilitation group was significantly lower than those randomised to usual care (14% versus 
22%, respectively, p=0.04) (Greening et al., 2014). Therefore, it may not be suitable for 
patients to undergo relatively vigorous activity and exercise at this time. Future studies 
examining early post-exacerbation rehabilitation or other interventions should routinely 
capture patient uptake to conventional pulmonary rehabilitation. 
Home-based self-monitoring programmes may help to provide additional options for patients 
who do not feel able to take part in pulmonary rehabilitation. In an effort to increase walking 
in 30 post-exacerbation patients, Hornikx and colleagues (Hornikx, Demeyer, Camillo, 
Janssens, & Troosters, 2015) provided physical activity coaching by telephone (three times 
per week) and a Fitbit Ultra worn around the ankle to provide real-time feedback on step 
count for one month. Whilst an increase in physical activity was observed over time there 
was no significant difference between intervention and control (usual care) groups. One 
potential reason not mentioned by the authors might be the ease of access to the real-time 
feedback given the self-monitoring device was positioned on the ankle and so difficult to 
view.  With the high levels of breathlessness and limited mobility of patients, feedback from 
self-monitoring technology needs to be easily accessible and easily understood. Therefore, 
future research should explore more accessible platforms to provide behavioural information 
such as those worn on more convenient wear locations like the wrist or providing information 
on portable devices such as a smart phone. Additional limitations of this study (Hornikx et al., 
2015) include its recruitment as it was estimated that a sample size of 62 would be needed to 
achieve statistical power. However, after one year recruitment was stopped due to difficulty 
recruiting patients. This highlights the impact of the breathlessness-induced fear and anxiety 
of patients increasing their daily physical activity levels. Importantly, this should not detract 
from the value such initiatives could have on those patients willing and eligible to participate. 
Unfortunately, reasons why patients were refusing the intervention were not examined; 
invaluable information for future endeavours. 
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In a study of 42 COPD and 71 Type 2 Diabetes patients (58±8 years of age) recruited from 
General Practices in The Netherlands, Verwey and colleagues (Verwey et al., 2016) 
conducted a process evaluation of a self-monitoring intervention using wearable technology. 
Patients aged 40-75 years who did not take part in regular moderate intensity aerobic physical 
activity and who had access to the internet were provided real-time information on minutes 
spent in MVPA via a Smartphone and web application. Goals were mostly set by patients 
(61%) or in collaboration with a practice nurse (32%). For 20 patients who did not feel they 
achieved their goals, the most common reasons were physical or psychological symptoms 
and illness (70%) followed by work commitments (15%) and family issues (15%) (Verwey et 
al., 2016). Despite the relatively young age of these patients compared with those generally 
admitted for COPD exacerbations, the impact of symptoms and illness on patients’ ability to 
engage with physical activity is prominent. In this study targeting MVPA may not have been 
suitable for some patients. Therefore, having an additional component not reliant on activity 
intensity such as step count or targeting reductions of prolonged sedentary behaviour may 
also be worth exploring. In addition, 58% of patients experienced problems using the 
technology or web application (Verwey et al., 2016). Common problems were connection 
issues between the activity monitor and phone (46% of issues), connection issues between the 
phone and server (16% of issues) and patients being unable to log in (11%). Other issues 
included hardware problems with the activity monitor, patients forgetting their password and 
patients accidentally deleting the app (Verwey et al., 2016). Therefore, future endeavours 
should attempt to minimise technological barriers to intervention engagement.  
A sample of ten COPD patients (61±6 years, 50% female) recruited from a specialised COPD 
clinic free from any effects of an acute exacerbation were asked to wear a Fitbit One physical 
activity monitor and feedback device which provided patients with a real-time step count 
(Caulfield, Kaljo, & Donnelly, 2014). Patients were not required to have home internet access 
as all participants’ received a full installation of both a laptop computer and mobile 
broadband as part of the study. Patients also received regular calls and texts to remind them 
to wear the monitor. Compared with baseline activity levels, step counts improved 
significantly from 310±108 to 370±129 steps on average per hour (p=0.034) (Caulfield et al., 
2014). Whilst the sample size for this study was small and the study design is likely 
unscalable, findings suggest a potential for patients to engage with wearable self-monitoring 
technology. However, there is currently a lack of information regarding the level of 
engagement patients have with feedback provided by such devices. Such information will 
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help to understand what role self-monitoring technology may have in elderly patient 
populations and identify potential barriers and facilitators to successful engagement with their 
lifestyle-embedded physical activity levels.   
1.2.10 Summary 
Patients with COPD are more sedentary and less physically active compared with apparently 
healthy adults. This inactive lifestyle puts patients at risk of falling into the vicious cycle of 
inactivity/sedentary behaviour and breathlessness which can subsequently increase their risk 
of premature mortality and hospitalisation. Identifying correlates of both physical activity and 
sedentary behaviour in comparison to a large sample of apparently healthy adults is needed to 
better understand sedentary behaviour in COPD. Sedentary behaviour (both its measurement 
and understanding) has been too frequently overlooked. Findings from correlation studies 
may help to inform tailored physical activity and/or sedentary behaviour interventions. 
Additionally, patients mild-moderate disease who report high levels of symptom severity may 
represent a particular group of patients requiring lifestyle interventions. Therefore, 
understanding factors associated with patients with similar airflow obstruction report 
contrasting symptom burdens are needed to inform the design and implementation of such 
interventions. At the more severe end of COPD, patients admitted for an acute exacerbation 
may benefit from a behavioural intervention focussing on less intense movement. Targeting 
reductions in sedentary behaviour rather than aiming to increase exercise capacity or time 
spent in MVPA may be more appealing to acutely ill patients. The use of self-monitoring 
technologies may facilitate the provision of behavioural interventions in this population by 
bringing such interventions outside the four walls of the NHS and into the lives and homes of 
the patients. This approach removes important barriers to participation such as travel and 
financial encumbrance; resulting in an ‘always on’ intervention. 
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1.2.11 Thesis aims 
Study One 
1) To compare the objectively measured physical activity and sedentary time between mild-
moderate COPD patients and apparently healthy adults. 
2) To identify correlates of physical activity and sedentary time for mild-moderate COPD 
patients and apparently healthy adults. 
Study Two 
1) To identify factors associated with self-reported symptom severity and exacerbation 
history in mild-moderate COPD patients 
2) To compare physical activity and sedentary time in mild-moderate COPD patients 
according to their symptom severity (mMRC dyspnea grade and CAT score) and 
exacerbation history 
Study Three 
1) Examine the feasibility and acceptability of an at-home sedentary behaviour intervention 
using wearable self-monitoring technology for COPD patients following an acute 
exacerbation. 
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Chapter 2: Physical Activity and Respiratory Health (PhARaoH) Study Methods 
2.1 Study design 
The Physical Activity and Respiratory Health (PhARaoH) Study is a cross-sectional, 
observational study of adults with and without a diagnosis of COPD (ISRCTN78843393). 
Ethical approval was sought and obtained from the National Research Ethics Service 
Committee East Midlands – Nottingham 2 (13-EM-0389) (Appendix A) and University 
Hospitals of Leicester NHS Trust acted as study sponsor. Full details of PhARaoH data have 
been previously published (Orme et al., 2016) (Appendix B) and template informed consent 
form and participant information sheet can be found in Appendix C and D, respectively. 
Participants received reimbursement of travel in full. 
Recruitment 
The Primary Care Research Network (PCRN) invited General Practices across Leicestershire 
and Rutland, UK to conduct a search on their database to identify COPD patients aged 40-75 
years. Fifteen practices sent out invitations to identified patients. Patients who wished to 
participate were instructed to return the reply form to the Respiratory Biomedical Research 
Unit, Glenfield Hospital where it was passed to the PhARaoH administrative team. Upon 
receipt of the reply form, a researcher contacted the interested individual via telephone to 
confirm eligibility and to schedule an appointment. Fifteen general practices were recruited 
onto the study for COPD patient recruitment (two from East Leicestershire and Rutland 
Clinical Commissioning Group (CCG), six from West Leicestershire CCG and seven from 
Leicester City CCG). Apparently healthy participants were recruited through posters 
(Appendix E) and leaflets (Appendix F) distributed across Leicestershire in community 
organisations and facilities (e.g. libraries, community halls, leisure centres).  
For the COPD patients, 93 (85.3%) were recruited through general practices. Remaining 
COPD patients were recruited through an existing research contact database (7; 6.4%), word 
of mouth (2; 1.8%), leaflet/poster distribution (2; 1.8%) and other recruitment methods (e.g. 
newspaper advert) (4; 3.7%). Of the apparently healthy adults 40 (29.6%) were recruited 
through leaflet/poster distribution, 32 (23.7%) through University Hospitals of Leicester 
intranet adverts, 21 (15.6%) through word of mouth and 42 (31.1%) through other 
recruitment sources (e.g. community health events).  
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2.2 Measurements 
Data was collected between March and August 2014. Trained researchers collected all data 
and participants were required to attend the Respiratory Biomedical Research Unit, Glenfield 
Hospital, Leicestershire, UK on one occasion for approximately 2-3 hours. All participants 
provided written informed consent before measures were taken.  
Anthropometrics and Body Composition 
Height was measured using a portable stadiometer and weight and percentage body fat 
obtained using body composition scales (Tanita MC780MA) with body mass index (BMI) 
derived. Waist circumference was measured around the mid-point between the lowest rib and 
iliac crest (World Health Organization, 2008); taken twice using a tape measure with a third 
measure conducted if the difference between the first two exceeded 3cm. 
Spirometry 
An objective measure of lung function was conducted using forced spirometry. Spirometric 
assessment was not used to confirm or reject diagnosis. Daily expiratory calibration was 
performed with pass/fail criteria set to within 3.5% of a fixed 3L volume. Of the 118 
calibrations (one per day of testing), the mean percentage error was 0.45±1.17%. Exclusion 
criteria for spirometric assessment were: eye surgery in the last 3 months, chest/abdominal 
surgery in the last three months, participant or household member tuberculosis exposure, 
history of aneurysm or collapsed lung, history of detached retina, stroke or heart attack in the 
last six months, glaucoma or history of coughing up blood in the last month. Eligible 
participants then completed three to eight spirometry readings (MicroLab MK8 spirometer, 
serial number 68738). Airflow obstruction was defined as an FEV1/FVC <0.7. COPD 
severity was determined according to FEV1%pred with ≥80 as GOLD Stage I (mild), ≥50 to 
<80 GOLD Stage II (moderate), ≥30 to <50 GOLD Stage III (severe) and <30 as GOLD 
Stage IV (very severe). Patients with normal spirometry (FEV1/FVC ≥0.7; GOLD 0) were 
included in the present analysis, along with GOLD I and GOLD II patients, as these 
individuals had a diagnosis of COPD. FEV1 predicted values were derived from European 
Community for Steel and Coal (Quanjer et al., 1993). Spirometric outputs from all patients 
were reviewed by a respiratory clinician. 
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Exercise capacity 
The incremental shuttle walk test (ISWT) is a symptom-limited test of exercise capacity 
requiring participants to walk up and down a 10m course (Singh, Morgan, Scott, Walters, & 
Hardman, 1992) supervised and instructed by a trained technician. A pre-ISWT suitability to 
exercise check was conducted using the Physical Activity Readiness Questionnaire 
(Warburton, Jamnik, Bredin, & Gledhill, 2011) (Appendix G). If the participant answered 
‘Yes’ to any one or more of these questions they were referred to a healthcare professional 
for sign-off. Walking speed was externally paced using pre-recorded bleep signals provided 
by an .mp3 file. Walking pace for the test began at 0.5m/s and increased by 0.17m/s at the 
end of each minute (indicated by a triple bleep). The ISWT was terminated if participants 
reported symptoms (e.g. muscle pain or breathlessness), were unable to maintain the 
necessary pace, or completed the test (12 minutes, 1020m). Participants were not permitted to 
run. The ISWT was repeated by the same operator following at least 30 minutes rest with the 
best distance achieved used for analysis.  
Skeletal muscle strength 
For the quadriceps maximal voluntary contraction (QMVC) test, participants sat in a purpose‐
built chair with an inextensible strap connecting the ankle of their dominant leg to a strain 
gauge (HURLabs, PR1 force transducer, Finland). Dominant leg was determined by which 
leg the participant would use to kick a ball. Care was taken to ensure participants’ knees were 
flexed to 90° and that all the strain gauge and couplings were aligned to ensure an isometric 
contraction (Edwards, Young, Hosking, & Jones, 1977). Participants performed three 
sustained maximal isometric quadriceps contractions. The force produced was visible to the 
researcher who provided positive feedback and vigorous encouragement. There was a rest 
period of 30–60 seconds between each effort. The greatest of the 3 efforts was carried 
forward for analysis.  
Upper body skeletal muscle assessment was obtained by standing grip strength using a hand-
held dynamometer (Takeii analogue dynamometer, Niigata, Japan). Three measures of grip 
strength were taken for both hands. Participants were asked to squeeze the dynamometer with 
as much force as possible, with their elbow extended down by their side (Parvatikar & 
Mukkannavar, 2009). 
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Questionnaires 
The full PhARaoH questionnaire is provided in Appendix H. For the purpose of this chapter, 
self-reported breathlessness was obtained using the mMRC dyspnea scale (graded 0-4) with a 
score of 0 pertaining to “Not troubled by breathlessness except on strenuous exercise”, 1 
“Shortness of breath when hurrying on the level or walking up a slight hill”, 2 “Walks slower 
than people of the same age on the level because of breathlessness or has to stop for breath 
when walking at own pace on the level”, 3 “Stops for breath after walking about 100m or 
after a few minutes on the level” and 4 “Too breathless to leave the house or breathless when 
dressing or undressing”. The CAT questionnaire was used to examine a range of symptoms 
and total symptom burden (Jones et al., 2009). The CAT is an 8-item questionnaire 
comprised of 5-point (0-5) Likert scales for coughing, phlegm, sleep, confidence leaving the 
home, energy, tight chest and activity limitation with higher scores relating to higher 
severities (Figure 2.1). Patients were also asked to self-report the number of exacerbations 
requiring steroids or antibiotics experienced within the last 12 months.The EuroQol EQ-5D-
5L was used to assess perceived general health status; comprising Likert scales for problems 
with mobility, self-care and performing usual activities, pain/discomfort and 
anxiety/depression and a visual analogue scale (0-100) for self-rated overall health (Herdman 
et al., 2011). Likert scales were used to form a general health index value (Van Hout et al., 
2012). Participants self-reported their usual walking speed as either “slow”, “average”, “fairly 
brisk” or “brisk”. Postcode greenspace was obtained using physical environment data from 
http://www.neighbourhood.statistics.gov.uk/dissemination/. 
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Figure 2.1 The COPD Assessment Test (CAT) questionnaire 
 
2.3 Accelerometry 
Reliability testing 
Accelerometers are commonplace in the field of physical activity research, in part due to their 
small size, light weight and ability to measure human movement (acceleration) and store data 
over many days (Rothney, Apker, Song, & Chen, 2008). The capability of these devices to 
quantify acceleration with high sensitivity (e.g. acceleration data can be recorded 100 times 
every second; 100Hz) it is good practice to check that these devices are within an acceptable 
measurement error before deployment. This is particularly important when a large number of 
devices are being deployed in a single study due to the increased likelihood of inter-device 
variability. There are a plethora of examples of studies examining the validity of 
accelerometers in both controlled and free-living conditions using human participants (Welk, 
2005). However, variations in the participants themselves, even when a single person wears 
multiple devices (Nichols, Morgan, Chabot, Sallis, & Calfas, 2000), introduces inherent 
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variability in the assessment of monitor accuracy. A more standardised and robust approach 
for examining the accuracy of accelerometers has been through the use of mechanical shakers 
(Esliger & Tremblay, 2006; Metcalf, Curnow, Evans, Voss, & Wilkin, 2002). The advantages 
of using shakers include the large number of accelerations that can be produced, the ability to 
assess many accelerometers at once, and the reliable and precise oscillations that can be 
produced (Rothney et al., 2008). For wrist-worn accelerometry, used for Study One and 
Study Two, the importance of limiting inter-device variation and using devices with 
acceptable measure errors is pivotal for accurate and reliable behaviour quantification as 
greater magnitudes of acceleration occur at the wrist compared with near the centre of mass 
(Kamada, Shiroma, Harris, & Lee, 2016). 
Mechanical shaking and inter-device variability 
Before deploying the ActiGraph wGT3x-BT accelerometers (ActiGraph, Pensacola, USA) 
the reliability of the devices was examined to ensure each unit was measuring acceleration 
within acceptable limits. 155 units were tested of which 12 (7.7%) were returned and 113 
(72.9%) were used as part of the Study One and Study Two. Accelerometers from the pool of 
reliable units were also used in Study Three. 
Accelerometer reliability was assessed using an orbital shaker table (Figure 2.2) to provide 
the researcher full control of the magnitude of the acceleration and the frequency of the 
oscillation the devices were exposed to. The five different conditions chosen were selected to 
produce a range of physiologically relevant accelerometer counts within the confines of the 
shaker capacity; these were 100, 125, 150, 175 and 200 revolutions per minute (rpm). Each 
condition was time-stamped and lasted 2.5 minutes with 1.25 minutes between each condition 
to allow for changes in revolutions per minute. 
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Figure 2.2 Orbital shaker table 
Care was taken to secure the monitors were firmly fixed in a vertical position along their 
sensitive axis in order to maximize and standardize the output (Figure 2.3).  Once all 
accelerometers were in position the orbital shaker was switched on and allowed to warm up 
in order to facilitate the optimal execution of the conditions. 
 
Figure 2.3 Close-up of the positioning of the accelerometers 
In order to identify accelerometers working outside acceptable limits i.e. ±10% as per 
manufacturer guidelines, mean difference percent (Equation 2.1) was calculated for each unit 
and visualised using Bland-Altman plots for each condition. Units which exceeded this 
tolerance were deemed “out of calibration” and returned to the manufacturer. A positive 
mean difference percent means that the unit was high calibrated and a negative mean 
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difference percent means the unit was low calibrated. Unit serial numbers and corresponding 
mean difference percent for devices out of calibration are presented in Table 2.1.   
Equation 2.1: 𝑀𝑀𝑉𝑉𝑚𝑚𝑚𝑚 𝑚𝑚𝑚𝑚𝑑𝑑𝑑𝑑𝑉𝑉𝑉𝑉𝑉𝑉𝑚𝑚𝑉𝑉𝑉𝑉 𝑝𝑝𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑚𝑚𝑉𝑉 = (𝑢𝑢𝑢𝑢𝑢𝑢𝑢𝑢 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑢𝑢𝑠𝑠𝑢𝑢𝑠𝑠 𝑚𝑚𝑠𝑠𝑚𝑚𝑢𝑢−𝑠𝑠𝑐𝑐𝑢𝑢𝑐𝑐𝑢𝑢𝑢𝑢𝑢𝑢𝑐𝑐𝑢𝑢 𝑔𝑔𝑔𝑔𝑚𝑚𝑢𝑢𝑐𝑐 𝑚𝑚𝑠𝑠𝑚𝑚𝑢𝑢)
𝑠𝑠𝑐𝑐𝑢𝑢𝑐𝑐𝑢𝑢𝑢𝑢𝑢𝑢𝑐𝑐𝑢𝑢 𝑔𝑔𝑔𝑔𝑚𝑚𝑢𝑢𝑐𝑐 𝑚𝑚𝑠𝑠𝑚𝑚𝑢𝑢 × 100 
Table 2.1 Accelerometer units out of calibration (mean difference percent > ±10%) 
Condition Serial number Mean difference percent 
100rpm MOS2A02140347 -13.27 
 
MOS2A02140519 -10.53 
200rpm MOS2A02140563 33.33 
 
MOS2A02140636 28.23 
 
MOS2A02140517 23.53 
 
MOS2A02140635 21.08 
 
MOS2A02140523 17.72 
 
MOS2A02140650 16.24 
 
MOS2A02140620 14.05 
 
MOS2A02140544 11.60 
 
MOS2A02140549 11.15 
 
MOS2A02140516 11.02 
Ten of the 12 units were out of calibration at the higher acceleration (condition 5) with two 
units out of calibration at the slower acceleration (condition 1). Outputs for all conditions are 
provided in Figures 2.4-2.8. 
 
Figure 2.4 Condition 1 (100rpm) resulting in two low calibrated units 
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Figure 2.5 Condition 2 (125rpm) resulting in no units out of calibration 
 
 
Figure 2.6 Condition 3 (150rpm) resulting in no units out of calibration 
 
53 
 
 
Figure 2.7 Condition 4 (175rpm) resulting in no units out of calibration 
 
 
Figure 2.8 Condition 5 (200rpm) resulting in 10 high calibrated units 
 
Data processing 
Wrist-worn accelerometry is in its infancy within the field of physical activity and sedentary 
behaviour measurement but there is general consensus and initial evidence to suggest that this 
location will permit improvements in wear time compliance (van Hees et al., 2011); a vital 
advantage for capturing data representative of the wearer’s usual activities both within and 
between days. The main reason for this is the added comfort for the participant which enables 
them to wear the device during sleep. As a result, participants (for now at least) will only be 
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asked to take off the monitor for water-based activities such as showering. Therefore, wrist-
worn accelerometer protocols permit the capturing of the 24 hour day, limiting the chances or 
reasons why participants might remove the device. However, with this comes the challenge 
of differentiating waking and non-waking movement. Traditional approaches have utilised 
participant diaries whereby individuals record the time they went to bed and time they got up 
each day but this is thwart with recall inaccuracies and adds to the burden of study 
participation. Data-driven systematic approaches are needed to objectively identify sleep 
onset and end without the additional burden to participants.  
Location and device set-up 
Objectively derived physical activity and sedentary time were collected using the ActiGraph 
wGT3X-BT accelerometer worn on the non-dominant wrist (non-writing hand) continuously 
except for water-based activities at a sample rate of 100Hz. Monitors were deployed in delay 
mode on day 0 and commenced logging on day one at 00:00 with a seven day stop time 
indicated. Each accelerometer was returned via mail after seven full days of wear. Monitors 
were initialised and downloaded using ActiLife software (ActiGraph, Pensacola, USA) 
version 6.13.2 and were analysed using KineSoft (KineSoft, Loughborough, UK) version 
3.3.80. Data was processed in 60-second epochs. All pertinent data collection and analytical 
procedures related to the accelerometry portion of the study are described in Table 2.2. 
Pre-processing accelerometry analysis 
60-second .agd files were processed through KineSoft using Choi wear-time criteria (Choi et 
al., 2011; Choi et al., 2012) to identify periods of non-wear. This was conducted in order to 
avoid coding non-wear as time spent in bed in subsequent analysis. Individual files were 
exported in ‘processed mode’ using the File Inspector function in KineSoft. The processed 
data (i.e. with non-wear coded) was then inserted into the automated sleep algorithm system.  
Identifying time in bed and out of bed 
Participants were asked to wear the accelerometer 24 hours a day and no sleep diary was 
provided. Therefore, sleep detection was determined using sustained periods of (in)activity 
from vector magnitude count values based on the work of Carney and colleagues (Carney, 
Lajos, & Waters, 2004). To identify the time when participants went to sleep (INBED), the 
algorithm identified consecutive dips in activity, specifically a 90% reduction from the 
previous epoch for 15 minutes between the hours of 21:00 and 23:59 (Carney et al., 2004). 
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Once the INBED criteria were met, the original epoch containing the 90% reduction in counts 
was used to signify the start of sleep. To identify the time when participants were awake 
(OUTBED), the algorithm detected consecutive rises in activity level of at least 75% from the 
previous epoch for 5 minutes between 06:00 and 09:00 (Carney et al., 2004). Once the 
OUTBED criteria were met, the original epoch containing the 75% increase in counts was 
used to signify the end of sleep. 
Table 2.2 Accelerometry data collection and analytical procedures 
Information Details 
Accelerometer Model Actigraph wGT3X-BT (version 6.10.1-6.11.2; firmware 1.0.0-1.2.0) 
Serial number range 
113 unique devices were used ranging from MOS2A02140336 to MOS2A02140649; 
averaging four deployments per device 
Piezosensor orientation Triaxial 
Mode setup Mode 29 (x, y, z, steps, lux) 
Original sample rate 100 Hz (.gt3x file format) 
Deployment method Fitted in person by researcher (on day 0) 
Location worn Non-dominant wrist via nylon hook and loop strap 
Requested days of wear 7 d (10080 epochs) not including day 0 
Initialization 
Deployed in delay mode on day 0 and commenced logging on day 1 at 00:00 hrs with a 
7 d stop time indicated 
Wear instructions Wear continuously except for water based activities 
Analytical Processing  
Non-wear appropriation 
≥90 min of consecutive 0s with allowance for 2 minutes of interruptions were deemed 
biologically implausible and coded as non-wear (Choi et al., 2011; Choi et al., 2012) 
Valid day criteria ≥10 hours of valid waking wear time (Troiano et al., 2008) 
Valid file At least 4 valid days (Troiano et al., 2008) 
Missing data Data modelling or imputation was not performed 
Epoch length 60 seconds 
INBED criteria 90% reduction in counts from the previous epoch for 15 minutes (Carney et al., 2004) 
OUTBED criteria 75% increase in counts from the previous epoch for 5 minutes (Carney et al., 2004) 
Intensity classification 
Sedentary time: <1853 vmcpm (Koster et al., 2016) and <2000 vmcpm (Kamada et al., 
2016) 
Light: 2000-7499 vmcpm and 2000-8249 vmcpm (Kamada et al., 2016) 
MVPA: ≥7500 vmcpm and ≥8250 vmcpm (Kamada et al., 2016) 
 
Window identification 
In order to facilitate the aforementioned algorithm, a sub-sample of 80 (18.3%) Physical 
Activity and Respiratory Health (PhARaoH) study 60-second .agd files (comprising 20 
apparently healthy males, 20 apparently healthy females, 20 male COPD patients and 20 
female COPD patients) were used to visually inspect the suitability of using the 06:00 to 
09:00 and 21:00 to 23:59 windows as part of the sleep detection verification process. 
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Minute-by-minute vector magnitude was plotted for each of the 7 days of wear and subjected 
to visual inspection for spikes in activity between 06:00 and 09:00 and dips in activity 
between 21:00 and 00:00 (Figure 2.9). 
 
Figure 2.9 Hourly vector magnitude plots for 36 hour periods between days. Data are 
presented in the form of a stacked frequency bar chart for minute-by-minute vector 
magnitude counts for 80 participants (20 apparently healthy males, 20 apparently healthy 
females, 20 male patients and 20 female patients). Higher activity counts relate to more 
intense movement. Therefore, drops in activity intensity facilitate the identification of sleep 
and steep rises in activity counts facilitate the detection of waking behaviour. 
 
Whilst these patterns were consistently observed, for the 06:00-09:00 window it was noticed 
that activity was still relatively high before this window therefore additional criteria were 
included to identify OUTBED occurrences prior to 06:00 and after 09:00. Similarly, between 
21:00-00:00 it was noticed that activity was still relatively high after this window therefore 
additional criteria were included to identify INBED occurrences after 00:00. Consequently, 
additional criteria were put in place to account for variation in sleep/wake cycles between 
participants. 
 
 
57 
 
Post-processing data checking 
If no INBED occurrence from 21:00-23:59 was identified, the algorithm used a default 
timestamp of 23:59 and the file was flagged for visual inspection to determine the exact 
INBED occurrence. An example is provided in Figure 2.10. In these circumstances, 
participants were awake beyond midnight and the first timestamp after 23:59 was used to 
determine INBED time. In this case, the first occurrence of an INBED timestamp from 
midnight of the next day was used; in the example in Figure 2.10 this was 03:12.  
 
Figure 2.10 Example of algorithm INBED anomaly requiring visual inspection. On this day 
the wearer did not go to sleep before midnight, as signified by sustained movement detected 
after this time (vertical green line). 
 
For INBED timestamps that complied with the 21:00 to 23:59 window, visual inspection was 
required if additional timestamps were present (e.g. 21:05, 21:30 and 22:12) (Figure 2.11). 
The default timestamp (first occurrence i.e. 21:05) was altered based on visual inspection if 
subsequent spikes in activity (i.e. at 21:30 and 22:12) lasted at least two minutes at light or 
moderate intensity (≥2000vmcpm) or five minutes at a sedentary intensity (<2000vmcpm). 
For all OUTBED timestamps, an automated time-stamped detection of sustained spikes in 
vector magnitude was conducted. Files were flagged for visual inspection if a spike in 
activity occurred within one hour of the algorithm-derived timestamp. An example of when 
this occurred is provided in Figure 2.12. In this example, the algorithm has detected four 
spikes in activity of sufficient intensity and duration to signify the wearer is awake. However, 
as the algorithm was set up to provide a time stamp after 06:00, visual inspection was 
required to shift the timestamp from 06:01 to 05:33. 
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Figure 2.11 Example multiple INBED timestamps between 21:00 and 23:59 requiring visual 
inspection. On this day, the wearer went to sleep before midnight but likely had a highly 
sedentary evening. As a result, the algorithm detected two time-points where a sustained drop 
in activity intensity occurred (vertical green lines). On visual inspection it is clear that the 
first occurrence was caused by a sustained period of sedentariness. Therefore, the second 
time-point was used to classify sleep time. 
 
 
Figure 2.12 Example of OUTBED occurrences before 06:00 detected by the algorithm. On 
this day, the wearer has woken up before 06:00 and the algorithm has detected three spikes in 
activity of sufficient intensity and duration to signify the wearer is awake before this time. 
Visual inspection was required to shift the timestamp from 06:01 to 05:33. 
 
Accelerometry algorithm alterations 
Of the 436 total accelerometry files, 435 (99.8%) files were visually inspected for at least one 
day for either INBED or OUTBED classification. The whole sample of 436 files provided a 
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total number of 3052 potential days of wear for the PhARaoH participants. Of these, 2437 
(79.8%) required visual inspection for INBED detection of which 1515 (62.2%) required an 
alteration to the algorithm timestamp (originally windowed between 21:00 and 23:59). For 
OUTBED detection, 694 (22.7%) of days required visual inspection of which 598 (86.0%) 
required an alteration to the algorithm timestamp (originally windowed after 06:00).  
The distribution of the number of days requiring changes to the algorithm-derived timestamps 
for INBED and OUTBED detections is shown in Figure 2.13. For INBED detection, 25 
(5.7%) participants did not require changes to the algorithm-derived timestamps and 17 
(3.9%) participants required alterations to all seven days with an average of 3.5 days altered 
per participant. For OUTBED detection, 207 (47.5%) participants did not require changes to 
the algorithm-derived timestamps, and 11 (2.5%) participants required alterations to all seven 
days with an average of 1.4 days changed per participant.  
 
Figure 2.13 Distribution of changes to INBED and OUTBED algorithm-derived timestamps 
 
For the 1515 INBED detections requiring alterations from the original algorithm-derived 
timestamps, 596 (39.3%) were due to participants going to sleep after midnight, 870 (57.4%) 
were from adjustments made to the first timestamp after 21:00 and 49 (3.2%) were from 
visual inspection alone. Of the remaining 922 days the algorithm was not altered with 203 
(22.0%) because periods of non-wear were detected, 63 (6.8%) were for day 7 defaulting to 
23:59 and 10 (1.1%) were not altered following visual inspection. 
For the 598 OUTBED detections requiring amendment from the original algorithm output, 
540 (90.3%) were due to participants waking up before 06:00 and 58 (9.7%) were from visual 
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inspection alone. Of the remaining 96 days the algorithm was not altered with 57 (59.4%) due 
to periods of non-wear and 39 (40.6%) were not altered following visual inspection. 
Corrupt files 
During visual inspection, one corrupt file was identified (Figure 2.14), giving a variety of 
series of consecutive numbers (e.g. 6, 6, 6, 4, 4, 4, 4, 4, 8, 8, 8, 8, 8). This file was included 
for waking wear time assessment but excluded from activity analysis given the obvious 
technological fault in the sensor (i.e. such data are biologically implausible). 
 
Figure 2.14 Corrupt file FC366 seven day accelerometer plots in processed mode 
 
Accelerometry processing 
After establishing the INBED and OUTBED times for each day, sleep was coded as 0 counts 
(equivalent to non-wear) in order to be removed by non-wear algorithm during data 
processing. As a result, time spent in activity intensities were derived from waking wear time. 
Given the infancy of wrist-worn accelerometry analysis, vector magnitude counts per minute 
(vmcpm) were used to provide ‘raw’ indicators of overall movement levels. Counts per 
minute were calculated by dividing average total counts per day by average waking wear time.  
Physical activity intensities were defined according to published cut-points for sedentary time, 
light intensity activity and MVPA. Sedentary time was defined using cut-points of <1853 
vmcpm (Koster et al., 2016) and <2000 vmcpm (Kamada et al., 2016). Two sets of light 
intensity activity and MVPA cut-points were used. One set defined light activity as 2000-
7499vmcpm and MVPA as ≥7500vmcpm and the second defined light activity as 2000-
8249vmcpm and MVPA as ≥8250vmcpm (Kamada et al., 2016). 
2.4 Waking wear time compliance 
Asking participants to wear an activity monitor on the wrist for 24 hours a day (minus water-
based activities) is purported to increase overall wear compliance compared to waist-worn 
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deployments (van Hees et al., 2011). A waking-wear-time-valid-day matrix is provided in 
Table 2.3. The traditionally used criteria for adults based on waist-worn monitoring, is a 
minimum of 10 hours of waking activity data per day for at least four days (Troiano et al., 
2008). Using this definition, the PhARaoH sample achieved 98.9% compliance.  
Table 2.3 Number of participants (maximum n=436) and the percentage of the sample (%) 
providing a valid day of accelerometry data across a range of minimum waking wear time 
criteria (6-20 hours). Frequencies are highlighted to facilitate interpretation with green cells 
showing a high proportion of participants providing valid days and red cells showing a low 
proportion of participants. 
Whole sample (n=436) 
Valid 
days 
Valid day waking wear time (hours) 
≥ 8 ≥ 9 ≥ 10 ≥ 11 ≥ 12 ≥ 13 ≥ 14 ≥ 15 ≥ 16 ≥ 17 ≥ 18 ≥ 19 ≥ 20 
≥ 1 
434  
(99.5) 
434 
(99.5) 
434 
(99.5) 
434 
(99.5) 
433 
(99.3) 
433 
(99.3) 
430 
(98.6) 
429 
(98.4) 
422 
(96.8) 
348 
(79.8) 
165 
(37.8) 
46 
(10.6) 
19 
(4.4) 
≥ 2 
433  
(99.3) 
433 
(99.3) 
433 
(99.3) 
432 
(99.1) 
431 
(98.9) 
430 
(98.6) 
428 
(98.2) 
425 
(97.5) 
396 
(90.8) 
264 
(60.6) 
78 
(17.9) 
17 
(3.9) 
2 
(0.5) 
≥ 3 
432  
(99.1) 
432 
(99.1) 
431 
(98.9) 
430 
(98.6) 
429 
(98.4) 
429 
(98.4) 
426 
(97.7) 
419 
(96.1) 
348 
(79.8) 
182 
(41.7) 
46 
(10.6) 
5 
(1.1) 
1 
(0.2) 
≥ 4 
432  
(99.1) 
431 
(98.9) 
431 
(98.9) 
429 
(98.4) 
428 
(98.2) 
426 
(97.7) 
421 
(96.6) 
406 
(93.1) 
289 
(66.3) 
118 
(27.1) 
15 
(3.4) 
1 
(0.2) 
0 
(0) 
≥ 5 
428  
(98.2) 
428 
(98.2) 
426 
(97.7) 
425 
(97.5) 
424 
(97.2) 
420 
(96.3) 
411 
(94.3) 
364 
(83.5) 
235 
(53.9) 
59 
(13.5) 
8 
(1.8) 
1 
(0.2) 
0 
(0) 
≥ 6 
422  
(96.8) 
421 
(96.6) 
420 
(96.3) 
417 
(95.6) 
412 
(94.5) 
403 
(92.4) 
379 
(86.9) 
307 
(70.4) 
158 
(36.2) 
22 
(5.0) 
2 
(0.5) 
0 
(0) 
0 
(0) 
7 
401  
(92.0) 
400 
(91.7) 
393 
(90.1) 
386 
(88.5) 
374 
(85.8) 
358 
(82.1) 
296 
(67.9) 
190 
(43.6) 
66 
(15.1) 
10 
(2.3) 
0 
(0) 
0 
(0) 
0 
(0) 
 
 
The pattern of the matrix also provides information on which criteria (waking wear time or 
number of days required) has the greatest impact on whether a file is deemed valid and how 
these two factors interact. During the minimum wear-times of 8-16 hours, only a 2.7% (99.5% 
minus 96.8%) reduction in participants with at least one valid day was observed. During these 
wear-times, the choice of number of valid days required had a greater weighting on whether 
files were deemed to be valid (e.g. a 5.7% (99.5% minus 93.8%) and 81.7% (96.8% minus 
15.1%) reduction from ≥1 to seven days for ≥8 and ≥16 hours waking wear time, 
respectively). From ≥16 hours waking wear time, there were large reductions in the number 
of participants meeting valid day criteria due to the identification of sleep. 
A waking-wear-time-valid-day matrix for participants stratified by COPD diagnosis is 
provided in Table 2.4. Using a minimum of 10 hours per day for at least 4 days (Troiano et al. 
2008), COPD patients achieved 98.6% compliance and apparently healthy adults achieved 
99.0% compliance. COPD patients exceeded the most compliant group in the National Health 
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and Nutrition Examination Survey (84% meeting 10 hours on at least 4 days criteria) 
(Troiano et al., 2008) with a more stringent criterion of at least 13 hours for all seven days 
whilst the non-COPDs exceeded it with at least 14 hours for at least six days. Therefore, 
wrist-worn monitor deployment resulted in a greatly improved compliance regardless of 
COPD diagnosis. 
Table 2.4 Number of participants and the percentage of the sample (%) stratified by COPD 
diagnosis providing a valid day of accelerometry data across a range of minimum waking 
wear time criteria (6-20 hours). Frequencies are highlighted to facilitate interpretation with 
green cells showing a high proportion of participants providing valid days and red cells 
showing a low proportion of participants. 
COPD (n=139) 
Valid 
days 
Valid day waking wear time criteria (hours) 
≥ 8 ≥ 9 ≥ 10 ≥ 11 ≥ 12 ≥ 13 ≥ 14 ≥ 15 ≥ 16 ≥ 17 ≥ 18 ≥ 19 ≥ 20 
≥ 1 
138  
(99.3) 
138 
(99.3) 
138 
(99.3) 
138 
(99.3) 
138 
(99.3) 
138 
(99.3) 
136 
(97.8) 
135 
(97.1) 
134 
(96.4) 
116 
(83.5) 
71 
(51.1) 
23 
(16.5) 
9 
(6.5) 
≥ 2 
138  
(99.3) 
138 
(99.3) 
138 
(99.3) 
138 
(99.3) 
137 
(98.6) 
136 
(97.8) 
136 
(97.8) 
134 
(96.4) 
129 
(92.8) 
93 
(66.9) 
41 
(29.5) 
11 
(7.9) 
1 
(0.7) 
≥ 3 
137  
(98.6) 
137 
(98.6) 
137 
(98.6) 
137 
(98.6) 
136 
(97.8) 
136 
(97.8) 
135 
(97.1) 
133 
(95.7) 
115 
(82.7) 
73 
(52.5) 
22 
(15.8) 
3 
(2.2) 
1 
(0.7) 
≥ 4 
137  
(98.6) 
137 
(98.6) 
137 
(98.6) 
136 
(97.8) 
136 
(97.8) 
136 
(97.8) 
135 
(97.1) 
132 
(95.0) 
100 
(71.9) 
52 
(37.4) 
8 
(5.8) 
1 
(0.7) 
0 
(0) 
≥ 5 
137  
(98.6) 
137 
(98.6) 
136 
(97.8) 
136 
(97.8) 
136 
(97.8) 
135 
(97.1) 
134 
(96.4) 
121 
(87.1) 
87 
(62.6) 
24 
(17.3) 
4 
(2.9) 
1 
(0.7) 
0 
(0) 
≥ 6 
137  
(98.6) 
136 
(97.8) 
135 
(97.1) 
134 
(96.4) 
133 
(95.7) 
133 
(95.7) 
126 
(90.6) 
108 
(77.7) 
65 
(46.8) 
11 
(7.9) 
2 
(1.4) 
0 
(0) 
0 
(0) 
7 
131  
(94.2) 
131 
(95.7) 
127 
(91.4) 
126 
(90.6) 
122 
(87.8) 
121 
(87.1) 
100 
(71.9) 
73 
(52.5) 
31 
(22.3) 
6 
(4.3) 
0 
(0) 
0 
(0) 
0 
(0) 
Apparently healthy adults (n=297) 
Valid 
days 
Valid day waking wear time criteria (hours) 
≥ 8 ≥ 9 ≥ 10 ≥ 11 ≥ 12 ≥ 13 ≥ 14 ≥ 15 ≥ 16 ≥ 17 ≥ 18 ≥ 19 ≥ 20 
≥ 1 
296  
(99.7) 
296 
(99.7) 
296 
(99.7) 
296 
(99.7) 
295 
(99.3) 
295 
(99.3) 
294 
(99.0) 
294 
(99.0) 
288 
(97.0) 
232 
(78.1) 
94 
(31.6) 
23 
(7.7) 
10 
(3.4) 
≥ 2 
295  
(99.3) 
295 
(99.3) 
295 
(99.3) 
294 
(99.0) 
294 
(99.0) 
294 
(99.0) 
292 
(98.3) 
291 
(98.0) 
267 
(89.9) 
171 
(57.6) 
37 
(12.5) 
6 
(2.0) 
1 
(0.3) 
≥ 3 
295  
(99.3) 
295 
(99.3) 
294 
(99.0) 
293 
(98.7) 
293 
(98.7) 
293 
(98.7) 
291 
(98.0) 
286 
(96.3) 
233 
(78.5) 
109 
(36.7) 
24 
(8.1) 
2 
(0.7) 
0 
(0) 
≥ 4 
295  
(99.3) 
294 
(99.0) 
294 
(99.0) 
293 
(98.7) 
292 
(98.3) 
290 
(97.6) 
286 
(96.3) 
274 
(92.3) 
189 
(63.6) 
66 
(22.2) 
7 
(2.4) 
0 
(0) 
0 
(0) 
≥ 5 
291  
(98.0) 
291 
(98.0) 
290 
(97.6) 
289 
(97.3) 
288 
(97.0) 
285 
(96.0) 
277 
(93.3) 
243 
(81.8) 
148 
(49.8) 
35 
(11.8) 
4 
(1.3) 
0 
(0) 
0 
(0) 
≥ 6 
285  
(96.0) 
285 
(96.0) 
285 
(96.0) 
283 
(95.3) 
279 
(93.9) 
270 
(90.9) 
253 
(85.2) 
199 
(67.0) 
93 
(31.3) 
11 
(3.7) 
0 
(0) 
0 
(0) 
0 
(0) 
7 
270  
(90.9) 
269 
(90.6) 
266 
(89.6) 
260 
(87.5) 
252 
(84.8) 
237 
(79.8) 
196 
(66.0) 
117 
(39.4) 
35 
(11.8) 
4 
(1.3) 
0 
(0) 
0 
(0) 
0 
(0) 
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2.5 PhARaoH sample characteristics 
Table 2.5 shows the overall activity levels of the whole sample and between individuals with 
and without a diagnosis of COPD. Of the 436 PhARaoH participants, one accelerometer file 
was corrupt, two COPD patients did not meet valid day criteria and three control participants 
did not meet valid day criteria. COPD and control groups did not differ for the number of 
valid days provided (p=0.724) but COPD patients had longer waking wear time (999±73 
versus 980±69 minutes, p<0.001).  There was no significant difference in waking hours non-
wear time between COPD and apparently healthy adults (p=0.888). COPD patients were 
more sedentary and accrued less time in light intensity activity and MVPA with these 
differences remaining when accounting for overall waking wear time (p<0.001).  
Table 2.5 Accelerometry data for the whole sample and stratified by COPD diagnosis.  
  
  
Whole  
Sample 
COPD  
patients 
Apparently 
healthy adults  
Demographics    
Age (years) 59.7 (9.3) 65.8 (7.0) 56.8 (8.9) 
Gender (female, %) 234 (53.7) 47 (33.8) 187 (63.0) 
Employment status (%):    
Employed 214 (49.2) 36 (26.1) 178 (59.9) 
Unemployed 44 (10.1) 16 (11.6) 28 (9.4) 
Retired 177 (40.6) 86 (61.9) 91 (30.6) 
Household income β (%):    
<£18,000 124 (28.8) 51 (37.2) 73 (24.8) 
£18,000-30,999 113 (26.2) 37 (27.0) 76 (25.9) 
£31,000-51,999 79 (18.3) 23 (16.8) 56 (18.9) 
£52,000-99,999 60 (13.9) 6 (4.4) 54 (18.2) 
≥£100,000 7 (1.6) 0 (0) 7 (2.4) 
IMD deprivation score 19.3 (15.0) 22.2 (17.9) 17.9 (13.2) 
Postcode percentage green space 44.0 (30.9) 168.8 (9.1) 41.6 (29.9) 
Accelerometry    
Number of Valid Days  6.8 (0.8) 6.8 (0.9) 6.8 (0.8) 
Valid day frequencies (%, cum%):    
7 392 (91.2) 127 (92.7) 265 (90.4) 
6 27 (6.3, 97.5) 8 (5.8, 98.5) 19 (6.5, 96.9) 
5 6 (1.4, 98.9) 1 (0.7, 99.2) 5 (1.7, 98.6) 
4 5 (1.1, 100) 1 (0.7, 100) 4 (1.4, 100) 
Waking Wear Time  
(min per day) 
960.3 (61.4) 968.6 (67.2) 956.4 (58.2) * 
Non-wear time (min per day) 30.7 (70.4) 33.0 (87.1) 29.6 (61.3) 
Sleep (min per day) 448.3 (54.5) 437.4 (62.3) 453.3 (49.9) * 
Sedentary < 1853 vmcpm  (min per day) 523.7 (108.1) 579.9 (95.2) 497.7 (104.0) * 
Sedentary < 2000 vmcpm (min per day) 541.7 (108.4) 597.9 (94.5) 515.5 (104.5) * 
Light 2000-7499vmcpm (min per day) 388.9 (96.4) 356.0 (97.3) 404.3 (92.2) * 
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Light 2000-8249vmcpm  (min per day) 400.8 (102.2) 362.1 (101.6) 418.9 (97.6) * 
MVPA ≥7500 (min per day) 30.0 (28.6) 15.9 (15.7) 36.6 (30.8) * 
MVPA ≥8250 (min per day) 17.7 (19.2) 8.4 (10.0) 22.0 (20.9) * 
Vector magnitude counts per minute 2290.9 (621.4) 1941.5 (489.7) 2454.4 (609.5) * 
Respiratory health    
Smoking status (%):    
Current 39 (8.9) 24 (17.3) 15 (5.1) 
Former 178 (40.8) 97 (69.8) 81 (27.3) 
Never 219 (50.2) 18 (12.9) 201 (67.7) 
FEV1 (L) 2.3 (0.7) 1.9 (0.7) 2.5 (0.7) 
FEV1%pred 87.9 (23.1) 70.2 (21.2) 96.2 (13.9) 
FVC (L) 3.5 (1.0) 3.6 (1.0) 3.5 (0.9) 
FEV1/FVC 66.9 (13.1) 53.2 (13.1) 73.3 (6.5) 
mMRC score 0.7 (0.8) 1.1 (0.9) 0.5 (0.6) 
Body composition    
BMI (kg/m2) 27.5 (5.4) 28.3 (5.7) 27.2 (5.2) 
Percentage body fat 29.7 (8.4) 28.0 (8.8) 30.4 (8.1) 
Waist circumference (cm) 93.6 (14.8) 100.2 (14.5) 90.6 (13.9) 
Physical function    
ISWT (m) 481.5 (191.0) 381.8 (158.5) 527.4 (187.4) 
QMVC (kg) 34.4 (13.5) 34.7 (12.3) 34.2 (14.1) 
Grip strength (kg) 34.7 (10.6) 36.2 (10.5) 33.9 (10.6) 
Usual walking speed (%):    
Slow 66 (15.1) 40 (28.8) 26 (8.8) 
Average 249 (57.1) 77 (55.4) 172 (57.9) 
Fairly brisk 111 (25.5) 20 (14.4) 91 (30.6) 
Brisk 10 (2.3) 2 (1.4) 8 (2.7) 
Abbreviations: cum%, cumulative percentage; MVPA, moderate-to-vigorous physical activity; vmcpm, vector 
magnitude counts per minute 
* p<0.05 
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Chapter 3: Study One 
Title: Correlates of objectively measured physical activity and sedentary time in mild-
moderate COPD patients: Comparisons with apparently healthy adults 
3.1 Introduction 
COPD patients with moderate-severe airflow obstruction are typically less physically active 
and more sedentary compared with apparently healthy adults (Pitta et al., 2005); placing them 
at increased risk of hospitalisation and premature mortality (Garcia-Aymerich et al., 2003). 
For these patients with more advanced COPD, severe airflow limitation and more frequent 
exacerbations likely puts these patient at a greater risk of avoiding physical activity and 
spending more time sedentary; resulting in a downward spiral of muscle deconditioning, 
reduced fitness and increased breathlessness (Cooper, 2009; Polkey & Moxham, 2006). 
However, there is a paucity of data on the physical activity of patients with mild-moderate 
COPD and whether their behaviour differs from apparently healthy adults (Park et al., 2013; 
Van Helvoort et al., 2016). Furthermore, a greater understanding of factors associated with 
behaviour in mild-moderate COPD patients is pivotal for understanding how best to improve 
patients’ lifestyles. Furthermore, research to date has largely focussed on physical activity, 
rather than examining the full 24 hour day, which includes sedentary behaviour, "defined as 
any waking activity characterized by an energy expenditure ≤1.5 METS and a sitting or 
reclining posture” (Sedentary Behaviour Research, 2012). 
Identifying correlates of physical activity and sedentary behaviour are an important step in 
developing tailored interventions. The extent to which physical activity and sedentary 
behaviour share common correlates has not been sufficiently explored in mild-moderate 
COPD patients (Park et al., 2013). Understanding the factors influencing patients’ physical 
activity and sedentary behaviour is needed to inform the development of tailored 
interventions.  
A systematic review of 86 studies published in 2014 revealed inconsistent associations for a 
range of socio-demographic, lifestyle, environmental, clinical and functional factors with 
physical activity (Gimeno-Santos et al., 2014). Potential reasons for these discrepant findings 
may be related to most studies failing to adjust associations for potential confounders and 
only half of the studies used objective measures of behaviour (Gimeno-Santos et al., 2014). 
Whilst the use of objective monitoring to assess physical activity is improving in studies 
related to COPD, more work is needed to refine the accuracy and reliability of processing and 
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utilisation (Byrom & Rowe, 2016). Of the identified cross-sectional studies, only two 
specifically examined mild-moderate COPD patients compared to 12 studies specifically 
studying patients with moderate to very severe airflow obstruction. In addition, only seven 
studies included a control group in their analysis (mean n=29±16) (Gimeno-Santos et al., 
2014); limiting comparisons to healthier adults. This is particularly important for mild-
moderate COPD patients who may share similar correlates to physical activity as the general 
adult populations free from respiratory disease.  
Exercise capacity, as measured by the 6MWD, has been found to be the strongest correlate of 
time spent walking (partial R2=0.56), standing (partial R2=0.35) and movement intensity 
(partial R2=0.23) (Pitta et al., 2005). In a study of 73 COPD patients (67±7 years, 60% female 
FEV1%pred 43±16), lung function was found to explain the highest proportion of variance in 
physical activity (R2=0.20) followed by walking speed (R2=0.18), quadriceps strength 
(R2=0.16) and fat-free mass index (R2=0.08) (Andersson et al., 2013). Additionally, 
quadriceps muscle wasting and poor exercise capacity have been negatively associated with 
physical activity in mild-moderate COPD patients (Hartman et al., 2013; Shrikrishna et al., 
2012). Modified MRC score has also been independently associated with physical activity 
level and step count (Adami et al., 2015) with patients reporting an mMRC score of four 
averaging less than 2000 steps per day (Watz et al., 2009). 
Factors relating to sedentary behaviour and low intensity activity in this population have been 
scarcely examined (Park et al., 2013). This is an important knowledge gap given the 
sedentary lifestyles of many COPD patients (Kawagoshi et al., 2013) and the cardiometabolic 
health risks from spending too much time sedentary, independent of time spent in MVPA 
(Healy et al., 2007; Healy et al., 2008). In a US study, correlates of accelerometer assessed 
sedentary time were found to be different to those of physical activity; highlighting the 
importance of specifically examining this type of behaviour (Park et al., 2013). Furthermore, 
as both sedentary behaviour and light intensity activity have been associated with a reduced 
risk of hospitalisation (Andrzejowski et al., 2015; Donaire-Gonzalez et al., 2015) it seems 
pertinent to concomitantly explore behavioural correlates across the intensity spectrum. 
This study aimed to (i) compare the objectively measured physical activity and sedentary 
time and (ii) identify correlates of physical activity and sedentary time for mild-moderate 
patients and apparently healthy adults. It was hypothesised that mild-moderate COPD 
patients would be less physically active and more sedentary compared with apparently 
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healthy adults. Also, it was hypothesised that correlates would differ between groups and 
between physical activity and sedentary time. 
3.2 Methods 
Data used in this chapter was taken from the PhARaoH Study as described in Chapter 2 and 
has been previously published (Orme et al., 2016). 
Inclusion/exclusion criteria 
The original PhARaoH sample comprised 139 COPD patients (31.9%) and 297 apparently 
healthy adults (68.1%). COPD patients were excluded from the present study due to: being 
classified as GOLD III or IV (n=21), spirometry not being conducted (n=2), non-white 
ethnicity (n=5) and less than four valid days of accelerometry (n=2). Apparently healthy 
adults were excluded from the present study due to: reporting a respiratory condition (n=50), 
spirometry not being conducted (n=4), non-white ethnicity (n=107) and less than four valid 
days of accelerometry (n=1). The final sample comprised 109 COPD patients (80.1% of 
original patient cohort) and 135 apparently healthy adults (45.5% of original non-patient 
cohort) (Figure 3.1).  
 
Figure 3.1 Derivation of the present study sample from the original PhARaoH cohort 
 
 
68 
 
Statistical analysis 
Analyses were conducted using SPSS (version 23.0). Data are reported as mean (SD) with 
group comparisons performed using independent t-tests. Frequency comparisons between 
groups were performed using Chi-square (n>5) or Fischer exact test (n≤5). Covariate-
adjusted group comparisons for ratio data were performed using analysis of covariance 
(ANCOVA) controlling for age, gender, smoking status, employment status and 
accelerometer waking wear time where appropriate. 
Univariate analyses were conducted using partial correlations between predictors 
(independent variables) and behaviour (dependent variables). Strength of associations (Partial 
r) were interpreted as follows: Partial r 0.00-0.19 “very weak”; 0.20-0.39 “weak”; 0.40-0.59 
“moderate”; 0.60-0.79 “strong” and 0.80-1.00 “very strong” (Evans, 1996). Forced entry 
linear regressions were used to examine predictors of physical activity and sedentary time, 
controlling for the above covariates. Variables reaching statistical significance (p<0.05) for 
either patients or apparently healthy adults were entered into stepwise multivariate linear 
regression models to identify independent predictors of behaviour. For all models, data were 
checked for linear relationship, absence of multicollinearity, homoscedasticity and a normal 
distribution of residuals. 
3.3 Results 
3.3.1 Sample characteristics 
The distribution of GOLD stages for COPD patients were 13 (11.9%) normal spirometry 
(GOLD 0), 32 (29.4%) mild and 64 (58.7%) moderate. For COPD patients, 26.6% reported 
an mMRC dyspnea grade of 0 (“Not troubled by breathlessness except on strenuous 
exercise”), 54.1% reported an mMRC of 1, 12.8% reported an mMRC of 2 and 6.4% reported 
an mMRC of 3 (“Stops for breath after walking about 100m or after a few minutes on the 
level”). For apparently healthy adults, 71.9% reported an mMRC of 0, 25.9% reported an 
mMRC of 1 and 0.7% reported an mMRC of 2. On average, patient had been living with a 
diagnosis of COPD for a median (IQR) of 5.0 (9.3) years. 
Unadjusted sample characteristics are provided in Table 3.1. COPD patients were older, 
comprised fewer females, were more likely to be retired, had a lower household income, had 
a higher postcode deprivation score, comprised more current and former smokers, were more 
breathless, had a higher BMI and larger waist circumference, reported a lower usual walking 
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speed and achieved a shorter ISWT distance compared with apparently healthy adults. COPD 
patients had a low perceived general health index; reported more limitations with mobility, 
performing self-care tasks and usual activities and reported higher levels of pain or 
discomfort (Appendix I). Despite having a greater average BMI, the prevalence of 
overweight (41.3 versus 34.8%) or obesity (30.3 versus 25.2%) did not differ significantly 
between patients and apparently healthy adults.  
3.3.2 Physical activity and sedentary time 
Overall accelerometer compliance (≥10 waking hours) for seven days was 94.7%, ≥six days 
was 98.8% and ≥five days was 99.6%. Compliance did not differ significantly between 
COPD patients and apparently healthy adults. Average accelerometer waking wear time was 
957.2±50.6 minutes with COPD patients having longer waking wear time than apparently 
healthy adults (965.2±50.7 versus 950.6±49.8 minutes).  
Accelerometry-derived physical activity and sedentary time analysis revealed COPD patients 
to be more sedentary (by ~75 minutes/day) and accumulated less time in light activity (by 
~43 minutes/day) and MVPA (by ~20 minutes/day) compared with apparently healthy adults 
(Table 3.1). Average movement intensity (VMCPM) was significantly lower for COPD 
patients. These observations remained after controlling for confounders (age, gender, 
smoking status, employment status and accelerometer waking wear time). 
Table 3.1 Sample characteristics stratified by COPD status, reported as mean (SD) unless 
otherwise stated (* p<0.05) 
  
Whole  
sample  
(n=244) 
COPD 
patients 
(n=109) 
Apparently  
healthy adults 
(n=135) 
Demographics  
Age (years) 61.7 (8.9) 65.7 (7.1) 58.5 (9.0) * 
Gender (female, %) 131 (53.7) 42 (38.5) 89 (65.9) * 
Employment status (%):    
Employed 100 (41.0) 28 (25.7) 72 (53.3) * 
Unemployed 19 (7.8) 12 (11.0) 7 (5.2) * 
Retired 125 (51.2) 69 (63.3) 56 (41.5) * 
Household income β (%):    
<£18,000 55 (22.5) 40 (36.7) 15 (11.1) * 
£18,000-30,999 70 (28.7) 31 (28.4) 39 (28.9) 
£31,000-51,999 54 (22.1) 17 (15.6) 37 (27.4) * 
£52,000-99,999 40 (16.4) 6 (5.5) 34 (25.2) * 
≥£100,000 4 (1.6) 0 (0) 4 (3.0) * 
IMD deprivation score 17.2 (15.7) 21.6 (17.8) 13.8 (12.8) * 
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Postcode percentage green space 50.4 (31.2) 51.4 (31.7) 49.6 (30.9) 
24-hour accelerometry-derived behaviour  
Waking wear time (min) 957.2 (50.6) 965.2 (50.7) 950.6 (49.8) * 
Sleep (min) 449.7 (53.6) 440.7 (62.8) 456.8 (44.1) * 
VMCPM  2245 (573) 1974 (489) 2465 (543) * 
Sedentary (min) 549.0 (99.7) 591.7 (90.4) 514.3 (93.4) * 
Light activity (min) 379.8 (85.2) 356.3 (96.2) 399.0 (69.8) * 
MVPA (min) 28.2 (25.6) 17.1 (16.1) 37.2 (28.3) * 
Respiratory health 
Smoking status (%): 
   Current 26 (10.7) 18 (16.5) 8 (5.9) * 
Former 138 (56.6) 78 (71.6) 60 (44.4) * 
Never 79 (32.4) 12 (11.0) 67 (49.6) * 
Pack years 30.1 (24.4) 38.8 (25.0) 14.4 (12.8) * 
FEV1 (L) 2.5 (0.7) 2.0 (0.7) 2.8 (0.6) * 
FEV1%pred 93.2 (23.5) 76.2 (17.8) 107.0 (17.9) * 
FVC (L) 3.8 (0.9) 3.6 (1.0) 3.9 (0.8) * 
FEV1/FVC 65.3 (12.1) 56.0 (11.2) 72.8 (6.3) * 
mMRC score 0.6 (0.7) 1.0 (0.8) 0.3 (0.5) * 
Perceived general health    
General health index value 0.840 (0.157) 0.775 (0.181) 0.893 (0.109) * 
General health VAS score 82.0 (15.4) 75.0 (18.0) 87.7 (9.9) * 
Body composition 
BMI (kg/m2) 27.7 (5.4) 28.6 (5.6) 26.9 (5.2) * 
Percentage body fat 29.3 (8.4) 28.8 (8.6) 29.7 (8.2) 
Waist circumference (cm) 94.4 (15.0) 99.9 (13.9) 89.9 (14.4) * 
Physical function 
ISWT (m) 495.8 (200.6) 387.4 (158.5) 580.1 (189.5) * 
QMVC (kg) 36.8 (14.1) 34.9 (13.2) 38.3 (14.7) 
Grip strength (kg) 35.9 (10.7) 35.7 (10.9) 36.0 (10.5) 
Usual walking speed (%):    
Slow 32 (13.1) 29 (26.6) 3 (2.2) * 
Average 136 (55.7) 63 (57.8) 73 (54.1) 
Fairly brisk 71 (29.1) 15 (13.8) 56 (41.5) * 
Brisk 5 (2.0) 2 (1.8) 3 (2.2) 
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in one second; FEV1%pred, forced 
expiratory volume in one second percentage predicted; FVC, forced vital capacity; IMD, index of multiple 
deprivation; ISWT, incremental shuttle walk test; LPA, light physical activity; mMRC, modified Medical 
Research Council; MVPA, moderate-to-vigorous physical activity; QMVC, quadriceps maximal voluntary 
contraction; VAS, visual analogue scale; VMCPM, vector magnitude counts per minute 
β, 15 (13.7%) COPD patients and 6 (4.5%) apparently healthy adults did not provide an answer 
 
Figure 3.2 shows the proportion of time spent sleeping, sedentary, in light activity and in 
MVPA for COPD patients (Panel A) and apparently healthy adults (Panel B). COPD patients 
spent 42% of their day sedentary (equating to almost 66% of the waking day) compared with 
37% for apparently healthy adults (equating to just over 50% of their waking day).  
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Apparently healthy adults accumulated almost three times the amount of MVPA per day 
compared to COPD patients.  
 
Figure 3.2 Physical activity, sedentary time and sleep as a percentage of an average 24-hour 
day for COPD patients (Panel A) and apparently healthy adults (Panel B) 
 
3.3.3 Univariate correlates of behaviour 
COPD patients 
Partial correlations (controlling for accelerometer waking wear time) showed that being male, 
mMRC score, problems with mobility, problems performing usual activities, BMI and waist 
circumference were positively associated with sedentary time (Table 3.2). General health 
index value, general health score, usual walking speed and ISWT were significantly 
negatively associated with sedentary time. The same variables (except for general health 
score and index) value were associated with light activity, but in the opposite direction. For 
MVPA, significant positive associations were observed for general health score, usual 
walking speed and ISWT. Significant negative associations were found for age, mMRC score, 
problems with self-care (e.g. washing, getting dressed) and waist circumference. The strength 
of associations for all variables were either “weak” or “very weak”. Retired COPD patients 
had significantly lower levels of MVPA than employed patients, after controlling for 
accelerometer waking wear time (13.4±1.8 versus 25.2±2.3 min, p=0.002). 
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Apparently healthy adults 
Factors significantly positively associated with sedentary time in apparently healthy adults 
based on partial correlations were age, postcode deprivation, mMRC score, BMI, percentage 
body fat and waist circumference (Table 3.3). Usual walking speed and ISWT were 
significantly negatively correlated with sedentary time. The same variables (except for age), 
in the opposite direction, were associated with light activity.  Factors significantly positively 
associated with MVPA were usual walking speed and ISWT. Age and waist circumference 
were significantly negatively associated with MVPA. The strength of associations for all 
variables were either “weak” or “very weak”. Retired apparently healthy adults had 
significantly lower levels of MVPA than employed apparently healthy adults controlling for 
accelerometer waking wear time (28.4±3.7 versus 45.1±3.2 min, p=0.002). 
3.3.4 Independent correlates of behaviour 
Factors significantly correlated with each activity variable (VMCPM, sedentary time, light 
activity and MVPA) were entered into linear regression models, controlling for age, gender, 
smoking status, employment status and accelerometer waking wear time (Table 3.3). 
Separately for the two samples (COPD patients and apparently healthy adults), factors 
associated with behavioural variables were then included in stepwise multiple linear 
regression models to identify independent correlates of physical activity and sedentary time 
(Table 3.4). When multiple measures of the same construct were present, only one measure 
was entered into the models. For perceived general health the index value was preferentially 
entered, for body composition percentage body fat was preferentially entered and for physical 
function ISWT was preferentially entered.  
COPD patients 
Regression analyses revealed that modified MRC score, problems with mobility, problems 
with self-care, problems performing usual activities, general health score, BMI, percentage 
body fat and waist circumference and ISWT were correlates of VMCPM. Modified mMRC 
score, problems with mobility, BMI, percentage body fat, waist circumference and ISWT 
were correlates of sedentary time and light intensity activity in COPD patients. Problems with 
self-care and ISWT were correlates of MVPA. Partial regression plots for factors 
independently associated with sedentary time (percentage body fat (Panel A) and mMRC 
(Panel B)) and MVPA (ISWT distance (Panel C)) are provided in Appendix J. 
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Apparently healthy adults 
Regression analyses revealed that modified MRC score, BMI, percentage body fat, waist 
circumference and ISWT were correlates of VMCPM, sedentary time and light intensity 
physical activity. Percentage body fat and ISWT were correlates of MVPA. Partial regression 
plots for factors independently associated with sedentary time (ISWT distance (Panel A) and 
percentage body fat (Panel B)) and MVPA (percentage body fat (Panel C)) are provided in 
Appendix K. 
Table 3.2 Partial correlations between correlates and time spent sedentary and in physical 
activity, after controlling for accelerometer waking wear time (bold, p<0.05). For 
significantly correlated variables, partial r is colour-coded according to strength of 
associations: Dark orange “very weak” and amber “weak”. 
 
VMCPM Sedentary  Light MVPA 
COPD AHA COPD AHA COPD AHA COPD AHA 
Demographics 
Age -0.253 -0.284 0.109 0.173 -0.047 -0.073 -0.378 -0.330 
Gender A -0.168 -0.137 0.233 0.120 -0.214 -0.110 -0.181 -0.083 
Income B 0.061 0.109 0.024 -0.123 -0.023 0.092 -0.011 0.135 
IMD deprivation 0.031 -0.221 0.047 0.109 -0.065 -0.103 0.089 -0.067 
Postcode green space -0.193 0.014 0.100 0.009 -0.076 -0.010 -0.167 -0.003 
Respiratory health 
Smoking status C -0.064 0.111 0.026 -0.150 -0.021 0.130 -0.038 0.123 
Pack years 0.024 0.014 0.032 0.008 -0.028 -0.024 -0.035 0.038 
FEV1 -0.025 0.006 0.090 0.048 -0.117 -0.082 0.123 0.059 
FEV1%pred 0.002 0.086 -0.019 -0.010 -0.006 0.001 0.144 0.027 
mMRC score -0.301 -0.219 0.301 0.240 -0.296 -0.226 -0.123 -0.156 
Perceived general health 
Index value 0.258 0.103 -0.207 0.020 0.190 -0.049 0.163 0.068 
Mobility D -0.287 -0.107 0.268 0.075 -0.252 -0.047 -0.174 -0.105 
Self-care D -0.189 -0.031 0.146 -0.028 -0.119 0.061 -0.197 -0.068 
Usual activities D -0.245 -0.098 0.202 0.027 -0.181 -0.004 -0.178 -0.071 
Pain/discomfort D -0.178 -0.130 0.145 0.029 -0.127 0.027 -0.143 -0.150 
Anxiety/depression D 0.001 0.005 -0.018 -0.046 0.015 0.033 0.022 0.055 
Health scale 0.198 0.189 -0.190 -0.144 0.166 0.121 0.191 0.127 
Body composition 
BMI -0.239 -0.296 0.199 0.337 -0.193 -0.357 -0.099 -0.118 
Percentage body fat -0.119 -0.210 0.069 0.241 -0.076 -0.239 0.018 -0.125 
Waist circumference -0.318 -0.324 0.306 0.350 -0.285 -0.341 -0.211 -0.195 
Physical function 
ISWT 0.326 0.301 -0.270 -0.314 0.225 0.286 0.331 0.263 
QMVC 0.052 0.065 -0.002 -0.013 0.009 -0.028 -0.039 0.108 
Grip strength -0.117 -0.030 0.154 0.037 -0.148 -0.051 -0.084 0.016 
Usual walking speed E 0.277 0.292 -0.219 -0.241 0.191 0.182 0.228 0.264 
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Abbreviations: AHA, apparently healthy adults; BMI, body mass index; FEV1, forced expiratory volume in one 
second; FEV1%pred, forced expiratory volume in one second percentage predicted; IMD, index of multiple 
deprivation; ISWT, incremental shuttle walk test; LPA, light intensity physical activity; mMRC, modified 
Medical Research Council; MVPA, moderate-to-vigorous physical activity; QMVC, quadriceps maximal 
voluntary contraction; vmcpm, vector magnitude counts per minute 
A, 0=female, 1=male; B, 1= less than £18,000, 2=£18,000-30,999, 3=£31,000-51,999, 4=£52,000-99,999, 
5=£100,000+; C, 1=current, 2=former, 3=never; D, 1=no, 2=slight, 3=moderate, 4=severe, 5=unable/extreme 
(problems/pain/anxiety); E, 1=slow, 2= average, 3=fairly brisk, 4= brisk 
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Table 3.3 Linear regression analysis, controlling for age, gender, smoking status, employment status and accelerometer waking wear time, with 
VMCPM, sedentary time, light activity and MVPA as the dependent variables for COPD patients and apparently healthy adults (bold, p<0.05) 
 
VMCPM Sedentary time Light activity MVPA  
 
COPD AHA COPD AHA COPD AHA COPD AHA 
Variables 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
B 
(SE) 
Partial  
R2 
Respiratory health 
mMRC score -222.78 (53.84) 0.144 
-228.50  
(96.32) 0.043 
35.98  
(10.81) 0.099 
39.780  
(15.062) 0.053 
-33.334  
(10.367) 0.093 
-32.234  
(12.629) 0.050 
-2.642  
(1.794) 0.021 
-7.543  
(5.080) 0.017 
Perceived general health 
Index 
Value 
581.10 
(261.21) 0.047 
54.90 
(428.98) <0.001 
-79.43 
(50.43) 0.024 
56.227 
(70.328) 0.005 
69.976 
(48.357) 0.021 
-49.161 
(60.545) 0.005 
9.458 
(8.102) 0.014 
-7.123 
(21.865) 0.001 
Mobility A -131.35  (50.74) 0.062 
-84.08  
(127.77) 0.003 
23.71  
(9.58) 0.057 
6.560  
(20.192) 0.001 
-21.746  
(9.177) 0.052 
-5.366  
(17.095) 0.001 
-1.971  
(1.558) 0.016 
-1.192  
(6.661) <0.001 
Self-care A -202.05 (95.27) 0.042 
68.31  
(375.19) <0.001 
19.47  
(18.75) 0.011 
-40.162  
(58.975) 0.004 
-13.265  
(17.972) 0.005 
45.160  
(49.856) 0.006 
-6.204  
(2.937) 0.042 
-5.018  
(19.481) 0.001 
Usual  
activities A 
-153.21  
(58.79) 0.064 
-146.15  
(158.32) 0.007 
22.38  
(11.35) 0.038 
2.563  
(25.738) <0.001 
-19.907  
(10.879) 0.033 
1.364  
(22.160) <0.001 
-2.484  
(1.830) 0.018 
-3.928  
(7.977) 0.002 
Health scale 5.31  (2.57) 0.040 
8.92  
(4.60) 0.029 
-0.77  
(0.49) 0.024 
-1.017 
 (0.733) 0.015 
0.631  
(0.467) 0.018 
0.678  
(0.622) 0.009 
0.137  
(0.077) 0.030 
0.340  
(0.240) 0.016 
Body composition 
BMI -19.81  (8.01) 0.057 
-33.73  
(8.63) 0.107 
3.54  
(1.51) 0.052 
5.737  
(1.351) 0.125 
-3.217  
(1.446) 0.047 
-4.845  
(1.143) 0.124 
-0.319 
(0.245) 0.017 
-0.891  
(0.466) 0.028 
Percentage  
body fat 
-25.88  
(7.07) 0.116 
-25.62  
(6.17) 0.120 
4.61  
(1.36) 0.103 
4.195  
(0.973) 0.130 
-4.313  
(1.298) 0.099 
-3.355 
 (0.830) 0.116 
-0.297  
(0.226) 0.017 
-0.839  
(0.328) 0.050 
Waist Circ. -9.77  (3.28) 0.080 
-12.00  
(3.42) 0.088 
1.67  
(0.62) 0.067 
2.065  
(0.534) 0.106 
-1.485  
(0.596) 0.058 
-1.705 
(0.453) 0.100 
-0.182  
(0.101) 0.031 
-0.359  
(0.182) 0.030 
Physical function 
ISWT 1.22  (0.30) 0.149 
1.02  
(0.25) 0.120 
-0.19  
(0.06) 0.099 
-0.164  
(0.039) 0.125 
0.155  
(0.056) 0.074 
0.130  
(0.033) 0.110 
0.033  
(0.009) 0.116 
0.034  
(0.013) 0.049 
Usual walking 
speed B 
200.71  
(65.02) 0.085 
222.21 
(77.69) 0.060 
-27.92 
(12.60) 0.046 
-30.392 
(12.357) 0.045 
22.181  
(12.132) 0.032 
20.714 
(10.543) 0.030 
5.739 
(1.973) 0.077 
9.698  
(4.051) 0.043 
Abbreviations: AHA, apparently healthy adults; BMI, body mass index; ISWT, incremental shuttle walk test; mMRC, modified Medical Research Council; vmcpm, vector 
magnitude counts per minute 
A, 1=no, 2=slight, 3=moderate, 4=severe, 5=unable/extreme problems; B, 1=slow, 2= average, 3=fairly brisk, 4= brisk 
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Table 3.4 Stepwise multiple linear regression analysis identifying variables associated with 
physical activity and sedentary time; controlling for age, gender, smoking status, employment 
status and accelerometer waking wear time 
VMCPM 
 B (SE) Partial R2 p 
COPD (R2=0.283)    mMRC score -179.363 (54.682) 0.096 0.001 
Percentage body fat -19.054 (7.070) 0.067 0.008 
AHA (R2=0.243)    Percentage body fat -16.904 (7.406) 0.041 0.024 
ISWT 0.637 (0.294) 0.037 0.032 
Sedentary time 
 B (SE) Partial R2 p 
COPD (R2=0.229)    
Percentage  body fat 3.754 (1.374) 0.072 0.008 
mMRC score 29.567 (11.258) 0.067 0.010 
AHA (R2=0.363)    
ISWT -0.105 (0.046) 0.041 0.024 
Percentage body fat 2.566 (1.164) 0.038 0.029 
Light activity 
 B (SE) Partial R2 p 
COPD (R2=0.230)    Percentage body fat -3.555 (1.322) 0.070 0.008 
mMRC score -27.135 (10.833) 0.062 0.014 
AHA (R2=0.170) 
   ISWT 0.128 (0.033) 0.108 <0.001 
MVPA 
 B (SE) Partial R2 p 
COPD (R2=0.358)    
ISWT 0.033 (0.009) 0.116 0.001 
AHA (R2=0.173)    
Percentage body fat -0.839 (0.328) 0.050 0.012 
Abbreviations: AHA, apparently healthy adults; BMI, body mass index; ISWT, incremental shuttle walk test; 
mMRC, modified Medical Research Council; vmcpm, vector magnitude counts per minute 
3.4 Discussion 
Correlates of objectively measured physical activity and sedentary time have not been 
sufficiently explored in mild-moderate COPD patients. Understanding the factors associated 
with lifestyle behaviours are important for the successful development of early, tailored 
interventions in COPD. In this study, mild-moderate COPD patients were found to be less 
physically active and more sedentary than apparently healthy adults but had similar 
behavioural correlates. However, different correlates were identified for objectively measured 
physical activity and sedentary time in both groups. For COPD patients, exercise capacity 
(ISWT) was an independent correlate of MVPA whilst self-reported breathlessness and 
percentage body fat were independent correlates of sedentary time and light intensity activity.  
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Although patients in this study had mild-moderate COPD, they were still found to be less 
physically active (17 versus 37 minutes of MVPA per day) and spend more time sedentary 
(592 versus 514 minutes per day) compared with apparently healthy adults. Even when 
patients were physically active, most of their time was spent in light activity (97% of total 
activity time). Whilst direct comparisons cannot be made between wrist and waist 
accelerometry locations, this finding is consistent with previous work which found patients to 
spend 34 minutes more sedentary per day compared to apparently healthy adults in the US 
(Park et al., 2013). These patients were also found to spend only 0.007% of their day in 
MVPA (Park et al., 2013). Equally concerning is the high amount of total sedentary time  
accumulated each day (~62% of their waking day) given the independent health risks of 
being sedentary on cardiometabolic health (Healy et al., 2007; Healy et al., 2008). This is 
particularly important as over one-quarter of COPD patient deaths are primarily caused by 
cardiovascular disease (McGarvey et al., 2007). Overall these observations support existing 
work demonstrating lower levels of physical activity (Park et al., 2013; H. Van Remoortel et 
al., 2013) and more time spent sedentary (Park et al., 2013) in mild-moderate COPD 
compared with apparently healthy adults. Together, findings suggest that mild-moderate 
patients require interventions targeting increases in MVPA and reductions in sedentary time. 
Correlates identified in the present study can help inform tailored interventions for these 
patients. 
Dyspnea is the characteristic symptom of COPD and both the present study and previous 
work (Park et al., 2013) has found breathlessness to be related to more time sedentary. 
However, it is important to note that low explained variance (6-10%) was observed. 
Therefore, assessing patients’ breathlessness is not sufficient to infer levels of physical 
activity or sedentariness. Similar observations (Watz et al., 2009) support the notion that 
mild-moderate patients reporting a high breathlessness burden may require interventions 
targeting the displacement of sedentary time with light activity. However, other work has 
found longer sitting time to be associated with external regulation in exercise (no choice, 
“others make me do it”) and use of long-term oxygen therapy; suggesting symptoms may be 
more limiting in more advanced COPD rather than in mild disease (Hartman et al., 2013). 
Patients with mild-moderate COPD reporting high levels of dyspnea have been found to have 
worse 3-year all-cause hospitalisation rates compared to patients with severe airflow 
limitation reporting low levels of breathlessness (Lange et al., 2012). With a one unit change 
in mMRC score (e.g. from mMRC 0 to 1) associated with ~30 more minutes spent sedentary, 
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the present study clearly highlights that breathlessness and behaviour are associated even in 
the milder COPD. 
Body fat percentage was independently positively associated with sedentary time and 
negatively associated with light intensity activity in COPD patients. Whilst there is support 
for the impact of body composition on behaviour in COPD (Park et al., 2013), conflicting 
evidence in this population also exists (McGlone, Venn, Walters, & Wood-Baker, 2006; Moy 
et al., 2009). COPD patients reporting more severe symptoms have been found to have five-
to-eight-times higher mortality rates from cardiovascular disease than patients reporting low 
symptom burden, regardless of the level of airflow obstruction (Lange et al., 2012); 
supporting the need to help patients achieve a healthier body composition. However, 
percentage body fat could only explain a small amount of variance for behaviour (4-7%). 
Results from the present study suggest weight loss for general health may be an important 
target for these patients. Therefore, pulmonary rehabilitation may need to broaden outcomes 
beyond exercise capacity and respiratory health for milder stage patients and incorporate 
regular objective measures of body composition.  
Correlates of MVPA were found to differ from those of sedentary time and light activity in 
the present study; consistent with previous work (Park et al., 2013). Walking capacity, as 
measured by the ISWT, was independently associated with MVPA for COPD patients 
whereas body composition was found to be associated with MVPA for apparently healthy 
adults. Pitta and colleagues (Pitta et al., 2005) found exercise capacity (6MWD) to be the 
strongest predictor of walking time, standing time and movement intensity. COPD patients 
achieved shorter distances on the ISWT compared with apparently healthy adults, 
highlighting not only reduced levels of accelerometry-derived physical activity but also 
worse exercise capacity. Pulmonary rehabilitation has been found to be equally beneficial to 
patients with mild COPD compared with more severe patients (Jacome & Marques, 2016) 
supporting the need to refer patients before symptoms become too debilitating. Increased 
exercise capacity has been consistently positively associated with objectively assessed 
physical activity but improvements in physical functioning have failed to translate into 
subsequent increases in daily physical activity in COPD patients ranging in the severity of 
airflow obstruction (Egan et al., 2012). Therefore, it is not only important to improve exercise 
capacity but also to facilitate patients to make the most of these improvements in everyday 
life (through increasing their physical activity such as walking more).  
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The present study found that COPD patients in employment took part in more MVPA than 
those who were retired after controlling for age and other confounders. This is in contrast to 
previous work which found employment to be associated with lower sedentary time rather 
than more physical activity for COPD patients (Park et al., 2013). Together, these findings 
suggest that the transition from employment to retirement may be an important period for 
lifestyle interventions to reduce sedentary time and/or increase participation in MVPA in 
mild-moderate COPD patients. In future interventions and existing programmes such as 
pulmonary rehabilitation, employment status should not only be obtained for demographic 
descriptive data but should be used to help design tailored behaviour change strategies.  
Findings from the present study suggest that patients with higher percentage body fat and 
those reporting more severe breathlessness may benefit from lifestyle interventions focussing 
on replacing sedentary time with light activity. However, it is only breathlessness that is a 
unique correlate of sedentary time and light activity for COPD patients when compared to 
apparently healthy adults. Exercise capacity was a unique correlate of MVPA for COPD 
patients compared with apparently healthy adults, for which body composition was 
independently associated. Therefore tailored interventions for mild-moderate COPD patients 
must recognise the unique correlates of behaviour and account for differences in identified 
correlates between behaviours of differing intensities. Overall, the results of the present study 
support the idea that pulmonary rehabilitation (despite ~81% of patients reporting mMRC of 
0 or 1), physical activity promotion and reductions in sedentary time should be encouraged 
within the primary care setting (Chakravarthy, Joyner, & Booth, 2002) and that these 
initiatives need to be tailored for mild-moderate COPD patients. 
Overall explained variances in physical activity and sedentary time were similar to previous 
work in mild-moderate COPD patients. The present study explained 23% (sedentary time and 
light activity) to 36% (MVPA) of the variance in behaviour for patients. In a study of mild-
moderate patients recruited from primary care in the US, Park and colleagues (Park et al., 
2013) explained 21.7% of the variance in sedentary time, 29.4% for light intensity activity 
and 30.5% for MVPA as determined by waist-worn accelerometry. Similarly, Hartman and 
colleagues (Hartman et al., 2013) were able to explain 25% of the variance in time spent 
walking in mild-moderate COPD patients. 
Major strengths of the study include the recruitment of patients from primary care in which 
facilitated the recruitment of mild-moderate COPD patients who do not have the access to 
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research participation compared with patients attending rehabilitation or admitted to hospital. 
The comprehensive list of predictors and the use of objectively measured physical activity 
and sedentary time, the high accelerometer compliance and comparison to apparently healthy 
adults must also be noted. Recruitment bias may have occurred. For example, those patients 
concerned about their health, more able to complete the range of measures as part of the 
study or patients who are more physically active may have preferentially responded to the 
study invitation. The cross-sectional design of the study means causality cannot be inferred. 
Whilst the present sample was ethnically homogenous due to an insufficient sample of non-
White COPD patients recruited, the lower occurrence of smoking (10% for Indian South 
Asians and 26% for White British) translates into fewer South Asian COPD patients and 
lower COPD admission rates in Leicestershire (Director of Public Health., 2010). As data 
from this study relates to mild-moderate COPD patients, stronger associations between 
physical activity and some related variables may have existed had more severe patients from 
the study been included. Whilst findings were materially unchanged when additional cut-
point thresholds for sedentary time (<1853 vmcpm) (Koster et al., 2016), light activity (2000-
8249 vmcpm) and MVPA (≥8250 vmcpm) (Kamada et al., 2016) no cut-points have yet been 
developed against criterion methods such as indirect calorimetry. Sedentary time was unable 
to discriminate between sitting and standing. Further advancements in the objective 
measurement of behaviour will provide richer insights into the role of physical activity and 
sedentary time in COPD. 
3.5 Conclusion 
Despite the early disease progression, mild-moderate COPD patients were less physically 
active and more sedentary than apparently healthy adults. Whilst factors predicting behaviour 
were similar between patients and apparently healthy adults, correlates differed for sedentary 
time and light activity compared to those of MVPA for patients. Patients with mild-moderate 
COPD reporting more severe breathlessness, with higher body fat percentage and poor 
exercise capacity would benefit from interventions targeted at increasing physical activity 
levels and/or reducing sedentary time. In established interventions such as pulmonary 
rehabilitation the addition of body composition as a key outcome for patients with mild-
moderate COPD should be explored. 
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Chapter 4: Study Two 
Title: Associations between physical activity and sedentary behaviour and symptom severity 
in mild-moderate COPD 
4.1 Introduction 
Determining the grade of a patient’s COPD has traditionally been based solely on the degree 
of airflow limitation as determined by spirometry. More recently evidence has shown that due 
to the heterogeneous nature of COPD lung function alone does not sufficiently account for 
numerous extrapulmonary aspects of the disease such as breathlessness, muscle wasting and 
quality of life (Cooper, 2009; Hurst et al., 2010; Weatherall et al., 2009). Whilst 
breathlessness is the primary characteristic of COPD other symptoms include coughing, 
phlegm production and chest tightness with the severity of these symptoms fluctuating on a 
daily basis (Kessler et al., 2011). However, when these symptoms worsen beyond that of 
normal day-to-day variations patients can experience an exacerbation of their COPD (Celli & 
Barnes, 2007). Exacerbations are responsible for the majority of the economic burden of 
COPD; becoming more frequent and more severe as the disease progresses (Suter et al., 
2011). 
Commonly used measures of COPD symptom severity are the mMRC (Bestall et al., 1999) 
and CAT (Jones et al., 2009) questionnaires; both recommended for use by GOLD (Global 
Initiative for Chronic Obstructive Lung Disease., 2017). In an attempt to better reflect the 
complexity of COPD, the GOLD 2011 report created a combined assessment for improved 
patient stratification based on exacerbation risk (lung function or exacerbation history) and 
symptoms (CAT or mMRC) (Global Initiative for Chronic Obstructive Lung Disease., 2011). 
The combined assessment is provided in Figure 1.6 and its conception resulted in a ‘GOLD 
rush’ of research into its utility (Soriano, 2013). Following the subsequent findings a revised 
combined COPD assessment has been produced based only from exacerbation history and 
symptoms (mMRC and CAT) with spirometry now recommended in conjunction with the 
revised combined COPD assessment (Global Initiative for Chronic Obstructive Lung 
Disease., 2017).  
For all patients with COPD, symptom severity can vary greatly but it has generally been 
considered that patients with mild-moderate disease are less burdened by their symptoms 
compared with more advanced patients (Guenette et al., 2011). However, it is now recognised 
that considerable reductions in exercise capacity and increases in dyspnea can occur in mild-
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moderate patients and/or those with undiagnosed COPD (Troosters et al., 2010). Moreover, 
data from the Copenhagen Heart Study found that patients with mild-moderate COPD 
reporting high levels of dyspnea had significantly worse 3-year all-cause hospitalisation rates 
compared with severe COPD patients reporting low levels of breathlessness (Lange et al., 
2012). Indeed, patients reporting high symptom severity had five-to-eight-times higher 
mortality rates from cardiovascular disease and cancer than patients reporting low symptom 
burden, regardless of the level of airflow obstruction (Lange et al., 2012). Notably, an 
international survey across Europe and North America found that over a third of mild-
moderate patients reported sometimes being too breathless to leave the house (Rennard et al., 
2002). 
Patients with mild-moderate COPD reporting a high degree of symptom burden likely require 
additional self-management programmes. These individuals may be a particularly important 
sub-group of patients who may benefit from behavioural or exercise-based interventions. 
Despite this, pulmonary rehabilitation is scarcely prescribed to mild-moderate COPD patients 
(Steiner, Holzhauer-Barrie, Lowe, Searle, Skipper, Welham, & Roberts, 2015b). Therefore, 
understanding what factors are associated with patients reporting higher levels of symptom 
burden is needed in order to improve patient stratification and to identify the interventions 
that will be most beneficial to them. Exercise programmes are established interventions to 
improve patient wellbeing (Lacasse, Goldstein, Lasserson, & Martin, 2006) but there is 
increasing recognition of the importance of targeting increases in physical activity (Garcia-
Aymerich et al., 2006; Troosters et al., 2013) and reductions in sedentary behaviour (Hill et 
al., 2015). Much of the literature has focussed on evaluating patients’ symptoms in the 
context of the GOLD 2011 combined assessment and attempting to calibrate the range of 
questionnaires assessing symptoms but little is known about the factors associated with 
perceptions of more severe symptoms in patients with mild-moderate COPD.  
The aims of the present study on mild-moderate COPD patients were to (i) identify factors 
associated with self-reported symptom severity and exacerbation history and (ii) compare 
physical activity and sedentary time in patients according to their symptom severity and 
exacerbation history. It was hypothesised that better exercise capacity, more time being 
physically active and spending less time sedentary would be associated with lower self-
reported symptom severity and fewer exacerbations in the preceding year. 
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4.2 Methods 
Data used in this chapter was taken from the PhARaoH Study as described in Chapter 2 and 
has been previously published (Orme et al., 2016). 
Inclusion/exclusion criteria 
From the original PhARaoH sample (n=436), all participants aged 40-75 with a diagnosis of 
COPD according to their general practitioner were included (n=139). COPD patients were 
excluded from the present study if they were classified as GOLD III or IV (n=21), spirometry 
had not being conducted (n=2), if they reported a ‘non-white’ ethnicity (due to insufficient 
sample, n=5), if they had missing CAT score (n=2) and if they had less than four valid days 
of accelerometry (n=2). The final sample comprised 107 COPD patients. 
Statistical analysis 
Analyses were conducted using SPSS (version 23.0). Normal distribution for all variables 
was conducted using the Kolmogorov-Smirnov test with p<0.05 signifying non-normal 
distribution. Data were reported as mean (SD). Unadjusted comparisons between two groups 
for parametric data were performed using an independent t-test. Unadjusted frequency 
comparisons between groups were performed using Chi-square (n>5) or Fischer exact test 
(n≤5). Covariate-adjusted (age, gender, smoking status, employment status and accelerometer 
waking wear time where appropriate) group comparisons for ratio data were performed using 
ANCOVA. 
The level of agreement between symptoms scores for the components of the CAT 
questionnaire and between CAT score and mMRC grade were examined using the Kappa 
statistic (Landis & Koch, 1977) and were interpreted according to McHugh (McHugh, 2012) 
(Table 4.1). Univariate analyses were conducted using bivariate correlations. Pearson’s r was 
used for data meeting parametric assumptions and Spearman’s Rho was used for non-
parametric data. Correlation coefficients were interpreted according to Evans (Evans, 1996) 
(Table 4.1). 
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Table 4.1 Interpretation of the Kappa statistic (McHugh, 2012) and correlation coefficients 
(Evans, 1996) 
Kappa 
statistic 
Level of  
agreement 
Correlation  
coefficient 
Strength of  
association 
0.00-0.20 None 0.00-0.19 Very weak 
0.21-0.39 Minimal 0.20-0.39 Weak 
0.40-0.59 Weak 0.40-0.59 Moderate 
0.60-0.79 Moderate 0.60-0.79 Strong 
0.80-0.90 Strong 0.80-1.00 Very strong 
0.91-1.00 Almost perfect   
 
Forced entry multiple linear regressions were used to examine predictors of CAT (and 
components), mMRC and exacerbation history; controlling for the above covariates. 
Variables reaching statistical significance (p<0.05) were entered into stepwise multivariate 
linear regression models to identify independent predictors of symptoms and unique 
explained variance (partial R2). All models were checked for linear relationship, absence of 
multicollinearity, homoscedasticity and a normal distribution of residuals. 
4.3 Results 
4.3.1 Sample characteristics 
Patient characteristics are provided in Table 4.2. No patients reported mMRC 4 (“Too 
breathless to leave the house or breathless when dressing or undressing”) with 26.2% of 
patients reporting mMRC grade 0, 54.2% reporting mMRC 1 and 19.6% reporting mMRC ≥2. 
The majority of patients (56.1%) reported no exacerbations requiring steroids or antibiotics in 
the last 12 months. Using BMI, 30.8% of patients were classified as obese, 41.1% were 
overweight, 27.1% had a normal BMI and 0.9% of patients were classed as underweight. 
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Table 4.2 Sample characteristics, reported as mean (SD) unless otherwise stated (* p<0.05) 
Sample characteristics Whole sample (n=107) 
Demographics  
Age (years) 65.8 (7.1) 
Employment status: employed/unemployed/retired 28/11/68 
IMD deprivation score 21.8 (17.9) 
Respiratory health 
Smoking status: current/former/never 18/77/11 
Pack years 38.7 (25.2) 
FEV1 (L) 2.0 (0.7) 
FEV1%pred 76.4 (17.9) 
FVC (L) 3.7 (1.0) 
FEV1/FVC 55.0 (16.0) 
Years since COPD diagnosis 7.6 (7.7) 
Body composition 
BMI (kg/m2) 28.7 (5.7) 
Percentage body fat 28.7 (8.7) 
Waist circumference (cm) 100.2 (13.8) 
Physical function 
ISWT (m) 387.0 (159.7) 
QMVC (kg) 35.0 (13.3) 
Grip strength (kg) 36.0 (19.1) 
Usual walking speed: slow/average/fairly brisk/brisk 28/63/14/2 
24-hour accelerometry-derived behaviour 
Waking wear time (min) 965.7 (50.9) 
Sleep (min) 440.7 (63.3) 
VMCPM 1975 (493) 
Sedentary (min) 591.4 (91.2) 
Light activity (min) 357.2 (96.9) 
MVPA (min) 17.0 (16.1) 
Symptoms 
CAT score (0-40) 13.0 (7.5) 
CAT score: 0-9/10-19/20-29/≥30 38/47/20/2 
mMRC grade (0-4) 1.0 (0.8) 
mMRC grade: 0/1/2/3 28/58/14/7 
Exacerbations in the last 12 months 1.2 (1.8) 
Exacerbations: 0/1/≥2 60/20/27 
Abbreviations: BMI, body mass index; CAT, COPD Assessment Test; FEV1, forced expiratory volume in one 
second; FEV1%pred, forced expiratory volume in one second percentage predicted; FVC, forced vital capacity; 
ISWT, incremental shuttle walk test; LPA, light intensity physical activity; mMRC, modified Medical Research 
Council; MVPA, moderate-to-vigorous physical activity; QMVC, quadriceps maximal voluntary contraction; 
vmcpm, vector magnitude counts per minute 
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4.3.2 Comparison of CAT symptom components 
The components of the CAT questionnaire cover a range of COPD-related symptoms, to 
which patients assign a score 0-5 with a higher score indicating greater severity/burden. 
Large variability in the proportion of scores for each component were observed (Figure 4.2) 
with almost a third (30%) of patients reporting a score of ≥4 for breathlessness and 88% of 
patients scoring ≤1 for confidence leaving the home. Agreement between CAT components 
was rated as either “none” or “minimal” (Appendix L) and associations between CAT 
components ranged from “very weak” to “strong” (Appendix M).  
 
Figure 4.1 Proportion of patient scoring (0-5) the components of the CAT questionnaire. 
Abbreviation: CLH, confidence leaving the home 
 
4.3.3 Factors associated with symptom severity 
Linear regression analyses of factors associated with CAT score, mMRC grade and 
exacerbations (controlling for age, gender, smoking status, employment status and 
accelerometer waking wear time) are presented in Table 4.3. Factors associated with CAT 
score were gender, ISWT distance, usual walking speed, average movement intensity 
(VMCPM), sedentary time and light activity. Retired patients reported a significantly higher 
CAT score compared with employed patients after controlling for covariates (14.6±1.0 versus 
9.0±1.5, p=0.016). Factors associated with mMRC grade were BMI, percentage body fat, 
waist circumference, ISWT distance, usual walking speed, average movement intensity, 
sedentary time and light activity. Unemployed patients reported a significantly higher mMRC 
score compared with employed patients (1.5±0.3 versus 0.7±0.2, p=0.006). Factors associated 
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with exacerbations were age, ISWT distance, usual walking speed, sedentary time and 
MVPA.  
Sedentary time was significantly positively associated with mMRC independent of time spent 
in MVPA but produced a very small coefficient i.e. not clinically/behaviourally meaningful 
(B=0.003, p=0.003). MVPA was significantly negatively associated with exacerbation history 
independent of sedentary time (B=-0.031, p=0.014); equating to ~1 (0.93) less exacerbation 
in the last year with a 30 minute increase in MVPA per day. When sedentary time and MVPA 
were both entered into a multivariate regression model, significance was lost for both 
intensities for CAT score. 
Table 4.3 Linear regression analysis, controlling for age, gender, smoking status, 
employment status and accelerometer waking wear time, to predict CAT score, mMRC grade 
and exacerbations (bold, p<0.05) 
 
CAT score mMRC grade Exacerbations 
Variables B (SE) Partial R2 B (SE) Partial R2 B (SE) Partial R2 
Demographics       
Age -0.227 (0.127) 0.031 -0.017 (0.014) 0.014 -0.082 (0.030) 0.068 
Gender A -2.981 (1.449) 0.040 -0.075 (0.163) 0.002 -0.421 (0.344) 0.015 
Respiratory health       
Years with COPD 0.311 (0.115) 0.091 0.023 (0.013) 0.042 -0.009 (0.029) 0.001 
Body composition       
BMI  0.135 (0.126) 0.011 0.040 (0.014) 0.077 -0.009 (0.030) 0.001 
Percentage body fat 0.101 (0.114) 0.008 0.037 (0.012) 0.084 -0.006 (0.027) <0.001 
Waist circumference 0.074 (0.052) 0.020 0.018 (0.006) 0.097 -0.004 (0.012) 0.001 
Exercise capacity       
ISWT -0.015 (0.005) 0.093 -0.002 (0.000) 0.200 -0.003 (0.001) 0.052 
Usual walking speed B -3.774 (0.986) 0.127 -0.476 (0.109) 0.161 -0.535 (0.245) 0.045 
Accelerometer-derived behaviour      
VMCPM -0.004 (0.001) 0.066 -0.001 (0.000) 0.147 -0.001 (0.000) 0.030 
Sedentary † 0.018 (0.008) 0.051 0.003 (0.001) 0.106 0.004 (0.002) 0.040 
Light activity † -0.018 (0.008) 0.044 -0.003 (0.001) 0.100 -0.003 (0.002) 0.026 
MVPA † -0.078 (0.051) 0.023 -0.008 (0.005) 0.019 -0.036 (0.012) 0.088 
Abbreviations: BMI, body mass index; CAT, COPD Assessment Test; ISWT, incremental shuttle walk test; 
mMRC, modified Medical Research Council; vmcpm, vector magnitude counts per minute 
A, 0=female, 1=male; B, 1=slow, 2=average, 3=fairly brisk, 4=brisk 
 
Factors that were significantly associated with symptom variables were included in stepwise 
multiple linear regression models to identify independent associations with symptom severity. 
When multiple measures of the same construct are present, only one measure was entered 
into the models. For body composition percentage body fat was preferentially entered 
(followed by BMI) and for exercise capacity the ISWT was preferentially entered. For 
behaviour VMCPM was preferentially entered when significant. Sedentary time and MVPA 
were both entered for exacerbations. 
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ISWT (B=-0.016±0.005, p=0.004) and years with COPD (B=0.319±0.122, p=0.011) were 
independently associated with CAT score uniquely explaining 11.7% and 7.1% of the 
variance, respectively. ISWT (B=-0.002±0.001, p<0.001) and VMCPM (B=0.0001±0.0000, 
p=0.011) were independently associated with mMRC grade uniquely explaining 12.3% and 
5.0% of the variance, respectively. MVPA was independently associated with exacerbations 
(B=-0.034±0.012, p=0.005) uniquely explaining 8.1% of the variance.  
4.3.4 Factors associated with CAT components 
Analyses of factors associated with CAT components (controlling for age, gender, smoking 
status, employment status and accelerometer waking wear time) are presented in Table 4.4. 
Only deprivation score was associated with Coughing with no factors examined associated 
with Tight Chest.  
Retired patients reported significantly higher Phlegm compared with employed patients 
(2.3±0.2 versus 1.4±0.3, p=0.022). Factors associated with Breathlessness were gender, waist 
circumference, ISWT distance, usual walking speed, average movement intensity, sedentary 
time, light activity and MVPA.  Factors associated with Limited Activities were ISWT 
distance, usual walking speed average movement intensity, sedentary time, light activity and 
MVPA. Unemployed patients reported significantly higher Limited Activities compared with 
employed patients (2.1±0.5 versus 0.7±0.3, p=0.019). Factors associated with Confidence 
Leaving the Home were gender, BMI, percentage body fat, waist circumference, ISWT 
distance, usual walking speed average movement intensity and sedentary time. Retired 
patients reported significantly higher Confidence Leaving the Home scores compared with 
employed patients (1.0±0.2 versus 0.1±0.3, p=0.034). Factors associated with Sleep were 
gender and smoking status. Factors associated with Energy were gender, FEV1%pred, ISWT, 
usual walking speed, average movement intensity, sedentary time and light activity.  
When sedentary time and MVPA were both entered into a multivariate regression model, 
significance was lost for both intensities for Limited Activities. Sedentary time was 
significantly positively associated with Breathlessness (B=0.004, p=0.014) and Energy 
(B=0.003, p=0.026) independent of time spent in MVPA.  
Deprivation score uniquely explained 5.9% of Coughing. VMCPM (B=-0.001±0.000, 
p<0.001) was independently associated with Breathlessness uniquely explaining 12.5% of the 
variance. ISWT (B=-0.004±0.001, p<0.001) was independently associated with Limited 
Activities uniquely explaining 15.6% of the variance. ISWT was independently associated 
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with Confidence Leaving the Home (B=-0.002±0.001, p=0.002) uniquely explaining 9.2% of 
the variance. ISWT was independently associated with Energy (B=-0.003±0.001, p<0.001) 
uniquely explaining 16.2% of the variance. 
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Table 4.4 Linear regression analysis (controlling for age, gender, smoking status, employment status, accelerometer waking wear time) to 
predict CAT components (bold, p<0.05)  
 
Coughing Phlegm Tight chest Breathless Limited activities CLH Sleep Energy 
Variables 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
B  
(SE) 
Partial 
R2 
Demographics                 
Gender A -0.011  (0.243) <0.001 
0.116 
(0.260) 0.002 
-0.024 
(0.262) <0.001 
0.394 
(0.207) 0.051 
-0.337 
(0.192) 0.014 
-0.166 
(0.242) 0.005 
-0.710 
(0.279) 0.044 
-0.493 
(0.169) 0.037 
Smoking  
status B 
-0.124 
(0.245) 0.003 
0.001 
(0.263) <0.001 
0.029 
(0.264) <0.001 
0.099  
(0.309) 0.001 
-0.202 
(0.287) 0.005 
-0.806 
(0.240) 0.100 
-0.609 
(0.282) 0.060 
-0.296 
(0.252) 0.013 
Postcode  
deprivation  
-0.017  
(0.007) 0.060 
-0.014 
(0.007) 0.034 
-0.001 
(0.008) <0.001 
-0.009  
(0.009) 0.011 
-0.002 
(0.008) 0.001 
0.000 
(0.007) <0.001 
0.001 
(0.008) <0.001 
0.001 
(0.007) <0.001 
Respiratory health                
FEV1%pred 
-0.007  
(0.007) 0.013 
-0.001 
(0.007) <0.001 
0.003 
(0.007) 0.001 
-0.004  
(0.008) 0.003 
0.001 
(0.008) <0.001 
0.007 
(0.007) 0.011 
0.008 
(0.008) 0.011 
-0.014 
(0.007) 0.043 
Body composition                
BMI  -0.028  (0.021) 0.017 
-0.010 
(0.023) 0.002 
0.009 
(0.023) 0.001 
0.044 
(0.027) 0.027 
0.031 
(0.025) 0.015 
0.050 
(0.020) 0.056 
0.021 
(0.024) 0.007 
0.019 
(0.022) 0.008 
Waist  
circumference 
-0.005  
(0.009) 0.003 
0.000 
(0.009) <0.001 
0.002 
(0.009) <0.001 
0.020 
(0.011) 0.034 
0.017 
(0.010) 0.026 
0.019 
(0.008) 0.049 
0.007 
(0.010) 0.004 
0.014 
(0.009) 0.024 
Exercise capacity                
ISWT -0.001  (0.001) 0.008 
0.000 
(0.001) <0.001 
0.000 
(0.001) <0.001 
-0.003 
(0.001) 0.092 
-0.004 
(0.001) 0.169 
-0.002 
(0.001) 0.093 
-0.001 
(0.001) 0.016 
-0.003 
(0.001) 0.165 
Usual walking  
speed C 
-0.328  
(0.174) 0.035 
-0.063  
(0.190) 0.001 
-0.154 
(0.190) 0.007 
-0.832 
(0.207) 0.138 
-0.939 
(0.185) 0.205 
-0.596 
(0.164) 0.116 
-0.272 
(0.202) 0.018 
-0.591 
(0.172) 0.105 
Accelerometer-derived behaviour               
VMCPM 0.000  (0.000) 0.007 
0.000 
(0.000) 0.003 
0.000 
(0.000) <0.001 
-0.001 
(0.000) 0.136 
-0.001 
(0.000) 0.125 
-0.001 
(0.000) 0.047 
0.000 
(0.000) 0.001 
-0.001 
(0.000) 0.061 
Sedentary  0.001  (0.001) 0.009 
0.001 
(0.001) 0.005 
0.000 
(0.001) 0.001 
0.005 
(0.002) 0.097 
0.004 
(0.001) 0.061 
0.003 
(0.001) 0.045 
0.001 
(0.002) 0.003 
0.004 
(0.001) 0.064 
Light  -0.001  (0.001) 0.007 
0.001 
(0.002) 0.008 
0.000 
(0.002) 0.001 
-0.005 
(0.002) 0.081 
-0.003 
(0.002) 0.047 
-0.003 
(0.001) 0.041 
-0.001 
(0.002) 0.002 
-0.004 
(0.001) 0.059 
MVPA  0.008  (0.009) 0.008 
0.006 
(0.009) 0.004 
0.000 
(0.009) <0.001 
-0.026 
(0.010) 0.062 
-0.025 
(0.009) 0.068 
-0.011 
(0.008) 0.015 
-0.003 
(0.010) 0.001 
-0.012 
(0.009) 0.017 
Abbreviations: BMI, body mass index; CAT, COPD Assessment Test; CLH, confidence leaving the home; FEV1%pred, forced expiratory volume in one second percentage 
predicted; ISWT, incremental shuttle walk test; mMRC, modified Medical Research Council; vmcpm, vector magnitude counts per minute 
A, 0=female, 1=male; B, 1=current, 2=former, 3=never ; C, 1=slow, 2=average, 3=fairly brisk, 4=brisk 
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4.3.5 Physical activity and sedentary time across symptom severities 
For CAT, mMRC and exacerbation history, patients were grouped using pragmatic cut-offs to 
permit more equal sample sizes. Using the CAT score patients were put into three groups: 
CAT of 0-9 (n=38), 10-19 (n=47) and ≥20 (n=22). Using the mMRC patients were put into 
three groups: mMRC of 0 (n=28), 1 (n=58) and ≥2 (n=21). Using previous exacerbations 
patients were put into three groups: 0 (n=60), 1 (n=20) and ≥2 (n=27) exacerbations in the 
last year. 
Patients reporting a CAT score of >20 had lower average movement intensity (VMCPM) 
(2120±77 versus 1700±101vmcpm, p=0.005), were more sedentary and took part in less light 
activity than patients reporting a CAT score of 0-10 (Figure 4.3). Patients reporting an 
mMRC score of ≥2 had lower average movement intensity (VMCPM) (2208±86 versus 
1703±101vmcpm, p=0.001), were more sedentary and took part in less light activity than 
patients reporting an mMRC of 0 (Figure 4.4). Agreement between CAT and mMRC group 
classification was minimal (k=0.376). Half of patients classified as low CAT (0-10) also 
classified as low mMRC (grade 0) and 64% of patients classified as high CAT (>20) also 
classified as high mMRC (grade ≥2) (Appendix N). Patients reporting ≥2 exacerbations took 
part in less MVPA than patients reporting zero exacerbations (Figure 4.5).  
 
Figure 4.2 Comparison of sedentary time, light activity and MVPA across COPD patients 
grouped by CAT score. Higher the CAT score the greater the symptom severity. 
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Figure 4.3 Comparison of sedentary time, light activity and MVPA across COPD patients 
grouped by mMRC grade. Higher the mMRC score the greater the dyspnea severity. 
 
 
Figure 4.4 Comparison of sedentary time, light activity and MVPA across COPD patients 
grouped by the number of self-reported exacerbations in the last year. 
 
4.3.6 Exercise capacity across symptom severities 
After controlling for age, gender, smoking status and employment status, patients reporting a 
CAT score of >20 had a lower ISWT than patients reporting a CAT score of 0-10 
(327.5±34.5 versus 433.6±24.6m, p=0.048). Patients reporting an mMRC score of 1 
(382.8±18.3 versus 462.1±26.4m, p=0.045) or an mMRC score of ≥2 (267.8±34.1 versus 
462.1±26.4m, p<0.001) had a lower ISWT than patients reporting an mMRC of 0. Patients 
reporting ≥2 exacerbations had a lower ISWT than patients reporting zero exacerbations 
(312.6±33.5 versus 414.5±19.6m, p=0.034). 
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4.4 Discussion 
Patients with mild-moderate COPD who report severe symptoms are an important sub-group 
of patients who may require lifestyle and exercise interventions. The present study examined 
the relationships between measures of symptoms and previous exacerbations; identified 
factors associated with patient-reported symptom severity; and assessed how physical activity 
and sedentary time differ across degrees of symptom severity in mild-moderate COPD 
patients.  
CAT and mMRC questionnaires shared common correlates including lower exercise capacity, 
less light intensity physical activity and more time spent sedentary. The role of physical 
activity in the management of COPD has become increasingly recognised but sustained 
behaviour change remains one of the biggest challenges in this population. Whilst sedentary 
behaviour has been recommended as a more suitable conduit for behaviour change than 
exercise (Cavalheri, Straker, Gucciardi, Gardiner, & Hill, 2015; Hill et al., 2015) few studies 
have specifically examined this behaviour (Orme et al., 2016). The present study highlights 
the importance of sedentary time in COPD; advocating that future studies not only target 
physical activity and exercise but also movement at the lower end of the intensity continuum 
(Chaput et al., 2014); even for more mild stage COPD patients. 
Physical activity and exercise capacity should be interpreted as separate entities (Mitchell et 
al., 2016). In support of this was the finding in the present study that performance on the 
ISWT was associated with CAT score and mMRC grade after controlling for physical 
activity. However, the ISWT was only able to explain 12% of the variance for CAT and 
mMRC questionnaires. Physical activity (VMCPM for mMRC grade and MVPA for 
exacerbation history) was found to be independently associated with symptoms but explained 
less than 10% of symptom variance. That being said, patients reporting more severe 
symptoms (CAT score >20 or mMRC ≥2) spent 69-81 more minutes sedentary each day 
compared with patients reporting less severe symptoms (CAT score ≤10 or mMRC 0). 
Therefore, exercise capacity, physical activity and sedentary time partly explained some of 
the differences between mild-moderate patients reporting low and high symptom burdens. 
Whilst findings from the present study are in support of the National Institute for Health and 
Care Excellence (NICE) guidelines which state that pulmonary rehabilitation should be 
offered to patients who consider themselves functionally disabled by their COPD (usually 
mMRC ≥2) (National Institute for Health and Care Excellence (NICE)., 2010), exercise 
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capacity was found to be significantly lower in mMRC 1 patients compared to mMRC 0 
patients. Therefore, mild-moderate patients may benefit from pulmonary rehabilitation even 
if they do not report severe dyspnea-related disability (mMRC ≥2). However, more work is 
needed to explore factors that could not be addressed in the present study which may be 
associated with patients of similar airflow obstruction reporting contrasting symptom burdens. 
Such factors may include dynamic hyperinflation (Van Helvoort et al., 2016), diet quality and 
medication adherence (Rabe, 2006).  
Whilst the composite CAT score has been associated with hospitalisation (Papaioannou et al., 
2014) and recovery after an acute exacerbation (Feliz-Rodriguez et al., 2013), by breaking the 
score down into its constituent parts a more detailed understanding of the inter-relationships 
between COPD symptoms can be gleaned. In the present study, agreement in the scoring of 
the component symptoms was poor; with coughing, phlegm, breathlessness and lack of 
energy contributing more to the composite CAT score than other symptoms. Strong 
associations between only coughing and phlegm scores and breathlessness and limited 
activities scores suggest that the CAT questionnaire comprises largely distinct entities. 
Therefore, the CAT questionnaire can not only identify mild-moderate patients reporting 
severe symptom burden but can also be used to identify particular symptoms that need to be 
targeted; providing a more personalised approach to symptom management. For example, 
seven day coughing history has been independently associated with health-related quality of 
life (Deslee, Burgel, Escamilla, & Chanez, 2016) and breathlessness and phlegm components 
have been predictive of COPD diagnosis (Raghavan et al., 2012).  
Breaking down the CAT into its individual symptom components also provided additional 
insight into the role of physical activity, sedentary time and exercise capacity in patients of 
the same degree of airflow limitation reporting varying levels of symptom severity. 
Associations between behaviour and exercise capacity with breathlessness, limitations 
performing daily activities, confidence leaving the home and energy levels are supported by 
existing work. In a large international study conducting telephone interviews with over 1000 
patients, the most frequent complaint from patients was shortness of breath and an inability to 
take part or complete activities they used to enjoy (Miravitlles, Anzueto, Legnani, Forstmeier, 
& Fargel, 2007). Therefore, physical activity is an important construct to patients to which 
COPD has a markedly negative impact (Miravitlles et al., 2007). Additionally, patients have 
reported that climbing the stairs and walking uphill are the first activities to be impacted by 
their COPD (Dobbels et al., 2014), with the present study demonstrating that significant 
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impacts of COPD can occur even in patients with mild-moderate respiratory impairment. 
Therefore, interventions are suggested targeting patients with mild-moderate COPD reporting 
severe symptoms before patients transition from adapting their behaviour (e.g. pacing 
themselves or slowing down, using aids and resting longer) to avoiding many activities 
altogether (Dobbels et al., 2014). 
Strengths of the present study include the recruitment of patients from primary care in which 
facilitated the recruitment of mild-moderate COPD patients who do not have the access to 
research participation compared with patients attending rehabilitation or admitted to hospital. 
Additionally, the use of multiple measures of symptom severity, the examination of the 
component symptoms of the CAT questionnaire and the objective quantification of exercise 
capacity, physical activity and sedentary time with very high accelerometry compliance are 
also important strengths. However, the cross-sectional design of the study limits causal 
inference and the array of measures investigated may have led to some chance findings due to 
no correction for multiple comparisons The pragmatic analyses of individual CAT items 
when the questionnaire’s validation was based on the composite score must be noted. Whilst 
mild-moderate patients reporting severe symptoms the present study was unable to examine 
patients with severe COPD reporting low symptoms. Future studies should explore reasons 
why these patients are less burdened by their COPD despite having more advanced disease. 
Whilst findings were consistent between additional cut-point thresholds for sedentary time 
(<1853 vmcpm) (Koster et al., 2016), light activity (2000-8249 vmcpm) and MVPA (≥8250 
vmcpm) (Kamada et al., 2016) no cut-points have yet been developed against criterion 
methods such as indirect calorimetry.  Sedentary time was unable to discriminate between 
sitting and standing. As the advancement of wrist-worn accelerometry continues, further 
behavioural insights into the role of physical activity and sedentary time in COPD will be 
obtained. 
4.5 Conclusion 
This study showed that measures of COPD symptoms should not be used interchangeably 
and exploring the individual components of the CAT questionnaire provides valuable 
additional insight into patients’ perceptions of their symptoms and the factors associated with 
them. Patients with mild-moderate COPD vary considerably in the severity of their symptoms; 
with exercise capacity, low levels of physical activity and spending more time sedentary 
independently associated with greater symptom burden. Patients with mild-moderate COPD 
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reporting severe symptoms would benefit from lifestyle and exercise interventions. Patients 
should be stratified by exercise capacity and behaviour to inform personalised intervention 
designs. 
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Chapter 5: Study Three Rationale and Methods 
Title: Study protocol for Chronic Obstructive Pulmonary Disease-Sitting and ExacerbAtions 
Trial (COPD-SEAT): a randomised controlled feasibility trial of a home-based self-
monitoring sedentary behaviour intervention 
5.1 Introduction 
Targeting increases in physical activity in COPD patients has been the emphasis of a large 
number of exercise training and behaviour change interventions for over a decade (Watz et al., 
2014). Despite these considerable efforts, there has been limited success (Cindy Ng, 
Mackney, Jenkins, & Hill, 2012; H. Watz et al., 2014). The lower levels of physical activity 
coupled with the often fragile physical and psychological health (e.g. low exercise capacity 
and low self-esteem) among COPD patients may make reducing sedentary behaviour a more 
suitable conduit for behaviour change (Cavalheri et al., 2015; Hill et al., 2015). Sedentary 
behaviour is defined as ‘any waking behaviour characterised by an energy expenditure ≤1.5 
metabolic equivalents while in a sitting or reclining posture’ (Sedentary Behaviour Research, 
2012). Patients with COPD demonstrate significantly higher levels of sedentary behaviour 
compared with apparently healthy adults (Pitta et al., 2005). 
An acute exacerbation of COPD marks a critical life-event, characterised by a worsening of 
symptoms beyond normal day-to-day variation; bringing with it a plethora of negative 
impacts affecting both physical and psychological health (Celli & Barnes, 2007). For 
example, exacerbations contribute to reductions in patients’ abilities to perform activities of 
daily living (Suter et al., 2011). For patients hospitalised for an acute exacerbation of COPD, 
there is amplitude attention at the initial phase of admission followed by approximately seven 
days of monitored inactivity and sedentariness (Morgan, 2003). Consequently, patients may 
be discharged less well equipped to manage their ‘usual routine’ than when they were 
admitted (Morgan, 2003). Interventions for COPD patients in close temporal proximity to 
hospital admissions are promising, with pulmonary rehabilitation within four weeks post-
discharge, found to reduce re-hospitalisation in the preceding three months (Puhan et al., 
2011). Despite this, post-discharge pulmonary rehabilitation is sparsely taken up by patients 
who are offered it at the point of discharge (Jones et al., 2014). A stepping stone approach 
which does not emphasise exercise and does not require travel and additional 
time/appointments may serve to facilitate the physical and psychological well-being required 
for patients to invest in pulmonary rehabilitation. To date, few studies have specifically 
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targeted non-rehabilitation physical activity or sedentary behaviour immediately after 
discharge. There is a need to determine the feasibility and acceptance of such programmes. 
Such an approach may even offer as an alternative for those patients unable to exercise at 
sufficient capacity to reduce readmission risk (Greening et al., 2014). 
The time between hospital discharge and the commencement of pulmonary rehabilitation (for 
those who attend) marks an important period for patients. Pitta and colleagues (Pitta et al., 
2006) highlighted that patients with low activity levels at one month after discharge were 
more likely to be readmitted within the following year. Therefore, there is a need for 
behavioural interventions for patients upon leaving the hospital in order to prevent further 
decline in quality of life, functional capacity and potentially encourage uptake of pulmonary 
rehabilitation. Due to the impact of an acute exacerbation (e.g. dyspnea and fatigue) 
interventions requiring large amounts of effort or time may be impracticable (Jones et al., 
2014). Consequently, targeting sedentary behaviour (e.g. long periods of consecutive sitting) 
during the early stages of post-discharge recovery may act as a catalyst to encourage patients 
to sit less and move more; equipping them with the ethos and habits to better engage in 
pulmonary rehabilitation when the time comes. Furthermore, increasing light activity such as 
low intensity walking has been found to help to reduce the risk of readmissions (Donaire-
Gonzalez et al., 2015). Indeed, physical inactivity is widely regarded as the strongest 
predictor of all-cause mortality in COPD (Waschki et al., 2011) and preliminary evidence has 
suggested that a reduction in sedentary time from discharge to six weeks  will also help 
reduce the risk of  readmissions (Andrzejowski et al., 2015). 
Wearable technologies such as pedometers, which provide a basis for self-monitoring and 
real-time feedback, have been shown to elicit increases in physical activity in COPD patients 
(Kawagoshi et al., 2015; Mendoza et al., 2015). Patient-driven healthcare, facilitated by 
behavioural feedback and/or prompting, may empower patients to improve and track their 
health outcomes (Wicks, Vaughan, & Heywood, 2014). In a meta-regression to identify the 
active ingredients in activity promotion research, Michie (Michie, Abraham, Whittington, 
McAteer, & Gupta, 2009) found self-monitoring and feedback to be among the most potent 
behaviour change techniques. Coupling behaviour change strategies such as self-monitoring 
and feedback, which are grounded in Control Theory (Carver & Scheier, 1982), tend to have 
an impact greater than the sum of their independent effects (Michie et al., 2009). As 
supported by a comprehensive review of sedentary behaviour change strategies (Gardner, 
Smith, Lorencatto, Hamer, & Biddle, 2015), providing patients with education, self-
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monitoring, real-time feedback and behaviour prompts may yield promising results. However, 
in post-exacerbation care for COPD patients the use of wearable technology for behaviour 
change has not been widely explored. Technology competency and psychosocial issues in 
this population, particularly during phases of acute illness, makes examining the uptake and 
engagement with such interventions fundamental to future success. The ‘Chronic Obstructive 
Pulmonary Disease Sitting and ExacerbAtions Trial’ (‘COPD-SEAT’) focussed on the 
feasibility of delivering a home-based sedentary behaviour self-monitoring intervention in 
patients following hospital discharge for an acute exacerbation. 
The objectives of the trial were to: 
1. Examine the feasibility of the ‘COPD-SEAT’ intervention including the trial design, 
recruitment, adherence and procedures. 
2. Assess the acceptability of the intervention among patients receiving the intervention. 
3. Reduce prolonged periods of sedentary behaviour at home in COPD patients admitted 
for an acute exacerbation. 
5.2 Methods 
Trial design and registration 
The feasibility study was a three-armed randomised controlled trial with 1:1:1 individual 
allocation comparing usual care (Control) with usual care plus education (Education 
Intervention) and usual care with education plus feedback (Education + Feedback 
Intervention) (Orme et al., 2016) (Appendix O). Testing the feasibility of the randomisation 
process, patients responses to being randomised (e.g. drop-out before discharge) and 
comparing retention rates between groups was important to assess in order to inform a future 
larger trial. The design of the study and flow of participants is presented in Figure 5.1. 
This study was conducted, analysed and reported according to the CONSORT statement for 
parallel group RCTs (Schulz, Altman, & Moher, 2010). Ethical approval was obtained from 
the Research Ethics Committee East Midlands Leicester Central (15-EM-0433) (Appendix P) 
and University Hospitals of Leicester acted as study sponsor. The trial was prospectively 
registered on the ISRCTN website (ISRCTN13790881). Template informed consent form 
and participant information sheet are provided in Appendix Q and R, respectively. 
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Figure 5.1 Patient flow through the study 
 
Eligibility criteria for patients 
Patients eligible for inclusion in the study were: aged between 40 and 85 years; a confirmed 
diagnosis of COPD; fewer than 4 exacerbations requiring hospital admission in the previous 
12 months (as a marker for increased mortality risk (Soler-Cataluna et al., 2005)); a 
confirmed acute exacerbation as the reason for current hospitalisation; willingness and ability 
to comply with the trial protocol; ability to participate in light intensity physical activity (i.e. 
walking with an aid); and ability to provide informed consent (e.g. read and understand 
English). 
Patients were not eligible if the COPD specialist nurses or clinicians considered them 
unsuitable for any reason: for example, patients with severe mental impairment or terminally 
ill; patients with an injury or additional health condition that precluded their ability to take 
part in light intensity physical activity; patients with an overlying medical disorder that 
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interfered with provision of consent, completion of measurements, intervention, or follow-up; 
and/or were taking part in concomitant research studies. 
Sample size estimation and recruitment target 
The study aimed to recruit as many patients as are admitted to hospital for an acute COPD 
exacerbation within the operational period. One of the main objectives of this feasibility 
study was to provide data on eligibility and recruitment and to enable an accurate estimation 
of the required sample size for a future trial based on a realistic recruitment plan. The number 
of hospital admissions for an acute exacerbation of COPD is approximately 80-100 patients 
per month and in a previous in-hospital early rehabilitation trial conducted in part at Glenfield 
Hospital, overall recruitment uptake was 32.3% (Greening et al., 2014). Therefore, a similar 
admissions rate and uptake (~1 in 3) was expected for COPD-SEAT. 
Setting 
Participants were recruited from patients admitted to Glenfield Hospital, University Hospitals 
of Leicester NHS Trust for an acute exacerbation of COPD and were screened for eligibility 
by COPD specialist  nurses.  
Procedure 
Eligible patients were given a verbal description of the study, participant information sheet 
and expression of interest form by a researcher after they had received usual care from a 
COPD specialist nurse. A researcher revisited the patients at the bedside at an agreed time to 
collect the expression of interest form. For those patients who were not interested in taking 
part in the trial, reasons for this (if offered freely) were taken as field notes. For patients 
wishing to take part in the study, informed consent was obtained before patients were 
informed of their group allocation. If allocated to the Education or Education + Feedback 
group, patients then received the respective intervention. Questionnaires and activity monitor 
deployment were then completed prior to discharge (where possible). The timing of these 
procedures varied based on expected discharge. Upon discharge, patients were asked to wear 
the activity monitors for 14 days before returning for their follow-up appointment. 
Control group 
Although there are some variations in practice, ‘usual care’ offered to COPD patients 
admitted to hospital for an acute exacerbation typically comprised brief advice to take part in 
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regular exercise, information about pulmonary rehabilitation, and a referral to a follow-up 
clinic if the patient was eligible and did not decline pulmonary rehabilitation during their 
admission. No in-hospital rehabilitation was conducted as part of usual care. Patients also 
received brief discussions and advice regarding smoking cessation (if appropriate), 
medication and inhaler techniques, and oxygen therapy (if appropriate); generally lasting 15-
30 minutes. All patients received a phone call during the first week of discharge, as per usual 
care.  
Education group 
Written information was provided by an educational booklet, four pages in length, adapted 
for COPD patients from ‘On Your Feet to Earn Your Seat’ (Gardner et al., 2014). The ‘On 
Your Feet to Earn Your Seat’ booklet was originally developed in accordance with the habit 
formation model (Gardner, Lally, & Wardle, 2012; Lally, Van Jaarsveld, Potts, & Wardle, 
2010) and designed using a ‘small changes’ approach as detailed by Gardner and colleagues 
(Gardner et al., 2014). This booklet (Gardner et al., 2014) was modified to emphasise simpler 
behaviours, in this case standing up from a chair, which may be more appealing and 
attainable to COPD patients post-exacerbation compared with more daunting behaviours such 
as stair climbing (Lally et al., 2010). 
The researcher read through the revised booklet, entitled ‘Sit Less, Move More, Live 
Healthier’ (Appendix S), with the patient at the bed-side outlining the importance of breaking 
up long periods of sitting and discussing individualised strategies and opportunities for the 
patient to do this at home. This booklet contained seven suggestions: leave the house daily; 
make ad breaks active; stand-ups (e.g. when waiting for a bus); tiptoe through the queue; 
increase your steps, sit to stand with no hands, and treat the seat as a treat. For each of these 
tips, ‘handy-hints’ were provided to facilitate the adoption of these small changes (e.g. 
offering ways to incorporate them into everyday life). The components of the education 
delivery are presented in Table 1. In addition to the extensive focus groups and interviews for 
the original booklet (Gardner et al., 2014), the ‘Sit Less, Move More, Live Healthier’ booklet 
was put through a Pulmonary and Cardiac Rehabilitation Patient and Public Involvement 
Advisory group who provided feedback on content, readability and design. 
Education + Feedback group 
Patients randomised into the Education + Feedback group received the above education 
intervention (i.e. ‘Sit Less, Move More, Live Healthier’ booklet) plus a wearable device to 
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self-monitor their sedentary behaviour and physical activity as well as provide a behavioural 
nudge in the form of a vibration prompt. The wearable device provided real-time, visual and 
numeric feedback on time spent sitting, standing and lying down, number of sit-to-stand 
transitions and step count. It also allowed the user to look back at previous days, providing 
day-to-day comparisons in the form of a bar chart.  
Patients were shown how to wear the device at the bedside and fitted the monitor themselves 
to ensure the device is correctly adjusted to ensure a secure and snug fit. The device, LUMO 
(Lumo Bodytech, Palo Alto, CA), is a small (4.15 x 10 x 0.8cm; 25g) and flexible sensor 
(Figure 5.2) which was worn around the lower back on a belt. The sensor connects wirelessly 
via low energy Bluetooth to a mobile application on a Smart Device provided to patients. The 
embedded inertial sensors of the LUMO continuously tracked the amount of time spent lying 
down, slouching, sitting, standing and transitioning from sitting to standing providing the 
patients with up-to-date information of their behaviour whenever they wanted it.  
 
Figure 5.2 LUMO sensor 
 
Patients were trained whilst in hospital on how to navigate the app (touch screen). Real-time 
feedback was provided on a mobile app with panels displaying time spent sitting (including 
proportions of time spend standing and stepping) (Figure 5.3 Panel A), sit-to-stand transitions 
(Figure 5.3 Panel B) and step count (Figure 5.3 Panel C) using low cognitive load graphics 
and data presented on a daily, weekly and monthly format. Patients were also provided with 
written instructions on how to navigate the mobile app (Appendix T) 
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Figure 5.3 LUMO app panels showing: a) proportion of the day spent standing, stepping, 
sitting and lying down; b) daily number of sit-to-stand transitions; and c) daily step count 
 
Additionally, the LUMO alerted the patient to break up their sitting time when they had been 
sitting for ‘too long’ via gentle vibration. After a full explanation of the LUMO and app 
patients were asked how much consecutive sitting they would want to accumulate before 
being prompted (e.g. every hour of continuous sitting). The vibration frequency was fixed for 
the 2 week duration. The components of the LUMO app and vibration prompt delivery are 
shown in Table 5.1. Patients in all groups were provided with a 24 hour number to call if they 
had any questions during the course of their involvement in the trial. 
Feasibility 
Measures for assessing feasibility are provided in Table 5.2. Feasibility was assessed using 
information on patient recruitment and retention, whether patients wore and charged the 
study devices (LUMO and/or smart device) and missing data. Feasibility of the trial was 
assessed on patient recruitment and retention. In an audit of early pulmonary rehabilitation 
referral and uptake for 448 COPD patients admitted for an acute exacerbation, 286 (63.8%) 
patients were eligible for rehabilitation. 90 (31.5%) of these patients were referred to 
rehabilitation. 60 (66.6%) of these patients started the programme and 43 (65.2%) of these 
patients completed rehabilitation (Jones et al., 2014). Feasibility thresholds for eligibility, 
uptake and retention in the present study were 66.6%, 33.3% and 50.0%, respectively as 
involvement in research may not be as appealing compared to an established clinical service. 
Patients were asked to wear the LUMO for 14 days with discharge date considered day 0 and 
follow-up visit as day 15. Therefore, patients were asked to charge the device overnight 13 
times (between days 1 and 14) during the study period. Thirteen charging occurrences (one 
per day/overnight period for at least 15 uninterrupted minutes) were considered 100% 
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compliance. The feasibility threshold for charging the LUMO was set to 50% (every other 
day). Charging was automatically detected by the LUMO and coded as “NW” (non-wear). If 
the LUMO was worn and the period of charging starting after midnight (00:00:00) but before 
the first occurrence of physical activity (e.g. standing or walking) the charging period was 
considered as belonging to the previous day. 
Missing data from the LUMO can be caused by the battery dying or from being manually 
turned off by the patient. If missing data started at 15:00 and the next data point was at 16:00 
there was an hour of missing data. If the data point at 16:00 was coded as “NW” (put on 
charge) then the LUMO battery died. If the data point at 16:00 was coded as a behaviour (e.g. 
sitting, standing or walking) the LUMO was turned off by the patient. 
Acceptability 
Acceptability to the patients was assessed according to the: 
a) Proportion of patients who stopped wearing the device during the 2 weeks of follow-
up; when they did this (e.g. number of days into the follow-up). 
b) Proportion of patients who attended the follow-up appointment. 
c) Patients’ response to the vibration prompts, as examined by LUMO data (e.g. number 
of vibrations; average response time from vibration to stand-up; number of times the 
vibration prompt resulted in behaviour change). 
For patients in the Feedback group, engagement with the LUMO prompts (i.e. did the patient 
stand-up after the vibration prompt occurred?) was quantified using the LUMO inclinometer.  
Vibration prompt identification was based on periods of consecutive time spent sedentary 
(lying down or sitting) based on patients’ choice of vibration setting (e.g. after 30 minutes of 
consecutive sedentary behaviour). For each day the LUMO was worn, bouts of consecutive 
sedentariness were identified to determine the time of vibration prompt. LUMO data was in 
five minute (300 second) epochs. Six consecutive epochs of 300 seconds sedentary with 0 
seconds sedentary in the preceding epoch signified that the prompt occurred at the end of a 
five minute epoch. For example, if a period of sitting began at 12:00:00 and lasted until 
12:30:00, the vibration would have occurred at 12:30:00. 
After time-stamped vibration prompts were identified, the subsequent 15 minutes (three 300 
second epochs) were analysed to examine whether patients responded to the vibration prompt 
and, if they did, how long it took and what they decided to do (e.g. time spent standing and/or 
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stepping). For each vibration prompt responses were coded as one of the following: no 
response (patient remained sedentary for 15 minutes after the prompt occurred); response 
(patient stood up) within 5 minutes of the prompt; response 5-10 minutes after the prompt 
occurred; or response 10-15 minutes after the prompt occurred. For the three response 
timings (0-5, 5-10 and 10-15 minutes), time spent sedentary, standing and walking were 
analysed along with step count. 
Table 5.1 COPD-SEAT intervention components 
Education Booklet: Components to cover during intervention delivery 
It was explained that the booklet will provide information to help them to sit less and move more 
It was explained that sitting for too long can be harmful to their health 
It was explained that breaking up long periods of sitting can help reduce joint stiffness and pain 
The principle of ‘use it or lose it’ was explained in relation to deconditioning 
If deemed appropriate, other tailored examples of benefits to be had was explained 
The patient was directed to the 7 suggestions for an active recovery 
If deemed appropriate the first suggestion(Leave the house daily) was discussed 
If deemed appropriate the second suggestion (Make TV advert breaks active) was discussed 
If deemed appropriate the third suggestion (Stand up when waiting for something) was discussed 
If deemed appropriate the fourth suggestion (Tiptoe when waiting in a queue) was discussed 
If deemed appropriate the fifth suggestion (Increase your steps) was discussed 
If deemed appropriate the sixth suggestion (Sit to stand with no hands) was discussed 
If deemed appropriate the seventh suggestion (Treat the seat as a treat) was discussed 
If deemed appropriate additional tailored top tip examples was discussed 
Smart Device: Components to cover during intervention delivery 
It was explained that the LUMO and Smart Device communicate with each other automatically 
Patients were taught how to lock and unlock the Smart Device 
LUMO App: Components to cover during intervention delivery 
It was explained that the app provides the patient with information on sitting, standing and stepping 
Patients were shown where to find their time spent sitting ‘today’ on the app home screen 
Patients were shown where to find how many time they have stood up ‘today’ on the app home screen 
Patients were shown where to find their step count ‘today’ on the app home screen 
Sit Time Panel: Components to cover during intervention delivery 
Patients were shown how to access the pie chart for time sitting, standing, stepping and lying down 
Patients were shown the hourly bar chart for all behaviours 
Patients were shown how to look back at previous days 
Patients were shown how to return to ‘today's’ information 
Patients were shown how to return to the home screen 
Stand Ups Panel: Components to cover during intervention delivery 
Patients were shown the hourly bar chart for all behaviours 
Patients were shown how to look back at previous days 
Patients were shown how to return to ‘today's’ information 
Patients were shown how to return to the home screen 
Steps Panel: Components to cover during intervention delivery 
Patients were shown the hourly bar chart for all behaviours 
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Patients were shown how to look back at previous days 
Patients were shown how to return to ‘today's’ information 
Patients were shown how to return to the home screen 
Vibration Prompt: Components to cover during intervention delivery 
It was explained that the LUMO device provides a vibration prompt when they have sat for 'too long' 
It was explained that the vibration will only go off once then the timer will reset 
Patients chose the duration of consecutive sitting before the vibration occurs 
 
Intervention fidelity 
Examining intervention fidelity may help to explain variance in outcomes (e.g. wearing the 
activity monitors) related to non-adherence or partial adherence to the intervention (Bellg et 
al., 2004). Intervention deliveries for patients in the Education and Education + Feedback 
groups were audio recorded using TapMedia Voice Recorder (TapMedia, London, UK). Each 
component was coded separately by two trained, independent assessors using dichotomous 
scales (present or absent) to determine consistency and ordinal scales to determine quality 
(none, adequate or excellent) of the delivery. Quality definitions for Education components 
were: ‘Poor’, mentioned without examples; ‘Adequate’, explained without examples; 
‘Excellent’, explained with examples. Quality definitions for Feedback components were: 
‘Poor’, mentioned without patient performing task; ‘Adequate’, explained without patient 
performing task; ‘Excellent’, explained with patients performing task. All recordings were 
analysed by both assessors for quality control and quality assurance purposes. When scores 
for each component did not match between assessors, a third independent reviewer was 
consulted. 
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Table 5.2 Outline of feasibility indicators 
Indicators Data sources Timing 
Recruitment 
Feasibility of patient screening and 
recruitment 
Project records 
(e.g. number of eligible patients missed) 
Ongoing throughout the study 
Number of eligible patients, number of 
patients screened, number of patients 
invited to take part, actual number of 
patients who consent to take part 
Medical records and project records Ongoing throughout the study 
Number of patients who refuse, drop out 
or opt out 
Patient requests, field notes  
Intervention delivery 
Duration of intervention sessions 
(education and/or device training); 
patient engagement in the content. 
Audio recordings of the  
intervention sessions 
Ongoing throughout the study 
Description of unintended events 
It is important to note whether there 
were any unintended side effects or 
outcomes from the intervention.  
Medical notes 2 week follow-up appointment 
Hospital readmissions related to the 
study. For example, trying to move more 
resulting in a fall. 
Medical notes Ongoing throughout the study 
Potential sustainability 
The number of telephone contacts and 
duration of telephone conversations with 
patients during follow-up beyond usual 
care. 
Project records Ongoing throughout the study 
 
Data collection 
Data was collected January-August 2016 by trained researchers, following standard operating 
procedures. Researchers were not blinded to treatment allocation for study measurements. 
Baseline data were collected during patients’ hospital stay. The timing of baseline data 
collection could not be standardised due to variation in the timing of patients receiving usual 
care from COPD Specialist Nurses, screening and length of stay. 
Sample characteristics 
Baseline only 
Usual dyspnea severity 
In order to examine patients’ usual breathlessness severity i.e. when not acutely ill, the 
mMRC dyspnea scale (single item) (Mahler & Weels, 1988) was completed. 
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Baseline and follow-up 
Questionnaires 
The full COPD-SEAT questionnaire is provided in Appendix U. During hospital stay and at 
follow-up a range of health/psychosocial measures were taken. COPD-specific health status 
was examined using the CAT (8 items) (Jones et al., 2009). Overall health status was 
assessed using the EuroQol EQ-5D-5L (5 items) (Herdman et al., 2011). Additional symptom 
burdens were assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue (40 
items) with a score <30 indicating severe fatigue (Webster, Cella, & Yost, 2003)and the 
Hospital Anxiety and Depression Scale (HADS) (14 items) (Zigmond & Snaith, 1983) with 
normal anxiety/depression levels classified as a score 0-7, borderline abnormal levels 
classified as a score of 8-10 and abnormal levels considered a score of 11-21 (Snaith, 2003). 
Fear of falling was assessed using the Falls Efficacy Scale-International (FES-I) (16 items) 
(Yardley et al., 2005). Patients self-reported information on the ownership and usage of 
technology (computer and smart phone) relating to browsing the internet, emails, 
entertainment (e.g. listening to music), online shopping and social networking. Deprivation 
levels were examined using patients’ home postcodes using the IMD 2015 explorer 
(http://dclgapps.communities.gov.uk/imd/idmap.html). 
Self-reported physical activity and sitting 
During hospital stay patients’ usual time spent sitting in domain-specific activities (TV, 
transport, work, computer and other) during weekdays and weekend days was self-reported 
using an adapted version of the Marshall Sitting Time Survey (10 items) (Marshall, Miller, 
Burton, & Brown, 2010). Patients were asked to complete an adapted version of the 
International Physical Activity Questionnaire (IPAQ) Short Form (3 items) (Craig et al., 2003) 
to assess usual physical activity levels.  
Follow-up only 
Body composition and physical function 
At follow-up height, weight and waist circumference were measured to the nearest 0.1cm, 
0.1 kg and 0.1 cm, respectively. Waist circumference was measured twice, with a third 
conducted if the difference between the first two was greater than 3cm. Patients were also 
asked to complete the Short Physical Performance Battery (SPPB) which comprised repeated 
chair stands; balance tests and a 4m walk (Puthoff, 2004). Upper limb skeletal muscle 
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strength was assessed using a hand-held dynamometer (Takeii analogue dynamometer, 
Niigata, Japan) (Parvatikar & Mukkannavar, 2009). 
Pulmonary rehabilitation 
Past and present pulmonary rehabilitation referral and attendance information was obtained 
through the Hospital Information Support System by senior pulmonary rehabilitation 
physiotherapists on-site at Glenfield Hospital, UK. Present pulmonary rehabilitation 
attendance was established based on the referral during the hospital stay related to their 
participation in this trial. Attendance was defined as completing at least one class and 
completion was defined as finishing the six week programme. 
Continuous measurement 
Objectively measured physical activity and sedentary behaviour 
Following hospital discharge (day 0), patients were asked to wear two monitors, one posture 
sensor (gyroscope) and one triaxial accelerometer, for 14 days and returned the devices at the 
follow-up appointment (day 15). An ActiGraph wGT3X-BT triaxial accelerometer was worn 
on a waistband (on the right anterior axillary line) for 2 weeks to measure time spent in 
physical activity (i.e. sedentary, light, moderate, and vigorous) using common cut-points and 
step count. Patients were asked to wear the device during waking hours and to only remove it 
during that period for water-based activities. 
Accelerometers recorded data at 100Hz and were initialised, downloaded and converted to 
60-second epoch files using ActiLife version 6.13.2 (Pensacola, FL). Non-wear was defined 
as 60 minutes of consecutive zeros with allowance for two minutes of interruptions and a 
valid day was defined as at least 600 minutes of wear during waking hours (Troiano et al., 
2008). Accelerometer processing was conducted using KineSoft version 3.3.80 
(Loughborough, UK). A summary of accelerometry methodology is provided in Table 5.3. 
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Table 5.3 Accelerometry data collection and analytical procedures 
Information Details 
Accelerometer Model Actigraph wGT3X-BT (version 6.13.2; firmware 1.6.1) 
Serial number range Sixteen unique devices were used ranging from MOS2A02140493 to 
MOS2A02140631; averaging two deployments per device 
Piezosensor orientation Triaxial 
Mode setup Mode 29 (x, y, z, steps, lux) 
Original sample rate 100 Hz (.gt3x file format) 
Deployment method Fitted by patient (on day 1) and after demonstration and practice (on day 0) 
Location worn Anterior hip adjacent to the mid-line of the thigh 
Requested days of wear 14 d (20160 epochs) not including day 0 
Initialization Deployed in delay mode on day 0 (during admission) and commenced logging on 
day 1(first full day after discharge) at 00:00 hrs with no stop time (estimated date of 
discharge not reliable) 
Wear instructions Wear continuously except for sleep and water based activities 
Analytical Processing  
Non-wear appropriation ≥60 min of consecutive 0s with allowance for 2 minutes of interruptions were 
deemed biologically implausible and coded as non-wear (Troiano et al., 2008) 
Valid day criteria ≥10 hours of valid waking wear time (Troiano et al., 2008) 
Valid file At least 4 valid days (Troiano et al., 2008) 
Missing data Data modelling or imputation was not performed 
Epoch length 60 seconds 
Intensity classification 
 
Uniaxial (x-axis) cut-points as follows: 
Sedentary time: <100 cpm (Troiano et al., 2008) 
Light: 100-2019 cpm (Troiano et al., 2008) 
MVPA: ≥2020 cpm (Troiano et al., 2008) 
 
The LUMO posture sensor served to objectively quantify sedentary behaviour in all groups 
(Control, Education and Education + Feedback). Therefore, it acted as both the measurement 
and intervention device for the Education + Feedback Group. In addition to physical activity 
intensity data collected by the ActiGraph accelerometer, the LUMO provided information on 
sitting, driving, lying, standing, sit-to-stand transitions and stepping. The device was worn on 
the lower back (in contact with skin) for 2 weeks post-discharge. Patients were asked to wear 
the monitor during waking hours and to remove it for water-based activities. The LUMO has 
been found to produce valid measurements of free-living sedentary behaviour (mean error of 
9.5%) (Rosenberger et al., 2016) and step count (mean absolute percentage error 0.4%) 
(Kooiman et al., 2015) compared with the ActivPAL (PAL Technologies Ltd, Glasgow, UK). 
Whilst no validation study to date has specifically examined LUMO stand-ups, valid free-
living sedentary behaviour against the ActivPAL supports accurate detection of sit-to-stand 
transitions. LUMO data was analysed in five minute epochs with behaviours summarised as a 
proportion of each five minute epoch (e.g. 50% sitting will be converted to 2.5 minutes 
sitting).  
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Patients were asked to wear for the ActiGraph and LUMO monitors concomitantly for two 
main reasons. Firstly, as noted above, the LUMO monitor was a relatively new device and 
had not yet been subject to multiple validation studies across different populations (e.g. ages, 
disease states and habitual activity levels). Therefore, the ActiGraph provided a well-
established measurement of physical activity and sedentary time in COPD and general 
populations. Secondly, it was unclear whether patients would dislike the nudge/vibration 
feature of the LUMO and thus remove it. Consequently there was a need for an independent 
evaluation and intervention sensor. 
Randomisation 
Block randomisation (1:1:1) was used to ensure a balance in sample size between the three 
study groups. Balanced combinations of group allocations within blocks were conducted by a 
researcher at Loughborough University independent of the research team. This ensured study 
team researchers were blinded to group allocation prior to patients deciding whether to take 
part in the study. Due to limited study team members and logistical barriers study team 
researchers were made aware of group allocation before consent. However, study team 
members were not aware of prospective group allocation when approaching patients to 
provide the information sheet. Patients were only informed of their group allocation after 
providing informed consent. Baseline measures were conducted after group allocation. 
Quantitative data analysis 
All participant information collected as part of the research was kept strictly confidential. 
With permission, patients’ general practitioner was informed of their participation in the 
study. Any information regarding patients which left the hospital had their name and address 
removed.  
Data were entered and housed on a secure web-based database system, Research Electronic 
Data Capture (REDCap), which has discrepancy management capabilities. Data were 
transferred from REDCap to the Statistical Package for the Social Sciences (SPSS) for 
statistical analysis. 
Comparisons between study groups (Control, Education and Feedback) were conducted using 
analysis of variance (ANOVA) with Bonferroni post-hoc tests. Changes in characteristics 
from baseline to follow-up were examined using paired t-test. Comparisons between patients 
who did or did not complete the study were performed using independent t-tests. Categorical 
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data was analysed using Fischer exact test for frequencies of less than five patients and Chi-
squared for frequencies of at least five patients. Analysis was conducted using SPSS version 
22.0 for Windows (SPSS Inc, Chicago, IL) with alpha set to 0.05. 
Adverse events 
To monitor intervention safety, adverse events including readmissions, deaths and falls 
during each patient’s study involvement were recorded. 
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Chapter 6: Study Three Results and Discussion 
Title: A feasibility study of a home-based self-monitoring sedentary behaviour intervention 
in COPD patients suffering from an acute exacerbation: Trial results 
6.1 Results 
6.1.1 Feasibility of recruitment and retention 
Patient screening 
Of the 346 patients admitted during the study period 300 (86.7%) were screened for inclusion 
in this study, comprising 164 females (54.7%, 69.9±9.6 years) and 136 males (45.3%, 
71.0±8.4 years). The remaining 46 (13.3%) patients were seen by the COPD specialist nurses 
but were not entered on the screening log. Gender and age distributions of the screened 
patients are presented in Figure 6.1. Two (0.7%) patients had missing age data. 
 
Figure 6.1 Age and gender distribution for screened patients 
 
Patient flow 
Participant flow through the trial is presented in Figure 6.2. Of the 300 patients screened, 212 
(70.7%) were eligible to take part in the study (69.6±8.6years, 52.4% female). Of these, 100 
(47.2%) were discharged before the researcher could approach them (69.3±9.0 years, 52% 
female) and for 1 (0.4%) male patient, the ward nurses advised the researcher not to approach 
due to an unspecified complicated social situation. Therefore 111 (52.4%) were approached 
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to take part in the study with 35 (31.5%) consenting to participate. Of these, 2 patients (1 
Control and 1 Education) were identified as having early stage dementia after consent and 
randomisation. These patients were withdrawn from the study leaving 33 patients (11 Control, 
10 Education and 12 Education+Feedback). 17 patients (51.2%; 6 Control, 3 Education and 8 
Education+Feedback) attended the follow-up appointment. 
 
Figure 6.2 CONSORT diagram for COPD-SEAT 
 
Reasons for ineligibility 
Of the 88 ineligible patients, the mean age was 72.2 years comprising 53 (60.2%) females. 
The most cited reasons for exclusion by COPD specialist nurses were: too severe 
comorbidities (25.0%), more than 4 exacerbations in the previous year (20.5%), taking part in 
other research (14.8%) and physically incapable (11.4%). No patient screened was under the 
age of 40 years whilst 8 patients (9.1%) were older than 85 years. A diagnosis of COPD 
could not be confirmed in 7 (8.0%) patients screened. 
Of the 22 patients excluded because of comorbidities, 8 (36.4%) had a psychological 
condition (e.g. bipolar or schizophrenia), 3 (13.6%) had dementia, 3 (13.6%) had poor 
eyesight (e.g. macular degeneration), 4 (18.2%) had additional lung conditions (e.g. cancer) 
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and 4 (18.2%) suffered from neurological or skeletal ailments severely impairing mobility 
(e.g. multiple sclerosis or spinal stenosis). 
Patients approached 
Of the 111 patients (70.1±8.3 years, 52.3% female) approached for the study, 92 (82.9%) 
accepted and read the patient information sheet. There were 2 (1.8%) patients aged 40-49 
years, 17 (15.3%) patients aged 50-59 years, 30 (27.0%) patients aged 60-69 years, 46 
(41.4%) patients aged 70-79 years and 16 (14.4%) patients aged at least 80 years. There were 
9 (8.1%) patients admitted to the clinical decisions unit, 23 (20.7%) to a short-term stay ward 
and 79 (71.2%) to long-term stay wards. 
Reasons for refusal 
Of the 111 patients approached, 76 (68.5%) refused to take part in the study. More than one 
main reason for refusal was reported for 9 (8.1%) patients. The most common reasons were: 
feeling too unwell or having too many health-related issues/commitments (40.0%) and 
considering themselves sufficiently active (12.9%). Other reasons for refusal included being a 
carer for their partner (7.1%), not wanting to commit to the time (5.9%) or travel 
commitments (1.2%), and being content with taking part in pulmonary rehabilitation (5.9%). 
Two (2.4%) patients were put off by wearing the activity monitors. 
Length of hospital stay 
The average length of hospital stay was 5.6±3.2 days with an average of 3.6±1.7 days from 
admission to consent and 2.0±3.2 days from consent to discharge. No significant differences 
were observed between groups. Time from admission to consent ranged between 1-7 days 
with 12.1% of patients consented the day after their admission date. Over one-third (36.4%) 
of patients were discharged the same day as they were consented, 30.3% were discharged the 
day after consent and 20.1% of patients were discharged more than 3 days after consenting.  
Adverse events 
Four patients (12%) (1 Control, 3 Education + Feedback) were readmitted for an acute 
exacerbation of COPD during the 2 week follow-up.  Two patients (6%) (2 Education) were 
admitted to hospital for at least one overnight stay for bronchoscopy or undiagnosed stomach 
pains. No hospital admissions were as a result of the trial and no deaths occurred to patients 
during their trial involvement.  
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6.1.2 Patient characteristics 
Baseline characteristics 
Sample characteristics are presented in Table 6.2 and comprise 33 patients (69.7% female) 
aged 71±20 years. No differences in baseline characteristics were observed between study 
groups. Two-thirds of patients were former smokers and one-third current smokers at the time 
of admission with a combined pack year history of 46.7±25.6 years. Patients reported a 
median mMRC dyspnea grade of 3 when stable (pre-hospitalisation) and 9.1% of patients 
required ambulatory oxygen upon discharge. For self-reported general health using EQ-5D-
5L, 82.6% of patients reported at least moderate problems with mobility, 39.1% for self-care, 
73.9% for performing their usual activities and 47.7% for pain or discomfort. 30.3% of 
patients were classified as having abnormal (high) depression levels, 39.4% of patients had 
abnormal (high) anxiety and 81.8% reported severe fatigue. There were no significant 
differences in comorbidity prevalence between study groups.  
Follow-up characteristics 
For the 17 patients who completed the trial, mobility limitation (SPPB <10 points) was 
observed in 95.7% of patients. The prevalence of overweight or obesity based on BMI was 
64.7% with one patient (5.9%) classified as underweight. Control group patients had 
significantly greater BMI and waist circumference values compared with Education and 
Education + Feedback groups. 
Pulmonary rehabilitation 
Of the 33 patients who took part in the trial, 14 (42.4%) attended the pulmonary rehabilitation 
clinic appointment as part of usual post-exacerbation care. Seven (21.2%) patients agreed to 
attend pulmonary rehabilitation of which four (12.1%) did attend. Overall pulmonary 
rehabilitation uptake was 12.1%. Ten (30.3%) patients had previously completed pulmonary 
rehabilitation with one (9.1%) patient attending within 12 months of admission, another 
(9.1%) patient attending within 12-24 months of admission, nine (27.3%) attending more 
than two years ago and the remaining 22 (66.7%) never attending. No significant differences 
were observed between study groups. 
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Table 6.1 Baseline patient characteristics for the whole sample and group allocations, 
reported as mean (SD) unless otherwise stated 
 Whole  
Sample 
(n=33) 
Control 
 
(n=11) 
Education 
 
(n=10) 
Education +  
Feedback 
 (n=12) 
Demographics     
Age 71.0 (20.0) 65.3 (13.0) 66.2 (9.2) 72.0 (7.9) 
Female gender (%) 23 (69.7) 7 (63.6) 9 (90.0) 7 (58.3) 
IMD decile 4.5 (3.2) 3.8 (2.9) 3.7 (3.4) 5.7 (3.1) 
Employment status (%):     
Retired 25 (75.8) 6 (54.5) 8 (80.0) 11 (91.7) 
Unemployed 5 (15.1) 3 (27.3) 1 (10.0) 1 (8.3) 
Employed 3 (9.1) 2 (18.2) 1 (10.0) 0 (0) 
Lung health and comorbidities     
Smoking status (%):     
Current 11 (33.3) 5 (50.0) 5 (50.0) 1 (8.3) 
Former 21 (63.6) 5 (50.0) 5 (50.0) 11 (91.7) 
Pack years 46.7 (25.6) 40.2 (27.6) 53.2 (28.2) 47.4 (22.2) 
Usual mMRC grade 2.6 (1.2) 2.3 (0.9) 3.1 (1.4) 2.6 (1.2) 
Home oxygen (%) 3 (9.1) 0 (0) 1 (10.0) 2 (16.7) 
12 month all-cause admissions 1.7 (1.8) 1.7 (2.0) 0.9 (0.9) 2.3 (2.1) 
12 month AECOPD admissions 0.9 (1.2) 1.2 (1.5) 0.5 (0.9) 1.0 (1.1) 
New diagnosis of COPD (%) 3 (9.1) 1 (9.1) 1 (10.0) 1 (8.3) 
Number of comorbidities 3 (3) 3 (5) 4 (3) 3 (3) 
Self-reported health     
EQ-VAS 40.8 (20.4) 43.6 (18.7) 31.4 (22.5) 43.3 (21.7) 
CAT score 24.9 (7.5) 23.6 (7.2) 27.9 (8.5) 23.7 (6.7) 
Fatigue score 19.8 (11.8) 22.6 (8.2) 11.4 (9.4) 22.1 (13.8) 
HADS depression score 8.2 (4.7) 9.2 (3.1) 10.4 (6.0) 5.9 (4.2) 
HADS anxiety score 9.2 (5.8) 10.6 (6.0) 12.5 (12.0) 6.8 (4.5) 
FESI score 33.4 (13.7) 34.7 (1.1) 35.0 (15.0) 31.0 (15.4) 
Self-reported physical activity     
Daily walking time (min) 12.9 (15.8) 16.1 (14.8) 9.0 (20.1) 12.2 (15.6) 
Daily moderate PA (min) 2.2 (7.7) 7.0 (12.9) 0.0 (0.0 0.0 (0.0) 
Daily vigorous PA (min) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 
Self-reported sitting time β     
Daily TV sitting time (min) 354.4 (246.9) 362.9 (260.2) 382.3 (288.0) 333.7 (242.0) 
Daily travel sitting time (min) 56.0 (67.2) 51.2 (50.4) 17.0 (25.4) 79.4 (85.5) 
Daily computer sitting time (min) 40.2 (59.3) 38.6 (46.9) 44.0 (77.0) 39.7 (65.1) 
Daily other sitting time (min) 102.4 (130.4) 115.2 (67.8) 150.0 (256.3) 68.4 (78.0) 
Daily total sitting time (min) 553.0 (253.6) 567.8 (198.1) 593.3 (223.0) 521.1 (319.9) 
Pulmonary rehabilitation     
Attended clinic appointment (%) 14 (42.4) 8 (72.7) 3 (30.0) 3 (25.0) 
PR accepted (%) 7 (21.2) 3 (27.3) 2 (20.0) 2 (16.7) 
PR attended (%) 4 (12.1) 1 (9.1) 1 (10.0) 2 (16.7) 
Previously completed PR (%):     
Within 12 months 1 (3.0) 1 (9.1) 0 (0) 0 (0) 
Within 24 months 1 (3.0) 0 (0) 0 (0) 1 (8.3) 
More than 24 months ago 9 (27.3) 4 (36.4) 1 (10.0) 4 (33.3) 
Never 22 (66.7) 6 (54.5) 9 (90.0) 7 (58.3) 
Abbreviations: AECOPD, acute exacerbation of chronic obstructive pulmonary disease; CAT, COPD 
assessment test; EQ-VAS, EuroQol visual analogue scale; FESI, falls efficacy scale international; HADS, 
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hospital anxiety and depression scale; IMD, Index of Multiple Deprivation; mMRC, modified Medical Research 
Council; PA, physical activity; TV, television 
β, daily work sitting is missing for the three patients in employment 
Table 6.2 Follow-up patient characteristics for the whole sample and group allocations, 
reported as mean (SD) unless otherwise stated 
 Whole  
Sample 
(n=33) 
Control 
 
(n=11) 
Education 
 
(n=10) 
Education +  
Feedback 
 (n=12) 
Body composition     
Height (cm) † 163.1 (8.4) 164.8 (8.5) 160.2 (6.5) 163.5 (9.4) 
Weight (kg) † 73.4 (16.6) 59.2 (9.1) A, B 90.4 (17.6) 77.7 (12.8) 
BMI (kg/m2) †  27.6 (7.4) 21.3 (3.2) B 37.3 (9.7) 28.8 (3.8) 
BMI category † (%):     
Underweight 1 (5.9) 1 (16.7) 0 (0) 0 (0) 
Normal weight 5 (29.4) 4 (66.7) 0 (0) 1 (12.5) 
Overweight 7 (41.2) 1 (16.7) 1 (33.3) 5 (62.5) 
Obesity 4 (23.5) 0 (0) 2 (66.7) 2 (25.0) 
Waist circumference (cm) †  99.1 (13.8) 86.7 (11.1) A, B 106.5 (15.3) 106.6 (8.5) 
Lung health and comorbidities     
FEV1 † 1.2 (0.6) 1.2 (0.8) 1.7 (0.4) 1.1 (0.5) 
FEV1%predicted † 57.3 (29.9) 52.3 (34.9) 84.7 (26.6) 50.8 (24.1) 
FVC † 2.6 (1.0) 2.4 (0.7) 2.5 (0.6) 2.6 (0.7) 
FEV1/FVC ratio † 45.0 (19.1) 45.0 (20.5) 67.0 (3.0) 42.0 (18.2) 
Physical function     
Grip strength (kg) †  27.9 (7.5) 29.2 (5.0) 23.7 (1.5) 28.5 (10.0) 
SPPB points † 7.4 (1.9) 8.2 (1.9) 5.3 (2.1) 7.6 (1.4) 
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital 
capacity; SPPB, short physical performance battery  
BMI categories: underweight <18.5kg/m2; normal, ≥18.5 and <25.0kg/m2; overweight, ≥25.0 kg/m2 and obesity, 
<30.0kg/m2 (World Health Organization, 2000)  
SPPB: mobility limitation defined as <10 points (Bernabeu-Mora et al., 2015)  
A, different to Education + Feedback group; B, different to Education group 
 
Technology ownership and usage 
Given the use of wearable self-monitoring technology in the present study it is important to 
examine the potential for adoption of technology in this population (Table 6.3). Twenty 
(60.6%) patients reported owning a computer (desktop, laptop or tablet). Eight (24.2%) 
patients reported owning a Smart phone (e.g. iPhone or Android). Seven (21.2%) patients 
reported owning both a computer and Smart phone. No significant differences in the 
ownership of a computer or Smart phone were observed between study group allocations. A 
significantly larger proportion of patients in the Education group used a computer or Smart 
phone for entertainment compared with Control and Education + Feedback groups. 
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Table 6.3 Technology usage in patients stratified by group allocation 
 Control 
 
(n=11) 
Education 
 
(n=10) 
Education 
+ Feedback 
(n=12) 
Computer usage 
Computer ownership (%) 5 (45.5) 6 (60.0) 9 (75.0) 
Computer usage (%):    
Go on the internet 4 (80.0) 4 (66.7) 6 (66.7) 
Emails 3 (60.0) 3 (50.0) 4 (44.4) 
Entertainment 1 (20.0) 5 (83.3) A 3 (33.3) 
Shopping 2 (40.0) 3 (50.0) 4 (44.4) 
Social networking 0 (0) 3 (50.0) A 0 (0) 
Smart phone ownership 
Smart phone ownership (%) 3 (27.3) 3 (30.0) 2 (16.7) 
Smart phone usage (%):    
Go on the internet 1 (33.3) 2 (66.7) 1 (50.0) 
Emails 0 (0) 1 (33.3) 1 (50.0) 
Entertainment 0 (0) 3 (100) A 0 (0) 
Shopping 0 (0) 1 (33.3) 0 (0) 
Social networking 2 (66.7) 2 (66.7) 1 (50.0) 
A, significantly different to other two groups  
Physical activity and sedentary time 
Patients who completed the study provided significantly more valid days (≥600 minutes) 
compared with those who did not attend the follow-up appointment (5.3±3.4 versus 1.6±2.0 
days, p=0.005). Ten patients (38.5%) provided at least four valid days with an average wear 
time of 731±78 minutes. Patients spent 559±115 minutes sedentary, 169±87 minutes in light 
activity and 2±3 minutes in moderate intensity activity; accruing 2272±1712 steps per day. 
6.1.3 Feasibility of intervention delivery 
Intervention fidelity 
Twenty-one (95%) of interventions were delivered; comprising 9 (90%) for Education and 12 
(100%) for Education + Feedback. For one patient, who was randomised to the Education 
group, the intervention was not delivered verbally because the patient had been discharged 
before it could be delivered. The patient only received the educational booklet to take home. 
A full breakdown of intervention fidelity is provided in Table 6.4. Overall consistency of the 
intervention delivery was 77.3% with “poor”, “good” and “excellent” quality ratings for 0.2%, 
9.4% and 90.4% of all occurrences, respectively. 
For the Education component, the overall consistency score was 188 out of a possible 273 
highlighting moderate adherence (68.9%). Two factors had very poor adherence; “tiptoe 
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when waiting in a queue” (0%) and “sit to stand with no hands” (10%). Removal of the two 
factors increased overall consistency to 186 out of 231 (80.5%). Of the 188 occurrences, 
overall quality scores for “poor”, “good” and “excellent” were 1 (0.5%), 3 (1.6%) and 184 
(97.9%), respectively, indicating excellent quality in delivery. 
For the feedback component, the overall consistency score was 227 out of a possible 264 
highlighting overall good adherence (86.0%). Of the 227 occurrences, overall quality scores 
for “good” and “excellent” were 36 (15.9%) and 191 (84.1%), respectively, indicating 
excellent quality in delivery.  
Table 6.4 Intervention fidelity for education and feedback components 
  Consistency (%) Quality (%) 
  Present Absent Poor Adequate Excellent 
Education Booklet (n=21)           
The booklet is designed to help you to sit less  
and move more 
21 (100) 0 (0) 0 (0) 0 (0) 21 (100) 
Sitting for too long can be harmful to your 
health 
21 (100) 0 (0) 0 (0) 1 (5) 20 (95) 
Use it or lose it - Keep muscles active to  
help prevent deconditioning 
19 (90) 2 (10) 1 (5) 0 (0) 18 (95) 
Other examples of benefits to be had 20 (95) 1 (5) 0 (0) 0 (0) 20 (100) 
Directed to 7 suggestions for an active recovery 21 (100) 0 (0) 0 (0) 0 (0) 21 (100) 
1 - Leave the house daily 14 (67) 7 (33) 0 (0) 0 (0) 14 (100) 
2 - Make TV advert breaks active 21 (100) 0 (0) 0 (0) 0 (0) 21 (100) 
3 - Stand up when waiting for something  
(e.g. bus, kettle) 
7 (33) 14 (67) 0 (0) 0 (0) 7 (100) 
4 - Tiptoe when waiting in a queue 0 (0) 21 (100) N/A N/A N/A 
5 - Increase your steps 18 (86) 3 (14) 0 (0) 0 (0) 18 (100) 
6 - Sit to stand with no hands 2 (10) 19 (90) 0 (0) 0 (0) 2 (100) 
7 - Treat the seat as a treat 7 (33) 14 (67) 0 (0) 2 (29) 5 (71) 
Additional tailored top tip examples 17 (81) 4 (19) 0 (0) 0 (0) 17 (100) 
Total score 188 (68.9) 85 (31.1) 1 (0.5) 3 (1.6) 184 (97.9) 
Smart Device (n=12) 
     LUMO and Smart Device communicate  
with each other 
12 (100) 0 (0) 0 (0) 0 (0) 12 (100) 
Patient shown how to lock and unlock the 
Smart Device 
9 (75) 3 (15) 0 (0) 0 (0) 9 (100) 
Total score 21 (87.5) 3 (12.5) 0 (0) 0 (0) 21 (100) 
LUMO App (n=12) 
     App provides you with information on sitting,  
standing and stepping 
12 (100) 0 (0) 0 (0) 0 (0) 12 (100) 
Patient shown where to find time spent sitting 12 (100) 0 (0) 0 (0) 0 (0) 12 (100) 
Patient shown where to find how many times  
they have stood up  
12 (100) 0 (0) 0 (0) 1 (8) 11 (92) 
Patient shown where to find their step count 12 (100) 0 (0) 0 (0) 0 (0) 12 (100) 
Total score 48 (100) 0 (0) 0 (0) 1 (2.1) 47 (97.9) 
Sit Time Panel (n=12) 
     Patient shown the pie chart for sitting,  12 (100) 0 (0) 0 (0) 0 (0) 12 (100) 
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standing, stepping, lying down 
Patient shown the hourly bar chart for all  
behaviours 
12 (100) 0 (0) 0 (0) 1 (8) 11 (92) 
Patient shown how to look back at previous  
days 
10 (83) 2 (17) 0 (0) 5 (50) 5 (50) 
Patient shown how to return to today's  
information 
5 (42) 7 (58) 0 (0) 0 (0) 5 (100) 
Patient shown how to return to the home  
screen 
12 (100) 0 (0) 0 (0) 1 (8) 11 (92) 
Total score 51 (85.0) 9 (15.0) 0 (0) 7 (13.7) 44 (86.3) 
Stand Ups Panel (n=12) 
     Patient shown the hourly bar chart for all  
behaviours 
10 (83) 2 (17) 0 (0) 3 (30) 7 (70) 
Patient shown how to look back at previous  
days 
10 (83) 2 (17) 0 (0) 5 (50) 5 (50) 
Patient shown how to return to today's  
information 
7 (58) 5 (42) 0 (0) 2 (29) 5 (71) 
Patient shown how to return to the home  
screen 
9 (75) 3 (15) 0 (0) 0 (0) 9 (100) 
Total score 36 (75.0) 12 (25.0) 0 (0) 10 (27.8) 26 (72.2) 
Steps Panel (n=12) 
     Patient shown the hourly bar chart for all  
behaviours 
10 (83) 2 (17) 0 (0) 2 (20) 8 (80) 
Patient shown how to look back at previous  
days 
11 (92) 1 (8) 0 (0) 7 (64) 4 (36) 
Patient shown how to return to today's  
information 
7 (58) 5 (42) 0 (0) 4 (57) 3 (43) 
Patient shown how to return to the home  
screen 
11 (92) 1 (8) 0 (0) 1 (9) 10 (91) 
Total score 39 (81.3) 9 (18.8) 0 (0) 14 (35.9) 25 (64.1) 
Vibration Prompt (n=12) 
     LUMO provides a vibration prompt when 
patient sits for 'too long' 
12 (100) 0 (0) 0 (0) 1 (8) 11 (92) 
Vibration will only go off once then the timer  
will reset 
8 (67) 4 (33) 0 (0) 1 (12) 7 (88) 
Patient chooses the duration of sitting before  
vibration occurs 
12 (100) 0 (0) 0 (0) 2 (17) 10 (83) 
Total score 32 (88.9) 4 (11.1) 0 (0) 4 (12.5) 28 (87.5) 
 
Duration of intervention deliveries 
On average, the educational component (n=21) delivery took 6.9±3.5 minutes and the 
feedback component (n=12) took 10.0±6.0 minutes. Individual timings of intervention 
deliveries are provided in Figure 6.3.  
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Figure 6.3 Individual durations of intervention deliveries stratified by intervention 
component (education and feedback) and person speaking (researcher or patient) 
 
6.1.4 Feasibility of intervention technology 
Device malfunctions 
Three patients (25%) experienced a device malfunction. For two patients, the smart device 
malfunctioned which meant patients were unable to look at the LUMO app. For the other 
patient, it was reported that the step count was not updating even though the patient was 
stepping (day 5). There was a delay in communication between the LUMO and smart device 
but the problem did not persistent and no replacement device was required. Five phone calls 
were required to resolve the issues (2.80±0.75minutes per phone call). 
Missing data 
Missing data occurred for three patients (20%) with one patient having one missing day 
(patient turned the LUMO off), one patient having eight missing days (battery died for 5 days 
and patients turned LUMO off for 3 days) and one patient having 12 missing days (patient 
turned LUMO off).  
6.1.5 Acceptability of activity monitors 
Choice of vibration frequency 
Of the 12 patients (58.3% female) randomised to the Education + Feedback group, 6 (50%; 
66.7% female) chose for the vibration to occur after 30 minutes, 1 (8.3%; 0% female) after 45 
minutes and 5 (41.7%; 60% female) after 60 minutes of consecutive sitting. 
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LUMO wear compliance 
Patients wore the LUMO for 11.8±2.3 days over the 14 day period with 9.0±3.4 days having 
at least one vibration prompt occurring. Individual compliance with the LUMO and days 
prompted are presented in Figure 6.4. Two patients (25%) wore the LUMO for the full 14 
days with wear compliance ranging 8-14 days. The number of days prompted ranged 2-12 
with patients selecting a vibration setting of 30 minutes averaging 8.3±4.4 days prompted 
compared with 9.8±2.6 for patients selecting a vibration setting >30 minutes of consecutive 
sedentary behaviour (p=0.414).  
 
Figure 6.4 Wear compliance for the LUMO and number of days prompted 
 
The day-by-day wear compliance and prompt occurrence over the 14 days is shown in Figure 
6.5. The LUMO was worn on days 2-5 by all patients with day 14 having the lowest 
compliance (50%). Out of a total of 94 days the LUMO was worn, at least one vibration 
prompts occurred on 72 days (76.6%) with an average of five prompts per day.  
 
Figure 6.5 Wear compliance for the LUMO and number of days prompted over the 14 day 
period 
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Charging compliance 
Charging compliance for 15 patients (88.2% of patients who completed the study) was 
examined, with a maximum 13 overnight occurrence where patients were asked to charge the 
LUMO. Thirteen charging occurrence (one per day/overnight) was considered 100% 
compliance. On average, patients charged the LUMO 8.4±3.9 times lasting 617±320 minutes 
over the 14 days. Ten patients (66.6%) had more than 50% charging compliance (≥7 days) 
and seven patients (46.6%) had greater than 75% charging compliance (≥10 days).  
6.1.6 Acceptability: Comparison of completers and non-completers 
Characteristics of patients by study completion 
Examining differences between patients who did and did not complete the trial may help to 
identify potential reasons for this (Table 6.5). Patients who did not complete the study had 
higher postcode deprivation and had more comorbidities than patients who completed the 
study. 
Table 6.5 Baseline characteristics of patients stratified by trial completion, reported as mean 
(SD) unless otherwise stated 
 Not Completed 
(n=16) 
Completed 
(n=17) 
Demographics 
Age 69.5 (11.2) 66.6 (9.6) 
Female gender (%) 11 (68.8) 12 (70.6) 
IMD decile 3.0 (2.6) 5.8 (3.1) * 
Income decile 2.9 (2.4) 5.3 (2.8) * 
Employment decile 3.1 (2.7) 5.7 (2.8) * 
Education and skills decile 2.3 (1.8) 4.4 (2.6) * 
Health and disability decile 3.4 (2.8) 6.1 (3.0) * 
Crime decile 3.5 (2.4) 5.3 (2.3) * 
Barriers to housing and services decile 5.9 (2.4) 7.2 (2.5) 
Living environment decile 5.4 (2.4) 6.4 (1.8) 
IDACI decile 2.3 (2.1) 5.4 (2.9) * 
IDAOPI decile 3.0 (2.2) 5.7 (2.7) * 
Distance to travel for appointment (miles) 9.3 (6.9) 7.2 (3.7) 
Employment status (%):   
Retired 13 (81.3) 12 (70.6) 
Unemployed / Unable to work 1 (6.3) 4 (23.6) 
Employed 2 (12.5) 1 (5.9) 
Lung health and comorbidities 
Smoking status (%):   
Current 7 (43.8) 4 (23.5) 
Former 9 (56.3) 12 (70.6) 
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Pack years 49.5 (25.1) 44.3 (26.5) 
Usual mMRC grade 2.6 (1.3) 2.7 (1.1) 
Home oxygen (%) 1 (6.3) 2 (11.8) 
12 month all-cause admissions 1.6 (1.2) 1.7 (2.3) 
12 month AECOPD admissions 1.2 (1.3) 0.7 (1.1) 
New diagnosis of COPD (%) 0 (0) 3 (17.6) 
Number of comorbidities 4 (3) 2 (3) * 
Hospital stay 
Time from admission to consent (days) 3.3 (1.9) 3.7 (1.6) 
Time from consent to discharge (days) 2.1 (3.8) 2.1 (2.5) 
Time from admission to discharge (days) 5.4 (3.7) 5.8 (2.8) 
AECOPD readmissions (%) 4 (25.0) 0 (0) * 
Self-reported symptoms 
EQ-VAS 40.5 (22.4) 41.2 (19.3) 
CAT score 25.4 (7.8) 24.5 (7.4) 
Fatigue score 18.1 (11.7) 21.0 (12.2) 
HADS depression score 9.3 (3.9) 7.4 (5.2) 
HADS anxiety score 9.6 (6.2) 8.9 (5.5) 
FESI score 35.4 (14.2) 31.5 (13.5) 
Self-reported physical activity 
Daily walking time (minutes) 19.3 (19.4) 6.5 (7.7) 
Daily moderate PA (minutes) 2.5 (8.7) 2.0 (7.1) 
Daily vigorous PA (minutes) 0.0 (0.0) 0.0 (0.0) 
Self-reported sitting time β 
Daily TV sitting time (minutes) 378.0 (267.5) 336.3 (239.4) 
Daily travel sitting time (minutes) 28.0 (35.1) 77.5 (78.7) 
Daily computer sitting time (minutes) 30.0 (58.3) 48.1 (61.2) 
Daily other sitting time (minutes) 51.9 (50.6) 141.2 (159.7) 
Daily sitting time (minutes) 487.9 (245.9) 603.1 (257.4) 
Pulmonary rehabilitation 
Attended clinic appointment (%) 6 (37.5) 8 (47.1) 
PR accepted (%) 2 (12.5) 5 (29.4) 
PR attended (%) 2 (12.5) 2 (11.8) 
Previously attended PR (%):   
Within 12 months 0 (0) 1 (5.9) 
Within 24 months 0 (0) 1 (5.9) 
More than 24 months ago 3 (18.8) 6 (35.3) 
Never 13 (81.3) 8 (47.1) 
Abbreviations: AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BMI, body mass index; 
CAT, COPD assessment test; EQ-VAS, EuroQol visual analogue scale; COPD, chronic obstructive pulmonary 
disease; FESI, falls efficacy scale international; FEV1, forced expiratory volume in one second; FVC, forced 
vital capacity; HADS, hospital anxiety and depression scale; IDACI, income deprivation affecting children 
index; IDAOPI, income deprivation affecting older people index; IMD, Index of Multiple Deprivation; mMRC, 
modified Medical Research Council; PA, physical activity; PR, pulmonary rehabilitation; SPPB, short physical 
performance battery; TV, television 
β, daily work sitting is missing for the three patients in employment 
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6.1.7 Indicators of intervention efficacy 
Vibration prompt occurrences and response timings 
Overall, 325 vibration prompts occurred with patients not responding 219 times (67.4%) 
(Figure 6.6). Of the 106 responses, 43 (40.6%) occurred within 5 minutes, 25 (23.6%) 
occurred 5-10 minutes after the prompt and 38 (35.8%) occurred 10-15 minutes after the 
prompt.  
 
Figure 6.6 Overall responses to vibration prompts 
 
Behavioural response to vibration prompts 
Behavioural responses (sedentary, standing and walking) to the vibration prompts within five 
minutes of the prompt occurring are provided in Figure 6.7. When patients responded to the 
prompt, they spent 1.4±0.8 minutes standing and 0.4±0.3 minutes walking, taking 21.2±11.0 
steps. Time standing ranged 0.3-3.0 minutes and time walking ranged 0.2-1.2 minutes (Figure 
6.8).  
 
Figure 6.7 Behavioural responses to the LUMO vibration prompt as a group within five 
minutes of the prompt occurring  
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Figure 6.8 Behavioural responses to LUMO vibration prompts for individual patients within 
five minutes of the prompt occurring 
 
6.2 Discussion 
This study examined the feasibility of conducting an education and self-monitoring 
intervention using wearable technology to reduce sedentary behaviour in COPD patients 
admitted for an acute exacerbation. Almost one-third of patients offered the study took part or 
which around half attended their follow-up appointment. Reasons for not attending were 
predominantly around to being unable to cope or being readmitted.  Patients responded to 
approximately one-third of the vibration prompts of which ~40% occurred within 5 minutes.  
The proportion of eligible patients (70.7%) exceeded the threshold of feasibility set for the 
trial (66.6%). Patient uptake to the trial (31.5%) approached the specified threshold for 
feasibility (33.3%). Study uptake was similar to that of a peri-exacerbation pulmonary 
rehabilitation study (32.3%) conducted in the same hospital (Greening et al., 2014) with the 
rate of recruitment faster than a physical activity intervention using wearable technology 
(Fitbit Ultra) at a similar time point (average of 2.2 versus 0.6 patients per week) (Hornikx et 
al., 2015). Main reasons for refusing the intervention in-hospital were feeling too unwell or 
having concomitant ailments. Retention of patients to the two week follow-up appointment 
(51.2%) met the feasibility threshold (50.0%). The screening method in the present study 
failed to capture ~13% of patients and ~47% of admitted patients were discharged before they 
could be offered the study. The main reasons for this were: 1) patients received usual care 
before being entered onto the screening log, 2) usual care may have occurred close to 
discharge, and 3) only one researcher recruited patients. This has important implications for 
the feasibility of service implementation as well as future trials. 
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For patients receiving the education and self-monitoring interventions 75% of patients 
completed the trial; comparable to previous behavioural interventions in this population 
(Tabak, Brusse-Keizer, van der Valk, Hermens, & Vollenbroek-Hutten, 2014). Given the 
greater flexibility of at-home self-monitoring interventions with regard to facility 
requirements and travel commitments, offering such interventions at multiple time-points 
when symptoms are more stable may improve uptake. Whilst this ‘light-touch’ (i.e. no study-
specific contacts with patients until a telephone call on day 12 (out of 14) to confirm 
attendance to the follow-up appointment) approach may be more scalable and better 
implemented into routine care, study-specific contacts may need to be better tailored 
depending on patients’ circumstances. For example, patients burdened by more comorbidities 
and those living in more deprived areas were found to be less likely not to attend the follow-
up visit. Therefore, more ‘touches’ may be needed for these individuals. 
The accelerometer wear compliance was poor (38.5%) when evaluated using traditional wear 
time criteria of at least 10 waking hours. For example, older US adults have been found to 
achieve 84% compliance based on this criterion (Troiano et al., 2008). This may have been 
attributable, at least in part, to the dual monitor deployment. With advancements in activity 
monitoring technology and increasing recognition of the importance of capturing the 24 hour 
day for understanding behaviour and health outcomes (Chaput et al., 2014) there is a need to 
shift the traditional form-factors (e.g. wear location and attachment mechanism) for activity 
monitoring. Wrist-worn activity monitoring appears to be the most popular location for 
commercially available activity trackers with 53% of adults preferring to wear such devices at 
this location (Alley et al., 2015). Moreover, consumer devices are becoming increasingly 
sophisticated with many devices able to measure multiple health indices (Piwek, Ellis, 
Andrews, & Joinson, 2016). Therefore, the future RCT should consider moving activity 
monitors to a more desirable location to improve compliance (van Hees et al., 2011). 
Despite patients not responding to the vibration prompt two-thirds of the time, positive 
responses within 5 minutes of the vibration prompts involved an additional 18-23 steps (~1% 
increase in total daily step count) and 1.1-1.9 minutes less sedentary time each time a patient 
responded. It is perhaps unrealistic to expect patients to respond to all vibration prompts as 
even in apparently healthy office workers barriers such concentrating on work tasks prevent 
behaviour change from occurring (Geleijnse, Van Halteren, & Diekhoff, 2011). Furthermore, 
some of the unheeded nudges may have been the result of poor timing as the technology was 
not ‘context aware’. For example, prompts could have gone off whilst driving. Due to usage 
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restrictions placed on the smart device the choice of vibration setting could not be changed 
during the 14 days. As patients report considerable variations in day-to-day symptoms 
(Miravitlles et al., 2014a) additional flexibility permitting patients to easily alter the 
frequency of the haptic feedback may facilitate greater engagement with the intervention.  
Whilst the post-discharge period is a critical time for intervention, additional opportunities 
for patients to engage with programmes to reduce sedentary behaviour and promote increases 
in physical activity may also be warranted. For example, reducing prolonged sedentary 
behaviour during patients’ hospital stay has been advocated (Lazarus, Murphy, Coletta, 
McQuade, & Culpepper, 1991) as prolonged bed rest has been associated with complications 
which may negate recovery including disuse muscle atrophy, joint deformity and rigidity, and 
thromboembolic disease (Brower, 2009). Important barriers to the adoption of physical 
activity or sedentary behaviour programmes in-hospital include the misconception that 
activity is only a preventative measure, lack of time, lack of structural support and lack of 
high quality studies testing the approach (Börjesson, 2013). Additionally, patients generally 
have short-stays when admitted, creating logistical barriers (Börjesson, 2013). However, 
implementation of an intervention that begins in-hospital and continues after discharge may 
help overcome some of these issues. Objective quantification of in-hospital physical activity 
and sedentary behaviour in COPD patients is lacking but observations from hospital staff 
found to be lying in bed for 51% of the day, sitting out of bed for 43%, standing for 1% and 
walking for 5% of the day (Cattanach, Sheedy, Gill, & Hughes, 2014). 
Previous physical activity or sedentary behaviour self-monitoring studies in COPD seldom 
report on the fidelity of the intervention. In the present study, intervention fidelity was good, 
indicating that the education and feedback components were consistently delivered at a 
sufficient quality. However, inter-rater variation could not be examined in the present study 
as only one person delivered the education and feedback components. Therefore, no 
inferences can be made on how multiple delivers may vary in the provision of the 
interventions. For the education component, two suggestions were deemed unsuitable for 
most patients and were therefore not suggested verbally to them; these were “tiptoe when 
waiting in a queue” and “sit to stand with no hands”. Future designs of the educational 
booklet should explore more attainable and less daunting alternatives for patients. 
The study eligibility criteria, uptake and retention were deemed to be feasible overall and 
acceptable by some of the patients and most hospital staff. Several modifications are 
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proposed: (a) to offer the interventions at multiple time-points along the care pathway; (b) 
improve the targeting of patients who may need more contacts to comply with the 
intervention; (c) explore alternative form-factors (e.g. wear location and attachment 
mechanism) for objective physical activity and sedentary behaviour monitoring; (d) focus on 
the haptic feedback aspect of the self-monitoring technology; (e) increase the flexibility of 
patients’ ability to engage with the intervention tool (e.g. changing the vibration frequency); 
(f) use data from the present study to inform flexible goal setting; and (g) adjust the education 
booklet to ensure suggestions resonate with all patients. 
Key strengths of the present study include the successful recruitment of older, multi-morbid 
and acutely ill patients to a lifestyle behaviour change intervention using wearable self-
monitoring technology during hospital admission; the rich information collected to 
thoroughly examine the feasibility and acceptability of trial and the objective quantification 
of physical activity and sedentary behaviour. However, retention rates and activity monitor 
wear time compliance of this ‘low-touch’ trial require improvement in order to sufficiently 
assess the efficacy of a full trial. Additionally, health economic analyses are needed to ensure 
the intervention is cost-effective before incorporation into routine care. 
6.3 Conclusion 
Eligibility, recruitment and retention rates suggest a trial targeting sedentary behaviour in 
hospitalised COPD patients is feasible. Strategies to improve overall activity monitor 
compliance are needed in order for a full-scale trial to obtain reliable primary outcome data. 
The vibration prompts were acceptable to patients and resulted in meaningful increases in 
time spent standing and step count. A revised intervention, building on the successful 
components of the present feasibility study is justified. 
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Chapter 7: General discussion  
In the UK an estimated 3.7 million adults have a diagnosis of COPD (Shahab et al., 2006) 
and it is the second most common reason for emergency hospital admission (Healthcare 
Commission, 2006); costing the NHS approximately £500 million each year (Pauwels & 
Rabe, 2004). Physically inactive and sedentary lifestyles put patients at risk of falling into the 
vicious cycle of inactivity-breathlessness, in turn increasing their risk of hospitalisation 
(Donaire-Gonzalez et al., 2015; Garcia-Aymerich et al., 2006). Whilst it is suspected that 
COPD impacts physical activity in milder disease, there has been little focus on the role of 
sedentary behaviour and understanding the drivers of this deleterious health behaviour. 
Equally, it has been postulated that sedentary behaviour may be successful conduit for 
lifestyle behaviour change in COPD patients (Hill et al., 2015) but no studies have addressed 
this idea to date. 
The approach taken in this three study thesis was to examine the role of physical activity and 
sedentary behaviour across the spectrum of COPD severities, using objective quantification 
of behaviour to better understand the need for lifestyle interventions in this population. The 
work comprising this thesis has explored the factors associated with lifestyle behaviours in 
mild-moderate COPD patients (Study One), assessed the role of these behaviours in mild-
moderate COPD patients reporting severe symptoms (Study Two) and examined the 
feasibility of an intervention in patients with severe COPD admitted for an exacerbation to 
reduce their sedentary behaviour using wearable self-monitoring technology (Study Three). 
The individual findings, strength and limitations of these studies have been provided in the 
respective chapters. This chapter will discuss the findings of the thesis as a whole and how 
these findings add to existing literature in the context of proposed directions for future 
research. 
Gaps identified for Study One were: 
a. Need for the examination of correlates of physical activity in mild-moderate COPD 
using objective monitoring and comparisons to apparently healthy adults 
b. Paucity of evidence assessing correlates of sedentary time in COPD and whether these 
correlates differ with those of physical activity 
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Gaps identified for Study Two were: 
c. Need to understand factors associated with mild-moderate COPD patients reporting 
severe symptom burden 
d. Need to explore the potential role of physical activity and sedentary time in patients 
reporting more severe symptoms 
Gaps identified for Study Three were: 
e. Lack of behavioural interventions for patients after an acute exacerbation 
f. No studies have specifically targeted reductions in sedentary behaviour in COPD 
7.1 Key findings from the thesis 
In Study One mild-moderate COPD patients were found to be more sedentary and less 
physically active than apparently healthy adults. Breathlessness and percentage body fat were 
independently positively associated with sedentary time and negatively associated with light 
activity. Exercise capacity was independently positively associated with MVPA for COPD 
patients. Factors associated with behaviour were similar to apparently healthy adults. 
Although cross-sectional, these findings demonstrate that even in patients with milder COPD 
interventions to boost physical activity levels and reduce sedentary time are required; 
particularly for patients reporting more severe breathlessness and/or who are overweight or 
obese. Study Two found that physical activity and sedentary time were associated with more 
severe breathlessness, physical limitations performing activities of daily living, confidence 
leaving the home, energy levels and previous exacerbations in mild-moderate COPD patients. 
Study Three was the first intervention in COPD specifically targeting reductions in sedentary 
behaviour. This randomised controlled feasibility trial provided evidence that targeting 
reductions in sedentary behaviour is a feasible and suitable conduit for advanced patients and 
supports the conduct of a revised intervention, building on the successful components of this 
trial. Together, this work highlights the importance of examining lifestyle behaviours across 
the intensity spectrum, from time spent sedentary to engaging in MVPA, regardless of the 
grade of patients’ COPD.  
7.1.1 The timing of behavioural interventions 
This thesis has explored physical activity and sedentary behaviour across the spectrum of 
disease severity, from mild-moderate patients to those with more advanced disease admitted 
for an acute exacerbation. It is clear that patients with COPD would benefit from lifestyle 
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and/or exercise interventions regardless of the severity of airflow limitation and symptom 
burden. For patients with mild-moderate COPD, Study One identified breathlessness, body 
composition and exercise capacity to be important factors associated with behaviour. Study 
Two found physical activity, sedentary time and exercise capacity to be related to patients 
reporting more severe symptoms. These are important findings given the milder stage of the 
disease. As a result, interventions to prevent patients falling into the vicious cycle of physical 
inactivity and increased dyspnea are needed within existing care pathways.  
The benefits of leading a physically active lifestyle follow the law of diminishing returns 
whereby those individuals leading highly inactive and sedentary lifestyles have the most to 
gain from small improvements to their daily routine (Sparling, Howard, Dunstan, & Owen, 
2015). Therefore, achieving small changes in the lifestyle activity of COPD patients are 
likely to have significant impacts on health. Pulmonary rehabilitation is an established 
intervention for COPD patients in order to improve exercise capacity and health-related 
quality of life (Lacasse et al., 2006). Whilst rehabilitation plays a pivotal role in patient 
recovery and the prevention of readmissions lifestyle-embedded physical activity must also 
be addressed in order to reduce the risk of hospitalisation and mortality (Garcia-Aymerich et 
al., 2006). In a meta-analysis (Cindy Ng et al., 2012), pulmonary rehabilitation was found to 
have only a small effect on physical activity beyond that of the structured exercise classes. 
Moreover, when patients complete pulmonary rehabilitation improvements in fitness are lost, 
suggesting that patients do not take part in sufficient physical activity to maintain the benefits 
gained from the supervised sessions (Egan et al., 2012). Consequently, physical activity 
requires its own module within the multidisciplinary system of pulmonary rehabilitation. 
Objective monitoring of patients’ physical activity and sedentary behaviour inside and 
outside of pulmonary rehabilitation will be fundamental to the successful integration of 
behaviour change programmes.  
Whilst specific physical activity and sedentary behaviour modules are needed within 
pulmonary rehabilitation, Study One and Study Two have highlighted the need to address 
these issues sooner i.e. before patients present to hospital. One avenue may be through 
primary care. For example, ‘making every contact count’ (MECC) initiatives such as general 
practitioners offering advice on increasing physical activity has shown signs of potential 
based on self-reported behavioural outcomes (Orrow, Kinmonth, Sanderson, & Sutton, 2012). 
However, data is lacking on whether this approach is feasible or effective for COPD patients. 
Given the rigorous time constraints placed on primary care consultations, the coupling of 
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these appointments with objective data (e.g. physical activity, inhaler compliance) from 
sensors providing data prior to the appointment (e.g. through a secure cloud-based system) 
may facilitate such MECC schemes. Another approach, specific to COPD, has been the Self-
management Programme of Activity, Coping and Education for Chronic Obstructive 
Pulmonary Disease (SPACE for COPD) trial which has shown positive results in patients 
recruited from primary care (Steiner, 2013). Patients engaging with the SPACE for COPD 
manual, which includes help and advice on staying fit and active, managing symptoms, 
improving diet, resistance training and dealing with setbacks was found to improve anxiety, 
disease knowledge and exercise capacity in a sample of 184 patients (Mitchell et al., 2014). 
Study Three found that a self-monitoring intervention targeting sedentary behaviour using 
wearable technology is feasible for COPD patients post-discharge following an exacerbation. 
Therefore, future research should continue to explore the use of low intensity movement 
prescription as a conduit for increases in physical activity and reductions in sedentary time. 
Few devices are currently available to allow patients to specifically monitor their sedentary 
behaviour (Sanders et al., 2016) but results from this thesis support the potential for such 
devices to positively impact patients’ lifestyles. As highlighted in previous chapters, the post-
exacerbation period marks a critical period for intervention but it has received little attention 
as a potential opportunity to influence behaviour.  
Whilst there have been efforts to increase physical activity (Mantoani, Rubio, McKinstry, 
MacNee, & Rabinovich, 2016), including during the post-discharge period (Hornikx et al., 
2015) and after pulmonary rehabilitation (Vorrink, Kort, Troosters, Zanen, & Lammers, 
2016), Study Three was the first to target reductions in sedentary behaviour for COPD 
patients. Whilst there is more evidence for the benefits of increasing physical activity on 
reduced risk of hospitalisation and premature mortality (Donaire-Gonzalez et al., 2015; 
Esteban et al., 2016; Garcia-Aymerich et al., 2006), the sedentary lifestyles led by more 
severe patients, although well recognised (Pitta et al., 2005), have not been extensively 
examined. Perhaps one reason for the lack of attention for sedentary behaviour has been 
confusion over its distinction with physical inactivity. Physical inactivity is considered to be a 
level of MVPA not sufficient to meet physical activity guidelines (Davies et al., 2011) 
whereas sedentary behaviour is defined as any waking activity characterized by an energy 
expenditure ≤1.5 METS in a sitting or reclining posture (Sedentary Behaviour Research, 
2012). For example, in a systematic review of studies using objective monitors for 
behavioural assessment, only nine out of 76 identified studies were found to have assessment 
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sedentary behaviour. However, one of these nine studies defined sedentary behaviour as 1.0-
1.9 METS and three of these studies used <3.0 METS which incorporates light intensity 
physical activity (Byrom & Rowe, 2016). Therefore, before interventions can be designed, 
the knowledge and measurement of sedentary behaviour in COPD must be improved and its 
distinction from physical inactivity understood.  
7.1.2 Patient stratification 
This thesis has shown that a patient’s physical activity, sedentary time and exercise capacity 
are associated with the severity of their COPD symptoms. Therefore, these baseline 
characteristics should be accounted for when designing interventions. It is important to 
highlight that exercise and/or physical activity centred approaches may be too unrealistic for 
many COPD patients; particularly those recently admitted for an acute exacerbation. Study 
Three found that for many of these individuals, targeting reductions in their sedentary time 
was appealing and feasible to conduct during the post-exacerbation period. Therefore, an 
additional component to the stratification model proposed by Singh (Singh, 2014) (Figure 
1.7). A modified version is provided in Figure 7.1. The polar groups by this stratification are 
coded green (e.g. similar exercise capacity to healthy adults and meets recommended levels 
of MVPA and sedentary behaviour) and red (e.g. poor exercise capacity, does not meet 
recommended levels of MVPA and exceeds the recommended time sedentary). A particularly 
important group to target would be the “S&P” group who, despite being physically capable 
(i.e. similar exercise capacity to healthy adults), do not participate in sufficient physical 
activity and spend too much time being sedentary. By stratifying patients based on their 
functional capacity and their behaviour (activity and sedentariness) existing and future 
interventions may better tailor their content and delivery to suit the needs and preferences of 
patients. For example, patients attending pulmonary rehabilitation do not necessarily share 
the same end goal. For example, there are a range of baseline levels of fitness, symptoms, 
airflow limitation, exacerbation history and activity levels which makes a ‘one size fits all’ 
approach very difficult and can result in an inefficient use of both patient and staff resources. 
Having multiple options within a single programme may not only improve the relevance and 
quality of delivery for individual patients but it may also encourage more patients to attend, 
engage with and complete such interventions. 
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Figure 7.1 The potential stratification of interventions based on physical activity, exercise 
capacity and sedentary behaviour. The figure is colour coded as follows: red, requires three-
component intervention; amber, requires two-component intervention; yellow, requires 
single-component intervention; green, requires maintenance programme. Abbreviations are as 
follows: E, requires exercise capacity intervention; P, requires physical activity intervention; 
S, requires sedentary behaviour intervention. 
 
Interventions aiming to increase physical activity and reduce sedentary behaviour must not 
only take into account baseline levels and patient ambitions relating to these constructs but 
also extraneous factors such as social circumstances and frequency of hospital or General 
Practice visits. Figure 7.2 presents the three C’s: Capability, Context and Category which 
should also be considered for patient stratification. The focus of an intervention should be 
related to the context in which a patients lives and the context in which the intervention will 
be set. For example, patients in the earlier stages of the disease may have more regular 
contact with their general practitioner compared with more severe patients who likely spend 
more time in hospital. For patients with a strong social support, interventions may need to 
engage family members as well as the patient themselves. The capability (i.e. what type of 
intervention is most suited to the patients physical or mental state) and category (i.e. which 
mode of intervention delivery is most appealing to the patient) should also be considered. For 
example, exercise capacity is routinely examined prior to a patient starting pulmonary 
rehabilitation but patients are not yet asked to wear an activity monitor to capture baseline 
138 
 
physical activity and sedentary behaviour. Future research to optimise patient stratification 
approaches to intervention development is needed.  
 
Figure 7.2 The three C’s of patient considerations for interventions 
7.1.3 The “Quantified Patient” 
COPD patients were found to be highly compliant wearing a wrist-worn physical activity 
monitor in the PhARaoH Study (Study One and Study Two) with findings from COPD-
SEAT (Study Three) supporting the potential for patients to use wearable self-monitoring 
technology; even when recovering from an exacerbation at home. Moreover, as time goes on 
the level of technology competency and adoption in elderly populations will increase as 
technology as a whole becomes ever-present in daily life. Consequently, efforts to engage 
patient populations with technology-based intervention will become increasingly important 
and more feasible. With recent technological advancements in wearable self-monitoring 
technology has emerged the Quantified Self movement (Swan, 2013) which aims to empower 
individuals to improve their health through the reviewing of data related to their own 
physiology and lifestyle. The movement began in the management of diabetes, notably the 
self-management of blood sugar levels through capillary sample analysis at home. However, 
health markers fluctuate invariably every second in response to environmental changes, 
stresses, sickness, emotional states and physical activity (or lack of). Thus, technology to 
monitor health must adapt just as quickly in order to adequately account for the severity, 
frequency, duration and regularity of these occurrences.  
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In respiratory disease, patients typically rely on the use of peak flow meters and inhalers to 
manage their breathlessness; with some inhalers acting as ‘preventers’ with others used as 
‘responders’ i.e. prevent symptoms occurring or respond when symptoms become severe. 
However, adherence to inhalers is poor (Corden, Bosley, Rees, & Cochrane, 1997) and many 
patients struggle to management their symptoms on a daily basis (Bourbeau & Bartlett, 2008). 
It is clear from Study One and Study Two that even patients with mild COPD can report 
severe symptom burden such as severe breathlessness. Consequently, the next steps in 
improving the management of COPD symptoms is to further empower patients to understand 
their disease and how best to manage it in the context of its inevitable fluctuations and in 
relation to their own body and behaviour. Advances in commercial technology now mean that 
the real-time unobtrusive and non-invasive measure of a range of health markers (e.g. 
behaviour, medication adherence, and physiology) is paving the way for more long-term and 
sophisticated monitoring. As advances in health technology continue, both patients and 
healthcare providers will have the potential to have a veritable armoury of self-monitoring 
tools to improve the daily management of disease for patients with COPD and other ailments.  
Results from Study Two revealed consistent associations of physical activity and sedentary 
time with symptom severity; demonstrating the importance of targeting behaviour in the 
context of symptom management. A potential avenue for future research and a potential use 
of the advancing technologies is bio-behavioural feedback whereby both the behaviour and 
the physiological consequence of the behaviour are provided to the user. For example, many 
patients experiencing an exacerbation are particularly fearful of pushing themselves to be 
physically active, thereby entering the vicious inactivity-breathlessness cycle (Polkey & 
Moxham, 2006). However, if patients could see in real-time their breathing rate, depth and 
oxygen levels, for example, whilst engaging in physical activity also quantified in real-time 
they could see first-hand when their body needs to rest/recover. This concept is used as 
standard stopping criteria for field walking tests (Holland, Spruit, & Singh, 2015), supporting 
the need for research to transition this principle from the confines of a controlled setting to 
patients’ homes. Over time, patients can learn how much they can push themselves in 
accordance with their own physiological response rather than the premature fear of becoming 
too breathless or becoming too desaturated. By facilitating patients to understand their body’s 
response to physical activity and sedentary behaviour we may be able to empower them to 
move more and sit less, safely, informed by their own physiological response to movement. 
Future research should first explore this concept during pulmonary rehabilitation and/or 
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during hospital admission where patients can be educated by trained healthcare staff in a safe 
and structured environment.   
7.2 Strengths and limitations 
7.2.1 Strengths 
“The NHS belongs to the people. It is there to improve our health and wellbeing, supporting 
us to keep mentally and physically well, to get better when we are ill, and when we cannot 
fully recover, to stay as well as we can to the end of our lives” 
- The NHS constitution 
We cannot hope to conduct impactful research without consulting those we are trying to 
impact. A strength of this thesis was the genuine and early PPI. For the PhARaoH Study 
(Study One and Study Two), feedback from PPI members included advice and suggestions on 
the order of tests performed in order to provide frequent rest periods for patients (e.g. using 
the questionnaire between spirometry efforts) as well as the types of physical tests conducted 
as part of the 2-3 hour visit and the length/suitability/language of the questionnaire and study 
documentation.  For COPD-SEAT (Study Three), PPI members provided extensive input into 
the design and content of the educational booklet and the suitability of the self-monitoring 
technology (e.g. app designs and patient-driven vibration frequency). PPI members also 
provided valuable insight into study documentation and offered advice and input on how to 
make the study more appealing in the context of experiencing an acute exacerbation of COPD. 
Much of the published research and clinical focus on COPD has been on patients in the more 
severe stages of the disease; notably patients classified as GOLD 1 (mild) comprise a small 
proportion of referrals to pulmonary rehabilitation across England and Wales (Steiner, 
Holzhauer-Barrie, Lowe, Searle, Skipper, Welham, & Roberts, 2015b). A key strength of this 
thesis is the recruitment from primary care (Study One and Study Two) in order to reach 
patients who do not necessarily meet the entry criteria for pulmonary rehabilitation or get 
admitted to hospital often and therefore are not provided with clear opportunities to engage 
with research. Consequently, it was possible to understand the physical activity and sedentary 
behaviour of patients who may be less burdened by their COPD. It is understandable that 
patients with more advanced disease require more intensive and more frequent healthcare 
services, resulting in an estimated annual cost of £149 for a patient with mild COPD 
compared with £1307 for a patient with severe COPD (PEARSON, 2004). However, by 
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better understanding the role of behaviour in COPD the three studies in this thesis were able 
to provide valuable insight into the types of interventions which may be more suitable and 
yield improvements in symptom management; potentially reducing or delaying subsequent 
healthcare costs.  
Unlike many other measures which are obtained in controlled settings under ideal conditions 
(e.g. walking tests or anthropometry), the deployment of activity monitors often relies on the 
participant to wear the device each day and for a sufficient duration to be considered 
representative. An important strength of the wrist-worn deployment used in the PhARaoH 
Study (Study One and Study Two) was the high compliance obtained over the seven day 
wear period. During a one week monitoring period, 4-7 days of data are considered a reliable 
measure of physical activity (Janz, Witt, & Mahoney, 1995; Trost, Pate, Freedson, Sallis, & 
Taylor, 2000). In the original sample used for these thesis studies (i.e. the PhARaoH Study 
sample), 98.9% of participants met the minimum four days of at least 10 waking hours 
criteria. Much of this high compliance was likely due to the placement of the monitor on the 
wrist rather than traditional locations such as the waist (van Hees et al., 2011) which 
permitted participants to wear the monitor during sleep. As a result of this, participants did 
not need to remember to put the monitor on in the morning or remove it at bedtime, limiting 
the opportunities for human error and increasing the comfort of wearing the device. 
The transparency and rigour of the behavioural measurement in this thesis is a strength; 
allowing fully reproducible deployment, processing and analysis for both wrist-worn and 
waist-worn accelerometer locations. The reporting of information pertaining to data 
collection parameters, data cleaning and the identification of valid accelerometer data is 
lacking in existing COPD literature (Byrom & Rowe, 2016) which limits data pooling 
capabilities and comparisons between studies. Of note is the omission of four processing 
criteria that should be reported as standard: 36% of studies were found not to report the 
number of days patients were instructed to wear the device; 70% of studies did not state how 
many days were required from patients to be included in analysis; 87% of studies did not 
report criteria for determining non-wear; and 47% of studies did not report how a valid day of 
accelerometer data was defined (Byrom & Rowe, 2016). In addition 11% of studies included 
days where the activity monitor was worn for 22-24 hours each day (Byrom & Rowe, 2016) 
which is likely to contain a large amount of sleep which may have been misclassified as 
sedentary.  Therefore, whilst methodological transparency should be standard, the detail 
provided in the present thesis goes well beyond what has been observed to date. 
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7.2.2 Limitations 
Whilst the use of accelerometry is an important strength of this thesis, accelerometers are not 
without their limitations. Accelerometers used were not waterproof which meant participants 
were asked to take them off for shower, baths and swimming. Ideally, wearable devices 
should be able to capture every second of the day regardless of the types of activities being 
performed by the wearer. In addition, the accuracy of measurement from these devices 
(particularly when worn on the waist, Study Three) is directly related to proper placement of 
the devices by study participants (i.e. correct orientation). Therefore, the quality of the 
resulting data can be negatively impacted by deviations from proper placement which can 
arise by participant error, waist circumference and clothing. For waist-worn accelerometer 
placements (Study Three), accelerometry would be unable to capture activities such as 
cycling and resistance training due to the body (centre of mass) remaining still during 
performance (Montoye, Kemper, Saris, & Washburn, 1996). Wrist-worn accelerometry may 
be able to detect these types of activities in the future (e.g. through pattern recognition and 
machine learning) (Mannini, Intille, Rosenberger, Sabatini, & Haskell, 2013). However, this 
is not currently possible without extensive controlled calibration; limiting utility for 
observation studies requiring intense data collection periods. Given the location on the 
extremities, wrist-worn accelerometry has not yet been calibrated using criterion measures 
such as indirect calorimetry. Therefore, the cut-points used in this thesis (Study One and 
Study Two) were derived from concurrent validity studies against established waist-worn 
accelerometry criteria for sedentary time, light activity and MVPA (Kamada et al., 2016) and 
a thigh-worn inclinometer for sedentary time (Koster et al., 2016). 
It would have been preferable for apparently healthy adults and COPD patients taking part in 
the PhARaoH Study (Study One) to have been better matched for age and gender (these 
factors were instead controlled for statistically as covariates). Unfortunately, matching was 
difficult to achieve in part due to the recruitment strategy for patients i.e. mostly from 
General Practice invitations through the Primary Care Research Network. It was largely 
unknown the timescales for invitation and how receptive both General Practices and the 
patients would be to taking part in a study comprising a large battery of measures. The final 
samples of apparently healthy adults and COPD patients did not permit matching on age and 
gender. One potential solution may have been to actively encourage spouse participation for 
the COPD patients who took part in the study as well as the apparently healthy controls 
meeting similar age ranges of the completed patients. 
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Although not unique to the studies conducted as part of this thesis, participation bias, 
whereby the individuals taking part in research disproportionally possess particular 
characteristics which prevent a representative sample being obtained, may have occurred in 
PhARaoH (Study One and Study Two) and COPD-SEAT (Study Three). For example, the 
array of measures taken as part of the PhARaoH Study may have attracted individuals who 
may be concerned about their health (e.g. someone may have a family history of asthma or 
heart disease). Equally, the COPD patients who took part in the study may be those 
individuals who felt able to complete the large battery of tests. In COPD-SEAT, the study 
information sheet given to eligible patients clearly identifies sedentary behaviour and 
wearable technology as important components of the study; thereby potentially attracting 
patients with a greater understanding or interest in these areas. However, much like for 
pulmonary rehabilitation, those individuals finding the method of delivery or target outcome 
more appealing will naturally be more likely to participate. Just as the self-monitoring 
technology and subsequent study designs will continue to advance so will the level of 
technology competency and experience of the patients who may benefit. Despite this, it 
should be noted that a technology-based intervention will never be acceptable for some 
people. 
A limitation of the COPD-SEAT intervention (Study Three) was the assumption of patients’ 
motivation to reduce their sedentary behaviour and/or motivation to be active. The LUMO 
was designed to support the volitional phase of behaviour change (Schwarzer, 2008) by 
nudging/prompting the wearer and providing information on activity and sitting. However, 
the information and behavioural prompts could not be set up to adjust for established 
fluctuations in people’s motivation levels (Conroy, Elavsky, Doerksen, & Maher, 2013) as 
well as symptom severity (Kessler et al., 2011). Assessing patients’ motivation and precise 
intentions at the start of the intervention may facilitate their engagement with the programme 
and produce tailored goals to assist with maintenance. 
Practical barriers, primarily concomitant research studies and training commitments, meant 
that COPD-SEAT (Study Three) was not delivered by healthcare staff in routine contact with 
patients i.e. COPD Specialist Nurses or physiotherapists. However, the intervention delivery 
was designed in line with current routine practice (e.g. within comparable timeframes as 
smoking cessation advice or inhaler technique training). Nevertheless, future iterations should 
explore whether the status/role of the intervention deliverer plays a significant role in the 
uptake, retention or engagement levels of patients with the intervention. 
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Chapter 8: Future directions and conclusions 
8.1 Future directions 
There has been an exponential rise in the volume of research into physical activity in COPD, 
but as with research into public health, the holy grail of behaviour change remains hidden. In 
addition, the recognition of sedentary behaviour as a key target for intervention has appeared 
late on the scene and as such a large gap in the evidence base exists. Much like the field of 
physical activity and public health, the primary challenge faced by researchers is to find ways 
to evoke sustainable and sufficient behaviour change to ameliorate symptoms, reduce 
admissions and prevent premature mortality. This thesis supports the following areas for 
future research: 
1. The potential impact of sedentary behaviour in COPD, including symptom severity, using 
prospective study designs. 
2. Personalised behavioural and exercise interventions based on baseline characteristics e.g. 
participation in MVPA, time spent sedentary and walking capacity. 
3. Behavioural interventions for patients with mild disease (particular those reporting high 
symptom burden) before they present to hospital in order to prevent patients falling into 
the vicious cycle of inactivity and breathlessness. 
4. Exploring the use of targeting reductions in sedentary behaviour as a conduit for 
behaviour change; particularly for patients with more advanced COPD or for whom more 
intense activity may be unrealistic or unsuitable. 
5. Incorporating significant advancements in technology such as non-invasive, unobtrusive 
physiological and behavioural devices into existing care pathways (e.g. pulmonary 
rehabilitation and during admission) to facilitate positive behaviour change and improved 
self-management. 
As the objective measurement of physical activity and sedentary behaviour is likely to remain 
a prominent feature in COPD research, improvements in the quality and transparency of 
deployment, processing and analysis are urgently required. Future research endeavours 
should continue to meld expertise across disciplines, including measurement experts in the 
field of physical activity and sedentary behaviour. The incorporation of objective behaviour 
quantification for patients is an important area for future research; from informing general 
practitioners about the lifestyles of their patients, to evaluating activity levels inside and away 
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from pulmonary rehabilitation, to in-hospital monitoring as a potential marker of readiness 
for discharge. 
8.2 Conclusions 
Mild-moderate COPD patients were less physically active and spent more time sedentary 
then apparently healthy adults. However, factors predicting behaviour were similar between 
groups. Correlates were different between sedentary time, light activity and MVPA for both 
groups. Lower exercise capacity, less time spent being physically active and spending more 
time sedentary are associated with patients of the same severity of airflow limitation 
reporting contrasting symptom severities. These findings support the need for interventions to 
boost exercise capacity, physical activity and reduce sedentary time to be offered to patients 
with mild-moderate COPD, particularly those reporting more severe symptoms. In the first 
intervention targeting sedentary behaviour in COPD, the use of wearable self-monitoring 
technology was feasible and acceptable to patients following an acute exacerbation. Evidence 
from this thesis has contributed a greater understanding of physical activity and sedentary 
behaviour in COPD patients across the spectrum of disease severity, from understanding the 
correlates of behaviour in mild-moderate COPD patients to intervening during periods of 
acute illness in patients with advanced COPD. 
 
 
 
 
 
 
 
 
 
 
 
146 
 
References  
Adami, A., Cao, R., Porszasz, J., Casaburi, R., & Rossiter, H. B. (2015). Skeletal muscle 
oxidative capacity is an independent predictor of physical activity in smokers with and 
without COPD. European Respiratory Journal, 46(suppl 59), OA1985.  
Adamo, K. B., Prince, S. A., Tricco, A. C., Connor-Gorber, S., & Tremblay, M. (2009). A 
comparison of indirect versus direct measures for assessing physical activity in the 
pediatric population: A systematic review. International Journal of Pediatric Obesity, 
4(1), 2-27.  
Agusti, A., Calverley, P. M., Celli, B., & et al. (2010). Characterisation of COPD 
heterogeneity in the ECLIPSE cohort. Respiratory Research, 11, 122.  
Agusti, A., Sobradillo, P., & Celli, B. (2011). Addressing the complexity of chronic 
obstructive pulmonary disease: From phenotypes and biomarkers to scale-free networks, 
systems biology, and P4 medicine. American Journal of Respiratory and Critical Care 
Medicine, 183(9), 1129-1137.  
Alahmari, A. D., Patel, A. R., Kowlessar, B. S., Mackay, A. J., Singh, R., Wedzicha, J. A., & 
Donaldson, G. C. (2014). Daily activity during stability and exacerbation of chronic 
obstructive pulmonary disease. BMC Pulmonary Medicine, 14(1), 1.  
Allen, N., Sudlow, C., Downey, P., Peakman, T., Danesh, J., Elliott, P., . . . Pell, J. (2012). 
UK biobank: Current status and what it means for epidemiology. Health Policy and 
Technology, 1(3), 123-126.  
Allender, S., Foster, C., Scarborough, P., & Rayner, M. (2007). The burden of physical 
activity-related ill health in the UK. Journal of Epidemiology and Community Health, 
61(4), 344-348. doi:61/4/344 [pii]  
Alley, S., Jennings, C., Duncan, M., Schoeppe, S., Gurtler, D., & Vandelanotte, C. (2015). 
Attitudes, intentions and preferences for using physical activity tracking devices. Journal 
of Science and Medicine in Sport, 19, e44-e45.  
Alley, D. E., Shardell, M. D., Peters, K. W., McLean, R. R., Dam, T. T., Kenny, A. M., . . . 
Cawthon, P. M. (2014). Grip strength cutpoints for the identification of clinically 
relevant weakness. The Journals of Gerontology.Series A, Biological Sciences and 
Medical Sciences, 69(5), 559-566. doi:10.1093/gerona/glu011 [doi]  
Altenburg, W. A., Bossenbroek, L., de Greef, M. H., Kerstjens, H. A., ten Hacken, N. H., & 
Wempe, J. B. (2013). Functional and psychological variables both affect daily physical 
activity in COPD: A structural equations model. Respiratory Medicine, 107(11), 1740-
1747.  
147 
 
Andersson, M., Slinde, F., Grönberg, A. M., Svantesson, U., Janson, C., & Emtner, M. (2013). 
Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: 
A cross-sectional study. Respiratory Research, 14(1), 128.  
Andrzejowski, P., Greening, N., Richardson, M., HarveyDunstan, T., Houchen-Wolloff, L., 
Chaplin, E., . . . Singh, S. (2015). Change in physical activity level following COPD 
exacerbation. Best Abstracts in Physical Activity in Chronic Lung Diseases, European 
Respiratory Society Conference Amsterdam.  
Bahadori, K., & FitzGerald, J. M. (2007). Risk factors of hospitalization and readmission of 
patients with COPD exacerbation–systematic. International Journal of COPD, 2(3), 
241-251.  
Bailey, P. H. (2004). The dyspnea-anxiety-dyspnea cycle--COPD patients' stories of 
breathlessness: "it's scary /when you can't breathe". Qualitative Health Research, 14(6), 
760-778. doi:10.1177/1049732304265973 [doi]  
Beauchamp, M. K., Sibley, K. M., Lakhani, B., Romano, J., Mathur, S., Goldstein, R. S., & 
Brooks, D. (2012). Impairments in systems underlying control of balance in COPD. 
CHEST Journal, 141(6), 1496-1503.  
Bellg, A. J., Borrelli, B., Resnick, B., Hecht, J., Minicucci, D. S., Ory, M., . . . Czajkowski, S. 
(2004). Enhancing treatment fidelity in health behavior change studies: Best practices 
and recommendations from the NIH behavior change consortium. Health Psychology, 
23(5), 443.  
Benzo, R. P., Chang, C. C., Farrell, M. H., Kaplan, R., Ries, A., Martinez, F. J., . . . NETT 
Research Group. (2010). Physical activity, health status and risk of hospitalization in 
patients with severe chronic obstructive pulmonary disease. Respiration; International 
Review of Thoracic Diseases, 80(1), 10-18. doi:10.1159/000296504 [doi]  
Bernabeu-Mora, R., Medina-Mirapeix, F., Llamazares-Herrán, E., García-Guillamón, G., 
Giménez-Giménez, L. M., & Sánchez-Nieto, J. M. (2015). The short physical 
performance battery is a discriminative tool for identifying patients with COPD at risk of 
disability. International Journal of Chronic Obstructive Pulmonary Disease, 10, 2619.  
Berry, M. J., Adair, N. E., & Rejeski, W. J. (2006). Use of peak oxygen consumption in 
predicting physical function and quality of life in COPD patients. CHEST Journal, 
129(6), 1516-1522.  
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999). 
Usefulness of the medical research council (MRC) dyspnoea scale as a measure of 
disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7), 581-586.  
148 
 
Blair, S. N., Kohl, H. W., Gordon, N. F., & Paffenbarger Jr, R. S. (1992). How much physical 
activity is good for health? Annual Review of Public Health, 13(1), 99-126.  
Bon, J., Fuhrman, C. R., Weissfeld, J. L., Duncan, S. R., Branch, R. A., Chang, C. H., . . . 
Greenspan, S. L. (2011). Radiographic emphysema predicts low bone mineral density in 
a tobacco-exposed cohort. American Journal of Respiratory and Critical Care Medicine, 
183(7), 885-890.  
Börjesson, M. (2013). Promotion of physical activity in the hospital setting. Deutsche 
Zeitschrift für Sportmedizin, 64, 162-163, 164, 165. 
Bourbeau, J., & Bartlett, S. J. (2008). Patient adherence in COPD. Thorax, 63(9), 831-838. 
doi:10.1136/thx.2007.086041 [doi]  
British Thoracic Society. (2014). BTS quality standards for pulmonary rehabilitation in 
adults. london: BTS, 2014. ().  
Brower, R. G. (2009). Consequences of bed rest. Critical Care Medicine, 37(10 Suppl), 
S422-8. doi:10.1097/CCM.0b013e3181b6e30a [doi]  
Brownson, R. C., Boehmer, T. K., & Luke, D. A. (2005). Declining rates of physical activity 
in the united states: What are the contributors? Annual Review of Public Health, 26, 421-
443.  
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., . . . 
Weiss, K. B. (2007). International variation in the prevalence of COPD (the BOLD 
study): A population-based prevalence study. The Lancet, 370(9589), 741-750.  
Byrom, B., & Rowe, D. A. (2016). Measuring free-living physical activity in COPD patients: 
Deriving methodology standards for clinical trials through a review of research studies. 
Contemporary Clinical Trials,  
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & CONSORT Group. (2012). 
Consort 2010 statement: Extension to cluster randomised trials. BMJ (Clinical Research 
Ed.), 345, e5661. doi:10.1136/bmj.e5661 [doi]  
Carney, C. E., Lajos, L. E., & Waters, W. F. (2004). Wrist actigraph versus self-report in 
normal sleepers: Sleep schedule adherence and self-report validity. Behavioral Sleep 
Medicine, 2(3), 134-143.  
Carver, C. S., & Scheier, M. F. (1982). Control theory: A useful conceptual framework for 
personality–social, clinical, and health psychology. Psychological Bulletin, 92(1), 111.  
149 
 
Caspersen, C. J., Powell, K. E., & Christenson, G. M. (1985). Physical activity, exercise, and 
physical fitness: Definitions and distinctions for health-related research. Public Health 
Reports (Washington, D.C.: 1974), 100(2), 126-131.  
Cattanach, N., Sheedy, R., Gill, S., & Hughes, A. (2014). Physical activity levels and patients' 
expectations of physical activity during acute general medical admission. Internal 
Medicine Journal, 44(5), 501-504.  
Caulfield, B., Kaljo, I., & Donnelly, S. (2014). Use of a consumer market activity monitoring 
and feedback device improves exercise capacity and activity levels in COPD. Paper 
presented at the 2014 36th Annual International Conference of the IEEE Engineering in 
Medicine and Biology Society, 1765-1768.  
Cavalheri, V., Straker, L., Gucciardi, D. F., Gardiner, P. A., & Hill, K. (2015). Changing 
physical activity and sedentary behaviour in people with COPD. Respirology,  
Celli, B. R., & Barnes, P. J. (2007). Exacerbations of chronic obstructive pulmonary disease. 
The European Respiratory Journal, 29(6), 1224-1238. doi:29/6/1224 [pii]  
Centers for Disease Control and Prevention. (2010). National physical activity plan of the 
united states of america. health care, strategy 1 ‘Make physical activity a patient “vital 
sign” that all health care providers assess and discuss with their patients’.  
Chakravarthy, M. V., Joyner, M. J., & Booth, F. W. (2002). An obligation for primary care 
physicians to prescribe physical activity to sedentary patients to reduce the risk of 
chronic health conditions. Paper presented at the Mayo Clinic Proceedings,77(2) 165-
173.  
Chao, P. W., Ramsdell, J., Renvall, M., & Vora, C. (2011). Does a history of exercise in 
COPD patients affect functional status? A study using a lifetime physical activity 
questionnaire investigates a correlation between exercise and functional status as 
evidenced by six-minute walk distance. COPD: Journal of Chronic Obstructive 
Pulmonary Disease, 8(6), 429-436.  
Chaput, J., Carson, V., Gray, C. E., & Tremblay, M. S. (2014). Importance of all movement 
behaviors in a 24 hour period for overall health. International Journal of Environmental 
Research and Public Health, 11(12), 12575-12581.  
Chawla, H., Bulathsinghala, C., Tejada, J. P., Wakefield, D., & ZuWallack, R. (2014). 
Physical activity as a predictor of thirty-day hospital readmission after a discharge for a 
clinical exacerbation of chronic obstructive pulmonary disease. Annals of the American 
Thoracic Society, 11(8), 1203-1209.  
Chin, R. C., Guenette, J. A., Cheng, S., Raghavan, N., Amornputtisathaporn, N., Cortés-
Télles, A., & O’Donnell, D. E. (2013). Does the respiratory system limit exercise in mild 
150 
 
chronic obstructive pulmonary disease? American Journal of Respiratory and Critical 
Care Medicine, 187(12), 1315-1323.  
Choi, L., Liu, Z., Matthews, C. E., & Buchowski, M. S. (2011). Validation of accelerometer 
wear and nonwear time classification algorithm. Medicine & Science in Sports & 
Exercise, 43, 357-364.  
Choi, L., Ward, S. C., Schnelle, J. F., & Buchowski, M. S. (2012). Assessment of 
wear/nonwear time classification algorithms for triaxial accelerometer. Medicine & 
Science in Sports & Exercise, 44, 2009-2016.  
Cindy Ng, L. W., Mackney, J., Jenkins, S., & Hill, K. (2012). Does exercise training change 
physical activity in people with COPD? A systematic review and meta-analysis. Chronic 
Respiratory Disease, 9(1), 17-26. doi:10.1177/1479972311430335 [doi]  
Conroy, D. E., Elavsky, S., Doerksen, S. E., & Maher, J. P. (2013). A daily process analysis 
of intentions and physical activity in college students. Journal of Sport & Exercise 
Psychology, 35(5), 493-502.  
Cooper, C. B. (2009). Airflow obstruction and exercise. Respiratory Medicine, 103(3), 325-
334.  
Corden, Z. M., Bosley, C. M., Rees, P. J., & Cochrane, G. M. (1997). Home nebulized 
therapy for patients with COPD: Patient compliance with treatment and its relation to 
quality of life. CHEST Journal, 112(5), 1278-1282.  
Craig, C., Marshall, A., Sjöström, M., Bauman, A., Booth, M., Ainsworth, B., Sallis, J. 
(2003). And the IPAQ consensus group and the IPAQ reliability and validity study group. 
international physical activity questionnaire (IPAQ): 12-country reliability and validity. 
Med Sci Sports Exerc, 35(13), 81-95.  
Craig, R., Mindell, J., & Hirani, V. (2009). Health survey for England 2008. volume 1: 
Physical activity and fitness. Health Survey for England, 1, 8-395.  
Dahlgren, G., Carlsson, D., Moorhead, A., Häger-Ross, C., & McDonough, S. M. (2010). 
Test–retest reliability of step counts with the ActivPAL™ device in common daily 
activities. Gait & Posture, 32(3), 386-390.  
Davies, S., Burns, H., Jewell, T., & McBride, M. (2011). Start active, stay active: A report on 
physical activity from the four home countries. Chief Medical Officers, 16306, 1-62.  
Demeyer, H., Gimeno-Santos, E., Rabinovich, R. A., Hornikx, M., Louvaris, Z., de Boer, W. 
I., PROactive consortium. (2016). Physical activity characteristics across GOLD 
quadrants depend on the questionnaire used. PloS One, 11(3), e0151255. 
doi:10.1371/journal.pone.0151255 [doi]  
151 
 
Deslee, G., Burgel, P., Escamilla, R., & Chanez, P. (2016). Impact of current cough on 
health-related quality of life in patients with COPD. International Journal of Chronic 
Obstructive Pulmonary Disease, 11, 2091.  
Ding, D., Lawson, K. D., Kolbe-Alexander, T. L., Finkelstein, E. A., Katzmarzyk, P. T., van 
Mechelen, W., Lancet Physical Activity Series 2 Executive Committee. (2016). The 
economic burden of physical inactivity: A global analysis of major non-communicable 
diseases. The Lancet,  
Director of Public Health. (2010). Improving health in Leicester. Annual report of the 
director of public health and health improvement 2010.   
Dishman, R. K., Washburn, R. A., & Schoeller, D. A. (2001). Measurement of physical 
activity. Quest, 53(3), 295-309.  
Dobbels, F., de Jong, C., Drost, E., Elberse, J., Feridou, C., Jacobs, L., PROactive consortium. 
(2014). The PROactive innovative conceptual framework on physical activity. The 
European Respiratory Journal, 44(5), 1223-1233. doi:10.1183/09031936.00004814 [doi]  
Donaire-Gonzalez, D., Gimeno-Santos, E., Balcells, E., de Batlle, J., Ramon, M. A., 
Rodriguez, E., PAC-COPD Study Group. (2015). Benefits of physical activity on COPD 
hospitalisation depend on intensity. The European Respiratory Journal, 46(5), 1281-
1289. doi:10.1183/13993003.01699-2014 [doi]  
Duefias-Espin, I., Demeyer, H., Gimeno-Santos, E., Polkey, M., Hopkinson, N., Rabinovich, 
R., Garcia-Aymerich, J. (2016). Depression symptoms reduce physical activity in COPD 
patients. A prospective multicenter study. International Journal of Chronic Obstructive 
Pulmonary Disease,  
Dunstan, D. W., Barr, E. L., Healy, G. N., Salmon, J., Magliano, D. J., Matthews, C. E., . . . 
Owen, N. (2009). Television viewing time and mortality. the AusDiab study: 591 may 
27 1: 00 PM-1: 15 PM. Medicine & Science in Sports & Exercise, 41(5), 21.  
Dunstan, D., Healy, G. N., Sugiyama, T., & Owen, N. (2010). Too Much Sitting and 
Metabolic Risk¿ has Modern Technology Caught Up with Us,  
Dunstan, D., Salmon, J., Owen, N., Armstrong, T., Zimmet, P., Welborn, T., Shaw, J. (2005). 
Associations of TV viewing and physical activity with the metabolic syndrome in 
australian adults. Diabetologia, 48(11), 2254-2261.  
Durheim, M. T., Smith, P. J., Babyak, M. A., Mabe, S. K., Martinu, T., Welty-Wolf, K. E., . . . 
Blumenthal, J. A. (2015). Six-minute-walk distance and accelerometry predict outcomes 
in chronic obstructive pulmonary disease independent of global initiative for chronic 
obstructive lung disease 2011 group. Annals of the American Thoracic Society, 12(3), 
349-356.  
152 
 
Dürr, S., Zogg, S., Miedinger, D., Steveling, E. H., Maier, S., & Leuppi, J. D. (2014). Daily 
physical activity, functional capacity and quality of life in patients with COPD. COPD: 
Journal of Chronic Obstructive Pulmonary Disease, 11(6), 689-696.  
Eaton, T., Young, P., Fergusson, W., Moodie, L., Zeng, I., O'KANE, F., . . . Kolbe, J. (2009). 
Does early pulmonary rehabilitation reduce acute health‐care utilization in COPD 
patients admitted with an exacerbation? A randomized controlled study. Respirology, 
14(2), 230-238.  
Edwards, R. H., Young, A., Hosking, G. P., & Jones, D. A. (1977). Human skeletal muscle 
function: Description of tests and normal values. Clinical Science and Molecular 
Medicine, 52(3), 283-290.  
Egan, C., Deering, B. M., Blake, C., Fullen, B. M., McCormack, N. M., Spruit, M. A., & 
Costello, R. W. (2012). Short term and long term effects of pulmonary rehabilitation on 
physical activity in COPD. Respiratory Medicine, 106(12), 1671-1679.  
Eijsvogels, T. M., George, K. P., & Thompson, P. D. (2016). Cardiovascular benefits and 
risks across the physical activity continuum. Current Opinion in Cardiology, 31(5), 566-
571. doi:10.1097/HCO.0000000000000321 [doi]  
Eisner, M. D., Iribarren, C., Yelin, E. H., Sidney, S., Katz, P. P., Ackerson, L., . . . Blanc, P. 
D. (2008). Pulmonary function and the risk of functional limitation in chronic 
obstructive pulmonary disease. American Journal of Epidemiology, 167(9), 1090-1101. 
doi:10.1093/aje/kwn025 [doi]  
Eliason, G., Zakrisson, A., Piehl-Aulin, K., & Hurtig-Wennlöf, A. (2011). Physical activity 
patterns in patients in different stages of chronic obstructive pulmonary disease. COPD: 
Journal of Chronic Obstructive Pulmonary Disease, 8(5), 369-374.  
Esliger, D. W. (2011). Refining the accelerometric measurement of physical activity (Degree 
of Doctorate of Philosophy).  
Esliger, D. W., & Tremblay, M. S. (2006). Technical reliability assessment of three 
accelerometer models in a mechanical setup. Medicine and Science in Sports and 
Exercise, 38(12), 2173-2181. doi:10.1249/01.mss.0000239394.55461.08 [doi]  
Esteban, C., Arostegui, I., Aburto, M., Moraza, J., Quintana, J. M., Aizpiri, S., . . . 
Capelastegui, A. (2014). Influence of changes in physical activity on frequency of 
hospitalization in chronic obstructive pulmonary disease. Respirology, 19(3), 330-338.  
Esteban, C., Garcia-Gutierrez, S., Legarreta, M. J., Anton-Ladislao, A., Gonzalez, N., 
Lafuente, I., . . . Quintana, J. M. (2016). One-year mortality in COPD after an 
exacerbation: The effect of physical activity changes during the event. COPD: Journal 
of Chronic Obstructive Pulmonary Disease, , 1-8.  
153 
 
Evans, J. D. (1996). Straightforward statistics for the behavioral sciences. California: 
Brooks/Cole Publishing, Pacific Grove.  
Falzon, C., Soljak, M., Elkin, S. L., Blake, I. D., & Hopkinson, N. S. (2013). Finding the 
missing millions–the impact of a locally enhanced service for COPD on current and 
projected rates of diagnosis: A population-based prevalence study using interrupted time 
series analysis. Primary Care Respiratory Journal, 22(1), 59-63.  
Feliz-Rodriguez, D., Zudaire, S., Carpio, C., Martínez, E., Gómez-Mendieta, A., Santiago, 
A., . . . García-Río, F. (2013). Evolution of the COPD assessment test score during 
chronic obstructive pulmonary disease exacerbations: Determinants and prognostic value. 
Canadian Respiratory Journal, 20(5), e92-e97.  
Fox, S., & Duggan, M. (2013). Health online 2013. Health, 1-55.  
Freedson, P. S., Melanson, E., & Sirard, J. (1998). Calibration of the computer science and 
applications, inc. accelerometer. Medicine and Science in Sports and Exercise, 30(5), 
777-781.  
Frei, A., Williams, K., Vetsch, A., Dobbels, F., Jacobs, L., Rüdell, K., & Puhan, M. A. (2011). 
A comprehensive systematic review of the development process of 104 patient-reported 
outcomes (PROs) for physical activity in chronically ill and elderly people. Health and 
Quality of Life Outcomes, 9(1), 1.  
Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006). Regular 
physical activity reduces hospital admission and mortality in chronic obstructive 
pulmonary disease: A population-based cohort study. Thorax, 61, 772-778.  
Garcia-Aymerich, J., Serra, I., Gómez, F. P., Farrero, E., Balcells, E., Rodriguez, D. A., . . . 
Orozco-Levi, M. (2009). Physical activity and clinical and functional status in COPD. 
CHEST Journal, 136(1), 62-70.  
Garcia-Aymerich, J., Farrero, E., Felez, M. A., Izquierdo, J., Marrades, R. M., Anto, J. M., & 
Estudi del Factors de Risc d'Aguditzacio de la MPOC investigators. (2003). Risk factors 
of readmission to hospital for a COPD exacerbation: A prospective study. Thorax, 58(2), 
100-105.  
Garcia-Aymerich, J., Felez, M. A., Escarrabill, J., Marrades, R. M., Morera, J., Elosua, R., & 
Anto, J. M. (2004). Physical activity and its determinants in severe chronic obstructive 
pulmonary disease. Medicine and Science in Sports and Exercise, 36(10), 1667-1673.  
Garcia-Aymerich, J., Gomez, F. P., Benet, M., Farrero, E., Basagana, X., Gayete, A., . . . 
PAC-COPD Study Group. (2011). Identification and prospective validation of clinically 
relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax, 66(5), 430-
437. doi:10.1136/thx.2010.154484 [doi]  
154 
 
Garcia-Rio, F., Lores, V., Mediano, O., Rojo, B., Hernanz, A., López-Collazo, E., & Alvarez-
Sala, R. (2009). Daily physical activity in patients with chronic obstructive pulmonary 
disease is mainly associated with dynamic hyperinflation. American Journal of 
Respiratory and Critical Care Medicine, 180(6), 506-512.  
Gardner, B., Smith, L., Lorencatto, F., Hamer, M., & Biddle, S. J. (2015). How to reduce 
sitting time? A review of behaviour change strategies used in sedentary behaviour 
reduction interventions among adults. Health Psychology Review, , 1-24.  
Gardner, B., Lally, P., & Wardle, J. (2012). Making health habitual: The psychology of 
'habit-formation' and general practice. The British Journal of General Practice : The 
Journal of the Royal College of General Practitioners, 62(605), 664-666. 
doi:10.3399/bjgp12X659466 [doi]  
Gardner, B., Thune-Boyle, I., Iliffe, S., Fox, K. R., Jefferis, B. J., Hamer, M., . . . Wardle, J. 
(2014). 'On your feet to earn your seat', a habit-based intervention to reduce sedentary 
behaviour in older adults: Study protocol for a randomized controlled trial. Trials, 15, 
368-6215-15-368. doi:10.1186/1745-6215-15-368 [doi]  
Geleijnse, G., Van Halteren, A., & Diekhoff, J. (2011). Towards a mobile application to 
create sedentary awareness. Paper presented at the CHI 2011: 29th ACM Conference on 
Human Factors in Computing Systems, Vancouver, Canada, 7-12 may 2011,  
Gimeno, D., Delclos, G. L., Ferrie, J. E., De Vogli, R., Elovainio, M., Marmot, M. G., & 
Kivimäki, M. (2011). Association of CRP and IL-6 with lung function in a middle-aged 
population initially free from self-reported respiratory problems: The Whitehall II study. 
European Journal of Epidemiology, 26(2), 135-144.  
Gimeno-Santos, E., Frei, A., Dobbels, F., Rüdell, K., Puhan, M. A., & Garcia-Aymerich, J. 
(2011). Validity of instruments to measure physical activity may be questionable due to 
a lack of conceptual frameworks: A systematic review. Health and Quality of Life 
Outcomes, 9(1), 1.  
Gimeno-Santos, E., Frei, A., Steurer-Stey, C., de Batlle, J., Rabinovich, R. A., Raste, Y., . . . 
PROactive consortium. (2014). Determinants and outcomes of physical activity in 
patients with COPD: A systematic review. Thorax, 69(8), 731-739. 
doi:10.1136/thoraxjnl-2013-204763 [doi]  
Gimeno-Santos, E., Raste, Y., Demeyer, H., Louvaris, Z., de Jong, C., Rabinovich, R. A., . . . 
PROactive consortium. (2015). The PROactive instruments to measure physical activity 
in patients with chronic obstructive pulmonary disease. The European Respiratory 
Journal, 46(4), 988-1000. doi:10.1183/09031936.00183014 [doi]  
155 
 
Global Initiative for Chronic Obstructive Lung Disease. (2011). Global strategy for the 
diagnosis, management and prevention of chronic obstructive pulmonary disease 
(GOLD), revised 2011.  
Global Initiative for Chronic Obstructive Lung Disease. (2014). Global strategy for the 
diagnosis, management, and prevention of chronic obstructive pulmonary disease 
[updated 2014].  
Global Initiative for Chronic Obstructive Lung Disease. (2017). Global strategy for the 
diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 
report.  
Grant, P. M., Dall, P. M., Mitchell, S. L., & Granat, M. H. (2008). Activity-monitor accuracy 
in measuring step number and cadence in community-dwelling older adults. Journal of 
Aging and Physical Activity, 16(2), 201.  
Gray, M. (2009). Dr gray's walking cure. Offox Press.  
Greening, N. J. (2015). Non-adherence to peri-exacerbation pulmonary rehabilitation: The 
people have spoken. Chronic Respiratory Disease, 12(1), 3-4. 
doi:10.1177/1479972314565360 [doi]  
Greening, N. J., Williams, J. E., Hussain, S. F., Harvey-Dunstan, T. C., Bankart, M. J., 
Chaplin, E. J., . . . Steiner, M. C. (2014). An early rehabilitation intervention to enhance 
recovery during hospital admission for an exacerbation of chronic respiratory disease: 
Randomised controlled trial. BMJ (Clinical Research Ed.), 349, g4315. 
doi:10.1136/bmj.g4315 [doi]  
Gruffydd-Jones, K., Langley-Johnson, C., Dyer, C., Badlan, K., & Ward, S. (2007). What are 
the needs of patients following discharge from hospital after an acute exacerbation of 
chronic obstructive pulmonary disease (COPD)? Primary Care Respiratory Journal : 
Journal of the General Practice Airways Group, 16(6), 363-368. doi:SG00034 [pii]  
Guenette, J. A., Jensen, D., Webb, K. A., Ofir, D., Raghavan, N., & O’Donnell, D. E. (2011). 
Sex differences in exertional dyspnea in patients with mild COPD: Physiological 
mechanisms. Respiratory Physiology & Neurobiology, 177(3), 218-227.  
Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. 
(2006). Global burden of COPD: Systematic review and meta-analysis. The European 
Respiratory Journal, 28(3), 523-532. doi:09031936.06.00124605 [pii]  
Hamilton, M. T., Healy, G. N., Dunstan, D. W., Zderic, T. W., & Owen, N. (2008). Too little 
exercise and too much sitting: Inactivity physiology and the need for new 
recommendations on sedentary behavior. Current Cardiovascular Risk Reports, 2(4), 
292-298.  
156 
 
Hartman, J. E., Boezen, H. M., de Greef, M. H., & Nick, H. (2013). Physical and 
psychosocial factors associated with physical activity in patients with chronic obstructive 
pulmonary disease. Archives of Physical Medicine and Rehabilitation, 94(12), 2396-
2402. e7.  
Hartman, J. E., Boezen, H. M., de Greef, M. H., & Ten Hacken, N. H. (2013). Physical and 
psychosocial factors associated with physical activity in patients with chronic obstructive 
pulmonary disease. Archives of Physical Medicine and Rehabilitation, 94(12), 2396-
2402.e7. doi:10.1016/j.apmr.2013.06.029 [doi]  
Harvey, J. A., Chastin, S. F., & Skelton, D. A. (2013). Prevalence of sedentary behavior in 
older adults: A systematic review. International Journal of Environmental Research and 
Public Health, 10(12), 6645-6661.  
Haskell, W. L. (2001). What to look for in assessing responsiveness to exercise in a health 
context. Medicine and Science in Sports and Exercise, 33(6 Suppl), S454-8; discussion 
S493-4.  
Healthcare Commission. (2006). Clearing the air: A national study of chronic obstructive 
pulmonary disease. London: Commission for Healthcare Audit and Inspection,  
Healy, G. N., Dunstan, D. W., Salmon, J., Cerin, E., Shaw, J. E., Zimmet, P. Z., & Owen, N. 
(2007). Objectively measured light-intensity physical activity is independently 
associated with 2-h plasma glucose. Diabetes Care, 30(6), 1384-1389. doi:dc07-0114 
[pii]  
Healy, G. N., Dunstan, D. W., Salmon, J., Cerin, E., Shaw, J. E., Zimmet, P. Z., & Owen, N. 
(2008). Breaks in sedentary time: Beneficial associations with metabolic risk. Diabetes 
Care, 31(4), 661-666. doi:10.2337/dc07-2046 [doi]  
Healy, G. N., Matthews, C. E., Dunstan, D. W., Winkler, E. A., & Owen, N. (2011). 
Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. 
European Heart Journal, 32(5), 590-597. doi:10.1093/eurheartj/ehq451 [doi]  
Healy, G. N., Wijndaele, K., Dunstan, D. W., Shaw, J. E., Salmon, J., Zimmet, P. Z., & Owen, 
N. (2008). Objectively measured sedentary time, physical activity, and metabolic risk: 
The australian diabetes, obesity and lifestyle study (AusDiab). Diabetes Care, 31(2), 
369-371. doi:dc07-1795 [pii]  
Helmerhorst, H. J., Wijndaele, K., Brage, S., Wareham, N. J., & Ekelund, U. (2009). 
Objectively measured sedentary time may predict insulin resistance independent of 
moderate- and vigorous-intensity physical activity. Diabetes, 58(8), 1776-1779. 
doi:10.2337/db08-1773 [doi]  
157 
 
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., . . . Badia, X. (2011). 
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-
5L). Quality of Life Research, 20(10), 1727-1736.  
Hill, K., Gardiner, P. A., Cavalheri, V., Jenkins, S. C., & Healy, G. N. (2015). Physical 
activity and sedentary behaviour: Applying lessons to chronic obstructive pulmonary 
disease. Internal Medicine, 45, 474-482.  
Holland, A. E., Spruit, M. A., & Singh, S. J. (2015). How to carry out a field walking test in 
chronic respiratory disease. Breathe, 11(2), 128.  
Hoogendoorn, M., Feenstra, T. L., Hoogenveen, R. T., Al, M., & Molken, M. (2010). 
Association between lung function and exacerbation frequency in patients with COPD. 
Int J Chron Obstruct Pulmon Dis, 5(435), 44.  
Hoogendoorn, M., Hoogenveen, R. T., Rutten-van Molken, M. P., Vestbo, J., & Feenstra, T. 
L. (2011). Case fatality of COPD exacerbations: A meta-analysis and statistical 
modelling approach. The European Respiratory Journal, 37(3), 508-515. 
doi:10.1183/09031936.00043710 [doi]  
Hornikx, M., Demeyer, H., Camillo, C. A., Janssens, W., & Troosters, T. (2015). The effects 
of a physical activity counseling program after an exacerbation in patients with chronic 
obstructive pulmonary disease: A randomized controlled pilot study. BMC Pulmonary 
Medicine, 15(1), 136.  
Hunt, T., Madigan, S., Williams, M. T., & Olds, T. S. (2014). Use of time in people with 
chronic obstructive pulmonary disease--a systematic review. International Journal of 
Chronic Obstructive Pulmonary Disease, 9, 1377-1388. doi:10.2147/COPD.S74298 [doi]  
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., . . . 
MacNee, W. (2010). Susceptibility to exacerbation in chronic obstructive pulmonary 
disease. New England Journal of Medicine, 363(12), 1128-1138.  
Inal-Ince, D., Savci, S., Coplu, L., & Arikan, H. (2005). Factors determining self-efficacy in 
chronic obstructive pulmonary disease. Saudi Medical Journal, 26(4), 542-547.  
Jacome, C., & Marques, A. (2016). Short- and long-term effects of pulmonary rehabilitation 
in patients with mild COPD: A comparison with patients with moderate to severe COPD. 
Journal of Cardiopulmonary Rehabilitation and Prevention, 36(6), 445-453. 
doi:10.1097/HCR.0000000000000219 [doi]  
Jago, R., Zakeri, I., Baranowski, T., & Watson, K. (2007). Decision boundaries and receiver 
operating characteristic curves: New methods for determining accelerometer cutpoints. 
Journal of Sports Sciences, 25(8), 937-944.  
158 
 
Janz, K. F., Witt, J., & Mahoney, L. T. (1995). The stability of children's physical activity as 
measured by accelerometry and self-report. Medicine & Science in Sports & Exercise,  
Jehn, M., Schindler, C., Meyer, A., Tamm, M., Schmidt-Trucksass, A., & Stolz, D. (2012). 
Daily walking intensity as a predictor of quality of life in patients with chronic 
obstructive pulmonary disease. Medicine and Science in Sports and Exercise, 44(7), 
1212-1218. doi:10.1249/MSS.0b013e318249d8d8 [doi]  
Jensen, H. H., Godtfredsen, N. S., Lange, P., & Vestbo, J. (2006). Potential misclassification 
of causes of death from COPD. The European Respiratory Journal, 28(4), 781-785. 
doi:09031936.06.00152205 [pii]  
Jette, M., Sidney, K., & Blumchen, G. (1990). Metabolic equivalents (METS) in exercise 
testing, exercise prescription, and evaluation of functional capacity. Clinical Cardiology, 
13(8), 555-565.  
Jones, P. W., Adamek, L., Nadeau, G., & Banik, N. (2013). Comparisons of health status 
scores with MRC grades in COPD: Implications for the GOLD 2011 classification. 
European Respiratory Journal, 42, 647-654.  
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W., & Leidy, N. K. (2009). 
Development and first validation of the COPD assessment tool. European Respiratory 
Journal, 34, 648-654.  
Jones, S. E., Green, S. A., Clark, A. L., Dickson, M. J., Nolan, A. M., Moloney, C., . . . Man, 
W. D. (2014). Pulmonary rehabilitation following hospitalisation for acute exacerbation 
of COPD: Referrals, uptake and adherence. Thorax, 69(2), 181-182. 
doi:10.1136/thoraxjnl-2013-204227 [doi]  
Kamada, M., Shiroma, E. J., Harris, T. B., & Lee, I. (2016). Comparison of physical activity 
assessed using hip- and waist-worn accelerometers. Gait & Posture, 44, 23-28.  
Katajisto, M., Kupiainen, H., Rantanen, P., Lindqvist, A., Kilpelainen, M., Tikkanen, H., & 
Laitinen, T. (2012). Physical inactivity in COPD and increased patient perception of 
dyspnea. International Journal of Chronic Obstructive Pulmonary Disease, 7, 743-755. 
doi:10.2147/COPD.S35497 [doi]  
Katzmarzyk, P. T., Church, T. S., Craig, C. L., & Bouchard, C. (2009). Sitting time and 
mortality from all causes, cardiovascular disease, and cancer. Medicine and Science in 
Sports and Exercise, 41(5), 998-1005. doi:10.1249/MSS.0b013e3181930355 [doi]  
Kawagoshi, A., Kiyokawa, N., Sugawara, K., Takahashi, H., Sakata, S., Satake, M., & 
Shioya, T. (2015). Effects of low-intensity exercise and home-based pulmonary 
rehabilitation with pedometer feedback on physical activity in elderly patients with 
chronic obstructive pulmonary disease. Respiratory Medicine, 109(3), 364-371.  
159 
 
Kawagoshi, A., Kiyokawa, N., Sugawara, K., Takahashi, H., Sakata, S., Miura, S., . . . Shioya, 
T. (2013). Quantitative assessment of walking time and postural change in patients with 
COPD using a new triaxial accelerometer system. International Journal of Chronic 
Obstructive Pulmonary Disease, 8, 397-404. doi:10.2147/COPD.S49491 [doi]  
Kessler, R., Partridge, M. R., Miravitlles, M., Cazzola, M., Vogelmeier, C., Leynaud, D., & 
Ostinelli, J. (2011). Symptom variability in patients with severe COPD: A pan-european 
cross-sectional study. The European Respiratory Journal, 37(2), 264-272. 
doi:10.1183/09031936.00051110 [doi]  
Khakban, A., Sin, D. D., FitzGerald, J. M., McManus, B., Ng, R., Hollander, Z., & 
Sadatsafavi, M. (2016). The projected epidemic of COPD hospitalizations over the next 
15 years: A population based perspective. American Journal of Respiratory and Critical 
Care Medicine, (ja)  
Kooiman, T. J., Dontje, M. L., Sprenger, S. R., Krijnen, W. P., van der Schans, Cees P, & de 
Groot, M. (2015). Reliability and validity of ten consumer activity trackers. BMC Sports 
Science, Medicine and Rehabilitation, 7(1), 1.  
Kortebein, P. (2009). Rehabilitation for hospital-associated deconditioning. American 
Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists, 
88(1), 66-77. doi:10.1097/PHM.0b013e3181838f70 [doi]  
Koster, A., Shiroma, E. J., Caserotti, P., Matthews, C. E., Chen, K. Y., Glynn, N. W., & 
Harris, T. B. (2016). Comparison of sedentary estimates between activPAL and hip- and 
wrist-worn ActiGraph. Medicine and Science in Sports and Exercise, 48(8), 1514-1522. 
doi:10.1249/MSS.0000000000000924 [doi]  
Kozey-Keadle, S., Libertine, A., Lyden, K., Staudenmayer, J., & Freedson, P. S. (2011). 
Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc, 
43(8), 1561-1567.  
Lacasse, Y., Goldstein, R., Lasserson, T. J., & Martin, S. (2006). Pulmonary rehabilitation for 
chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 4(4)  
Lahaije, A. J., van Helvoort, H. A., Dekhuijzen, P. R., Vercoulen, J. H., & Heijdra, Y. F. 
(2013). Resting and ADL-induced dynamic hyperinflation explain physical inactivity in 
COPD better than FEV 1. Respiratory Medicine, 107(6), 834-840.  
Lally, P., Van Jaarsveld, C. H., Potts, H. W., & Wardle, J. (2010). How are habits formed: 
Modelling habit formation in the real world. European Journal of Social Psychology, 
40(6), 998-1009.  
160 
 
Lamonte, M. J., & Ainsworth, B. E. (2001). Quantifying energy expenditure and physical 
activity in the context of dose response. Medicine and Science in Sports and Exercise, 
33(6 Suppl), S370-8; discussion S419-20.  
Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical 
data. Biometrics, , 159-174.  
Lange, P., Marott, J. L., Vestbo, J., Olsen, K. R., Ingebrigtsen, T. S., Dahl, M., & 
Nordestgaard, B. G. (2012). Prediction of the clinical course of chronic obstructive 
pulmonary disease, using the new GOLD classification: A study of the general 
population. American Journal of Respiratory and Critical Care Medicine, 186(10), 975-
981.  
LaPorte, R. E., Montoye, H. J., & Caspersen, C. J. (1985). Assessment of physical activity in 
epidemiologic research: Problems and prospects. Public Health Reports (Washington, 
D.C.: 1974), 100(2), 131-146.  
Laverty, A. A., Elkin, S. L., Watt, H. C., Millett, C., Restrick, L. J., Williams, S., . . . 
Hopkinson, N. S. (2015). Impact of a COPD discharge care bundle on readmissions 
following admission with acute exacerbation: Interrupted time series analysis. PloS One, 
10(2), e0116187.  
Lazarus, B. A., Murphy, J. B., Coletta, E. M., McQuade, W. H., & Culpepper, L. (1991). The 
provision of physical activity to hospitalized elderly patients. Archives of Internal 
Medicine, 151(12), 2452-2456.  
Lee, H., Kim, I., Lim, Y., Jung, H. Y., & Park, H. (2011). Depression and sleep disturbance 
in patients with chronic obstructive pulmonary disease. Geriatric Nursing, 32(6), 408-
417.  
Lee, I. M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., Katzmarzyk, P. T., & Lancet 
Physical Activity Series Working Group. (2012). Effect of physical inactivity on major 
non-communicable diseases worldwide: An analysis of burden of disease and life 
expectancy. Lancet (London, England), 380(9838), 219-229. doi:10.1016/S0140-
6736(12)61031-9 [doi]  
Lemmens, K., Nieboer, A., & Huijsman, R. (2008). Designing patient-related interventions in 
COPD care: Empirical test of a theoretical model. Patient Education and Counseling, 
72(2), 223-231.  
Loddenkemper, R. (2003). European lung white book. the first comprehensive survey on 
respiratory health in europe. European Respiratory Society.  
161 
 
Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., . . . Buist, S. 
(2006). Chronic obstructive pulmonary disease: Current burden and future projections. 
The European Respiratory Journal, 27(2), 397-412. doi:27/2/397 [pii]  
Lores, V., García-Río, F., Rojo, B., Alcolea, S., & Mediano, O. (2006). Recording the daily 
physical activity of COPD patients with an accelerometer: An analysis of agreement and 
repeatability. Archivos De Bronconeumología ((English Edition)), 42(12), 627-632.  
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., . . . Ahn, S. Y. 
(2013). Global and regional mortality from 235 causes of death for 20 age groups in 
1990 and 2010: A systematic analysis for the global burden of disease study 2010. The 
Lancet, 380(9859), 2095-2128.  
Mahler, D., & Weels, C. (1988). Evaluation of clinical methods for rating dyspnea. Chest, 93, 
580-586.  
Mannini, A., Intille, S. S., Rosenberger, M., Sabatini, A. M., & Haskell, W. (2013). Activity 
recognition using a single accelerometer placed at the wrist or ankle. Medicine and 
Science in Sports and Exercise, 45(11), 2193-2203. 
doi:10.1249/MSS.0b013e31829736d6 [doi]  
Mantoani, L. C., Rubio, N., McKinstry, B., MacNee, W., & Rabinovich, R. A. (2016). 
Interventions to modify physical activity in patients with COPD: A systematic review. 
The European Respiratory Journal, 48(1), 69-81. doi:10.1183/13993003.01744-2015 
[doi]  
Marschollek, M. (2013). A semi-quantitative method to denote generic physical activity 
phenotypes from long-term accelerometer data–the ATLAS index. PloS One, 8(5), 
e63522.  
Marshall, A. L., Miller, Y. D., Burton, N. W., & Brown, W. J. (2010). Measuring total and 
domain-specific sitting: A study of reliability and validity. Medicine and Science in 
Sports and Exercise, 42(6), 1094-1102. doi:10.1249/MSS.0b013e3181c5ec18 [doi]  
Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M. E., Yohannes, A. M., & 
Hanania, N. A. (2008). Anxiety and depression in COPD: Current understanding, 
unanswered questions, and research needs. Chest Journal, 134(4_suppl), 43S-56S.  
McGarvey, L. P., John, M., Anderson, J. A., Zvarich, M., Wise, R. A., & TORCH Clinical 
Endpoint Committee. (2007). Ascertainment of cause-specific mortality in COPD: 
Operations of the TORCH clinical endpoint committee. Thorax, 62(5), 411-415. 
doi:thx.2006.072348 [pii]  
162 
 
McGlone, S., Venn, A., Walters, E. H., & Wood-Baker, R. (2006). Physical activity, 
spirometry and quality-of-life in chronic obstructive pulmonary disease. COPD: Journal 
of Chronic Obstructive Pulmonary Disease, 3(2), 83-88.  
McHugh, M. L. (2012). Interrater reliability: The kappa statistic. Biochemia Medica, 22(3), 
276-282.  
McNamara, R. J., McKeough, Z. J., McKenzie, D. K., & Alison, J. A. (2014). Physical 
comorbidities affect physical activity in chronic obstructive pulmonary disease: A 
prospective cohort study. Respirology, 19(6), 866-872.  
Mendoza, L., Horta, P., Espinoza, J., Aguilera, M., Balmaceda, N., Castro, A., . . . Hopkinson, 
N. S. (2015). Pedometers to enhance physical activity in COPD: A randomised 
controlled trial. The European Respiratory Journal, 45(2), 347-354. 
doi:10.1183/09031936.00084514 [doi]  
Menezes, A. M. B., Perez-Padilla, R., Jardim, J. B., Muiño, A., Lopez, M. V., Valdivia, 
G., . . . Victora, C. G. (2005). Chronic obstructive pulmonary disease in five Latin 
American cities (the PLATINO study): A prevalence study. The Lancet, 366(9500), 
1875-1881.  
Metcalf, B. S., Curnow, J. S., Evans, C., Voss, L. D., & Wilkin, T. J. (2002). Technical 
reliability of the CSA activity monitor: The EarlyBird study. Medicine and Science in 
Sports and Exercise, 34(9), 1533-1537.  
Michie, S., Abraham, C., Whittington, C., McAteer, J., & Gupta, S. (2009). Effective 
techniques in healthy eating and physical activity interventions: A meta-regression. 
Health Psychology, 28(6), 690.  
Miravitlles, M., Anzueto, A., Legnani, D., Forstmeier, L., & Fargel, M. (2007). Patient's 
perception of exacerbations of COPD—the PERCEIVE study. Respiratory Medicine, 
101(3), 453-460.  
Miravitlles, M., Cantoni, J., & Naberan, K. (2014). Factors associated with a low level of 
physical activity in patients with chronic obstructive pulmonary disease. Lung, 192(2), 
259-265.  
Miravitlles, M., Worth, H., Cataluña, J. J. S., Price, D., De Benedetto, F., Roche, N., . . . 
Padullés, L. (2014a). Observational study to characterise 24-hour COPD symptoms and 
their relationship with patient-reported outcomes: Results from the ASSESS study. 
Respiratory Research, 15(1), 1.  
Miravitlles, M., Worth, H., Soler Cataluna, J. J., Price, D., De Benedetto, F., Roche, N., . . . 
Ribera, A. (2014b). Observational study to characterise 24-hour COPD symptoms and 
163 
 
their relationship with patient-reported outcomes: Results from the ASSESS study. 
Respiratory Research, 15, 122-014-0122-1. doi:10.1186/s12931-014-0122-1 [doi]  
Mitchell, K. E., Johnson, V., Houchen‐Wolloff, L., Sewell, L., Morgan, M. D., Steiner, M. C., 
& Singh, S. J. (2016). Agreement between adherences to four physical activity 
recommendations in patients with COPD: Does the incremental shuttle walk test predict 
adherence? The Clinical Respiratory Journal,Oct 1.  
Mitchell, K. E., Johnson-Warrington, V., Apps, L. D., Bankart, J., Sewell, L., Williams, J. 
E., . . . Singh, S. J. (2014). A self-management programme for COPD: A randomised 
controlled trial. The European Respiratory Journal, 44(6), 1538-1547. 
doi:10.1183/09031936.00047814 [doi]  
Monteiro, F., Camillo, C. A., Vitorasso, R., Sant’Anna, T., Hernandes, N. A., Probst, V. S., & 
Pitta, F. (2012). Obesity and physical activity in the daily life of patients with COPD. 
Lung, 190(4), 403-410.  
Montoye, H. J., Kemper, H. C., Saris, W. H., & Washburn, R. A. (1996). Measuring physical 
activity and energy expenditure Human Kinetics Champaign, IL.  
Montoye, H. J. (2000). Introduction: Evaluation of some measurements of physical activity 
and energy expenditure. Medicine and Science in Sports and Exercise, 32(9 Suppl), 
S439-41.  
Morgan, M. D. (2003). Preventing hospital admissions for COPD: Role of physical activity. 
Thorax, 58(2), 95-96.  
Moy, M. L., Matthess, K., Stolzmann, K., Reilly, J., & Garshick, E. (2009). Free-living 
physical activity in COPD: Assessment with accelerometer and activity checklist. 
Journal of Rehabilitation Research and Development, 46(2), 277-286.  
Mutrie, N., Doolin, O., Fitzsimons, C. F., Grant, P. M., Granat, M., Grealy, M., . . . Skelton, 
D. A. (2012). Increasing older adults' walking through primary care: Results of a pilot 
randomized controlled trial. Family Practice, 29(6), 633-642. 
doi:10.1093/fampra/cms038 [doi]  
Nandeesha, H. (2009). Insulin: A novel agent in the pathogenesis of prostate cancer. 
International Urology and Nephrology, 41(2), 267-272.  
National Institute for Health and Care Excellence (NICE). (2010). Chronic obstructive 
pulmonary disease in over 16s: Diagnosis and management.  
National Statistics. (2008). Deaths by age, sex and selected underlying cause, 2008 
registrations.  
164 
 
Nguyen, H. Q., Fan, V. S., Herting, J., Lee, J., Fu, M., Chen, Z., . . . Pagalilauan, G. (2013). 
Patients with COPD with higher levels of anxiety are more physically active. CHEST 
Journal, 144(1), 145-151.  
Nichols, J. F., Morgan, C. G., Chabot, L. E., Sallis, J. F., & Calfas, K. J. (2000). Assessment 
of physical activity with the computer science and applications, inc., accelerometer: 
Laboratory versus field validation. Research Quarterly for Exercise and Sport, 71(1), 
36-43.  
O’Donnell, D., & Gebke, K. B. (2014). Activity restriction in mild COPD: A challenging 
clinical problem. International Journal of Chronic Obstructive Pulmonary Disease, 9, 
577-588.  
Orme, M. W., Esliger, D. W., Kingsnorth, A. P., Steiner, M. C., Singh, S. J., Malcolm, D., . . . 
Sherar, L. B. (2016). Physical activity and respiratory health (PhARaoH): Data from a 
cross-sectional study. Journal of Open Health Data.  
Orme, M., Weedon, A., Esliger, D., Saukko, P., Morgan, M., Steiner, M., . . . Sherar, L. 
(2016). Study protocol for chronic obstructive pulmonary disease-sitting and 
ExacerbAtions trial (COPD-SEAT): A randomised controlled feasibility trial of a home-
based self-monitoring sedentary behaviour intervention. BMJ Open, 6(10), e013014-
2016-013014. doi:10.1136/bmjopen-2016-013014 [doi]  
Orme, M., Wijndaele, K., Sharp, S. J., Westgate, K., Ekelund, U., & Brage, S. (2014). 
Combined influence of epoch length, cut-point and bout duration on accelerometry-
derived physical activity. The International Journal of Behavioral Nutrition and 
Physical Activity, 11(1), 34-5868-11-34. doi:10.1186/1479-5868-11-34 [doi]  
Orrow, G., Kinmonth, A. L., Sanderson, S., & Sutton, S. (2012). Effectiveness of physical 
activity promotion based in primary care: Systematic review and meta-analysis of 
randomised controlled trials. BMJ (Clinical Research Ed.), 344, e1389. 
doi:10.1136/bmj.e1389 [doi]  
Papaioannou, M., Pitsiou, G., Manika, K., Kontou, P., Zarogoulidis, P., Sichletidis, L., & 
Kioumis, I. P. (2014). COPD assessment test: A simple tool to evaluate disease severity 
and response to treatment. Journal of Chronic Obstructive Pulmonary Disease, 11, 489-
495.  
Park, S. K., Richardson, C. R., Holleman, R. G., & Larson, J. L. (2013). Physical activity in 
people with COPD, using the national health and nutrition evaluation survey dataset 
(2003-2006). Heart & Lung, 42, 235-240.  
Parvatikar, V., & Mukkannavar, P. (2009). Comparative study of grip strength in different 
positions of shoulder and elbow with wrist in neutral and extension positions. Journal of 
Exercise Science and Physiotherapy, 5(2), 67.  
165 
 
Pauwels, R. A., & Rabe, K. F. (2004). Burden and clinical features of chronic obstructive 
pulmonary disease (COPD). The Lancet, 364(9434), 613-620.  
Pearson, M. (2004). Chronic obstructive pulmonary disease: National clinical guideline on 
management of chronic obstructive pulmonary disease in adults in primary and 
secondary care. Thorax, 59, 1-232.  
Physical Activity Guidelines Advisory Committee. (2008). Physical activity guidelines 
advisory committee report, 2008. Washington, DC: US Department of Health and 
Human Services, 2008, A1-H14.  
Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005). 
Characteristics of physical activities in daily life in chronic obstructive pulmonary 
disease. American Journal of Respiratory and Critical Care Medicine, 171, 972-977.  
Pitta, F., Breyer, M., Hernandes, N. A., Teixeira, D., Sant'Anna, T. J., Fontana, A. D., . . . 
Wouters, E. F. (2009). Comparison of daily physical activity between COPD patients 
from central europe and south america. Respiratory Medicine, 103(3), 421-426.  
Pitta, F., Takaki, M. Y., de Oliveira, N. H., Sant'Anna, T. J., Fontana, A. D., Kovelis, D., . . . 
Brunetto, A. F. (2008). Relationship between pulmonary function and physical activity 
in daily life in patients with COPD. Respiratory Medicine, 102(8), 1203-1207.  
Pitta, F., Troosters, T., Probst, V. S., Spruit, M. A., Decramer, M., & Gosselink, R. (2006). 
Physical activity and hospitalization for exacerbation of COPD. CHEST Journal, 129(3), 
536-544.  
Pitta, F., Troosters, T., Spruit, M. A., Decramer, M., & Gosselink, R. (2005). Activity 
monitoring for assessment of physical activities in daily life in patients with chronic 
obstructive pulmonary disease. Archives of Physical Medicine and Rehabilitation, 86(10), 
1979-1985.  
Piwek, L., Ellis, D. A., Andrews, S., & Joinson, A. (2016). The rise of consumer health 
wearables: Promises and barriers. PLoS Med, 13(2), e1001953.  
Polkey, M. I., & Moxham, J. (2006). Attacking the disease spiral in chronic obstructive 
pulmonary disease. Clinical Medicine (London, England), 6(2), 190-196.  
Powell, K. E., Paluch, A. E., & Blair, S. N. (2011). Physical activity for health: What kind? 
how much? how intense? on top of what? Annual Review of Public Health, 32(1), 349.  
Price, D. B., Baker, C. L., Zou, K. H., Higgins, V. S., Bailey, J. T., & Pike, J. S. (2014). Real-
world characterization and differentiation of the global initiative for chronic obstructive 
lung strategy classification. International Journal of Chronic Obstructive Pulmonary 
Disease, 9, 551-561.  
166 
 
Puhan, M. A., Gimeno-Santos, E., Scharplatz, M., Troosters, T., Walters, E. H., & Steurer, J. 
(2011). Pulmonary rehabilitation following exacerbations of chronic obstructive 
pulmonary disease. Cochrane Database Syst Rev, 10(10)  
Puhan, M. A., Spaar, A., Frey, M., Turk, A., Brandli, O., Ritscher, D., . . . Karrer, W. (2012). 
Early versus late pulmonary rehabilitation in chronic obstructive pulmonary disease 
patients with acute exacerbations: A randomized trial. Respiration; International Review 
of Thoracic Diseases, 83(6), 499-506. doi:10.1159/000329884 [doi]  
Puthoff, M. L. (2004). Research corner outcome measures in cardiopulmonary physical 
therapy: Short physical performance battery. Cardiopulmonary Physical Therapy 
Journal, 19(1), 17-22.  
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J. C. 
(1993). Lung volumes and forced ventilatory flows. The European Respiratory Journal, 
6 Suppl 16, 5-40. doi:10.1183/09041950.005s1693 [doi]  
Rabe, K. F. (2006). Improving dyspnea in chronic obstructive pulmonary disease: Optimal 
treatment strategies. Proceedings of the American Thoracic Society, 3(3), 270-275.  
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., . . . Van Weel, C. 
(2007). Global strategy for the diagnosis, management, and prevention of chronic 
obstructive pulmonary disease: GOLD executive summary. American Journal of 
Respiratory and Critical Care Medicine, 176(6), 532-555.  
Rabinovich, R. A., Louvaris, Z., Raste, Y., Langer, D., Van Remoortel, H., Giavedoni, S., . . . 
PROactive Consortium. (2013). Validity of physical activity monitors during daily life in 
patients with COPD. The European Respiratory Journal, 42(5), 1205-1215. 
doi:10.1183/09031936.00134312 [doi]  
Raghavan, N., Lam, Y., Webb, K. A., Guenette, J. A., Amornputtisathaporn, N., Raghavan, 
R., . . . O'Donnell, D. E. (2012). Components of the COPD assessment test (CAT) 
associated with a diagnosis of COPD in a random population sample. COPD: Journal of 
Chronic Obstructive Pulmonary Disease, 9(2), 175-183.  
Rennard, S., Decramer, M., Calverley, P. M., Pride, N. B., Soriano, J. B., Vermeire, P. A., & 
Vestbo, J. (2002). Impact of COPD in north america and europe in 2000: Subjects' 
perspective of confronting COPD international survey. The European Respiratory 
Journal, 20(4), 799-805.  
Respiratory Alliance. (Jan 2003). Bridging the gap. Cookham: Direct Publishing Solutions,  
Rochester, C. L., Vogiatzis, I., Holland, A. E., Lareau, S. C., Marciniuk, D. D., Puhan, M. 
A., . . . Clini, E. M. (2015). An official american thoracic society/european respiratory 
society policy statement: Enhancing implementation, use, and delivery of pulmonary 
167 
 
rehabilitation. American Journal of Respiratory and Critical Care Medicine, 192(11), 
1373-1386.  
Rosenberger, M. E., Buman, M. P., Haskell, W. L., McConnell, M. V., & Carstensen, L. L. 
(2016). Twenty-four hours of sleep, sedentary behavior, and physical activity with nine 
wearable devices. Medicine and Science in Sports and Exercise, 48(3), 457-465. 
doi:10.1249/MSS.0000000000000778 [doi]  
Rothman, M., Burke, L., Erickson, P., Leidy, N. K., Patrick, D. L., & Petrie, C. D. (2009). 
Use of existing Patient‐Reported outcome (PRO) instruments and their modification: 
The ISPOR good research practices for evaluating and documenting content validity for 
the use of existing instruments and their modification PRO task force report. Value in 
Health, 12(8), 1075-1083.  
Rothney, M. P., Apker, G. A., Song, Y., & Chen, K. Y. (2008). Comparing the performance 
of three generations of ActiGraph accelerometers. Journal of Applied Physiology 
(Bethesda, Md.: 1985), 105(4), 1091-1097. doi:10.1152/japplphysiol.90641.2008 [doi]  
Rowlands, A. V., Yates, T., Olds, T. S., Davies, M., Khunti, K., & Edwardson, C. L. (2016). 
Sedentary sphere: Wrist-worn accelerometer-brand independent posture classification. 
Medicine and Science in Sports and Exercise, 48(4), 748-754. 
doi:10.1249/MSS.0000000000000813 [doi]  
Salvi, S. S., & Barnes, P. J. (2009). Chronic obstructive pulmonary disease in non-smokers. 
The Lancet, 374(9691), 733-743.  
Sanders, J. P., Loveday, A., Pearson, N., Edwardson, C., Yates, T., Biddle, S. J., & Esliger, D. 
W. (2016). Devices for self-monitoring sedentary time or physical activity: A scoping 
review. Journal of Medical Internet Research, 18(5), e90. doi:10.2196/jmir.5373 [doi]  
Santacroce, S. J., Maccarelli, L. M., & Grey, M. (2004). Intervention fidelity. Nursing 
Research, 53(1), 63-66.  
Schuit, A. J., van Loon, A Jeanne M, Tijhuis, M., & Ocké, M. C. (2002). Clustering of 
lifestyle risk factors in a general adult population. Preventive Medicine, 35(3), 219-224.  
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated 
guidelines for reporting parallel group randomised trials. BMC Medicine, 8(1), 1.  
Schwarzer, R. (2008). Modeling health behavior change: How to predict and modify the 
adoption and maintenance of health behaviors. Applied Psychology, 57(1), 1-29.  
Sedentary Behaviour Research, N. (2012). Letter to the editor: Standardized use of the terms 
"sedentary" and "sedentary behaviours". Applied Physiology, Nutrition, and Metabolism 
168 
 
= Physiologie Appliquee, Nutrition Et Metabolisme, 37(3), 540-542. doi:10.1139/h2012-
024 [doi]  
Seemungal, T. A., Donaldson, G. C., Paul, E. A., & et al. (1998). Effect of exacerbation on 
quality of life in patients with chronic obstructive pulmonary disease. American Journal 
of Respiratory and Critical Care Medicine, 157, 1418-1422.  
Seymour, J. M., Moore, L., Jolley, C. J., Ward, K., Creasey, J., Steier, J. S., . . . Moxham, J. 
(2010). Outpatient pulmonary rehabilitation following acute exacerbations of COPD. 
Thorax, 65(5), 423-428. doi:10.1136/thx.2009.124164 [doi]  
Shahab, L., Jarvis, M. J., Britton, J., & West, R. (2006). Prevalence, diagnosis and relation to 
tobacco dependence of chronic obstructive pulmonary disease in a nationally 
representative population sample. Thorax, 61(12), 1043-1047. doi:thx.2006.064410 [pii]  
Shrikrishna, D., & Hopkinson, N. S. (2012). Chronic obstructive pulmonary disease: 
Consequences beyond the lung. Clinical Medicine (London, England), 12(1), 71-74.  
Shrikrishna, D., Patel, M., Tanner, R. J., Seymour, J. M., Connolly, B. A., Puthucheary, Z. 
A., . . . Hopkinson, N. S. (2012). Quadriceps wasting and physical inactivity in patients 
with COPD. The European Respiratory Journal, 40(5), 1115-1122. 
doi:10.1183/09031936.00170111 [doi]  
Sievi, N. A., Senn, O., Brack, T., Brutsche, M. H., Frey, M., Irani, S., . . . Kohler, M. (2015). 
Impact of comorbidities on physical activity in COPD. Respirology, 20(3), 413-418.  
Silva, D. R., Coelho, A. C., Dumke, A., Valentini, J. D., de Nunes, J. N., Stefani, C. L., . . . 
Knorst, M. M. (2011). Osteoporosis prevalence and associated factors in patients with 
COPD: A cross-sectional study. Respiratory Care, 56(7), 961-968. 
doi:10.4187/respcare.01056 [doi]  
Singh, S. (2014). Physical activity and pulmonary rehabilitation - A competing agenda? 
Chronic Respiratory Disease, 11(4), 187-189. doi:10.1177/1479972314552999 [doi]  
Singh, S. J., Morgan, M. D., Scott, S., Walters, D., & Hardman, A. E. (1992). Development 
of a shuttle walking test of disability in patients with chronic airways obstruction. 
Thorax, 47(12), 1019-1024.  
Skumlien, S., Haave, E., Morland, L., Bjortuft, O., & Ryg, M. S. (2006). Gender differences 
in the performance of activities of daily living among patients with chronic obstructive 
pulmonary disease. Chronic Respiratory Disease, 3(3), 141-148.  
Smith, L., Ekelund, U., & Hamer, M. (2015). The potential yield of non-exercise physical 
activity energy expenditure in public health. Sports Medicine, 45(4), 449-452.  
169 
 
Snaith, R. P. (2003). The hospital anxiety and depression scale. Health and Quality of Life 
Outcomes, 1(1), 1.  
Soler-Cataluna, J. J., Martinez-Garcia, M. A., Roman Sanchez, P., Salcedo, E., Navarro, M., 
& Ochando, R. (2005). Severe acute exacerbations and mortality in patients with chronic 
obstructive pulmonary disease. Thorax, 60(11), 925-931. doi:thx.2005.040527 [pii]  
Soriano, J. B. (2013). The GOLD rush. Thorax, 68(10), 902-903. doi:10.1136/thoraxjnl-
2013-203595 [doi]  
Sparling, P. B., Howard, B. J., Dunstan, D. W., & Owen, N. (2015). Recommendations for 
physical activity in older adults. BMJ (Clinical Research Ed.), 350, h100. 
doi:10.1136/bmj.h100 [doi]  
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., . . . Man, W. D. 
(2013). An official american thoracic Society/European respiratory society statement: 
Key concepts and advances in pulmonary rehabilitation. American Journal of 
Respiratory and Critical Care Medicine, 188(8), e13-e64.  
Stanovich, K. E. (2013). How to think straight about psychology. Pearson.  
Steiner, M., Holzhauer-Barrie, J., Lowe, D., Searle, L., Skipper, E., Welham, S., & Roberts, 
C. (2015a). Pulmonary rehabilitation: Time to breath better. national chronic 
obstructive pulmonary disease (COPD) audit programme: Local report for glenfield 
hospital pulmonary rehabilitation service 2015. ().  
Steiner, M., Holzhauer-Barrie, J., Lowe, D., Searle, L., Skipper, E., Welham, S., & Roberts, 
C. (2015b). Pulmonary rehabilitation: Time to breath better. national chronic 
obstructive pulmonary disease (COPD) audit programme: Resources and organisation 
of pulmonary rehabilitation services in england and wales 2015. ().  
Steiner, M. C. (2013). The development and pilot testing of the self-management programme 
of activity, coping and education for chronic obstructive pulmonary disease (SPACE for 
COPD).  
Strath, S., Bassett Jr, D., & Swartz, A. (2003). Comparison of MTI accelerometer cut-points 
for predicting time spent in physical activity. International Journal of Sports Medicine, 
24(04), 298-303.  
Suter, P., Hennessey, B., Florez, D., & Newton Suter, W. (2011). Review series: Examples of 
chronic care model: The home-based chronic care model: Redesigning home health for 
high quality care delivery. Chronic Respiratory Disease, 8(1), 43-52. 
doi:10.1177/1479972310396031 [doi]  
170 
 
Swan, M. (2013). The quantified self: Fundamental disruption in big data science and 
biological discovery. Big Data, 1(2), 85-99.  
Tabak, M., Brusse-Keizer, M., van der Valk, P., Hermens, H., & Vollenbroek-Hutten, M. 
(2014). A telehealth program for self-management of COPD exacerbations and 
promotion of an active lifestyle: A pilot randomized controlled trial. International 
Journal of Chronic Obstructive Pulmonary Disease, 9, 935-944. 
doi:10.2147/COPD.S60179 [doi]  
Tálamo, C., de Oca, M. M., Halbert, R., Perez-Padilla, R., Jardim, J. R. B., Muino, A., . . . 
Moreno, D. (2007). Diagnostic labeling of COPD in five latin american cities. CHEST 
Journal, 131(1), 60-67.  
Thorpe, O., Kumar, S., & Johnston, K. (2014). Barriers to and enablers of physical activity in 
patients with COPD following a hospital admission: A qualitative study. International 
Journal of Chronic Obstructive Pulmonary Disease, 9, 115-128. 
doi:10.2147/COPD.S54457 [doi]  
Tremblay, M. S., Colley, R. C., Saunders, T. J., Healy, G. N., & Owen, N. (2010). 
Physiological and health implications of a sedentary lifestyle. Applied Physiology, 
Nutrition, and Metabolism, 35(6), 725-740.  
Troiano, R. P., Berrigan, D., Dodd, K. W., Masse, L. C., Tilert, T., & McDowell, M. (2008). 
Physical activity in the united states measured by accelerometer. Medicine and Science 
in Sports and Exercise, 40(1), 181.  
Troosters, T., Sciurba, F., Battaglia, S., Langer, D., Valluri, S. R., Martino, L., . . . Decramer, 
M. (2010). Physical inactivity in patients with COPD, a controlled multi-center pilot-
study. Respiratory Medicine, 104(7), 1005-1011.  
Troosters, T., van der Molen, T., Polkey, M., Rabinovich, R. A., Vogiatzis, I., Weisman, I., & 
Kulich, K. (2013). Improving physical activity in COPD: Towards a new paradigm. 
Respir Res, 14(1), 115.  
Trost, S. G., Pate, R. R., Freedson, P. S., Sallis, J. F., & Taylor, W. C. (2000). Using 
objective physical activity measures with youth: How many days of monitoring are 
needed? Medicine and Science in Sports and Exercise, 32(2), 426-431.  
Tsai, L. L., Alison, J. A., McKenzie, D. K., & McKeough, Z. J. (2016). Physical activity 
levels improve following discharge in people admitted to hospital with an acute 
exacerbation of chronic obstructive pulmonary disease. Chronic Respiratory Disease, 
13(1), 23-32. doi:10.1177/1479972315603715 [doi]  
171 
 
Tucker, J. M., Welk, G. J., & Beyler, N. K. (2011). Physical activity in US adults: 
Compliance with the physical activity guidelines for americans. American Journal of 
Preventive Medicine, 40(4), 454-461.  
Ukawa, S., Tamakoshi, A., Yatsuya, H., Yamagishi, K., Ando, M., & Iso, H. (2015). 
Association between average daily television viewing time and chronic obstructive 
pulmonary disease-related mortality: Findings from the japan collaborative cohort study. 
Journal of Epidemiology / Japan Epidemiological Association, 25(6), 431-436. 
doi:10.2188/jea.JE20140185 [doi]  
Vaes, A. W., Garcia-Aymerich, J., Marott, J. L., Benet, M., Groenen, M. T., Schnohr, P., . . . 
Spruit, M. A. (2014). Changes in physical activity and all-cause mortality in COPD. The 
European Respiratory Journal, 44(5), 1199-1209. doi:10.1183/09031936.00023214 [doi]  
van Gestel, A. J., Clarenbach, C. F., Stöwhas, A. C., Rossi, V. A., Sievi, N. A., Camen, 
G., . . . Kohler, M. (2012). Predicting daily physical activity in patients with chronic 
obstructive pulmonary disease. PLoS One, 7(11), e48081.  
Van Gestel, A. J., Kohler, M., Steier, J., Sommerwerck, U., Teschler, S., Russi, E. W., & 
Teschler, H. (2012). Cardiac autonomic function and cardiovascular response to exercise 
in patients with chronic obstructive pulmonary disease. COPD: Journal of Chronic 
Obstructive Pulmonary Disease, 9(2), 160-165.  
van Hees, V. T., Renström, F., Wright, A., Gradmark, A., Catt, M., Chen, K. Y., . . . 
Wareham, N. J. (2011). Estimation of daily energy expenditure in pregnant and non-
pregnant women using a wrist-worn tri-axial accelerometer. PloS One, 6(7), e22922.  
Van Helvoort, H. A., Willems, L. M., Dekhuijzen, P. R., Van Hees, H. W., & Heijdra, Y. F. 
(2016). Respiratory constraints during activities in daily life and the impact on health 
status in patients with early-stage COPD: A cross-sectional study. NPJ Primary Care 
Respiratory Medicine, 26, 16054.  
Van Hout, B., Janssen, M., Feng, Y., Kohlmann, T., Busschbach, J., Golicki, D., . . . Pickard, 
A. S. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L 
value sets. Value in Health, 15(5), 708-715.  
Van Manen, J., Bindels, P., IJzermans, C., Van der Zee, J., Bottema, B., & Schade, E. (2001). 
Prevalence of comorbidity in patients with a chronic airway obstruction and controls 
over the age of 40. Journal of Clinical Epidemiology, 54(3), 287-293.  
Van Remoortel, H., Giavedoni, S., Raste, Y., Burtin, C., Louvaris, Z., Gimeno-Santos, E., . . . 
Vogiatzis, I. (2012). Validity of activity monitors in health and chronic disease: A 
systematic review. International Journal of Behavioral Nutrition and Physical Activity, 
9(1), 1.  
172 
 
Van Remoortel, H., Hornikx, M., Demeyer, H., Langer, D., Burtin, C., Decramer, M., . . . 
Troosters, T. (2013). Daily physical activity in subjects with newly diagnosed COPD. 
Thorax, 68(10), 962-963. doi:10.1136/thoraxjnl-2013-203534 [doi]  
Vandelanotte, C., Müller, A. M., Short, C. E., Hingle, M., Nathan, N., Williams, S. L., . . . 
Maher, C. A. (2016). Past, present, and future of eHealth and mHealth research to 
improve physical activity and dietary behaviors. Journal of Nutrition Education and 
Behavior, 48(3), 219-228. e1.  
Verwey, R., Van der Weegen, S., Spreeuwenberg, M., Tange, H., Van der Weijden, T., & De 
Witte, L. (2016). Process evaluation of physical activity counselling with and without the 
use of mobile technology: A mixed methods study. International Journal of Nursing 
Studies, 53, 3-16.  
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., . . . 
Nishimura, M. (2013). Global strategy for the diagnosis, management, and prevention of 
chronic obstructive pulmonary disease: GOLD executive summary. American Journal of 
Respiratory and Critical Care Medicine, 187(4), 347-365.  
Vitorasso, R., Camillo, C. A., Cavalheri, V., Aparecida Hernandes, N., Cortez Verceze, A., 
Sant'Anna, T., . . . Pitta, F. (2012). Is walking in daily life a moderate intensity activity in 
patients with chronic obstructive pulmonary disease? European Journal of Physical and 
Rehabilitation Medicine, 48(4), 587-592. doi:R33122653 [pii]  
Vorrink, S. N., Kort, H. S., Troosters, T., Zanen, P., & Lammers, J. J. (2016). Efficacy of an 
mHealth intervention to stimulate physical activity in COPD patients after pulmonary 
rehabilitation. European Respiratory Journal, , ERJ-00083-2016.  
Waatevik, M., Johannessen, A., Hardie, J. A., Bjordal, J. M., Aukrust, P., Bakke, P. S., & 
Eagan, T. M. (2012). Different COPD disease characteristics are related to different 
outcomes in the 6-minute walk test. COPD: Journal of Chronic Obstructive Pulmonary 
Disease, 9(3), 227-234.  
Wakabayashi, R., Motegi, T., Yamada, K., Ishii, T., Gemma, A., & Kida, K. (2011). Presence 
of In‐Home caregiver and health outcomes of older adults with chronic obstructive 
pulmonary disease. Journal of the American Geriatrics Society, 59(1), 44-49.  
Warburton, D. E., Jamnik, V. K., Bredin, S. S., & Gledhill, N. (2011). The physical activity 
readiness questionnaire for everyone (PAR-Q ) and electronic physical activity readiness 
medical examination (ePARmed-X ). The Health & Fitness Journal of Canada, 4(2), 3-
17.  
Warren, T. Y., Barry, V., Hooker, S. P., Sui, X., Church, T. S., & Blair, S. N. (2010). 
Sedentary behaviors increase risk of cardiovascular disease mortality in men. Medicine 
173 
 
and Science in Sports and Exercise, 42(5), 879-885. 
doi:10.1249/MSS.0b013e3181c3aa7e [doi]  
Waschki, B., Kirsten, A., Holz, O., Muller, K. C., Meyer, T., Watz, H., & Magnussen, H. 
(2011). Physical activity is the strongest predictor of all-cause mortality in patients with 
COPD: A prospective cohort study. Chest, 140(2), 331-342. doi:10.1378/chest.10-2521 
[doi]  
Watz, H., Waschki, B., Meyer, T., & Magnussen, H. (2009). Physical activity in patients with 
COPD. European Respiratory Journal, 33, 262-272.  
Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T., & Magnussen, H. (2008). 
Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: A 
cross-sectional study. American Journal of Respiratory and Critical Care Medicine, 
177(7), 743-751.  
Watz, H., Waschki, B., Kirsten, A., Müller, K., Kretschmar, G., Meyer, T., . . . Magnussen, H. 
(2009). The metabolic syndrome in patients with chronic bronchitis and COPD: 
Frequency and associated consequences for systemic inflammation and physical 
inactivity. CHEST Journal, 136(4), 1039-1046.  
Watz, H., Pitta, F., Rochester, C. L., Garcia-Aymerich, J., ZuWallack, R., Troosters, T., . . . 
Spruit, M. A. (2014). An official european respiratory society statement on physical 
activity in COPD. The European Respiratory Journal, 44(6), 1521-1537. 
doi:10.1183/09031936.00046814 [doi]  
Weatherall, M., Marsh, S., Shirtcliffe, P., Williams, M., Travers, J., & Beasley, R. (2009). 
Quality of life measured by the st george's respiratory questionnaire and spirometry. The 
European Respiratory Journal, 33(5), 1025-1030. doi:10.1183/09031936.00116808 [doi]  
Webster, K., Cella, D., & Yost, K. (2003). The functional assessment of chronic illness 
therapy (FACIT) measurement system: Properties, applications, and interpretation. 
Health and Quality of Life Outcomes, 1, 79. doi:10.1186/1477-7525-1-79 [doi]  
Welk, G. (2002). Physical activity assessments for health-related research Human Kinetics.  
Welk, G. J. (2005). Principles of design and analyses for the calibration of accelerometry-
based activity monitors. Medicine and Science in Sports and Exercise, 37(11 Suppl), 
S501-11. doi:00005768-200511001-00003 [pii]  
Wicks, P., Vaughan, T., & Heywood, J. (2014). Subjects no more: What happens when trial 
participants realize they hold the power? BMJ (Clinical Research Ed.), 348, g368. 
doi:10.1136/bmj.g368 [doi]  
174 
 
Williams, D. M., Raynor, H. A., & Ciccolo, J. T. (2008). A review of TV viewing and its 
association with health outcomes in adults. American Journal of Lifestyle Medicine, 2(3), 
250-259.  
Wolf, M. S., Gazmararian, J. A., & Baker, D. W. (2005). Health literacy and functional 
health status among older adults. Archives of Internal Medicine, 165(17), 1946-1952.  
World Health Organization. (2000). Obesity: Preventing and managing the global epidemic 
World Health Organization.  
World Health Organization. (2008). WHO STEPwise approach to surveillance (STEPS): 
Guide to physical measurements. World Health Organization,  
Yardley, L., Beyer, N., Hauer, K., Kempen, G., Piot-Ziegler, C., & Todd, C. (2005). 
Development and initial validation of the falls efficacy scale-international (FES-I). Age 
and Ageing, 34(6), 614-619. doi:34/6/614 [pii]  
Yeo, J., Karimova, G., & Bansal, S. (2006). Co-morbidity in older patients with COPD--its 
impact on health service utilisation and quality of life, a community study. Age and 
Ageing, 35(1), 33-37. doi:35/1/33 [pii]  
Yu, T., Frei, A., & Puhan, M. (2015). Determinants of physical activity in patients with 
COPD: A longitudinal study. European Respiratory Journal, 46(suppl 59), PA3562.  
Zhan, P., Wang, J., Lv, X., Wang, Q., Qiu, L., Lin, X., . . . Song, Y. (2009). Prognostic value 
of vascular endothelial growth factor expression in patients with lung cancer: A 
systematic review with meta-analysis. Journal of Thoracic Oncology, 4(9), 1094-1103.  
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta 
Psychiatrica Scandinavica, 67(6), 361-370.  
Zwar, N. A., Marks, G. B., Hermiz, O., Middleton, S., Comino, E. J., Hasan, I., . . . Wilson, S. 
F. (2011). Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease 
in general practice. Med J Aust, 195(4), 168-171.  
 
 
 
 
 
 
175 
 
 
 
 
Appendices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
176 
 
Appendix A 
PhARaoH Study research ethics committee approval letter 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
177 
 
Health Research Authority 
NRES Committee East Midlands - Nottingham 2 
The Old Chapel Royal Standard Place 
Nottingham NG1 6FS 
Telephone : 0115 8839695
11 November 2013  
Professor Mike Morgan 
National Clinical Director for respiratory 
disease University Hospitals of Leicester 
Glenfield Hospital 
Groby Road 
Leicester 
LE39QP 
 
Dear Professor Morgan, 
 
Study title: Physical Activity and Respiratory Health (PhARaoH) Study 
REC reference: 13/EM/0389 
IRAS project ID: 127506 
The Research Ethics Committee reviewed the above application at the meeting held on 
28 October 2013. 
 
We plan to publish your research summary wording for the above study on the NRES 
website, together with your contact details, unless you expressly withhold permission to 
do so. Publication will be no earlier than three months from the date of this favourable 
opinion letter. Should you wish to provide a substitute contact point, require further 
information, or wish to withhold permission to publish, please contact the REC Manager 
- Liza Selway 0115 8839695 
Ethical opinion 
• The chair introduced himself and the committee and welcomed the researchers to the 
meeting 
• The committee asked what will happen to the audio recordings at the end of the study 
and the researchers advised the once transcribed then all audio tapes will be destroyed 
• The committee asked what is the role of the undergraduates and the researchers advised 
that they will not be taking any blood samples or analysing participants personal data. 
Both undergraduates are studying sport science 
• The committee asked how the early stages of recruitment of participants would occur. 
The researchers advised that participants will be identified through Clinical Care Groups 
that will contact GP surgeries within their area by using a database of patients. 
Participants will also self-refer through advertisement in GP surgeries. The GP practices 
will then send out Patient Information Sheets to different patient groups who have 
previously given spirometry readings 
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Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum .nhs.uk. 
Where a NHS organisation 's role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre'}, guidance should be 
sought from the R&D office on the information it requires to give permission for this activity. 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
Sponsors are not required to notify the Committee of approvals from host organisations 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database within 6 weeks of recruitment of the first 
participant (for medical device studies, within the timeline determined by the current 
registration and publication trees). 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g when submitting an amendment.  We will audit the registration details as 
part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered 
but for non clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net ), the HRA does not, however, expect exceptions to be made. 
 
Guidance on where to register is provided within IRAS. 
It is responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
Approved documents 
The documents reviewed and approved at the meeting were: 
Document Version Date 
Advertisement Website Advert   V1 30 September 
 Advertisement Radio Advert 30 September 
 Advertisement 1 30 September 
 Covering Letter  01 October 2013 
GP/Consultant Information Sheets 1 30 September 
 Interview Schedules/Topic Guides Sub study 
interview 
   
30 September 
2013 
Investigator CV Professor Morgan  
Adding new sites and investigators 
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• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
 
Feedback 
 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.   If you wish to make your views 
known please use the feedback form available on the website . 
 
Further information is available at National Research Ethics Service website > After Review 
 13/EM/0389                                    Please quote this number on all correspondence    
We are pleased to welcome researchers and R & D staff at our NRES committee members' 
training days - see details at http://www.hra.nhs.uk/hra-training/ 
 
With the Committee's best wishes for the success of this project. 
 
Yours sincerely 
Dr Martin Hewitt Chair 
 
Email: NRESCommittee .EastMidlands-Nottingham2@nhs.net 
 
Enclosures:  List of names and professions of members who were present at the 
meeting and those who submitted written comments 
"After ethical review - guidance for researchers" SL-AR2 
 
Copy to: Mrs Carolyn Maloney, Research and Development Manager 
University Hospitals of Leicester 
Mrs Carolyn Maloney, Research and Development Manager 
University Hospitals of Leicester 
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PhARaoH Study consent form 
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Yes          No 
CONSENT FORM 
Physical Activity and Respiratory Health (PhARaoH) Study 
Chief Investigator: Professor Mike Morgan 
Contact Investigator: Dr Lauren Sherar 
Contact: Dr Lauren Sherar, +44 (0)1509 223285 
Participant Study ID Label: 
 
1. I confirm that I have read and understood the Participant Information Sheet version 3, dated 7th 
January 2014 and have had the opportunity to ask questions. 
 
2. I understand that my consent and participation are voluntary and that I am free to withdraw 
from the study at any time without my medical care or legal rights being affected. 
 
3. I agree to undertake the investigations as described in the information sheet. 
 
4. I agree to my GP being informed about my participation in the study. 
 
5. My GP can be informed of the results obtained from my participation in the study.  
 
6. I understand that my data may be used by, shared and stored with other ethically approved 
research, and with academic or industry partners, if it is anonymised, now and in the future. 
 
7. I understand that relevant sections of my medical notes and/or study data may be looked at by 
responsible individuals from the study team, the sponsor, NHS Trust or from regulatory 
authorities where it is relevant to my taking part in the research. I give permission for these 
individuals to access my records. 
 
8. I agree to take part in the study. 
 
9. I wish to be contacted regarding the one-to-one interviews (sub-study).   
 
10. I wish to be contacted regarding other studies 
 
 
PLEASE INITIAL  
EACH BOX 
Yes          No 
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PATIENT INFORMATION SHEET 
Physical Activity and Respiratory Health  
(PhARaoH) Study 
 
An observational study investigating the roles of physical activity and sedentary 
behaviours, and psychological and social factors in chronic obstructive pulmonary 
disease (COPD) patients in order to inform strategies to delay COPD development or 
progression. 
 
TO TAKE PART IN THE STUDY PLEASE CALL 
01509 228225 
Chief Investigator: Professor Mike Morgan 
Co- Researchers: Professor Stuart Biddle, Dr Dale  Esliger, Dr Dominic 
Malcolm, Professor Myra Nimmo, Dr Lauren Sherar, 
Professor Sally Singh, Dr Michael Steiner 
 
You may contact:: Dr Lauren Sherar 
+44 (0)1509 228225 
 
If you have any questions regarding your health please contact your GP. 
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Invitation 
You are being invited to take part in an observational study looking at the associations 
among physical activity and sedentary behaviours, and psychological and social factors 
in the development of chronic obstructive pulmonary disease (COPD). The information 
obtained from this study will be used to inform strategies to delay COPD progression or 
development. Before you decide whether or not you want to take part, you should 
understand what the purpose of the study is and how you will be involved. Please take 
time to read this information sheet and discuss it with family and friends if you wish. 
Please ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
The purpose of this study is to examine the physical, psychological and social factors that 
are related to physical activity and sedentary behaviours (such as watching television) 
on respiratory health in patients diagnosed and not diagnosed with COPD. We hope that the 
findings of this study will enable a greater understanding of COPD and will inform 
strategies to improve respiratory health. 
 
Why have I been chosen? 
You have been identified as potentially eligible for the study because you are between the 
age of 40 and 75 years, registered with a GP practice in Leicestershire and Rutland 
 
Do I have to take part? 
It is up to you to decide to join the study. We will describe the study and go through the 
information sheet with you. If you agree to take part, we will ask you to sign a consent 
form. You are free to withdraw at any time, without giving a reason. If you decide not 
to participate or withdraw from the study, your NHS care will not be affected in any 
way. If you do decide to withdraw we may still use the data and samples collected up 
until the point you withdraw from the study. 
 
What will happen to me if I take part? 
We ask that you arrive to your appointment having fasted for 4 hours(not eaten or drank 
anything except water) and, if possible, refrain from smoking and being exposed to 
second-hand smoke for 24 hours prior to your appointment. We also ask that you do not 
take part in exercise on the day of your visit. 
You will be asked to participate in a one-off visit to the Respiratory Biomedical 
Research Unit at Glenfield Hospital in Leicester for approximately 2 hours. 
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Assessment Visit Flow Chart 
 
Description of the investigations 
Height, weight, waist circumference, percentage body fat, blood pressure 
Measurements of height and weight will be used to calculate your body mass index. 
You will be asked to remove your shoes, socks and personal belongings during the 
measurements. Weight and percentage body fat will involve standing on a weighing 
scale device. Waist circumference is measured using a tape measure and is an 
important indicator of abdominal or central obesity. Blood pressure will be measured 
whilst you are seated at rest. Immediate feedback of these results will be provided to 
you. 
 
Blood sample 
We kindly ask that you do not eat or drink (except water) 4 hours prior to your 
appointment time as blood samples will need to obtained with you in a fasted 
state. A small blood sample will be taken by a trained health professional in order to 
examine your cardiovascular and metabolic health status including blood sugar and 
blood cholesterol levels. These results will be sent to your GP if consented, who will 
contact you directly if the results suggest that you may require treatment or advice. 
Breathing Tests 
We kindly ask that, if possible, you do not smoke and avoid second-hand 
smoke for 24 hours prior to your appointment time. An opportunity to have a 
cigarette will be provided during the visit. These will involve several breathing 
tests on different machines by breathing out as hard as you can several times 
separated by recovery periods. These breathing tests may cause some temporary 
light headedness, and coughing. 
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Incremental Shuttle Walk Test (ISWT) 
The ISWT is a fitness test requiring you to walk only. You will walk up and down a 
10meter (11 yard) course in an empty corridor with the speed of the walk dictated by a CD 
player. The time limit to walk the 10m course will be signalled by bleeps, with the time 
between bleeps shortening as the test progresses. You will be asked to continue 
walking until you feel unable to maintain the necessary speed without becoming unduly 
breathless. A researcher will help with pacing by walking alongside you at the beginning 
of the walk. This test will be performed twice, with a 30 minute rest period in between. 
Portable oxygen or walking aids can be used if this is what you are used to. You will also 
be asked to wear a chest strap which monitors heart and breathing rate during the test. 
 
Questionnaires 
The rest period between the shuttle walk tests provides the ideal time to complete the 
questionnaires. The questionnaires cover a variety of factors important for understanding 
the effects of lifestyle (e.g. physical activity and smoking); psychological factors (e.g. 
anxiety and perceived health); social factors (e.g. demographics); and physical 
influences (e.g. breathlessness) on respiratory health. Researchers will be on hand to 
answer any questions you may have whilst filling them in. 
 
Leg and Grip Strength Tests 
We will measure the strength of your leg muscles by asking you to sit on a specially 
designed strength testing machine and push with your leg as hard as you can against a pad, 
while we measure the force you produce. The grip strength test involves you squeezing a 
measuring device with maximal force on three occasions with a rest period in between. 
 
Cardiovascular Health 
These quick, non-invasive measurements will be taken whilst you are seated at rest in 
order to measure the function and health of your blood vessels (arteries). The first involves 
a sensor being placed on your finger for a few seconds.  The  second involves resting your 
forearm on a device which assesses, using light, blood vessel heath. 
 
Physical activity 
You will be given a wrist-worn activity monitor and a waist-worn activity monitor to 
take home after the assessment. These are to measure your physical activity and sitting 
time over an 8 day period. You are asked to take the waist-worn device off during 
water-based activities e.g. bath, swimming, etc. and overnight. The wrist-worn monitor can 
be kept on continuously. We do not wish you to change your normal day- to-day routine. 
These devices will be returned after the 8 days using the free-post envelope we provide 
you with. An information sheet about the monitors and verbal instructions will be 
provided at the visit. We ask that you do not change your usual activity habits. 
 
Interview Sub-study 
In addition to the visit conducted at Glenfield Hospital, approximately 50 COPD patients 
will take part in a smaller-scale qualitative study which will involve one-on- one 
interviews, at the participant’s chosen location, to obtain responses to developing COPD; 
particularly regarding physical activity. Evidence will be used to inform tailored 
interventions to increase physical activity in an effort to reduce the rate of decline in lung 
function and improve health-related quality-of-life. Each participant will complete one 
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interview lasting no longer than 1 hour. Participation in this sub-study is also entirely 
voluntary with interviews scheduled to suit you. As only a sub-sample of individuals will 
be recruited, consenting to be contacted does not mean you will definitely be asked to take 
part. More information can be found in the enclosed information sheet. 
Expenses 
We will reimburse you for your travel expenses (petrol and parking) from home to 
Glenfield Hospital and if required we can arrange taxis for you. Refreshments will also 
be provided during study visits. 
 
What will I have to do? 
We kindly ask that you do not eat or drink (except water) 4 hours prior to your 
appointment time. 
 
If you are a smoker, we kindly ask that you do not smoke for 24 hours or as long as 
possible prior to your appointment time. 
We also ask that you do not take part in exercise on the day of your visit. 
If you currently take prescription medication, please bring a copy of your 
prescription or medication packaging with you to the visit. 
Please wear light clothing for the visit. A snack will be provided after your blood sample has 
been taken. We do not ask that you make any other changes to your lifestyle. 
 
What are the possible benefits of taking part? 
By taking part in this study, you will receive a comprehensive health check sent to both 
yourself and your GP as well as written information and explanation of your physical 
activity levels. Any clinically important results will be passed on to your GP. Ultimately, 
taking part in the research will help to facilitate better care for COPD patients and 
those at risk of developing COPD. 
 
What are the possible disadvantages and risks of taking part? 
As with all physical activity, there is a very small risk of accident or injury during the 
exercise tests (walking and strength tests). All the exercise will be supervised by 
trained research staff and will take place on NHS premises with resuscitation equipment 
available and trained staff on hand to use it. Taking blood samples from your arm may 
cause slight pain or bruising afterwards. There are no specific disadvantages other than the 
time commitment for the visit. 
 
What will happen to the samples that I have donated? 
The blood samples will be processed at Glenfield Hospital by the research team. If you 
do not complete the whole study we will still use the samples that you have donated 
up until the point you withdrew unless you request otherwise. 
 
What happens when the research study ends? 
The results of this study will be circulated in medical journals, professional 
publications and presentations made at relevant conferences. Results will be reported in 
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such a way that you or your information will not be identifiable. You will receive a 
summary of the results and will be invited to a presentation of the findings. 
What if there is a problem? 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements. If you are harmed due to someone’s negligence, then you may have grounds 
for a legal action but you may have to pay for it. Regardless of this, if you wish to 
complain, or have any concerns about any aspect of the way you have been approached 
or treated during the course of this study, the normal National Health Service 
complaints mechanisms would be available to you. Advice can also be sought from the 
Patient Information and Liaison Service, contact 0808 178 8337 (free number). 
 
Will my taking part in this study be kept confidential? 
When you enter this study you will be given a unique study number. This number will be 
used in place of any identifiable information, such as your name. All information which is 
collected about you during the course of the research will be kept strictly confidential. 
Any information about you which leaves the hospital, for example for data analysis or 
monitoring, will have your name and address removed so that you cannot be recognised 
from it. Your medical records may also be looked at by the regulatory authorities, the 
sponsor or the NHS Trust to check that the study is being carried out correctly. All 
information resulting from you taking part in the study will be stored both in paper and 
computerised form, and will be treated confidentially. 
 
Who is organising and funding the research? 
The study is sponsored by University Hospitals of Leicester NHS Trust. The study is being 
funded by the Department of Health, UK after thorough review by leading scientists 
in this field. The study is supported by NIHR Leicester Respiratory Biomedical Research 
Unit. 
 
Who has reviewed the study? 
All research that involves NHS patients or staff, information from NHS  medical records or 
uses NHS premises or facilities must be reviewed by an NHS Research Ethics 
Committee before it goes ahead. Approval does not guarantee that you will not come to 
any harm if you take part. However, approval means that the committee is satisfied that 
your rights will be respected, that any risks have been reduced to a minimum and 
balanced against possible benefits and that you have been given sufficient information 
on which to make an informed decision. The NHS Research Ethics Committee(East 
Midlands Nottingham 2) approved the study on (11th November 2013).The UHL Trust 
Research Management Governance team has also reviewed and given permission for the 
study to be carried out. 
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Appendix E 
PhARaoH Study recruitment poster 
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Appendix F 
PhARaoH Study recruitment leaflet 
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Appendix G 
Physical Activity Readiness Questionnaire (PAR-Q) 
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 
PAR-Q+ 
The Physical Activity Readiness Questionnaire for Everyone 
Regular physical activity is fun and healthy, and more people should become more physically active every day of 
the week. Being more physically active is very safe for MOST people. This questionnaire will tell you whether it is 
necessary for you to seek further advice from your doctor OR a qualified exercise professional before becoming more 
physically active. 
 
Please read the 7 questions below carefully and answer each one honestly: check YES or NO. YE
 
NO 
1. Has your doctor ever said that you have a heart condition OR high blood pressure?   
2. Do you feel pain in your chest at rest, during your daily activities of living, OR when you do physical activity?   
3. Do you lose balance because of dizziness OR have you lost consciousness in the last 12 months? Please answer NO if your dizziness was associated with over-breathing (including 
   
  
4. Have you ever been diagnosed with another chronic medical condition (other than heart disease or high blood pressure)?   
5. Are you currently taking prescribed medications for a chronic medical condition?   
 
6. 
Do you have a bone or joint problem that could be made worse by becoming more physically 
active? Please answer NO if you had a joint problem in the past, but it does not limit your 
current ability to be physically active. For example, knee, ankle, shoulder or other. 
 
 
 
 
7. Has your doctor ever said that you should only do medically supervised physical activity?   
If you answered NO to all of the questions above, you are cleared for physical activity. Go to Section 3 to sign the 
form. You do not need to complete Section 2. 
› Start becoming much more physically active – start slowly and build up gradually. 
›   Follow the Canadian Physical Activity Guidelines for your age (www.csep.ca/guidelines). 
›  You may take part in a health and fitness appraisal. 
› If you have any further questions, contact a qualified exercise 
professional such as a CSEP Certified Exercise Physiologist® 
(CSEP-CEP) or CSEP Certified Personal Trainer® (CSEP-CPT). 
›  If you are over the age of 45 yrs. and NOT accustomed to regular vigorous 
physical activity, please consult a qualified exercise professional (CSEP-CEP) 
before engaging in maximal effort exercise. 
 
If you answered YES to one or more of the questions above, please GO TO SECTION 2. 
 
Delay becoming more active if: 
›  You are not feeling well because of a temporary illness such as a cold or fever – 
wait until you feel better 
›  You are pregnant – talk to your health care practitioner, your physician, a 
qualified exercise professional, and/or complete the PARmed-X for Pregnancy 
before becoming more physically active OR 
›   Your health changes – please answer the questions on Section 2 of this 
document and/or talk to your doctor or qualified exercise professional (CSEP-
CEP or CSEP-CPT) before continuing with any physical activity programme. 
 
 
SECTION 1 - GENERAL HEALTH 
SECTION 2 - CHRONIC MEDICAL CONDITIONS 

! 
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Please read the questions below carefully and answer each one honestly: check YES or NO. YES NO 
 
 
1. 
 
 
Do you have Arthritis, Osteoporosis, or Back Problems? 
 
If yes, answer 
questions 1a-1c 
 
If no, go to 
question 2 
 
1a. 
Do you have difficulty controlling your condition with medications or 
other physician-prescribed therapies? (Answer NO if you are not 
currently taking medications or other treatments) 
 
 
 
 
 
1b. 
Do you have joint problems causing pain, a recent fracture or fracture 
caused by osteoporosis or cancer, displaced vertebra (e.g., 
spondylolisthesis), and/ 
or spondylolysis/pars defect (a crack in the bony ring on the back of the 
  
 
 
 
 
1c. Have you had steroid injections or taken steroid tablets regularly for more than 3 months?   
 
 
2. 
 
 
Do you have Cancer of any kind? 
 
If yes, answer 
questions 2a-2b 
 
If no, go to 
question 3 
2a. Does your cancer diagnosis include any of the following types: lung/bronchogenic, multiple myeloma (cancer of plasma cells), head, and 
 
  
2b. Are you currently receiving cancer therapy (such as chemotherapy or radiotherapy)?   
 
 
3. 
 
Do you have Heart Disease or Cardiovascular Disease? 
This includes Coronary Artery Disease, High Blood Pressure, Heart Failure, 
Diagnosed Abnormality of Heart Rhythm 
 
If yes, answer 
questions 3a-3e 
 
If no, go to 
question 4 
 
3a. 
Do you have difficulty controlling your condition with medications or 
other physician-prescribed  therapies? 
(Answer NO if you are not currently taking medications or other treatments) 
 
 
 
 
3b. Do you have an irregular heart beat that requires medical management? (e.g. atrial fibrillation, premature ventricular 
 
  
3c. Do you have chronic heart failure?   
3d. Do you have a resting blood pressure equal to or greater than 160/90 mmHg with or without medication? (Answer YES if you do not know your resting 
  
  
3e. Do you have diagnosed coronary artery (cardiovascular) disease and have not participated in regular physical activity in the last 2 months?   
 
4. 
 
Do you have any Metabolic Conditions? 
This includes Type 1 Diabetes, Type 2 Diabetes, Pre-Diabetes 
 
If yes, answer 
questions 
4a-4c 
 
If no, go to 
question 5 
4a. Is your blood sugar often above 13.0 mmol/L? (Answer YES if you are not sure)   
 
4b. 
Do you have any signs or symptoms of diabetes complications such as 
heart or vascular disease and/or complications affecting your eyes, 
kidneys, and the sensation in your toes and feet? 
 
 
 
 
4c. Do you have other metabolic conditions (such as thyroid disorders, pregnancy- related diabetes, chronic kidney disease, liver problems)?   
 
 
5. 
 
Do you have any Mental Health Problems or Learning Difficulties? 
This includes Alzheimer’s, Dementia, Depression, Anxiety Disorder, Eating 
Disorder, Psychotic Disorder, Intellectual Disability, Down Syndrome) 
 
If yes, answer 
questions 
5a-5b 
 
If no, go to 
question 6 
 
5a. 
Do you have difficulty controlling your condition with medications or 
other physician-prescribed therapies? (Answer NO if you are not 
currently taking medications or other treatments) 
 
 
 
 
5b. Do you also have back problems affecting nerves or muscles?   
Please read the questions below carefully and answer each one honestly: check YES or NO. YES NO 
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6. 
 
Do you have a Respiratory Disease? 
This includes Chronic Obstructive Pulmonary Disease, Asthma, Pulmonary 
High Blood Pressure 
 
If yes, answer 
questions 
6a-6d 
 
If no, go to 
question 7 
 
6a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed  therapies? 
(Answer NO if you are not currently taking medications or other treatments) 
 
 
 
 
6b. Has your doctor ever said your blood oxygen level is low at rest or during exercise and/or that you require supplemental oxygen 
 
  
 
6c. 
If asthmatic, do you currently have symptoms of chest tightness, 
wheezing, laboured breathing, consistent cough (more than 2 
days/week), or have you used your rescue medication more than twice 
    
 
 
 
 
6d. Has your doctor ever said you have high blood pressure in the blood vessels of your lungs?   
 
 
7. 
 
 
Do you have a Spinal Cord Injury? This includes Tetraplegia and Paraplegia 
 
If yes, answer 
questions 
7a-7c 
 
If no, go to 
question 8 
 
7a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed  therapies? 
(Answer NO if you are not currently taking medications or other treatments) 
 
 
 
 
7b. Do you commonly exhibit low resting blood pressure significant enough to cause dizziness, light-headedness, and/or fainting?   
7c. Has your physician indicated that you exhibit sudden bouts of high blood pressure (known as Autonomic Dysreflexia)?   
 
8. 
 
Have you had a Stroke? 
This includes Transient Ischemic Attack (TIA) or Cerebrovascular Event 
 
If yes, answer 
questions 
8a-c 
 
If no, go to 
question 9 
 
8a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed  therapies? 
(Answer NO if you are not currently taking medications or other treatments) 
 
 
 
 
8b. Do you have any impairment in walking or mobility?   
8c. Have you experienced a stroke or impairment in nerves or muscles in the past 6 months?   
 
9. 
 
Do you have any other medical condition not listed above or do you live with two 
chronic conditions? 
 
If yes, answer 
questions 
9a-c 
 
If no, read 
the advice 
on page 4 
 
9a. 
Have you experienced a blackout, fainted, or lost consciousness as a 
result of a head injury within the last 12 months OR have you had a 
diagnosed concussion within the last 12 months? 
 
 
 
 
9b. Do you have a medical condition that is not listed (such as epilepsy, neurological conditions, kidney problems)? 
  
9c. Do you currently live with two chronic conditions?   
Please proceed to Page 4 for recommendations for your current medical condition and sign this document. 
If you answered NO to all of the follow-up questions about your medical condition, you are 
ready to become more physically active: 
›   It is advised that you consult a qualified exercise professional (e.g., a CSEP-CEP or CSEP-CPT) to help 
you develop a safe and effective physical activity plan to meet your health needs. 
›   You are encouraged to start slowly and build up gradually – 20-60 min. of low- to moderate-
intensity exercise, 3-5 days per week including aerobic and muscle strengthening exercises. 
›   As you progress, you should aim to accumulate 150 minutes or more of moderate-intensity 
physical activity per week. 
 
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›   If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical 
activity, please consult a qualified exercise professional (CSEP-CEP) before engaging 
in maximal effort exercise. 
If you answered YES to one or more of the follow-up questions about your medical condition: 
›   You should seek further information from a licensed health care professional before 
becoming more physically active or engaging in a fitness appraisal and/or visit a or 
qualified exercise professional (CSEP-CEP) for further information. 
Delay becoming more active if: 
› You are not feeling well because of a temporary illness such as a cold or fever – wait until you feel better 
›  You are pregnant - talk to your health care practitioner, your physician, a qualified exercise 
profesional, and/or complete the PARmed-X for Pregnancy before becoming more physically 
active OR 
›   Your health changes - please talk to your doctor or qualified exercise professional (CSEP-CEP) 
before continuing with any physical activity programme. 
 
›   You are encouraged to photocopy the PAR-Q+. You must use the entire questionnaire and NO changes are permitted. 
›   The Canadian Society for Exercise Physiology, the PAR-Q+ Collaboration, and their agents 
assume no liability for persons  who undertake physical activity. If in doubt after completing the 
questionnaire, consult your doctor prior to physical activity. 
›  If you are less than the legal age required for consent or require the assent of a care provider, your parent, 
guardian or care provider must also sign this form. 
›  Please read and sign the declaration below: 
I, the undersigned, have read, understood to my full satisfaction and completed this 
questionnaire. I acknowledge that this physical activity clearance is valid for a maximum of 
12 months from the date it is completed and becomes invalid if my condition changes. I also  
acknowledge  that  a Trustee  (such  as  my  employer,  community/fitness  centre,  health care 
provider, or other designate) may retain a copy of this form for their records. In these instances, 
the Trustee will be required to adhere to local, national, and international guidelines 
regarding the storage of personal health information ensuring that they maintain the privacy of 
the information and do not misuse or wrongfully disclose such information. 
NAME DATE    
 
SIGNATURE WITNESS    
 
SIGNATURE OF PARENT/GUARDIAN/CARE PROVIDER    
 
 
 
 
SECTION 3 - DECLARATION 
 
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Appendix H 
PhARaoH Study Questionnaire 
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Questionnaire 
 
Participant ID: 
 
 
 
 
 
 
 
To be completed by study staff only: 
 
D1 – 
 
 
S1 – 
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This questionnaire is made up of modules that ask you about 
a specific aspect of your life. Your answers will be treated as 
strictly confidential and will only be used for research 
purposes. 
Please complete the questionnaire by checking answers or 
enter a response in the boxes provided next to or below the 
question. Try to answer every question, except when there is 
a specific request to skip a section. 
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D1 - To which of the groups do you consider you belong? 
□ White – British 
□ White – Irish 
□ Any other white background 
□ Mixed – White and Black Caribbean 
□ Mixed – White and Black African 
□ Mixed – White and Asian 
□ Asian or Asian British – Indian 
□ Asian or Asian British – Pakistani 
□ Asian or Asian British – Bangladeshi 
□ Any other Asian/Asian British Background 
□ Black or Black British – Caribbean 
□ Black or Black British – African 
□ Any other Black/Black British background 
□ Chinese 
□ Any other (please specify) 
D2 - Where were you born? 
Select one from: 
□ England 
□ Wales 
□ Scotland 
□ Northern Ireland 
□ Republic of Ireland 
□ Elsewhere (please specify) 
□ Do not know 
 
D3 - What year did you first come to live in the UK? 
 
□ From birth 
□ Do not know 
 
Section A – Demographics 
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D4 - Do you own or rent the accommodation that you live in? 
□ Own outright 
□ Own with a mortgage 
□ Rent – from local authority, local council, housing association 
□ Rent – from private landlord or letting agency 
□ Pay part rent and part mortgage 
□ Live in accommodation rent free 
□ None of the above 
 
D5 - Including yourself, how many people are living together in your household? (Include 
those who usually live in the house such as students living away from home during term, 
partners in the armed forces or professions such as pilots) 
 
 
D6 - At what age did you finish your continuous full-time education at school or college? 
□ Never went to school 
□ 14 or under 
□ 15 
□ 16 
□ 17 
□ 18 
□ 19 or over 
 
D7 - What is the highest education you have completed? 
□ Primary school 
□ Some secondary school 
□ Completed secondary school 
□ Some additional training (e.g. apprenticeship, GNVQ) 
□ Undergraduate university 
□ Postgraduate university 
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Please answer the following questions in relation to your childhood (i.e. when you were 
less than 18 years of age). 
CH1 - What was the highest education completed by your father? 
□ Primary school 
□ Some secondary school 
□ Completed secondary school 
□ Some additional training (e.g. apprenticeship, GNVQ) 
□ Undergraduate university 
□ Postgraduate university 
 
CH2 - What was the highest education completed by either your mother? 
□ Primary school 
□ Some secondary school 
□ Completed secondary school 
□ Some additional training (e.g. apprenticeship, GNVQ) 
□ Undergraduate university 
□ Postgraduate university 
 
CH3 - What was the employment status of your father? 
□ Unemployed 
□ Employed 
□ Self-employed 
 
CH4 - What was the employment status of your mother? 
□ Unemployed 
□ Employed 
□ Self-employed 
 
 
 
 
Section B – Childhood 
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CH5 – What was the highest income range your father earned per year? 
□ £0 - £5,000 
□ £5,000 - £10,000 
□ £10,000 - £15,000 
□ £15,000 - £20,000 
□ £20,000 - £25,000 
□ £25,000 - £30,000 
□ £30,000 - £35,000 
□ £35,000 - £40,000 
□ £40,000 - £45,000 
□ £45,000 - £50,000 
□ £50,000 + 
□ Do not know 
 
CH6 - What was the highest income range your mother earned per year? 
□ £0 - £5,000 
□ £5,000 - £10,000 
□ £10,000 - £15,000 
□ £15,000 - £20,000 
□ £20,000 - £25,000 
□ £25,000 - £30,000 
□ £30,000 - £35,000 
□ £35,000 - £40,000 
□ £40,000 - £45,000 
□ £45,000 - £50,000 
□ £50,000 + 
□ Do not know 
 
CH7 - Please tick which of the following were present inside your childhood home. 
□ Bathroom 
□ Toilet 
□ Bath 
□ Hot water 
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CH8 - Did you have access to a car during your childhood? 
□ Yes 
□ No 
 
CH9 - Did you have a shared bedroom for most of your childhood? 
□ Yes 
□ No 
 
CH10 - Do you recall the presence of damp or mould inside the home? 
□ Yes 
□ No 
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W1 - Which of the following best describes your current situation? (Please tick only one) 
□ In paid employment or self-employed 
□ Retired 
□ Looking after home and/or family 
□ Unable to work because of sickness or disability 
□ Unemployed 
□ Doing unpaid or voluntary work 
□ Full-time or part-time student 
□ None of the above 
 
IF NOT “PAID EMPLOYMENT” OR “SELF-EMPLOYED” PLEASE GO TO W5 
W2 - How many years have you worked in your current job? (If you have more than one 
job please answer this, and the following questions on work, for your MAIN job only) 
 
 
W3 - Over the last 12 months, for how many months did you work full-time? 
 
 
W4 - In a typical week, how many hours do you spend at work? (Do not include hours 
travelling to and from work) 
 
□ Do not know 
 
W5 - What is the average total income before tax received by your household? 
□ Less than £18,000 
□ £18,000 - £30,999 
□ £31,000 – £51,999 
□ £52,000 - £100,000 
□ Greater than £100,000 
□ Do not know 
 
Section C – Work 
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GH1 - How is your health in general? Would you say it was (select from the following) 
□ Very good 
□ Good 
□ Fair 
□ Bad 
□ Very bad 
GH2 - Do you have any long-standing illness, disability or infirmity? By long-standing I 
mean anything that has troubled you over a period of time, or that is likely to affect you 
over a period of time? 
□ Yes 
□ No 
GH3 - Do you have an impairment or health problem that limits your ability to walk or 
run? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO GH5 
GH4 - Is this an impairment or health problem that has lasted, or is expected to last 12 
months or longer? 
□ Yes 
□ No 
GH5 - Because of a health problem, do you have difficulty walking without using any 
special equipment? 
□ Yes 
□ No 
GH6 - Do you get short of breath walking with people of your own age on level ground? 
□ Yes 
□ No 
□ Do not know 
 
 
 
Section D1 – General Health – Part 1 
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GH7 - Do you use private healthcare? 
□ Yes, all of the time 
□ Yes, most of the time 
□ Yes, sometimes 
□ No, never 
 
GH8 - How often do you visit friends or family or have them visit you? 
□ Almost daily 
□ 2 – 4 times a week 
□ About once a week 
□ About once a month 
□ Once every few months 
□ Never or almost never 
□ No friends/family outside household 
□ Do not know 
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Under each heading, please tick the ONE box that best describes your health TODAY 
 
MOBILITY 
I have no problems in walking about ..………………   
I have slight problems in walking about …………….   
I have moderate problems in walking about ……….   
I have severe problems in walking about …………..   
I am unable to walk about ……………………………  
 
SELF-CARE 
I have no problems washing or dressing myself …………..   
I have slight problems washing or dressing myself ………..   
I have moderate problems washing or dressing myself ……  
I have severe problems washing or dressing myself ………  
I am unable to wash or dress myself ………………………   
USUAL ACTIVITES (e.g. work, study, housework, family or leisure activities) 
I have no problems doing my usual activities ………………   
I have slight problems doing my usual activities …………..   
I have moderate problems doing my usual activities ………   
I have severe problems doing my usual activities ………….  
I am unable to do my usual activities ………………………..  
PAIN / DISCOMFORT 
I have no pain or discomfort ………………..  
I have slight pain or discomfort …………….   
I have moderate pain or discomfort ……….    
I have severe pain or discomfort …………..   
I have extreme pain or discomfort …………  
ANXIETY / DEPRESSION 
I am not anxious or depressed ……………..  
I am slightly anxious or depressed ………..    
I am moderately anxious or depressed ……  
I am severely anxious or depressed ……….  
I am extremely anxious or depressed ……..  
 
 
 
Section D2 – General Health – Part 2 
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• We would like to know how good or bad your health is 
TODAY. 
 
• This scale is numbered from 0 to 100 
 
• 100 means the best health you can imagine 
• 0 means the worst health you can imagine 
• Mark an X on the scale to indicate how your health is 
TODAY. Y. 
 
• Now, please write the number you marked on the scale in 
the box below. 
 
YOUR HEALTH TODAY =  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section D2 – General Health – Part 3 
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FH1 - Has/did your father ever suffer from? (You can select more than one answer) 
Select from: 
□ Heart disease 
□ Stroke 
□ High blood pressure 
□ Diabetes 
□ Chronic bronchitis/emphysema/COPD 
□ Alzheimer’s disease/dementia 
□ None of the above 
□ Do not know 
FH2 - Has/did your mother ever suffer from? (You can select more than one answer) 
Select from: 
□ Heart disease 
□ Stroke 
□ High blood pressure 
□ Diabetes 
□ Chronic bronchitis/emphysema/COPD 
□ Alzheimer’s disease/dementia 
□ None of the above 
□ Do not know 
 
FH3 - How many brothers and sisters do you have? (Please include those who have died. 
Do not include half, step or adopted sibling(s)) 
 
IF “0” PLEASE GO TO (SECTION F) 
 
 
 
 
 
 
 
Section E – Family History 
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FH4 - Have any of your brothers or sisters suffered from any of the following illnesses? 
(You can select more than one answer) 
Select from: 
□ Heart disease 
□ Stroke 
□ High blood pressure 
□ Diabetes 
□ Chronic bronchitis/emphysema 
□ Alzheimer’s disease/dementia 
□ None of the above 
□ Do not know 
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MBD1 - Do you regularly take any of the following medications? (You can select more 
than one answer) 
Select from: 
□ Cholesterol lowering medication 
□ Blood pressure medication 
□ Insulin 
□ None of the above 
□ Do not know 
 
MBD2 - Do you now have, or have you ever had high blood pressure (sometimes called 
hypertension)? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO MBD5 
 
MBD3 - Were you told by a doctor or nurse that you had high blood pressure? 
□ Yes 
□ No 
MBD4 - How old were you when you were first told by a (doctor/nurse) that you had high 
blood pressure? 
 
MBD5 - Do you now have, or have you ever had diabetes? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO MBD11 
 
MBD6 - Were you told by a doctor or nurse that you had diabetes? 
□ Yes 
□ No 
Section F – Medication, Blood Pressure and Diabetes 
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IF FEMALE: 
MBD7 - Can I just check, were you pregnant when you were told that you had diabetes? 
□ Yes 
□ No 
IF “YES”: 
 
MBD8 - Have you ever had diabetes apart from when you were pregnant? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO DB11 
 
MBD9 - Apart from when you were pregnant, approximately how old were you when you 
were first told by a doctor that you had diabetes? 
 
 
MBD10 - Do you currently inject insulin for diabetes? 
□ Yes 
□ No 
 
MBD11 - Have you ever been told by a doctor or other health professional that you have 
health conditions or a medical or family history that increases your risk for diabetes? 
□ Yes 
□ No 
□ Don’t know 
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S1 - Have you ever smoked cigarettes? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO S11 
S2 - Do you currently smoke cigarettes? 
□ Yes 
□ No 
IF “YES” PLEASE GO TO S5 
S3 - How long ago did you stop smoking cigarettes? 
 
S4 - How old were you when you last smoked cigarettes on most days? 
 
S5 - How old were you when you started to smoke cigarettes regularly? 
 
 
S6 - About how many cigarettes a day do you usually smoke on weekdays? 
 
 
S7 - About how many cigarettes a day do you usually smoke on weekend days? 
 
 
S8 - How soon after waking do you usually smoke your first cigarette of the day? 
□ Less than 5 minutes 
□ 5 – 14 minutes 
□ 15 – 29 minutes 
□ 30 minutes – 1 hour 
□ 1 – 2 hours 
□ 2 hours or more 
 
 
Section G – Smoking 
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S9 - Has a medical person, for example a doctor or nurse ever advised you to stop smoking 
altogether because of your health? 
□ Yes 
□ No 
S10 - How long ago was that? 
□ Within the last 12 months 
□ Over 12 months ago 
S11 - Does anyone in your household smoke? 
□ Yes, one household member smokes 
□ Yes, more than one household member smokes 
□ No 
 
S12 - Now, in most weeks, how many hours a week are you exposed to other people’s 
tobacco smoke? 
 
S13 - Did your father ever smoke regularly when you were a child? 
□ Yes 
□ No 
S14 - Did your mother ever smoke regularly when you were a child? 
□ Yes 
□ No 
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LH1 - Did a doctor ever tell you that you had chronic bronchitis, emphysema or COPD 
(Chronic Obstructive Pulmonary Disease)? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO LH4 
LH2 - Which of the following did the doctor tell you that you had? 
□ COPD 
□ Chronic bronchitis 
□ Emphysema 
LH3 - How old were you when you were first told by a doctor that you had COPD/chronic 
bronchitis/emphysema? 
 
LH4 - Did a doctor ever tell you that you had asthma? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO LH6 
LH5 - How old were you when you were first told by a doctor or nurse that you had 
asthma? 
 
LH6 - Over the last 12 months, have you used an inhaler, puffer or nebuliser prescribed by 
a doctor to treat asthma, wheezing or whistling, or difficulty in breathing? 
□ Yes 
□ No 
LH7 – Over the last 12 months, have you had or taken any treatment or medication for 
asthma, wheezing or whistling, or difficulty breathing? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO LH10 
 
 
Section H1 – Lung Health 
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LH8 - What treatment or medication, if any, are you taking every day for asthma, wheezing 
or whistling, or difficulty breathing? 
□ Steroid tablets 
□ Theophylline tablets (e.g. Nuelin, Slo-Phyllin, Uniphylline, Phylocontin) 
□ Antibiotics 
□ Tablets, capsule or other liquid medicine to help bring up phlegm – 
Carbocisteine, Erdotin, Visclair 
□ Other tablets or granules (e.g. montelukast/Singulair; 
zafirlukast/Accolate) 
□ Inhalers 
□ Oxygen 
□ Other treatment of mediation 
□ None 
IF “None” PLEASE GO TO LH10 
 
LH9 - How many courses of steroids or antibiotics have you received for 
exacerbations / chest infections in the last 12 months? 
 
 
LH10 - On average, during the past week, how limited were you in activities because of 
breathing problems for strenuous physical activities (such as climbing stairs, hurrying, 
doing sports)? 
□ Not limited at all 
□ Very slightly limited 
□ Slightly limited 
□ Moderately limited 
□ Very limited 
□ Extremely limited 
□ Totally limited/can’t do these activities 
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LH11 - On average during the past week, how limited were you because of your breathing 
problems for moderate physical activities (such as walking, housework, carrying things)? 
□ Not limited at all 
□ Very slightly limited 
□ Slightly limited 
□ Moderately limited 
□ Very limited 
□ Extremely limited 
□ Totally limited/can’t do these activities 
LH12 - On average during the past week, how limited were you because of your breathing 
problems for daily activities at home (such as dressing, washing)? 
□ Not limited at all 
□ Very slightly limited 
□ Slightly limited 
□ Moderately limited 
□ Very limited 
□ Extremely limited 
□ Totally limited/can’t do these activities 
LH13 - On average during the past week, how limited were you because of your breathing 
problems for social activities (such as talking, being with children, visiting 
friends/relatives)? 
□ Not limited at all 
□ Very slightly limited 
□ Slightly limited 
□ Moderately limited 
□ Very limited 
□ Extremely limited 
□ Totally limited/can’t do these activities 
LH14 - Have you ever been told by a doctor that you also have heart failure? 
□ Yes 
□ No 
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B1 - Are you ever too breathless to leave the house? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO B3 
B2 - Is that all or most days, at least once a week, or less often than that? 
□ All or most days 
□ At least once a week 
□ Less often 
B3 - Please choose the one best response to describe your shortness of breath. 
 
Grade 
0 “I only get breathless with strenuous exercise” 
1 “I get short of breath when hurrying on the level or walking up a slight hill” 
 
 
2 “I walk slower than people of the same age on the level because of breathlessness 
or have to stop for breath when walking at my own pace on the level” 
 
 
3 “I stop for breath after walking about 100 yards or after a few minutes on the level” 
 
 
4 “I am too breathless to leave the house” or “I am breathless when dressing” 
 
Grade 
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Below is a list of statements that other people with your illness have said are important. Please 
circle or mark one number per line to indicate your response as it applies to the past 7 days. 
 
PHYSICAL WELL-BEING 
 
Not 
  
 
A little 
 
 
Some- 
 
 
Quite 
  
 
Very 
 GP1 I have a lack of energy 
 
0 1 2 3 4 
GP2 I have nausea 
 
0 1 2 3 4 
GP3 Because of my physical condition, I have trouble      
meeting the needs of my family 
 
0 1 2 3 4 
GP4 I have pain 
 
0 1 2 3 4 
GP5 I am bothered by side effects of treatment 
 
0 1 2 3 4 
GP6 I feel ill 
 
0 1 2 3 4 
GP7 I am forced to spend time in bed 
........................................ 
0 1 2 3 4 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
 
A little 
bit 
 
Some- 
what 
 
Quite 
a bit 
 
Very 
much 
 
GS1 I feel close to my 
friends  
 
0 
 
1 
 
2 
 
3 
 
4 
GS2 I get emotional support from my family 
 
0 1 2 3 4 
GS3 I get support from my friends.......................................... 0 1 2 3 4 
GS4 My family has accepted my illness 
 
0 1 2 3 4 
GS5 I am satisfied with family communication about my 
illness................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
GS6 I feel close to my partner (or the person who is my main      
support) 
 
0 1 2 3 4 
Q1 Regardless of your current level of sexual activity, please 
answer the following question. If you prefer not to answer 
 
     
please mark this box and go to the next section.      
 
 
GS7 I am satisfied with my sex life 
 
0 1 2 3 4 
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 EMOTIONAL WELL-BEING  Not 
at all 
A little 
bit 
Some- 
what 
Quite 
a bit 
Very 
much 
 
 
 
GE1 
 
I feel sad .............................................................................. 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GE2 I am satisfied with how I am coping with my illness.......... 0 1 2 3 4 
 
GE3 I am losing hope in the fight against my illness.................. 0 1 2 3 4 
 
GE4 I feel nervous....................................................................... 0 1 2 3 4 
 
GE5 I worry about dying ............................................................. 0 1 2 3 4 
 
GE6 I worry that my condition will get worse ............................ 0 1 2 3 4 
 
 FUNCTIONAL WELL-BEING  Not 
at all 
A little 
bit 
Some- 
what 
Quite 
a bit 
Very 
much 
 
 
 
GF1 
 
I am able to work (include work at home) .......................... 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GF2 My work (include work at home) is fulfilling..................... 0 1 2 3 4 
 
GF3 I am able to enjoy life.......................................................... 0 1 2 3 4 
 
GF4 I have accepted my illness................................................... 0 1 2 3 4 
 
GF5 I am sleeping well ............................................................... 0 1 2 3 4 
 
GF6 I am enjoying the things I usually do for fun ...................... 0 1 2 3 4 
 
GF7 I am content with the quality of my life right now.............. 0 1 2 3 4 
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 ADDITIONAL CONCERNS  Not  
at all 
A little 
bit 
Some- 
what 
Quite 
a bit 
Very 
much 
 
 
 
HI7 
 
I feel fatigued ...................................................................... 
 
0 
 
1 
 
2 
 
3 
 
4 
 
HI12 I feel weak all over .............................................................. 0 1 2 3 4 
 
An1 I feel listless (“washed out”) ............................................... 0 1 2 3 4 
 
An2 I feel tired ............................................................................ 0 1 2 3 4 
 
An3 I have trouble starting things because I am tired................ 0 1 2 3 4 
 
An4 I have trouble finishing things because I am tired ............. 0 1 2 3 4 
 
An5 I have energy ....................................................................... 0 1 2 3 4 
 
An7 I am able to do my usual activities...................................... 0 1 2 3 4 
 
An8 I need to sleep during the day ............................................. 0 1 2 3 4 
 
An12 I am too tired to eat ............................................................. 0 1 2 3 4 
 
An14 I need help doing my usual activities .................................. 0 1 2 3 4 
 
An15 I am frustrated by being too tired to do the things I want 
to do..................................................................................... 
 
0 
 
1 
 
2 
 
3 
 
4 
 
An16 I have to limit my social activity because I am tired........... 0 1 2 3 4 
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We are now going to ask you about your ability to cope with your COPD condition. 
Please circle where you feel you are now. 
 
Statement Score 
I can always manage to solve difficult problems if I 
try hard enough. 1 2 3 4 
If someone opposes me, I can find the means and 
ways to get what I want. 1 2 3 4 
It is easy for me to stick to my aims and accomplish 
my goals. 1 2 3 4 
I am confident that I can walk for a good distance, 
at my own pace, despite it making me breathless. 1 2 3 4 
I am confident that I could deal efficiently with 
unexpected events. 1 2 3 4 
Thanks to my resourcefulness, I know how to 
handle unforeseen situations. 1 2 3 4 
I feel confident that I will be able to perform the 
exercises asked of me during the course of 
rehabilitation, even if I find them difficult. 
 
1 
 
2 
 
3 
 
4 
I can solve most problems if I invest the necessary 
effort. 1 2 3 4 
I feel that I have an adequate amount of knowledge 
about my lung disease, despite it being a complex 
condition. 
 
1 
 
2 
 
3 
 
4 
I can remain calm when facing difficulties because I 
can rely on my coping abilities. 1 2 3 4 
When I am confronted with a problem, I can usually 
find several solutions. 1 2 3 4 
I feel positive that I will be able to complete the 
exercises at home, despite there being no 
supervision from a health professional. 
 
1 
 
2 
 
3 
 
4 
If I am in trouble, I can usually think of a solution. 1 2 3 4 
I can handle whatever comes my way. 1 2 3 4 
On a day to day basis I feel in control of my lung 
disease and how that affects my lifestyle, even 
when my symptoms become distressing. 
 
1 
 
2 
 
3 
 
4 
 
Response Format. 
1= Not at all true 2= Hardly true 3= Moderately true             4= Exactly true 
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PA1 - In the last 4 weeks, which form of transport have you used most often to get about? 
(Not including any journeys to and from work; please only select the most frequent mode 
of transport used) 
□ Car/motor vehicle 
□ Walk 
□ Public transport 
□ Cycle 
□ None of the above 
 
PA2 - How many times in the last 4 weeks did you do swimming? 
□ None 
□ Once in the last 4 weeks 
□ 2 – 3 times in the last 4 weeks 
□ Once a week 
□ 2 – 3 times a week 
□ 4 – 5 times a week 
□ Every day 
□ Do not know 
 
PA3 - How many times in the last 4 weeks did you do cycling? 
□ None 
□ Once in the last 4 weeks 
□ 2 – 3 times in the last 4 weeks 
□ Once a week 
□ 2 – 3 times a week 
□ 4 – 5 times a week 
□ Every day 
□ Do not know 
 
 
 
 
Section J – Physical Activity and Sitting 
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PA4 - Which of the following do you attend once a week or more often? (you can select 
more than one) 
□ Sports club or gym 
□ Pub or social club 
□ Religious group 
□ Adult education class 
□ Other group activity 
□ None of the above 
 
PA5 - Which of the following best describes your usual walking pace? 
□ A slow pace 
□ An average pace 
□ A fairly brisk pace 
□ A fast pace 
 
PA6 - We are interested in finding out about the kinds of physical activities that people do 
as part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person. Please think about the activities you do at work, 
as part of your house and gardening, to get from place to place, and in your spare time for 
recreation, exercise or sport. 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much 
harder than normal. Think only about those physical activities that you did for at least 10 
minutes at a time. 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling? 
 
  days per week 
 
No vigorous physical activities Skip to question 3 
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2. How much time did you usually spend doing vigorous physical activities on 
one of those days? 
 
  hours per day 
  minutes per day 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal. Think only about those physical activities that you did 
for at least 10 minutes at a time. 
3. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles tennis? Do not 
include walking. 
 
  days per week 
 
No moderate physical activities Skip to question 5 
4. How much time did you usually spend doing moderate physical activities on 
one of those days? 
 
  hours per day 
  minutes per day 
Think about the time you spent walking in the last 7 days. This includes at work and 
at home, walking to travel from place to place, and any other walking that you might 
do solely for recreation, sport, exercise, or leisure. 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time? 
 
  days per week 
 
No walking Go to next section 
6. How much time did you usually spend walking on one of those days? 
 
  hours per day 
  minutes per day 
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I have already asked you about walking and cycling. I would now like to ask you about 
other types of sport, exercise, and recreational physical activity.  Please think about all the 
activities whether for competition, training or receiving tuition, socially, casually or for 
health and fitness. 
In the questions below ‘sporty’ refers to actively participating in sports rather than 
following/watching sport. 
PA7 – Do you consider yourself to have been a ‘sporty’ child? 
□ Yes 
□ No 
 
PA8 - Do you consider yourself a ‘sporty’ adult relative to your peers? 
□ Yes 
□ No 
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PA9 - We would like to know how sporty you consider yourself as an adult. The scale is 
numbered 0 to 100. 100 means you participate in sports/recreation regularly (i.e., on most 
days). 
0 means you never participate in sports/recreation Mark 
an X on the scale to indicate your sportiness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Y OUR SPORTINESS = 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not Sporty 
 
Sporty 
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PA10 - Please think about how much time you spend sitting on a typical week day and 
weekend day. 
When filling in the table below, if you take part in more than one of the activities at the 
same time, e.g. watching television whilst using a laptop computer, please record time 
spent taking part in the activity you mainly focus on e.g. it may be you watch television 
and only use the laptop when you get an email. In this case you would record time spent 
watching television. 
 
Please estimate how many hours you spend SITTING EACH DAY in the 
following situations: (please write your answer) 
On a WEEK Day On a WEEKEND Day 
 Hours Minutes Hours Minutes 
While travelling to and from places    
While at work    
While watching television    
While using a computer at home    
In your leisure time, NOT 
including television (e.g. visiting 
friends, movies, dining out, etc) 
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Now we are going to ask you about the types of activities you have previously 
completed or would like to complete in the future. 
Please only tick those activities you have completed outside of physical education (PE) 
lessons. 
Please state additional activities in the spaces provided at the end of the activity list. 
 
Section K – Sport Inventory 
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Appendix I 
Comparison of self-reported general health index value components between COPD patients 
and apparently healthy controls 
 Whole sample 
(n=244) 
COPD 
(n=109) 
Control 
(n=135) 
General health 
Mobility (%): 
No problems 174 (71.3) 54 (49.5) 120 (88.9) * 
Slight problems 38 (15.6) 26 (23.9) 12 (8.9) * 
Moderate problems 26 (10.7) 24 (22.0) 2 (1.5) * 
Severe problems 5 (2.0) 5 (4.6) 0 (0) * 
Unable to 0 (0) 0 (0) 0 (0) 
Self-care (%): 
No problems 223 (91.4) 91 (83.5) 132 (97.8) 
Slight problems 16 (6.6) 14 (12.8) 2 (1.5) 
Moderate problems 4 (1.6) 4 (3.7) 0 (0) 
Severe problems 0 (0) 0 (0) 0 (0) 
Unable to 0 (0) 0 (0) 0 (0) 
Usual activities (%): 
No problems 183 (75.0) 59 (54.1) 124 (91.9) * 
Slight problems 37 (15.2) 30 (27.5) 7 (5.2) * 
Moderate problems 17 (7.0) 16 (14.7) 1 (0.7) * 
Severe problems 2 (0.8) 2 (1.8) 0 (0) 
Unable to 0 (0) 0 (0) 0 (0) 
Pain discomfort (%): 
None 123 (50.4) 45 (41.3) 78 (57.8) * 
Slight 87 (35.7) 35 (32.1) 52 (38.5) * 
Moderate 27 (11.1) 23 (21.1) 4 (3.0) * 
Severe 6 (2.5) 6 (5.5) 0 (0) * 
Extreme 0 (0) 0 (0) 0 (0) 
Anxiety/depression (%): 
None 176 (72.1) 75 (68.8) 101 (74.8) 
Slight 49 (20.1) 22 (20.2) 27 (20.0) 
Moderate 14 (5.7) 9 (8.3) 5 (3.7) 
Severe 3 (1.2) 2 (1.8) 1 (0.7) 
Extreme 1 (0.4) 1 (0.9) 0 (0) 
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Appendix J 
Partial regression plots for factors independently associated with sedentary time (percentage 
body fat (Panel A) and mMRC (Panel B)) and MVPA (ISWT distance (Panel C)) in COPD.
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Appendix K 
Partial regression plots for factors independently associated with sedentary time (ISWT 
distance (Panel A) and percentage body fat (Panel B)) and MVPA (percentage body fat 
(Panel C)) in apparently healthy adults. 
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Appendix L 
Agreement (Kappa statistic) between CAT components (* p<0.05); cells are coded as follows: 
Dark orange, “none”; amber, “minimal” 
CAT 
Component Phlegm 
Tight 
Chest Breathless 
Limited 
Activities CLH Sleep Energy 
Coughing 
 0.334 * 0.115 * 0.183 * 0.132 * 0.007 0.115 * 0.232 * 
Phlegm 
  0.228 * 0.050 0.104 * 0.047 0.095 * 0.199 * 
Tight Chest 
   0.117 * 0.102 * 0.117 * 0.098 * 0.108 * 
Breathless 
    0.157 * 0.080 * 0.157 * 0.164 * 
Limited  
Activities     0.228 * 0.330 * 0.153 * 
CLH 
      0.306 * 0.027 
Sleep 
       0.235 * 
Abbreviations: CAT, COPD Assessment Test; CLH, confidence leaving the home 
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Appendix M 
Correlation coefficient between CAT components (* p<0.05); cells are coded as follows: 
Dark orange, “very weak”; amber, “weak”; yellow, “moderate”; green, “strong” 
CAT 
Component Phlegm 
Tight 
Chest Breathless 
Limited 
Activities CLH Sleep Energy 
Coughing 
 0.629 * 0.398 * 0.412 * 0.284 * 0.301 * 0.327 * 0.432 * 
Phlegm 
  0.435 * 0.322 * 0.139 0.169 0.234 * 0.388 * 
Tight Chest 
   0.295 * 0.367 * 0.339 * 0.371 * 0.358 * 
Breathless 
    0.644 * 0.436 * 0.396 * 0.525 * 
Limited  
Activities     0.597 * 0.463 * 0.583 * 
CLH 
      0.569 * 0.473 * 
Sleep 
       0.525 * 
Abbreviations: CAT, COPD Assessment Test; CLH, confidence leaving the home 
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Appendix N 
Comparison of patient classification into symptom severity groups between CAT score and 
mMRC grade 
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Appendix O 
COPD-SEAT protocol publication 
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Appendix P 
COPD-SEAT research ethics committee approval letter 
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East Midlands - Leicester Central Research Ethics Committee 
The Old Chapel Royal Standard Place 
Nottingham NG1 6FS 
Telephone: 0115 883 9275 
 
27 October 2015 
 
Professor Sally Singh 
Head of Pulmonary and Cardiac 
Rehabilitation University Hospitals of 
Leicester NHS Trust Centre for 
Exercise and Rehabilitation Science 
Glenfield Hospital 
Leicester LE3 9QP 
 
Dear Professor Singh 
Study title: The feasibility of a home-based sedentary behaviour intervention 
for hospitalised chronic obstructive pulmonary disease (COPD) 
patients following an acute exacerbation: Sitting and 
ExacerbAtions Trial (COPD-SEAT) 
REC reference: 15/EM/0433 
IRAS project ID: 181453 
 
Thank you for your letter responding to the Committee’s request for further information on 
the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter.  Should you wish to provide a substitute contact point, require 
further information, or wish to make a request to postpone publication, please contact the 
REC Manager, Ellen Swainston, nrescommittee.eastmidlands-leicester@nhs.net. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
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Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned. 
 
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites ("participant identification centre"), guidance 
should be sought from the R&D office on the information it requires to give permission for 
this activity. 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
Sponsors are not required to notify the Committee of approvals from host organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database within 6 weeks of recruitment of the first 
participant (for medical device studies, within the timeline determined by the current 
registration and publication trees). 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as 
part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered 
but for non clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. 
Guidance on where to register is provided within IRAS. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below). 
Non-NHS sites 
The Committee has not yet completed any site-specific assessment (SSA) for the non-NHS research site(s) taking part in 
this study.   The favourable opinion does not therefore apply to any non-NHS site at present. We will write to you again as 
soon as an SSA application(s) has been reviewed. In the meantime no study procedures should be initiated at non-NHS 
sites. 
Approved documents 
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The final list of documents reviewed and approved by the Committee is as follows: 
Document Version Date 
Interview schedules or topic guides for participants [Baseline 
Interview Education] 
1.0 30 July 2015 
Interview schedules or topic guides for participants [Baseline 
Interview Feedback] 
1.0 30 July 2015 
Interview schedules or topic guides for participants [Follow Up 
Interview Education] 
1.0 30 July 2015 
Interview schedules or topic guides for participants [Follow Up 
Interview Feedback] 
1.0 30 July 2015 
Interview schedules or topic guides for participants [Nonparticipation 
Interview] 
1.0 30 July 2015 
Interview schedules or topic guides for participants [Focus Groups 
Schedules] 
1.0 30 July 2015 
IRAS Checklist XML [Checklist_26102015]  26 October 2015 
Other [Education Booklet] 1.0 30 July 2015 
Other [Nonparticipation Consent Form] 1.0 30 July 2015 
Other [Monitor Instruction Manual]   
Other [App Instruction Manual]   
Other [Respiratory Discharge Letter]   
Other [Measurement Form] 1.0 30 July 2015 
Other [Agreement and Undertaking] 1.0 30 July 2015 
Other [Non Intervention Interview Consent Form] 1.1 24 October 2015 
Other [Expression of Interest] 1.1 24 October 2015 
Other [Letter to REC]   
Participant consent form [Main Consent Form] 1.1 24 October 2015 
Participant information sheet (PIS) [Participant Information Sheet] 1.1 24 October 2015 
REC Application Form [REC_Form_09092015]  09 September 2015 
Research protocol or project proposal [Protocol] 1.0 30 July 2015 
Summary CV for Chief Investigator (CI) [CI Curriculum vitae] 1.0 30 July 2015 
Validated questionnaire [Follow Up]   
Validated questionnaire [Montreal Cognitive Assessment]   
Validated questionnaire [Trail Making Test]   
Validated questionnaire [Baseline] 1.1 24 October 2015 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 
 
After ethical review 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including: 
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• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light 
of changes in reporting requirements or procedures. 
 
User Feedback 
 
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the 
feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/ 
 
HRA Training 
 
We are pleased to welcome researchers and R&D staff at our training days – see 
details at  http://www.hra.nhs.uk/hra-training/ 
 
 
 
 
With the Committee’s best wishes for the success of this project. 
Yours sincerely 
 
 
Mr Ken 
Willis Chair 
 
Email: nrescommittee.eastmidlands-leicestercentral@nhs.net 
 
Enclosures:  
“After ethical review – guidance for researchers” 
 
  Mark Orme  
Carolyn Maloney 
 
 
 
15/EM/0433 Please quote this number on all correspondence 
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Appendix Q 
COPD-SEAT consent form 
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Main Trial Consent Form 
Final Version 2.1, 05-March-2016, REC Ref: 15-EM-0433 
The feasibility of a sedentary behaviour intervention for hospitalised chronic 
obstructive pulmonary disease patients following an acute exacerbation: 
Sitting and ExacerbAtions Trial (COPD-SEAT) 
        Please Initial 
1. I confirm that I have read and understood the participant information sheet 
[Version 2.1, 05-March-2016] for the above study and have had the 
opportunity to ask questions 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
from the study at any time, without providing a reason, and without my 
medical care and legal rights being affected. I understand that should I 
withdraw from the study, the information collected so far cannot be erased and 
that this information may still be used in the study analysis. 
 
3. I understand that relevant sections of my medical notes and data collected as 
part of this study may be looked at by authorised individuals from the 
sponsor, Loughborough University, the research group and regulatory 
authorities where it is relevant to my taking part in this study. I give permission 
for these individuals to have access to these records and to collect, store, 
analyse and publish information obtained from my participation in this study. 
I understand that my details will be kept confidential. 
 
4. I understand that I will be asked to complete physical measurements, 
questionnaires and interviews, as detailed in the participant information 
sheet [Version 2.1, 05-March-2016]. 
 
5. I understand that the interviews will be recorded and that anonymous direct 
quotes from the interviews may be used in the study reports. 
 
 
6. I agree that all contact with the research team will be audio recorded for the 
purposes detailed in the participant information sheet [Version 2.1, 05-March-
2016].  
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7. I agree my General Practitioner (GP) being informed of my participation in 
the study. 
 
8. I would like the Respiratory Discharge Service to be informed of my 
participation in the study and results obtained from the study measurements to 
be entered into my medical notes. 
 
9.  I agree for identifiable information to be securely transferred to 
Loughborough University. 
 
10. I understand that information about me recorded during the study will be kept 
in a secure database. If the data is transferred it will be made anonymous. 
Data will be retained for 10 years after the end of the study and made 
anonymous and archived at secure archive facilities. 
 
11. I agree to take reasonable care of the loaned equipment and I agree to return all 
equipment once my involvement in the study has ended. 
 
12. I am happy to be contacted regarding other research studies being conducting 
by Loughborough University or the University Hospitals of Leicester. 
 
13. I agree to take part in the study. 
 
3 Copies: 1 for participant, 1 for medical notes & 1 original for study notes. 
 
 
Name of Participant   Date   Signature 
Name of Researcher   Date   Signature 
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Appendix R 
COPD-SEAT participant information sheet 
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Participant Information Sheet 
Final Version 2.1 05-March-2016, REC Ref: 15-EM-0433 
 
The feasibility of a sedentary behaviour intervention for hospitalised chronic 
obstructive pulmonary disease patients following an acute exacerbation: Sitting and 
ExacerbAtions Trial (COPD-SEAT) 
You have been invited to take part in a research study. Before you decide whether to take 
part it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with 
friends and relatives if you wish to. 
Please take time to decide whether you wish to take part or not. Do not hesitate to contact 
a member of the usual care team and/or research team if you have any questions or 
would like more information. Thank you. 
Background 
In this research, we want to test an intervention targeting people’s sitting time following 
admission to hospital for an exacerbation of chronic obstructive pulmonary disease 
(COPD). The research programme is called COPD-SEAT (Sitting and ExacerbAtions 
Trial) and we want to see how well an intervention aimed at reducing sitting time can 
be conducted in this setting. Information from this study will contribute towards PhD 
qualifications. 
It is important for everyone to try to limit the amount of sitting in daily life. Following an 
exacerbation of COPD, sitting time can often increase and this may not help individuals to 
maintain or improve their physical capabilities and quality of life. It is therefore important 
to find effective ways for some people to sit less after being discharged from hospital. 
Why have you been chosen? 
You have been chosen because you are aged between 40 and 85 years, have a clinical 
diagnosis of COPD and have had fewer than 4 exacerbations requiring hospital 
admission. You will be amongst up to 60 patients admitted to Glenfield Hospital taking 
part in this research. 
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Do you have to take part? 
No. This research is entirely voluntary. You will choose whether or not to take part. If you 
agree to take part, then you will be asked to sign a Consent Form, which states that you are 
happy to participate. You can change your mind about taking part at any time without 
giving a reason. Your usual care will not be affected if you decide to withdraw from the 
study. 
If you would like any further information to help you make your decision, please do not 
hesitate to speak to Mark Orme or a member of the REDs team at your convenience. 
 
What does the study involve? 
Participation in the study will last for ~3 weeks, from the time a member of the 
research team meets you following your expression of interest to the end of the 
follow-up visit. 
If you agree to take part, you will be randomly assigned to one of three groups. Two groups 
will take part in a COPD-SEAT intervention and one group will receive usual care. 
You will not be told which group you will be assigned to before agreeing to take part. 
Whether you are in one of the COPD-SEAT interventions or the usual care group will 
be decided at random (a bit like picking names out of a hat). If you agree to take part, you 
will then be given an envelope that will tell you which group you are in. Nobody knows 
which group they will be in until they open their envelope. 
The reason for selecting at random is so that every individual has an equal chance of being 
offered a COPD-SEAT programme. It also means that the groups should have an equal mix 
of different ages, gender, length of COPD diagnosis, and exacerbation history. 
If your envelope shows that you are not in the group that receives a COPD-SEAT 
intervention, we will ask you to complete the baseline measures and questionnaires and 
take part in one interview before your discharge. We would then like you to carry out 
your normal daily activities after discharge and we will see you again 4 weeks later for 
follow-up measures and questionnaire completion. You will have the option to receive 
the educational materials at the 2 week visit. 
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What happens next? 
We ask that you please complete the Expression of Interest form that came with this 
information pack indicating whether you do or do not wish to take part. Sending back 
this form does not mean you agree to take part in the study - it just means we can meet 
you to tell you more about it. 
When we meet you, we will ask you to fill in a Consent Form which states that you are 
happy to take part in the study. We will then ask you to fill in some questionnaires and 
perform the following physical measurements: 
Interview One 
Those Wanting to Take Part 
We would like to speak to you before your discharge to talk about your COPD 
diagnosis, exacerbation history and how physical activity and sedentary behaviours fit into 
your daily life and COPD management. This information will help us to understand 
the role that lifestyle plays in COPD and how best we can facilitate better care. Your 
participation in this interview is entirely voluntary and, with your permission, we would 
like to audio record the conversations so they can be used as part of our research. 
Those NOT Wanting to Take Part 
 
We would like to speak to you before your discharge to talk about your reasons for not 
wanting to take part in the COPD-SEAT programme. We want to learn as much as we can 
about how best to put in place a programme to reduce sedentary behaviour after an 
exacerbation. Understanding why people did not want to take part will provide invaluable 
information and help us to design and implement better ideas in the future. Taking part in 
this interview is entirely voluntary and, with your permission, we would like to audio 
record the conversations so they can be used as part of our research. 
If you agree to take part: 
Please Note: 
You are not required to complete any or all measurements as part of the study if 
you feel unable to do so. You will be asked throughout the completion of 
measurements if you are happy to do them or if you require rest. These measures do 
not have to be completed together and can be spaced apart as much as you like. 
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Questionnaires 
We kindly ask you to complete a questionnaire covering topics such as employment status, 
smoking history, symptoms, anxiety, depression, physical activity levels and sitting time. 
Cognitive Function 
A cognitive function test will be undertaken (paper-pen and verbally) with a member of 
the research team upon consenting to take part in the study. 
Body Composition 
Measurements of height and weight will be used to calculate your body mass index. You 
will be asked to remove your shoes, socks and personal belongings during the 
measurements. Weight will involve standing on a weighing scale device. Waist 
circumference will be measured using a tape measure and is an important indicator of 
abdominal body composition. 
Lung Function 
Spirometry will be conducted at the follow-up appointment only and will involve 
breathing out as hard as you can several times with recovery periods of at least a few 
minutes between each effort. These breathing tests may cause some temporary light 
headedness and coughing. 
Physical Function 
Please Note: 
You are not required to complete any or all measurements in this section if you feel 
unable to do so. You will be asked throughout the completion of measurements if you 
are happy to do them or if you require rest. The measures do not have to be completed 
together and can be spaced apart as much as you like. 
 
We will measure the strength of your upper body by performing a grip strength test which 
will involve you squeezing a measuring device with maximal force on three occasions 
with a rest period in between. 
 
To measure your ability to rise from a chair, we will ask you to perform a five 
repetition sit-to-stand test. This will involve rising from a chair with your arms folded 
across your chest. 
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To look at your balance, we will ask you to complete a tandem stance test which will 
involve you trying to hold your balance with one foot directly in front of the other and 
arms out sideways for 30 seconds. 
 
During the above physical function tests we will ask you to wear a sensor called a 
Physilog on your chest as well as around each foot. These sensors will not interfere with 
the performance of each test and will provide very detailed analysis of your physical 
function levels. 
 
Physical Activity and Sedentary Behaviour 
 
You will be given a device called a LUMO which will measure your posture (i.e. 
sitting, lying down and standing) and an activity monitor, both will be worn on a belt 
around your lower back and waist. These will be worn during some of your hospital 
admission and for the 2 weeks leading up to the follow-up visit. You are asked to take 
the monitors off during water-based activities and overnight. These devices will be 
returned to us during your follow-up visit 2 weeks after you are discharged from 
hospital. We will ask you to charge the LUMO overnight. We will also provide you with 
disinfectant wipes so you can clean the straps as often as you like during the 2 weeks. 
An information sheet about the monitors and verbal instructions will be provided before 
your discharge. 
These devices do not transmit or receive information (e.g. GPS, video). They are each a 
‘black box’ storing information about movement, activity and posture. 
 
  
 
Participant-Researcher Interactions 
In order to assess the quality of delivery and information regarding the study, we will 
ask your permission to audio record interactions/conversations between yourself and 
the researcher (Mark Orme). This information will  be kept strictly confidential and 
destroyed following transcription. It will be used to examine the consistency and 
accuracy of the delivered information. You will be asked if it is okay to record at the 
beginning of each interaction with the researcher and saying no will not impact on your 
participation in the study or your usual care. 
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What happens in the COPD-SEAT intervention groups? 
Education Group 
Before you are discharged we will spend time with you, providing one-to-one education 
and information on what sedentary behaviour is and why it is important to reduce it after 
being in hospital. Ideas about how to best achieve these reductions will be discussed. You 
will be provided with our ‘top tips’ booklet and, together we will discuss ways to reduce 
your time spent sedentary which might work best for you. We will be contacting you 
during your first week to see how you are getting on, to answer any questions you might 
have, and to provide support and advice as needed. 
Please Note: 
 
Both the Usual Care and Education groups will receive feedback on their sedentary 
behaviour and walking at the end of the follow-up visit. This will include 
information about time spent sitting and number of steps taken. 
 
Education plus Feedback Group 
Individuals in this group will receive the exact same intervention as 
described in the Education Group section above but will also receive 
feedback and prompts (gentle vibrations) by the waist worn LUMO 
device which will act as a reminder for you to try to break up your sitting 
time if you wish to do so. After talking to you about reducing 
your sitting time, together, we will decide how often you would like to be 
reminded to try to break up your sitting time. A full tutorial on the device 
will be provided as well as written information for you to take home. 
Interview Two 
We would like to speak to you about what you thought of the COPD-SEAT programme. 
This will be a short interview with one of the researchers. It will take place during your 
follow-up visit at the end of the study. These interviews are entirely voluntary, and if 
you are happy with it, we would like to audio record our conversations so they can be 
used as part of the research evaluation. These interviews will shed light on what aspects 
of the programme worked well, which parts require improvement to ultimately lead to 
improved intervention designs in the future. 
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What happens at the end of the study? 
We will arrange for participants in all COPD-SEAT groups to meet us 2 weeks after discharge 
to complete physical measures and fill in some questionnaires. Those individuals in one of 
the two intervention groups will also have an interview. 
If you did not receive an intervention as part of COPD-SEAT, you will be provided with the 
educational materials for reducing sitting time at the end of your 2 week visit. You will also 
receive feedback on their sedentary behaviour and walking at the end of the follow-up visit. 
Those of you in the Feedback Group will also be offered the chance to continue wearing the 
LUMO and receive feedback for an additional 2 weeks. This is entirely optional and your 
decision will not affect your usual care. 
What are the possible risks of taking part? 
When individuals with COPD reduce their sitting time, the increased time that could be spent 
being more physically active may cause breathlessness and other symptoms. Planning ahead 
with your daily activities can help. Please do not hesitate to talk to the research team of 
members of REDS if you want to find out more. 
Please note. This intervention will not prescribe or advise on any aspect of medication, 
provide information or guidance on smoking cessation, or refer individuals to pulmonary 
rehabilitation. These will be covered by the REDS team and clinicians as routine practice 
and will not affect your potential involvement in this study. 
 
What are the possible benefits of taking part? 
We cannot promise the study will have direct benefits for you, but we hope you will engage 
with the study and the information we get will help us to improve COPD care in the future. 
If you consent for us to do so, we will inform the Respiratory Discharge Service of your 
involvement in the study and the results of the measures will be entered into your medical 
records. 
What if something goes wrong? 
It is unlikely that anything will go wrong during this study. But if you have a complaint 
about anything as you go through the study, then please tell Mark or a member of the REDS 
team immediately. If you have reason to complain about this study, complaints should be 
addressed in the first instance to Prof Sally Singh whose details are at the end of this document. 
 
If you remain unhappy and wish to complain formally, you can do this by contacting Patient 
Information and Liaison Service, contact 0808 178 8337 (free number). 
 
 
 
 261 
 
Expenses 
Travel expenses will be offered for when you travel to and from the follow-up visit to 
Glenfield Hospital. Expenses will cover parking and petrol or travel by bus or train. Travel 
by taxi will be reimbursed in full. 
Will taking part in this study be kept confidential? 
We will follow ethical and legal practice and all information about you will be handled 
in confidence. 
If you join the study, some parts of your medical records (e.g. exacerbation and 
medication history) and the data collected for the study will be looked at by authorised 
persons from Loughborough University who are organising the research. They may also be 
looked at by regulatory authorities to check that the research is being conducted correctly. 
All will have a duty of confidentiality to you as research participants and we will do our best to 
meet this duty. 
Personal data (e.g. address, telephone number) will be kept for 3-6 months after the end of the 
study so that we are able to contact you about the findings of the study and possible follow-
up studies (unless you advise us that you do not wish to be contacted). All other data 
(research data) will be kept securely for 7 years. After this time your data will be disposed of 
securely. During this time all precautions will be taken by all those involved to maintain 
confidentiality. Only members of the research team will have access to personal data. 
Whilst everything about you is kept confidential, confidentiality will have to be broken if 
something is mentioned that we believe puts you or someone else in danger. If we 
believe this to incur immediate danger, we will have to contact the police without any delay. 
Any non-immediate cause for concern will be discussed in confidence with the research team. 
What will happen if I don’t want to carry on with the study? 
Your participation is voluntary and you are free to withdraw at any time, without giving a 
reason, and without your legal rights and usual care being affected. The treatment you 
receive from the REDS team and clinicians will not be affected. You should know, however, 
that if you withdraw then the information collected so far cannot be erased and this 
information may still be used in the research analysis. If you are happy to do so, we will ask 
you for a short interview over the phone at your convenience so we can learn more about 
some of the reasons people might not wish to continue their participation in the study. 
What will happen to the results of the research study? 
Results from this study will be used to help us understand whether the COPD-SEAT 
programme is acceptable for individuals with COPD following admission to hospital for an 
exacerbation.  The findings will be written up and presented as research publications and 
presentations (2016/2017) and as part of PhD theses. In the future, the COPD-SEAT 
programme might be used in a much larger study. The researchers will make sure all 
participant data is made anonymous and any identifying features will be removed before 
publication. 
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Who is organising and funding the research? 
The research is organised and funded by Loughborough University and University Hospitals 
of Leicester. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and approved by 
Research Ethics Committee East Midland-Leicester(15-EM-0433). Study design and content 
has been reviewed by individuals diagnosed with COPD and members of the REDS team. 
Contact for Further Information 
If you would like to know more about the research, then please talk to me in the 
clinic or inform a member of the REDS team who will inform me of your 
request. My name is Mark Orme and you can contact me by phone via the 
Rehabilitation Office on 0116 2502535 or 0116 2583181. You will see me 
around the Ward as well so please do not hesitate to ask me anything about the 
study. 
 
Thank you for taking the time to read this. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 263 
 
Appendix S 
COPD-SEAT education booklet 
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Appendix T 
COPD-SEAT LUMO mobile app instructions 
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LUMO App 
Instruction Manual 
Please read this document carefully for instructions on how to navigate the LUMO 
app during the 2 weeks of wearing the monitors. 
 
 
If you have any questions or concerns regarding any aspect of the study, please do not 
hesitate to contact Mark Orme on 07772810402 or email at m.w.orme@lboro.ac.uk. 
 
 
 
 
 270 
 
 
 
 
1. How do I open the app on the phone? 
• Touch the button on the top right corner of the device or the round 
button at the bottom 
• The app will then appear, taking up the full screen 
• You will then be able to navigate the app to look at the different 
feedback options 
 
2. How do I interpret the avatar? 
• The  avatar  represents   your   current   posture (sitting, standing or 
walking) 
• The avatar does not provide any other function than showing you 
your posture 
• The colour of the avatar (orange or green) denotes the quality of 
your posture compared to the ideal. We are not asking you to act 
on this information. 
 
3. How do I find out about my sitting time? 
• On the panel across the bottom of the screen, there is a slide titled 
“Sit Time”. This provides you with a count- up of how much time 
you have been sitting. For example, in the picture on the right, this 
would mean you have sat for over 5 hours 
• By pressing the slide you will be provided with more 
detailed information. It will look something like this. 
• The red box provides the same information as above 
• The pie chart shows the proportion time spent in 
different postures (standing, stepping, and sitting 
(including driving)) and the percentages are given 
next to the 
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posture names. The higher the percentage, the more time you have spent in that 
posture. 
• When you have been wearing the LUMO for at least a few days, you can also start 
to see how you are getting on a day-to-day basis 
• In the top right of the screen, press the    “week” icon 
to see the percentages of the postures across multiple 
days in the form of a bar chart 
• The more time spent in a posture each day, 
the greater amount of colour for that posture. 
For example, the   picture   on   the   right   
shows Thursday to be the day the wearer sat 
the most and Wednesday was the day they sat 
the least and stood the most. 
Standing 
 
Sitting 
 
 
Stepping 
 
• The pie chart presented here is the overall average time spent in each posture, 
provided as a percentage. 
• You can move between days by touching the left and right arrows 
• To  go back  to  today’s  information, touch the “Today”    icon 
• To  close  the  screen  and  return  to  the  panel  view, touch the 
cross in the top right corner 
 
4. How do I find out about my standing time? 
• On the panel across the bottom of the screen, there is a 
slide titled “Steps”. This provides you with how many 
steps you have taken for that day. For example, in the 
picture on the right, this would mean you have taken 1712 
steps for that day 
• The slide also converts the number of steps into an estimation of calories burned 
and distance walked (in kilometres) 
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• By pressing the slide you will be provided with more detailed information. It 
will look something like this 
• You can choose whether to see information on a day-to-day 
basis by touching the “Day” icon at the top of the screen 
• On the day view, the bar chart shows the number of steps 
taken each hour. The higher the bar, the more steps you 
have taken. The left side of the graph shows the 
number of steps taken each hour. 
• When you have been wearing the LUMO for at least a 
few days, you can also start to see how you are getting 
on, on a day-to-day basis 
• You can move between days by touching the left and right arrows 
• In the top right of the screen, press the “week” icon to see the 
number of steps taken on multiple days in the form of a bar chart 
• The more steps taken each day, the taller the bar. 
• The purple bar presented here is the overall number of steps 
you have taken in the selected week. 
• To go back to today’s information, touch the “Today” icon 
• To close the screen and return to the panel view, touch the cross in the top right 
corner 
 
5. How do I find out about the number of stand-ups I have done? 
• On the panel across the bottom of the screen, there is a slide 
titled “Stand Ups”. This provides you with how many times 
you have stood up from a seated position. For example, in the 
picture on the right, this would mean you have stood up 97 times 
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• By pressing the slide you will be provided with more 
detailed information. It will look something like this 
• You can choose whether to see information on a day-to-
day basis by touching the “Day” icon at the top of the 
screen 
• On the day view, the bar chart shows the number of 
times you have stood up each hour. 
The higher the bar, the more times you have 
stood. The left side of the graph shows the number of 
stand-ups each hour. 
• You can move between days by touching the left and 
right arrows 
• When you have been wearing the LUMO for at least a few days, you can also 
start to see how you are getting on, on a day-to-day basis 
• In the top right of the screen, press the “week” icon to see the number of 
stand-ups on multiple days in the form of a bar chart 
• The more times you have stood up each day, the taller the bar. The green bar 
presented here is the overall number of times you have stood up in the selected 
week. 
• To go back to today’s information, touch the “Today” icon 
• To close the screen and return to the panel view, touch the cross in the top right 
corner 
 
Thank you for taking part in the study and please do not hesitate to contact me if 
you have any questions or concerns 
 
Contact Details 
Mark Orme 
24-hour Contact Number: 07772810402  
m.w.orme@lboro.ac.uk 
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Appendix U 
COPD-SEAT questionnaire 
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COPD-SEAT 
Baseline 
Questionnaire 
 
 
Participant ID: 
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This questionnaire is made up of modules that ask you about a specific 
aspect of your life. Your answers will be treated as strictly 
confidential and will only be used for research purposes. 
Please complete the questionnaire by checking answers or enter a 
response in the boxes provided next to or below the question. Try to 
answer every question, except when there is a specific request to skip a 
section. 
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D1 - To which of the groups do you consider you belong? 
□ White – British 
□ White – Irish 
□ Any other white background 
□ Mixed – White and Black Caribbean 
□ Mixed – White and Black African 
□ Mixed – White and Asian 
□ Asian or Asian British – Indian 
□ Asian or Asian British – Pakistani 
□ Asian or Asian British – Bangladeshi 
□ Any other Asian/Asian British Background 
□ Black or Black British – Caribbean 
□ Black or Black British – African 
□ Any other Black/Black British background 
□ Chinese 
□ Any other (please specify) 
 
D2 - Do you own or rent the accommodation that you live in? 
□ Own outright 
□ Own with a mortgage 
□ Rent – from local authority, local council, housing association 
□ Rent – from private landlord or letting agency 
□ Pay part rent and part mortgage 
□ Live in accommodation rent free 
□ None of the above 
 
 
 
 
 
 
 
 
Section A – Demographics 
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D3 - Including yourself, how many people are living together in your household? 
(Include those who usually live in the house such as students living away from home during 
term, partners in the armed forces or professions such as pilots) 
 
 
□ Do not know 
 
D4 - At what age did you finish your continuous full-time education at school or 
college? 
□ Never went to school 
□ 14 or under 
□ 15 
□ 16 
□ 17 
□ 18 
□ 19 or over 
 
D5 - What is the highest education you have completed? 
□ Primary school 
□ Some secondary school 
□ Completed secondary school 
□ Some additional training (e.g. apprenticeship, GNVQ) 
□ Undergraduate university 
□ Postgraduate university 
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D6 - Which of the following best describes your current situation? (Please tick only 
one) 
□ In paid employment or self-employed 
□ Retired 
□ Looking after home and/or family 
□ Unable to work because of sickness or disability 
□ Unemployed 
□ Doing unpaid or voluntary work 
□ Full-time or part-time student 
□ None of the above 
 
D7 - What is the average total income before tax received by your household? 
□ Less than £18,000 
□ £18,000 - £30,999 
□ £31,000 – £51,999 
□ £52,000 - £100,000 
□ Greater than £100,000 
□ Do not know 
□ Prefer not to answer 
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Under each heading, please tick the ONE box that best describes your health TODAY 
MOBILITY 
I have no problems in walking about ..………………   
I have slight problems in walking about …………….   
I have moderate problems in walking about ……….   
I have severe problems in walking about …………..   
I am unable to walk about ……………………………  
SELF-CARE 
I have no problems washing or dressing myself …………..   
I have slight problems washing or dressing myself ………..   
I have moderate problems washing or dressing myself ……  
I have severe problems washing or dressing myself ………   
I am unable to wash or dress myself ………………………  
PAIN / DISCOMFORT 
I have no pain or discomfort ………………..   
I have slight pain or discomfort …………….   
I have moderate pain or discomfort ……….    
I have severe pain or discomfort …………..    
I have extreme pain or discomfort …………  
ANXIETY / DEPRESSION 
I am not anxious or depressed ……………..   
I am slightly anxious or depressed ………..    
I am moderately anxious or depressed ……   
I am severely anxious or depressed ……….   
I am extremely anxious or depressed ……..  
Section B – General Health 
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• We would like to know how good or bad your health is 
TODAY. 
 
• This scale is numbered from 0 to 100 
 
• 100 means the best health you can imagine 
• 0 means the worst health you can imagine 
• Mark an X on the scale to indicate how your health is 
TODAY.  
 
• Now, please write the number you marked on the scale in 
the box below. 
 
YOUR HEALTH TODAY =  
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S1 - Have you ever smoked cigarettes? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO S11 
S2 - Do you currently smoke cigarettes? 
□ Yes 
□ No 
IF “YES” PLEASE GO TO S5 
S3 - How long ago did you stop smoking cigarettes? 
 
 
S4 - How old were you when you last smoked cigarettes on most days? 
 
□ Do not know 
 
S5 - How old were you when you started to smoke cigarettes regularly? 
 
 
S6 - About how many cigarettes a day do/did you usually smoke on weekdays? 
 
 
 
S7 - About how many cigarettes a day do/did you usually smoke on weekend days? 
 
 
 
 
 
 
 
 
Section C – Smoking 
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S8 - How soon after waking do/did you usually smoke your first cigarette of the day? 
□ Less than 5 minutes 
□ 5 – 14 minutes 
□ 15 – 29 minutes 
□ 30 minutes – 1 hour 
□ 1 – 2 hours 
□ 2 hours or more 
 
S9 - Has a medical person, for example a doctor or nurse ever advised you to stop 
smoking altogether because of your health? 
□ Yes 
□ No 
 
S10 - How long ago was that? 
□ Within the last 12 months 
□ Over 12 months ago 
 
S11 - Does anyone in your household smoke? 
□ Yes, one household member smokes 
□ Yes, more than one household member smokes 
□ No 
 
S12 - Now, in most weeks, how many hours a week are you exposed to other people’s 
tobacco smoke? 
 
 
S13 - Did your father ever smoke regularly when you were a child? 
□ Yes 
□ No 
S14 - Did your mother ever smoke regularly when you were a child? 
□ Yes 
□ No 
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LH1 - How old were you when you were first told by a doctor that you had COPD/chronic 
bronchitis/emphysema? 
 
LH2 - How many times have you been admitted to hospital for any reason in the last 12 
months? 
 
LH3 - How many times have you been admitted to hospital for an exacerbation in the 
last 12 months? 
 
LH4 – Before being admitted to hospital, were you ever too breathless to leave the house? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO LH6 
 
LH5 - Was that all or most days, at least once a week, or less often than that? 
□ All or most days 
□ At least once a week 
□ Less often 
 
LH6 – Before being admitted to hospital, please choose the one best response which 
would describe your shortness of breath. 
0 “I only get breathless with strenuous exercise” 
 
1 “I get short of breath when hurrying on the level or walking up a slight hill” 
 
2 “I walk slower than people of the same age on the level because of 
breathlessness or have to stop for breath when walking at my own pace on the 
level” 
 
3 “I stop for breath after walking about 100 yards or after a few minutes on the 
level” 
 
4 “I am too breathless to leave the house” or “I am breathless when dressing” 
Grade 
 
Section D – Lung Health 
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Section E – COPD Health – Part 1 
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Below is a list of statements that other people with your illness have said are important. Please 
circle or mark one number per line to indicate your response as it applies to the past 7 days. 
 
PHYSICAL WELL-BEING 
 
Not 
  
 
A little 
 
 
Some- 
 
 
Quite 
  
 
Very 
 GP1 I have a lack of energy 
 
0 1 2 3 4 
GP2 I have nausea 
 
0 1 2 3 4 
GP3 Because of my physical condition, I have trouble      
meeting the needs of my family 
 
0 1 2 3 4 
GP4 I have pain 
 
0 1 2 3 4 
GP5 I am bothered by side effects of treatment 
 
0 1 2 3 4 
GP6 I feel ill 
 
0 1 2 3 4 
GP7 I am forced to spend time in bed 
........................................ 
0 1 2 3 4 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
 
A little 
bit 
 
Some- 
what 
 
Quite 
a bit 
 
Very 
much 
 
GS1 I feel close to my 
friends  
 
0 
 
1 
 
2 
 
3 
 
4 
GS2 I get emotional support from my family 
 
0 1 2 3 4 
GS3 I get support from my friends.......................................... 0 1 2 3 4 
GS4 My family has accepted my illness 
 
0 1 2 3 4 
GS5 I am satisfied with family communication about my 
illness................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
GS6 I feel close to my partner (or the person who is my main      
support) 
 
0 1 2 3 4 
Q1 Regardless of your current level of sexual activity, please 
answer the following question. If you prefer not to answer 
 
     
please mark this box and go to the next section.      
 
 
GS7 I am satisfied with my sex life 
 
0 1 2 3 4 
 
 
Section E – COPD Health – Part 2 
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 EMOTIONAL WELL-BEING  Not 
at all 
A little 
bit 
Some- 
what 
Quite 
a bit 
Very 
much 
 
 
 
GE1 
 
I feel sad .............................................................................. 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GE2 I am satisfied with how I am coping with my illness.......... 0 1 2 3 4 
 
GE3 I am losing hope in the fight against my illness.................. 0 1 2 3 4 
 
GE4 I feel nervous....................................................................... 0 1 2 3 4 
 
GE5 I worry about dying ............................................................. 0 1 2 3 4 
 
GE6 I worry that my condition will get worse ............................ 0 1 2 3 4 
 
 FUNCTIONAL WELL-BEING  Not 
at all 
A little 
bit 
Some- 
what 
Quite 
a bit 
Very 
much 
 
 
 
GF1 
 
I am able to work (include work at home) .......................... 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GF2 My work (include work at home) is fulfilling..................... 0 1 2 3 4 
 
GF3 I am able to enjoy life.......................................................... 0 1 2 3 4 
 
GF4 I have accepted my illness................................................... 0 1 2 3 4 
 
GF5 I am sleeping well ............................................................... 0 1 2 3 4 
 
GF6 I am enjoying the things I usually do for fun ...................... 0 1 2 3 4 
 
GF7 I am content with the quality of my life right now.............. 0 1 2 3 4 
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 ADDITIONAL CONCERNS  Not  
at all 
A little 
bit 
Some- 
what 
Quite 
a bit 
Very 
much 
 
 
 
HI7 
 
I feel fatigued ...................................................................... 
 
0 
 
1 
 
2 
 
3 
 
4 
 
HI12 I feel weak all over .............................................................. 0 1 2 3 4 
 
An1 I feel listless (“washed out”) ............................................... 0 1 2 3 4 
 
An2 I feel tired ............................................................................ 0 1 2 3 4 
 
An3 I have trouble starting things because I am tired................ 0 1 2 3 4 
 
An4 I have trouble finishing things because I am tired ............. 0 1 2 3 4 
 
An5 I have energy ....................................................................... 0 1 2 3 4 
 
An7 I am able to do my usual activities...................................... 0 1 2 3 4 
 
An8 I need to sleep during the day ............................................. 0 1 2 3 4 
 
An12 I am too tired to eat ............................................................. 0 1 2 3 4 
 
An14 I need help doing my usual activities .................................. 0 1 2 3 4 
 
An15 I am frustrated by being too tired to do the things I want 
to do..................................................................................... 
 
0 
 
1 
 
2 
 
3 
 
4 
 
An16 I have to limit my social activity because I am tired........... 0 1 2 3 4 
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PA1 - In the last 4 weeks, which form of transport have you used most often to get about? 
(Not including any journeys to and from work; please only select the most frequent mode 
of transport used) 
□ Car/motor vehicle 
□ Walk 
□ Public transport 
□ Cycle 
□ None of the above 
 
PA2 - How many times in the last 4 weeks did you do swimming? 
□ None 
□ Once in the last 4 weeks 
□ 2 – 3 times in the last 4 weeks 
□ Once a week 
□ 2 – 3 times a week 
□ 4 – 5 times a week 
□ Every day 
□ Do not know 
 
PA3 - How many times in the last 4 weeks did you do cycling? 
□ None 
□ Once in the last 4 weeks 
□ 2 – 3 times in the last 4 weeks 
□ Once a week 
□ 2 – 3 times a week 
□ 4 – 5 times a week 
□ Every day 
□ Do not know 
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PA4 - Which of the following do you attend once a week or more often? (you can select 
more than one) 
□ Sports club or gym 
□ Pub or social club 
□ Religious group 
□ Adult education class 
□ Other group activity 
□ None of the above 
 
PA5 - Which of the following best describes your usual walking pace? 
□ A slow pace 
□ An average pace 
□ A fairly brisk pace 
□ A fast pace 
 
PA6 - We are interested in finding out about the kinds of physical activities that people do 
as part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person. Please think about the activities you do at work, 
as part of your house and gardening, to get from place to place, and in your spare time for 
recreation, exercise or sport. 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much 
harder than normal. Think only about those physical activities that you did for at least 10 
minutes at a time. 
7. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling? 
 
  days per week 
 
No vigorous physical activities Skip to question 3 
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8. How much time did you usually spend doing vigorous physical activities on 
one of those days? 
 
  hours per day 
  minutes per day 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal. Think only about those physical activities that you did 
for at least 10 minutes at a time. 
9. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles tennis? Do not 
include walking. 
 
  days per week 
 
No moderate physical activities Skip to question 5 
10. How much time did you usually spend doing moderate physical activities on 
one of those days? 
 
  hours per day 
  minutes per day 
Think about the time you spent walking in the last 7 days. This includes at work and 
at home, walking to travel from place to place, and any other walking that you might 
do solely for recreation, sport, exercise, or leisure. 
11. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time? 
 
  days per week 
 
No walking Go to next section 
12. How much time did you usually spend walking on one of those days? 
 
  hours per day 
  minutes per day 
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PA7 - Please think about how much time you spend sitting on a typical week day and 
weekend day. 
When filling in the table below, if you take part in more than one of the activities at the 
same time, e.g. watching television whilst using a laptop computer, please record time 
spent taking part in the activity you mainly focus on e.g. it may be you watch television 
and only use the laptop when you get an email. In this case you would record time spent 
watching television. 
 
Please estimate how many hours you spend SITTING EACH DAY in the 
following situations: (please write your answer) 
On a WEEK Day On a WEEKEND Day 
 Hours Minutes Hours Minutes 
While travelling to and from places    
While at work    
While watching television    
While using a computer at home    
In your leisure time, NOT 
including television (e.g. visiting 
friends, movies, dining out, etc) 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 293 
 
 
 
Please circle one response from the four given for each question. Answer how it currently 
describes your feelings. 
Your answer should be your immediate response.  
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Now we would like to ask some questions about how concerned you are about the 
possibility of falling. 
For each of the following activities, please circle the opinion closest to your own to 
show how concerned you are that you might fall if you did this activity. 
 
Please reply thinking about how you usually do the activity. If you currently don’t do 
the activity (e.g. if someone does your shopping for you), please answer to show 
whether you think you would be concerned about falling IF you did the activity. 
 
 
Section H – Falling 
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T1 - Do you own a smartphone (a phone which has similar capability to a computer 
e.g. internet access)? 
□ Yes 
□ No 
IF “NO” PLEASE GO TO T4 
T2 – What type of smartphone do you own? (Please tick all that apply) 
□ Apple/iPhone 
□ Android 
□ Blackberry 
□ Any other (please specify) 
T3 – What do you use your smartphone for? (Please tick all that apply) 
□ To go on the internet 
□ Entertainment (e.g. games, videos) 
□ Business/work 
□ Emails 
□ Communication (calls, texts) 
□ Social networking (e.g. Facebook, Twitter) 
□ Reading books/articles 
□ Online banking 
□ Shopping/book holidays 
□ Downloading and using applications (e.g. weather, news) 
□ Any other (please specify) 
 
T4 – Do you own a personal computer (e.g. desktop, laptop, tablet)? 
□ Yes 
□ No 
 
IF “NO” YOU HAVE COMPLETED THE QUESTIONNAIRE 
 
Section I – Technology 
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T5 – What type of computer do you own? 
□ Laptop 
□ Desktop computer 
□ Tablet 
□ Any other (please specify) 
T6 - What do you use your computer for? (Please tick all that apply) 
□ To go on the internet 
□ Entertainment (e.g. games, videos) 
□ Business/work 
□ Emails 
□ Communication (calls, texts) 
□ Social networking (e.g. Facebook, Twitter) 
□ Reading books/articles 
□ Online banking 
□ Shopping/book holidays 
□ Downloading and using applications (e.g. weather, news) 
□ Any other (please specify) 
 
 
Thank you for completing the questionnaire 
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